test_order_name_SHORTNAME_sdist,test_order_name_LONG_COMMON_NAME_sdist,test_order_name_COMPONENT_sdist,test_result_name_SHORTNAME_sdist,test_result_name_LONG_COMMON_NAME_sdist,test_result_name_COMPONENT_sdist,test_order_name_SHORTNAME_tfidf,test_order_name_LONG_COMMON_NAME_tfidf,test_order_name_COMPONENT_tfidf,test_result_name_SHORTNAME_tfidf,test_result_name_LONG_COMMON_NAME_tfidf,test_result_name_COMPONENT_tfidf,label,assignment,test_order_name,test_result_name,LONG_COMMON_NAME,SHORTNAME,COMPONENT
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,LIVER FIBROSIS PANEL,ALT,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,NASH FIBROSURE,ALT SGPT P5P,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,VITAMIN D 25 OH,25 OH VITAMIN D,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,CMP14 6AC,PHOSPHORUS,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.022400253540001414,0.0,0.0,0.0,0.0,0,237610,COMPLETE BLOOD COUNT,WBC,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,COMPREHENSIVE METABOLIC PANEL E GFR,ALT,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.0,0.011764705882352941,0.025,0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,771477,COMP METAB PANEL,EGFR NON AFR AMERICAN,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,FIBROACT COMPLETE,NECROINFL SCORE,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,PROTHROMBIN TIME,PT POP MEAN,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,HEPATITIS PANEL ACUTE,HEPATITIS C AB CIA,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,ANA AUTOIMMUNE PROFILE,RHEUMATOID FACTOR QUANT,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.08287539106540942,0.0,0.0,0,285403,CBC NO DIFF,RBC,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,T LYMPHOCYTE HELPER SUPPRESSOR,LYMPHS,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,BUN CREAT RATIO,EGFR AFRICAN AMERICAN,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,PSA FREE TOTAL,PSA FREE,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.07142857142857142,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CBC W O DIFF WITH PLATELETS,MCH,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,CBC WITH DIFFERENTIAL PLATELETS,MCH,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,CMP14 CBC D PLT ESR WES ANA,POTASSIUM,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,CHEM SCREEN PANEL HDL,TRIGLYCERIDES,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.26333333333333336,0.155,0.0,0.26333333333333336,0.155,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,CHEM 20,CHOLESTEROL,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,URINALYSIS CULTURE IF INDICATED,PH,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.125,0.0,0.124,0.125,0.3333333333333333,0.0,0.07583869961926504,0.0,0.0,0.0,0.0,0,28688,PROTEIN ELECTROPHORESIS,BETA GLOBULINS,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.5,0.5,0.9,0.0,0.0,0.0,0.08506391669557933,0.14687247901289302,0.5773502691896257,1,81240,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,COMPLETE BLOOD COUNT,BASOPHILS %,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,SPECIAL PROFILE # 5144,TSH ULTRASENSITIVE,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE AG,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,PE INTERP RFX IFE S,BETA GLOBULIN,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.165,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,HB S AG W RFX CONF,HEPATITIS B SURFACE ANTIGEN,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,IRON TOTAL BINDING CAPACITY,IRON TOTAL,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Body weight Measured,Weight Measured,Body weight
0.0,0.0,0.0,0.2375,0.25,0.3333333333333333,0.0,0.0,0.0,0.0,0.08253790759907542,0.0946521642027649,1,264507,CBC W AUTO DIFF,% EOSINOPHILS,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.5,0.3333333333333333,0.5,0.0,0.0,0.0,0.08190888212768821,0.08109682212111924,0.40824829046386313,1,31419,FIBROACT COMPLETE,WEIGHT LBS,Body weight Measured,Weight Measured,Body weight
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,C REACTIVE PROTEIN INFLAMMATORY,C REACTIVE PROTEIN,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,ASH FIBROSURE,WEIGHT,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.5,0.41428571428571426,1.0,0.5,0.2857142857142857,1.0,0.08384227635677743,0.226779813772099,0.16381776425537642,0.10268539797375953,0.18516494256834526,0.10031748330730439,1,30247,FREE T4 THYROXINE,FREE T4,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,CBC INCLUDES DIFF PLT,RDW,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,CBC WITH AUTO DIFF,BASOPHILS #,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,DRUG ABUSE SCREEN W ETOH NO GCMS,BENZODIAZEPINES,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.05555555555555555,0.1,0.0,0.027777777777777776,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,MITOCHONDRIAL AB SCREEN,MITOCHONDRIAL AB SCREEN,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.072,0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,BASIC METABOLIC PANEL W EGFR,BUN CREATININE RATIO,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,HCV FIBROSURE,LIMITATIONS,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.03666666666666667,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,HCV GENOTYPE REFLEX NSA,HEPATITIS C GENOTYPE,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CBC W AUTO DIFF,% EOSINOPHILS,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.19000000000000003,0.14285714285714285,0.25,0.0,0.0,0.0,0.0,0.031610966010303554,0.0969878128389482,1,716951,CBC WITH DIFFERENTIAL,IMMATURE GRANS,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,CBC WITH DIFFERENTIAL,IMMATURE GRANS,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,CMP14 LP 5AC,VLDL CHOLESTEROL CAL,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,LIPID PANEL STANDARD,LDL CHOL CALCULATED,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.31,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.0840117798597445,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,823799,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp,Daclatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,CYSTIC FIBROSIS SCREEN,ETHNICITY,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,CBC W DIFF PLT,ABSOLUTE NEUTROPHILS,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,CBC PLATELET HEM REVIEW,EOS,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,CMP14 HP4 1AC PT AFP,PROTHROMBIN TIME,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.25,0.18181818181818182,1.0,0.0,0.0,0.0,0.04161640471378436,0.06113190236116095,0.7071067811865476,0,611517,COMP METABOLIC PANEL 13,ALBUMIN SERUM,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,URINALYSIS W MICRO W REFLEX CULTURE,WBC,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,VIT B 12 FOLATE PANEL,FOLIC ACID,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,HEP C VIRUS ANTIBODY,HEP C VIRUS ANTIBODY,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,T3 FREE,T3 FREE,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.022727272727272728,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,CBC WITH PLT DIFF,RBC MORPHOLOGY,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,COMP METABOLIC PANEL,,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,BASIC METABOLIC PANEL,OSMOLALITY,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,CHOL HDL RATIO,CHOL HDL RATIO,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,MICROALBUMIN RANDOM SPEC,MICROALBUMIN,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,HEPATIC FUNCT PANEL W O TP,BILIRUBIN DIRECT,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,COMP METABOLIC PANEL,CARBON DIOXIDE,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,DRUG ABUSE SCREEN II,OPIATES,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,CBC WITH AUTO DIFF,RDW,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.29333333333333333,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.917303309798122,0.1569574215481997,1,19752,PROFILE 104 LIVER,BILIRUBIN TOTAL,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,NASH FIBROSURE,HEIGHT,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,URINALYSIS W REFLEX MICRO,PROTEIN,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,PROTHROMBIN PTT,APTT,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.29400000000000004,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,CMP14 LP CBC D PLT TSH HB A,ALT SGPT,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06605502583691747,0.05720402135206337,0.7071067811865476,1,7047,CBC W DIFF PLT,BASOPHILS ABSOLUTE,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.047142857142857146,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CMP14,EGFR IF AFRICN AM,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,ESR WES CRP,C REACTIVE PROTEIN QUANT,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.2,0.16666666666666666,0.3333333333333333,0.346,0.16666666666666666,0.3333333333333333,0.06846967404361237,0.3219325786555107,1.0,0.04841537082187086,0.45528141890436646,0.7071067811865476,1,15586,GLUCOSE,GLUCOSE FASTING,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,NASH FIBROSURE,AST SGOT P5P,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,SPECIAL CUM 50 PLUS PROFILE # 10190,SEDIMENTATION RATE,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,CBC WITH DIFFERENTIAL,HEMATOCRIT,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.1875,0.0,0.0,0.0,0.0,0.0,0.0,0.07075841156459017,0.0,0.0,0.0,0.0,0,223271,PROTEIN ELECTROPHORESIS SERUM,ALPHA 1,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.037676737156380646,0.038305767913941025,0,98301,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,CBC WITH AUTO DIFF,BASOPHILS #,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,CBCI COMPLETE BLOOD COUNT W DIFF,BASOPHILS,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.25,0.14285714285714285,0.2,0.25,0.14285714285714285,0.2,0.046602184119143075,0.03301366825316199,0.037319258880631256,0.046602184119143075,0.03301366825316199,0.037319258880631256,0,128413,FREE T3,FREE T3,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,PROFILE 1236 LIPID PANEL WITH DIRECT LDL,CHOL HDL,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CMP12 LP TP TSH 6AC CBC D PLT,URIC ACID,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,URINALYSIS W REFLEX MICRO,PROTEIN,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,CMP14 HP4 1AC PT AFP,EGFR IF NONAFRICN AM,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,LIPID PANEL AMA,CHOL HDLC RATIO,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,MA CBC DIFF PLT,MONOCYTES %,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,HEMOGLOBIN A1C WITH MPG,HEMOGLOBIN A1C,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,URINALYSIS W REFLEX MICRO,KETONES,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.1425,0.09499999999999999,0.1425,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,DRUG ABUSE SCREEN II,METHAQUALONE,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,CBC WITH AUTO DIFF,LYMPHOCYTES #,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.010714285714285714,0.0375,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,CMP14 LP 3AC,ALKALINE PHOSPHATASE S,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0625,0.0,0.0,0.0,0.0,0.0,0.022679367039845966,0.0,0.0,0.0,0.0,0,339143,IFE PE SERUM,GAMMA GLOBULIN,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,URINALYSIS COMPLETE,GLUCOSE,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,CBC WITH PLT DIFF,NRBC,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,CBC INCLUDES DIFF PLT,EOSINOPHILS,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,CBC WITH DIFFERENTIAL,MCHC,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,DRUG ABUSE SCREEN I NO GCMS,AMPHETAMINES,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,CHOLESTEROL TOTAL,ICTERUS,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,HEPATITIS B CORE AB TOTAL REFL,HEPATITIS B CORE AB TOTAL REFL,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,CBC WITH AUTO DIFF,BASOPHILS #,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.24,0.39999999999999997,0.0,0.24,0.39999999999999997,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.372,0.39285714285714285,0.9166666666666666,0.172,0.3671428571428571,0.6666666666666666,0.009586772624209705,0.5117389382516007,0.9870524497488843,0.0,0.037677447047597123,0.07267302452237867,1,52217,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,HEPATITIS BS AB QUANT,HEPATITIS BS AB INTERP,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,GENERAL HEALTH PANEL,HEMATOCRIT,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,CBC PLT DIFF,POLYS,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,DRUG ABUSE SCREEN I NO GCMS,AMPHETAMINES,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,HEPATIC FUNCTION PANEL,ALT,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.04777777777777778,0.086,0.0,0.04777777777777778,0.086,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESIST ASSAY INTERP,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,TESTOSTERONE TOTAL LC MS MS,TESTOSTERONE TOTAL LC MS MS,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.1925,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,URINALYSIS CULTURE IF INDICATED,BACTERIA,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,LIPID PANEL W REFL DLDL,NON HDL CHOLESTEROL,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,LIPOPROTEIN ANALYSIS NMR,LDL P,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.05555555555555555,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,CD4 CD8 RATIO PROFILE,HEMATOLOGY COMMENTS,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,CBC WITH MANUAL DIFFERENTIAL,MCH,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,CBC,NEUTROPHIL,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.008571428571428572,0.012,0.0,0.02428571428571429,0.034,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,CMP14 LP 5AC CBC D PLT RPR,CHOLESTEROL TOTAL,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,T3 FREE,T3 FREE,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,CBC W AUTO DIFF WITH PLATELETS,BASOPHILS,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,CBC WITH DIFFERENTIAL PLATELETS,MCH,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,OBSTETRIC PANEL,RPR RESULT,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,PROTEIN ELEC INTERP SERUM,M SPIKE,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,HEMATOPATH CONSULTATION SMEAR,WBC,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0415,0.20750000000000002,0.0,0.0165,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,RPR REFLEX PER CDC,RPR,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.25,0.3333333333333333,0.0,0.125,0.16666666666666666,0.0,0.0,0.0,0.0,0.09336497228411789,0.06928146860324524,0,519132,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.125,0.0,0.316,0.375,0.3333333333333333,0.0,0.053626058777151875,0.0,0.0,0.624939177332759,1.0,1,28688,PROTEIN ELEC INTERP SERUM,ALPHA 2 GLOBULIN,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,MORPHOLOGICAL REVIEW,PLATELET ESTIMATE,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,PROTHROMBIN TIME,PT POP MEAN,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH TOTAL,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.43333333333333335,0.2857142857142857,1.0,0.43333333333333335,0.2857142857142857,1.0,0.0,0.43337723529131744,0.10031748330730439,0.0,0.43337723529131744,0.10031748330730439,1,30510,FREE T3,FREE T3,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,HCV FIBROSURE,NECROINFLAMMAT ACTIVITY SCORE,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,HEPATIC FUNCTION PNL,GLOBULIN,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.03871536850085311,0.0,0,716951,CBC INCLUDES DIFF PLT W SMEAR RVW,PLATELET COUNT,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,URINALYSIS COMPLETE,GLUCOSE QL,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,HEPATITIS B CORE AB,HEPATITIS B CORE AB,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.0,0.047619047619047616,0.0,0.0,0.0,0.0,0.0,0.01845920271835222,0.0,0.0,0.0,0.0,0,882944,IFE PE SERUM,ALBUMIN,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,DRUG ABUSE PANEL 10 WITH OXYCODONE,AMPHETAMINES,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.125,0.25,0.0,0.0,0.0,0.0,0.04403271978274104,0.04504617029593683,0,108860,SUNRISE LABS ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.2,0.0,0.3333333333333333,0.2,0.0,0.0,0.04035350753708156,0.0,0.08719609088829028,0.21223170681007852,0.0,1,7872,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.2,0.29666666666666663,0.534,0.2,0.29666666666666663,0.534,0.009775476476586498,0.017789718388423914,0.01849946018143911,0.009775476476586498,0.017789718388423914,0.01849946018143911,0,139501,HAV AB TOTAL,HAV AB TOTAL,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.07559327125736637,0.0,0.0,0.0,0.0,0,30247,IFE PE SERUM,GAMMA GLOBULIN,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHADONE,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.06666666666666667,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,CMP,TCO2,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,CBC WITH AUTO DIFF,BASOPHILS #,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,LIVER FIBROSIS FIBROMETER,FIBROMETER PATIENT SCORE,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,SED RATE WESTERGREN,SED RATE WESTERGREN,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,HEPATIC FUNCTION PANEL,BILIRUBIN INDIRECT,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.25,0.42857142857142855,0.6,0.0,0.028571428571428574,0.04,0.02631451296859655,0.0,0.0,0.0,0.0,0.0,0,487967,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,URINALYSIS REFLEX,GLUCOSE QL,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,HEPASCORE R,AGE,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,TESTOSTERONE FREE TOTAL LC MS MS,FREE TESTOSTERONE,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.027777777777777776,0.05,0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.06790824855576716,0.0,0,51961,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.03142857142857143,0.07333333333333333,0.0,0.03142857142857143,0.07333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CK TOTAL,CREATINE KINASE TOTAL,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,BILIRUBIN FRACTIONATED,BILIRUBIN INDIRECT,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.03738691252681969,0.0,0,7492,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,CBC PLATELET HEM REVIEW,PLATELETS,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,PTH INTACT WITHOUT CALCIUM,PARATHYROID HORMONE INTACT,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,RPR W RFLX CONFIRM,RPR SYPHILIS SCREEN,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.011764705882352941,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,HAV AB TOTAL,HAV AB TOTAL,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,ANA AUTOIMMUNE PROFILE,RHEUMATOID FACTOR QUANT,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,CMP14 HP4 1AC PT AFP,EGFR IF NONAFRICN AM,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.1925,0.10600000000000001,0.0,0.125,0.062,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,URINALYSIS CULTURE IF INDICATED,PH,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,COMP METAB PANEL,CALCIUM PLASMA,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,NASH FIBROSURE,HEIGHT,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.14666666666666667,0.04888888888888889,0.0,0.0,0.04888888888888889,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODY IGG,CCP ANTIBODY IGG,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,GENERAL HEALTH PANEL,HEMATOCRIT,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,ASH FIBROSURE,FIBROSIS STAGE,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,PT PROTIME,INR,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,NASH FIBROSURE,ALT SGPT P5P,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,CBC WITH DIFFERENTIAL,MCHC,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,LIPID PANEL,,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.011764705882352941,0.025,0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,771477,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,PROTHROMBIN TIME,PT POP MEAN,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,VIT B 12 FOLATE PANEL,FOLIC ACID,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,COMP METABOLIC PANEL,GLUCOSE NON FASTING,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,DRUG ABUSE SCREEN 9 NO THC W CONF,PHENCYCLIDINE,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.11833333333333333,0.355,0.23666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,HEPASCORE R,SEX,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0825,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,URINALYSIS W REFLEX MICRO,KETONES,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,HCV FIBROSURE,LIMITATIONS,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.3333333333333333,0.14285714285714285,0.5,0.0,0.0,0.0,0.061685809626148336,0.0,0.0,1,17426,CMP14 1AC,ALT SGPT,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,CBC PLATELET HEM REVIEW,PLATELETS,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,URINALYSIS ROUTINE,WBC,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.6666666666666666,0.5,1.0,0.0,0.0,0.0,0.1503314858492919,0.15505905338492743,1.0,1,264440,CBC WITH AUTO DIFF,BASOPHILS #,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,ASH FIBROSURE,COMMENT,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.07571428571428572,0.0,0.0,0.07571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,CHOL HDL RATIO,CHOL HDL RATIO,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.3333333333333333,0.4,1.0,0.0,0.0,0.0,0.06696411491014109,0.4808823462371743,0.7071067811865476,1,178616,CMP14 5AC CBC D PLT TSH T4F,CALCIUM SERUM,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,ASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.066,0.047142857142857146,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,CMP14 LP CBC D PLT TSH,NEUTROPHILS,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,AMYLASE,AMYLASE,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.0,0.07166666666666667,0.14333333333333334,0.335,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,MCCARJUH MCCARTHY PROFILE 1,PROTHROMBIN TIME PT,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,BASIC METABOLIC PANEL,BUN,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.055,0.06133333333333334,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,PTH INTACT WITHOUT CALCIUM,PARATHYROID HORMONE INTACT,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,IRON TOTAL BINDING CAPACITY,LIPEMIA,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.3333333333333333,0.16666666666666666,1.0,0.3333333333333333,0.31666666666666665,1.0,0.03495206666531736,0.12167907743603168,0.0,0.06538932921065,0.45528141890436646,0.7071067811865476,1,30262,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.09090909090909091,0.0,0.0,0.0,0.0,0.0,0.03166594870435313,0.0,0.0,0.0,0.0,0,322867,LIPID PANEL WITH DIRECT LDL,TRIGLYCERIDES,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,CBC WITH DIFF PLATELET,EOS ABSOLUTE,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,CMP14 LP CBC D PLT TSH HB A,ALT SGPT,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,CBC INC DIFF PLT,MONOCYTES,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,CARDIO IQ R VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,HCV FIBROSURE,INTERPRETATION,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.08,0.0,0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,CBC W AUTO DIFF,% MONOCYTES,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.28867513459481287,0.0,0,205708,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,CBC W AUTO DIFF WITH PLATELETS,MCV,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.155,0.2316666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,HIV 1 RNA QN RT PCR,HIV 1 RNA QN RT PCR,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual,Promyelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,CBC D PLT,HEMOGLOBIN,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.015316711982292452,0.0,0.0,0.0,0.0,0,264853,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.125,0.0475,0.0,0.125,0.0475,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,PROTIME PTT,PTT,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,CMP13 LP 2AC CBC D PLT,NEUTROPHILS ABSOLUTE,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,CBC W DIFF PLATELET,EOSINOPHILS,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.33399999999999996,0.2857142857142857,1.0,0.0,0.0,0.0,0.04215892569416535,0.1907240022327492,1.0,1,28746,PROTEIN ELECTRO S,GAMMA GLOBULIN,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,COMPREHENSIVE METABOLIC PNL W O CO2 ALT,POTASSIUM,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,CBC WITH AUTO DIFF,RDW,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,DRUG ABUSE PANEL NO CONFIRM,CREATININE,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,CREATINE KINASE TOTAL,HEMOLYSIS,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,BASIC METABOLIC PANEL,OSMOLALITY,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.1569574215481997,0.0,0.0,1,303842,CBC WITH MANUAL DIFFERENTIAL,RDW,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.16625,0.44333333333333336,0.0,0.16625,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,DRUG ABUSE SCREEN I NO GCMS,METHADONE,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,URINALYSIS W REFLEX MICRO,NITRITE,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.1775,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,BILIRUBIN FRACTIONATED,BILIRUBIN INDIRECT,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,FOLATE,FOLATE,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.24333333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0.06679361170328513,0.1964314811924487,1,28852,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.14666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,HB S AG W RFX CONF,HEPATITIS B SURFACE ANTIGEN,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,DIRECT LDL,TRIGLYCERIDES,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.15,0.21000000000000002,0.0,0.10428571428571429,0.146,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,CBC COMPLETE BLOOD COUNT W O DIFF,RED BLOOD CELL COUNT,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.2857142857142857,0.4,0.0,0.14285714285714285,0.2,0.0,0.0,0.0,0.0,0.09655062415867377,0.09746345547029489,0,223222,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,HCV AB WITH RFL RNA QT,HCV SIGNAL CUTOFF,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,CHOL HDL RATIO,CHOL HDL RATIO,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.11857142857142858,0.041666666666666664,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,LIPID PROFILE WRFL LDL DIRECT,NON HDL CHOLESTEROL,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,PROTEIN ELEC INTERP SERUM,M SPIKE,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,PSA TOTAL % FREE,% FREE PSA,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.009523809523809525,0.02,0.19125,0.047619047619047616,0.1,0.0,0.0,0.0,0.0,0.015986138487699808,0.026415305742815254,0,882944,COMPREHENSIVE METABOLIC PANEL W EGF,EGFR NON AFR AMERICAN,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,CMP,EGFR NON AFRICAN AMERICAN,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,ALPHA 2 MACROGLOBULIN,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,CBC COMPLETE BLOOD COUNT W O DIFF,RED BLOOD CELL COUNT,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,CBC INCLUDES DIFF PLT,BLASTS,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,HB S AG W REFLEX CONF,HFLAG,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,HB S AB QL,HB S AB QL,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,IRON BINDING CAPACITY,TIBC,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA PATTERN,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.46499999999999997,0.4,0.6666666666666666,0.0,0.0,0.0,0.034103916281504665,0.16901735079974012,1.0,1,104661,RENAL FUNCTION PANEL,ANION GAP,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,LD,LD,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,CBC WITH DIFFERENTIAL,MCHC,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,BASIC METABOLIC PANEL W EGFR,BUN CREATININE RATIO,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,AFP SERUM TUMOR MARKER,AFP SERUM TUMOR MARKER,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,STOOL CULTURE,RESULT 2,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,CMP14 LP CBC D PLT TSH,NEUTROPHILS,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.22333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,CARDIO IQ R VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.09247447620418048,0.34003516797720323,1.0,0.09247447620418048,0.34003516797720323,1.0,1,23457,GLUCOSE,GLUCOSE,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,PROFILE 1236 LIPID PANEL WITH DIRECT LDL,CHOL HDL,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,CMP14 1AC,EGFR IF NONAFRICN AM,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,CBC WITH PLT MAN DIFF,BANDS,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,URINALYSIS CULTURE IF INDICATED,COLOR,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,CBCI COMPLETE BLOOD COUNT W DIFF,ABS MONOCYTES,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,ASH FIBROSURE,AST SGOT P5P,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,UROGRAM,KETONES,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,CBC PLT DIFF,ABSOLUTE EOS,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.13333333333333333,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,URINALYSIS W REFLEX MICRO,SPECIFIC GRAVITY,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,ANA TITER PATTERN,ANA TITER,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,CMP14 LP 7AC CBC D PLT T B,IRON SATURATION,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.2866666666666667,0.2,0.0,0.0,0.2,1.0,0.0,0.0,0.0,0.0,0.13909830811578938,1.0,1,303503,AUTOMATED BLD CNT,HEMOGLOBIN,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.004,0.015,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,CMP14 HP4 DBILI CBC D PLT R,AMYLASE,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,CBC W AUTO DIFF WITH PLATELETS,MCHC,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,BMP8 ANION GAP,EGFR IF NONAFRICN AM,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.155,0.2,0.5,0.0,0.0,0.0,0.0,0.11289487630596429,0.7071067811865476,0,304519,CBC PLATELET HEM REVIEW,NEUTROPHILS,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,BUN CREATININE,BUN,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,DRUG ABUSE PANEL NO CONFIRM,CREATININE,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.25,0.5,0.5,0.0,0.0,0.0,0.00936672099634206,0.01954574209274329,0.01954574209274329,0.0,0.0,0.0,1,487942,LIVER FIBROSIS PNL HEPASCORE TM,F2,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.36,0.0,0.0,0.36,0.0,0.0,0.022889319382342066,0.0,0.0,0.022889319382342066,0.0,0.0,0,172841,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,DRUG ABUSE SCREEN I NO GCMS,METHADONE,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,CMP14 LP 3AC,ALKALINE PHOSPHATASE S,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,DRUG ABUSE SCREEN II,OPIATES,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,FASTING,FASTING STATUS,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.15,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,ANA CRP ASO PE,P E INTERPRETATION S,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,HCV GENOTYPE PCR PROBE,HCV GENOTYPE,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,CREATININE,EGFR IF AFRICN AM,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,CMP14 LP 7AC CBC D PLT T B,IRON SATURATION,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,MAGNESIUM,ICTERUS,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.05714285714285715,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,COMP METABOLIC PANEL,,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,OBSTETRIC PANEL,RPR RESULT,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,X HEPATITIS COMPLEX PROFILE,ANTI HCV,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,ANA AUTOIMMUNE PROFILE,RHEUMATOID FACTOR QUANT,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.33375,0.445,0.0,0.33375,0.445,0.0,0.04182263991042667,0.031034485878082996,0.0,0.04235721858521213,0.03143116993171713,0,519132,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.09090909090909091,0.0,0.0,0.0,0.0,0.0,0.0073963366520031215,0.0,0.0,0.0,0.0,0,542183,BUN CREAT RATIO,EGFR AFRICAN AMERICAN,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,AUTOMATED BLD CNT,MCH,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.07142857142857142,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CBC W DIFF PLT,PLATELET SUFFICIENCY,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,ANEMIA PROFILE B,EOS,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.15333333333333335,0.25,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,264499,CBC PLT DIFF,ABSOLUTE EOS,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,HEP C VIRUS ANTIBODY,HEP C VIRUS ANTIBODY,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.017058823529411765,0.03625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,IFE PE SERUM,ALPHA 1 GLOBULIN,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,CULTURE ROUTINE,CULTURE ROUTINE,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHADONE,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,HEPATITIS B SURFACE ANTIGEN W REFL CONFIRM,CONFIRMATION,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CBC,NEUTROPHIL,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.19999999999999998,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.03622836077219149,0.18114949547659975,0.22056758755212558,1,241109,RPR,TREPONEMA PALLIDUM ANTIBODIES,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,LIVER FIBROSIS FIBROTEST ACTITEST P,GGT,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.15,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,PROTEIN ELECTRO S,GAMMA GLOBULIN,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,CHEM SCREEN PANEL HDL,TRIGLYCERIDES,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.072,0.0,0.0,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,HDL AS % CHOLESTEROL,HDL AS % CHOLESTEROL,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.1075,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,882936,CMP14 CBC D PLT TSH,EGFR IF AFRICN AM,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.25,0.4,0.5,0.0,0.0,0.0,0.03711662676249161,0.08864481802382984,0.057918325991897945,0.0,0.0,0.0,0,81224,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,BASIC METABOLIC PANEL,BUN,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,DRUG ABUSE PANEL 10 WITH OXYCODONE,OPIATES,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,CARETC CMP LIPID URIC ACID DIR BILI PROFILE,RISK RATIO LDL HDL,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,ASH FIBROSURE,FIBROSIS STAGE,Body weight Measured,Weight Measured,Body weight
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,VIT B 12 FOLATE PANEL,FOLIC ACID,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.05,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,HEPATITIS B SURFACE ANTIGEN W REFL CONFIRM,CONFIRMATION,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.10964330813284906,0.0,0,264648,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,LIPOPROTEIN ANALYSIS NMR,LDL P,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.14285714285714285,0.25,0.0,0.14285714285714285,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CALCIUM,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,HEPATITIS BC AB IGM,HEPATITIS B CORE AB IGM,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.05,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,CBC WITH DIFFERENTIAL PLATELETS,POLYS,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,HCV RNA NAA QUALITATIVE,HCV RNA NAA QUALITATIVE,Reference lab test method,Ref lab test method,Reference lab test method
0.041666666666666664,0.1111111111111111,0.16666666666666666,0.04833333333333333,0.0,0.0,0.0,0.032824256728735124,0.05424998370944434,0.0,0.0,0.0,0,481598,HEPATITIS B SURFACE ANTIGEN,HBS AG SCREEN,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.195,0.78,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,PROFILE 1236 LIPID PANEL WITH DIRECT LDL,CHOL HDL,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,204552,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,LYMPHOCYTE SUBSET PANEL 3,% CD3 CD4 HELPER T4,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS C ANTIBODY,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,LIVER FIBROSIS PNL HEPASCORE TM,F2,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,IRON BINDING CAPACITY,TIBC,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,ANA REFLEX AUTOIMMUNE AB PROFILE,ANTI NUCLEAR ANTIBODIES,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,REFLEXED LDL,LDL DIRECT,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,CMP WITH ESTIMATED GFR CALCULATED,UREA NITROGEN,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,HEPATIC LIVER PANEL,DIRECT BILIRUBIN,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,T4 THYROXINE,T4 THYROXINE,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.06899999999999999,0.03636363636363637,0.05714285714285715,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,COMMENTS,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,PROFILE 104 LIVER,BILIRUBIN TOTAL,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,CMP14 HP5 LP 6AC CBC D PLT,BILIRUBIN INDIRECT,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp,Daclatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,CBC D WITH PLT CITRATED BLD,LYMPHS,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,CBC INCLUDES DIFF PLT,LYMPHOCYTES ABSOLUTE,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,CMP14 LP 5AC,VLDL CHOLESTEROL CAL,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,URINALYSIS REFLEX,GLUCOSE QL,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,UA MICROSCOPIC REFLEX CULTURE,PH,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,APTT,PARTIAL THROMBOPLASTIN,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,URINALYSIS SCREEN,BACTERIA,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,CBC INCLUDES DIFF PLT,HEMOGLOBIN,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,CBC WITH PLT DIFF,BANDS,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,URINALYSIS CULTURE IF INDICATED,PH,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,COMP METABOLIC PANEL,GLUCOSE NON FASTING,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,DIFFERENTIAL MANUAL,EOSINOPHILS,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,DRUG ABUSE SCREEN 9 NO THC W CONF,BARBITURATES,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,STOOL CULTURE,RESULT 2,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,LIVER PANEL II,LD,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,IRON TIBC,TIBC,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.012857142857142857,0.0225,0.0,0.02428571428571429,0.0425,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,CMP13 LP 2AC CBC D PLT,CHOLESTEROL TOTAL,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODY IGG,CCP ANTIBODY IGG,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,RENAL FUNCTION PANEL,CHLORIDE,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,LIVER FIBROSIS FIBROMETER,FIBROMETER PATIENT SCORE,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,CMP14 HP5 LP 6AC CBC D PLT,BILIRUBIN INDIRECT,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,SPECIAL PROFILE # 5144,TSH ULTRASENSITIVE,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,ALPHA FETOPROTEIN TUMOR MARKER,AFP TUMOR MARKER,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,AAA MALE PANEL,HIV 1 HIV 2 AB SCREEN,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.2375,0.0,0.0,0.1775,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,T LYMPHOCYTE HELPER SUPPRESSOR,LYMPHS,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,CMP14 LP TP TSH 4AC CBC D PLT,URIC ACID,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,HEPATITIS BE ANTIGEN,HEPATITIS BE ANTIGEN,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,HCV RNA QN REAL TIME PCR W RFLX QL,HCV RNA LOG IU ML,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODY IGG,CCP ANTIBODY IGG,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,UROGRAM,SPECIFIC GRAVITY,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,IRON TOTAL BINDING CAPACITY,LIPEMIA,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,HCV RNA QN REAL TIME PCR W RFLX QL,HCV RNA LOG IU ML,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,ACCUTYPE R IL28B,IL28B GENOTYPE,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.0,0.0,0.06666666666666667,0.04,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,RPR REFLEX TP PA,RPR,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODY IGG,CCP ANTIBODY IGG,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,PROTIME PTT,INR,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,CMP WITH ESTIMATED GFR CALCULATED,CHEMISTRY SODIUM,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp,Daclatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,MICROALBUMIN CONC,ALB CREAT RATIO,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.25,0.16666666666666666,1.0,0.25,0.16666666666666666,1.0,0.06539244069491312,0.1347605904070781,1.0,0.06539244069491312,0.1347605904070781,1.0,1,205674,FERRITIN,FERRITIN,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,PSA FREE TOTAL,% FREE PSA,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,REFLEX ANA PATTERN,PATTERN 1,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.25,0.16666666666666666,0.0,0.25,0.0,0.0,0.030900312566116694,0.0,0.0,0.0618006251322335,0.0,0.0,1,7880,CBC WITH AUTO DIFF,RDW,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,CMP,C02 BICARBONATE,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,MA COMP METABOLIC PNL,ALKALINE PHOSPHATASE,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,RENAL FUNCTION PANEL,CREATININE,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,UA MICROSCOPIC REFLEX CULTURE,PH,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.018942545350678186,0.0,0.0,0.0,0.0,0,32896,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.017857142857142856,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,PROTHROMBIN TIME PT,PT CONTROL,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,LD,LD,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,PROTIME PTT,INR,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,HEPATITIS B SURFACE ANTIGEN,HBS AG SCREEN,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,DRUG ABUSE PANEL 10 WITH OXYCODONE,COCAINE METABOLITE,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CBC W DIFF PLT,BASOPHILS ABSOLUTE,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,MAGNESIUM,HEMOLYSIS,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,LYMPHOCYTE SUBSET PANEL 4,%CD8 SUPPRESSOR T CELLS,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,PT PTT,PARTIAL THROMBOPLASTIN,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,CK TOTAL,CREATINE KINASE TOTAL,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,CMP14 LP CBC D PLT,HEMATOCRIT,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,CBC INCLUDES DIFF PLT,EOSINOPHILS,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.215,0.16666666666666666,0.5,0.0,0.0,0.0,0.0,0.0,0.0,1,203943,IRON TOTAL BINDING CAPACITY,LIPEMIA,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,30841,CMP14 LP TP TSH 4AC CBC D PLT,URIC ACID,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,HEPATITIS B SURFACE ANTIGEN W REFL CONFIRM,CONFIRMATION,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.022,0.044,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,BMP8 ANION GAP,EGFR IF NONAFRICN AM,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.05117681691383591,0.0,0.0,0.0,0.0,0,381806,IFE PE SERUM,M SPIKE,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,APOLIPOPROTEIN A1,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06812389033458222,0.051758104169687846,0.7071067811865476,0,7328,CBC INCLUDES DIFF PLT,LYMPHOCYTES ABSOLUTE,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,HCV RNA QN PCR W REFL GENOTYPE LIPA R,HCV RNA QUANTITATIVE REAL TIME PCR,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.2866666666666667,0.375,0.75,0.2866666666666667,0.125,0.25,0.0,0.2022445388452877,0.20966408989515994,0.0,0.06741484628176253,0.06988802996505328,1,25015,IRON BINDING CAPACITY IBC % SATURATION,UNSATURATED IBC,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,HEPATITIS BE AG,HB E AG,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,HEPATIC FUNCTION PANEL 6,AST SGOT,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,HEPATIC FUNCT PANEL W O TP,BILIRUBIN DIRECT,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,SUNRISE LABS ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,CMP WITH ESTIMATED GFR CALCULATED,CHEMISTRY SODIUM,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.3333333333333333,0.306,1.0,0.3333333333333333,0.306,1.0,0.09247447620418048,0.34003516797720323,1.0,0.09247447620418048,0.34003516797720323,1.0,1,20644,CERULOPLASMIN,CERULOPLASMIN,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,COMPREHENSIVE METABOLIC PANEL WITH GFR,T BILIRUBIN,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,UROGRAM,APPEARANCE,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,HEP A AB IGM,HEPATITIS A AB IGM,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.057999999999999996,0.0,0.0,0.16,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,PROTEIN ELECTROPHORESIS SERUM,ALPHA 1,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,TSH 3RD GENERATION,TSH 3RD GENERATION,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.325,0.0,0.0,0.45,0.0,0.0,0.0,0.0,0.0,0.04459053011835212,0.0,0.0,1,422543,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.15666666666666665,0.94,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,CBC WITH PLT DIFF,RBC MORPHOLOGY,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,PSA FREE TOTAL,INTERNAL %,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,PSA FREE TOTAL,INTERNAL %,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,CD4 CD8 RATIO PROFILE,HEMATOLOGY COMMENTS,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,CREATINE KINASE CPK TOTAL,CREATINE KINASE CPK TOTAL,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,HIV AB AG RFLX CONF,HIV AG AB,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.3333333333333333,1.0,0.0,0.0,0.0,0.0,0.25937854254408554,1.0,1,17830,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,LYMPHOCYTE SUBSET PANEL 4,COMMENT S,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.09499999999999999,0.13249999999999998,0.1875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,DRUG ABUSE SCREEN 9 NO THC W CONF,PHENCYCLIDINE,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,CMP14 CBC D PLT ESR WES ANA,POTASSIUM,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,MAGNESIUM,HEMOLYSIS,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,DRUG ABUSE SCREEN III,AMPHETAMINES,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,GLUCOSE,GLUCOSE,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,HCV RNA QN REAL TIME PCR W RFLX QL,HCV RNA LOG IU ML,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,CMP,C02 BICARBONATE,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,CMP12 2AC,BILIRUBIN TOTAL,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,IMMUNOGLOBULIN M IGM,IMMUNOGLOBULIN M,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.08833333333333333,0.0,0.0,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,HEPATIC FUNCTION PANEL 6,AST SGOT,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,HEPATITIS C REFLEX PCR,HEPATITIS C ANTIBODY,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,HIV AG AB 4TH GEN RFL,RACE NR,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,ANEMIA PROFILE B,EOS,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.0,0.0,0.06200000000000001,0.0,0.0,0.06200000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,IFE PE FLC SERUM,IMMUNOGLOBULIN G QN SERUM,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,VITAMIN D 25 OH TOTAL IA,VITAMIN D 25 OH TOTAL IA,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,203935,CREATINE KINASE TOTAL,HEMOLYSIS,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,CMP14 CBC D PLT RPR UA TSH,HCV AB,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,HB S AG W RFX CONF,HEPATITIS B SURFACE ANTIGEN,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.33399999999999996,0.3025,0.605,0.33399999999999996,0.3025,0.605,0.03976275807110774,0.05345799931322692,0.07240860968350848,0.03976275807110774,0.05345799931322692,0.07240860968350848,0,139550,HEP A AB TOTAL,HEP A AB TOTAL,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,CBC W DIFF PLATELET,EOSINOPHILS,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,CBC W AUTO DIFF WITH PLATELETS,BASOPHILS,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,CBC WITH PLT DIFF,MPV,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,LIVER FIBROSIS PANEL HEPASCORE,FIBROSIS SCORE,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,LIVER FIBRO HEPSCORE R,AGE,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.025,0.125,0.0,0.05,0.0,0.0,0.0,0.0,0.0,0.019934693104725842,0.0,0,347047,CBC INCLUDES DIFFERENTIAL PLATELETS,MEAN PLATELET VOLUME,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,IRON BINDING CAPACITY IBC % SATURATION,UNSATURATED IBC,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,APTT,PARTIAL THROMBOPLASTIN,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,CBC INC DIFF PLT,MONOCYTES,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.09090909090909091,0.0,0.0,0.18181818181818182,0.25,0.0,0.014772156923696378,0.0,0.0,0.0,0.0,0,542183,COMPLETE BLOOD COUNT,RBC,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.08333333333333333,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,CBC W DIFF PLT,MONOCYTES %,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.07333333333333333,0.22,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,DRGABU2,METHAQUALONE,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.08,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,CBC W AUTO DIFF ABS WBC MPV PLT,BASOPHILS,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,PHOSPHORUS,PHOSPHORUS,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.8,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,PSA FREE TOTAL,INTERNAL %,Age,Age,Age
0.0,0.05555555555555555,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,IRON BINDING CAPACITY IBC % SATURATION,UNSATURATED IBC,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,CBC W AUTO DIFF WITH PLATELETS,MCHC,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CBC WITH DIFFERENTIAL,HEMATOCRIT,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,NASH FIBROSURE,APOLIPOPROTEIN A 1,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.2276407094521833,0.0,0,19711,FE TIBC FER,FERRITIN SERUM,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.01,0.02,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,COMP METABOLIC PANEL,CARBON DIOXIDE,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.5,0.3333333333333333,0.0,0.0,0.0,0.0,0.1503314858492919,0.7071067811865476,0.0,1,304287,CBC W AUTO DIFF WITH PLATELETS,MCV,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,DRUG ABUSE SCREEN I NO GCMS,METHADONE,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,HIV 1 RNA QN RT PCR,RACE NR,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.3333333333333333,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.025569947555028505,0.0,0.06691275831255872,0.06348916544989514,0.09169555407390673,1,7062,COMPLETE BLOOD COUNT,BASOPHILS %,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,CBC W AUTO DIFF WITH PLATELETS,RDW,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,CBC H H RBC INDICES WBC PLT,MPV,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,CBC WITH MANUAL DIFFERENTIAL,MCH,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,FIBROACT COMPLETE,HEIGHT INCHES,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.07263157894736842,0.07444444444444445,0.0,0.0,0.0,0.0,0.004926859880255652,0.0,0,486431,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.04818181818181819,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,PROTEIN ELEC INTERP SERUM,M SPIKE,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,REFLEXED LDL,LDL DIRECT,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,HEPATIC FUNCTION PNL,PROTEIN TOTAL,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.009523809523809525,0.02,0.1075,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,882944,COMP METABOLIC PANEL 14,EGFR IF NONAFRICN AM,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,AFP TUMOR MARKER,AFP TUMOR MARKER,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,CBC INCLUDES DIFF PLT WITH PATHOLOGIST REVIEW,ABSOLUTE LYMPHOCYTES,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,CBC WITH PLT DIFF,BLASTS,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.2375,0.2375,0.31666666666666665,0.0,0.0,0.0,0.0,0.0,0.0,1,265116,CBC,NEUTROPHIL,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.07142857142857142,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CBC W AUTO DIFF,% MONOCYTES,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,PSA WITH FREE RATIO,PSA ROCHE E170,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD4 CELLS,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.146,0.3333333333333333,0.0,0.276,0.18666666666666668,0.0,0.0,0.07402207708426334,0.35355339059327373,0.0,0.07402207708426334,0.0,1,128512,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,PROTEIN TOTAL URINE,PROTEIN CR RATIO,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,23366,COMP METABOLIC PANEL,,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,HEPATITIS BS AB QUANT,HEPATITIS BS AB QUANT,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,MITOCHONDRIAL AB SCREEN,MITOCHONDRIAL AB SCREEN,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,C REACTIVE PROTEIN INFLAMMATORY,C REACTIVE PROTEIN,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.030763983977592058,0.0,0.0,0.0,0.0,0,7047,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,UA MICROSCOPIC REFLEX CULTURE,LEUKOCYTE ESTERASE,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.11399999999999999,0.08142857142857142,0.11399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,DRUG ABUSE PANEL 10 WITH OXYCODONE,AMPHETAMINES,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,NASH FIBROSURE,HAPTOGLOBIN,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.3333333333333333,0.2,1.0,0.3333333333333333,0.4,1.0,0.094701559498232,0.34003516797720323,1.0,0.06696411491014109,0.4808823462371743,0.7071067811865476,1,22764,FERRITIN,FERRITIN SERUM,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,FOLATE,FOLATE,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.25666666666666665,0.10600000000000001,0.0,0.24333333333333332,0.0,0.5,0.0,0.0,0.0,0.0,0.14704505836808368,0.1503314858492919,0,28902,URINALYSIS COMPLETE W REFLEX CULTURE,PROTEIN,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,PROTIME PTT,PTT,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0,17517,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.1375,0.0,0.0,0.4225,0.3333333333333333,0.3333333333333333,0.0,0.0,0.0,0.04280810441337335,0.11098565713428754,0.11098565713428754,1,487926,FIBROACT COMPLETE,NECROINFL SCORE,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,URINALYSIS WITH MICROSCOPIC,COLOR,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.14285714285714285,0.0,0.0,0.14285714285714285,0.0,0.0,0.037973596642889795,0.0,0.0,0.037973596642889795,0.0,0,110544,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.5675,0.23857142857142857,0.0,0.6675,0.3242857142857143,0.0,0.018299290118234723,0.10497865490644265,0.0,0.061241138223508074,0.058554296133023875,0.0,1,22368,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.07870803013413097,0.08752895424186691,0.10240603634159506,1,265116,OBSTETRIC PANEL,NEUTROPHILS,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,COMP METABOLIC PANEL,ANION GAP,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.025,0.08333333333333333,0.0,0.033,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,HEPATITIS B CORE AB,HEPATITIS B CORE AB,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,TESTOSTERONE TOTAL LC MS MS,TESTOSTERONE TOTAL LC MS MS,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.5233333333333333,0.25,0.0,0.6666666666666666,0.5,1.0,0.017234475460362608,0.10736577230861277,0.0,0.0828927568545671,0.0,0.0,1,21618,PROTEIN TOTAL 24HR URINE W CREAT,UR CREAT RANDOM MG DL,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,TSH SML,TSH,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.1925,0.10600000000000001,0.0,0.1825,0.0,1.0,0.0,0.0,0.0,0.0,0.09762443806815091,1.0,1,204545,URINALYSIS COMPLETE WITH REFLEX CULTURE,PROTEIN,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,LIPOPROTEIN ANALYSIS NMR,LDL P,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.14285714285714285,0.0,0.33399999999999996,0.2857142857142857,1.0,0.0,0.0778627478619458,0.0,0.04215892569416535,0.1907240022327492,1.0,1,28746,IFE PE SERUM,GAMMA GLOBULIN,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.134,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.1858678609476695,0.0,0.0,0.0,0.0,0,15586,PE FLC SERUM,ALBUMIN,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CBC W AUTO DIFF,MONOCYTES %,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.07692307692307693,0.0,0.0,0.0,0.0,0.0,0.047350448302201587,0.0,0.0,0.0,0.0,0,204479,PROTEIN ELEC INTERP SERUM,M SPIKE,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,CBCI COMPLETE BLOOD COUNT W DIFF,ABS MONOCYTES,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,CMP14 LP CBC D PLT TSH UA M,HDL CHOLESTEROL,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,APOLIPOPROTEIN A1,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,CMP14 LP CBC D PLT TSH T4F,NEUTROPHILS ABSOLUTE,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,CBC,HEMOGLOBIN,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.142,0.71,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,COMPREHENSIVE METABOLIC PNL W O CO2 ALT,POTASSIUM,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.007000000000000001,0.01,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,CMP12 LP TP TSH 6AC CBC D PLT,URIC ACID,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,HCV GENOTYPE REFLEX NSA,HCV GENOSURE R NSA INTERP,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,CBC WITH PLT DIFF,BLASTS,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.014499999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.1875,0.14285714285714285,0.0,0.0,0.03571428571428571,0.05,0.0,0.13697041783001718,0.0,0.0,0.0,0.0,0,223149,IFE PE SERUM,ALBUMIN,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,CBC WITH PLT DIFF,BANDS,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,PROTHROMBIN PTT,CONTROL,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,ACCUTYPE R IL28B NY,IL28B GENOTYPE,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,FREE T4 THYROXINE,FREE T4,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.014666666666666666,0.055,0.0,0.012,0.045,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,IRON BINDING CAPACITY % SATURATION,CALCULATED % IRON SAT,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.0,0.16625,0.44333333333333336,0.0,0.16625,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD LOG IU ML,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.04,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,HB S AG W RFX CONF,HEPATITIS B SURFACE ANTIGEN,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,FREE T3,FREE T3,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.16666666666666666,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,WESTERGREN SED RATE,WESTERGREN SED RATE,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,T4,T4,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.36750000000000005,0.2,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,MCCARJUH MCCARTHY PROFILE 1,PROTHROMBIN TIME PT,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.08,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,MITOCHONDRIAL ANTIBODY W RFX,MITOCHONDRIAL AB,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,BASIC METABOLIC PANEL,OSMOLALITY,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,CMP14 LP CBC D PLT TSH T4F,NEUTROPHILS ABSOLUTE,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,CMP14 1AC,EGFR IF NONAFRICN AM,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0,27771,CBC INCLUDES DIFFERENTIAL PLATELETS,MEAN PLATELET VOLUME,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,URINALYSIS REFLEX,NITRITE,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,FE TIBC FER,IRON BIND CAP TIBC,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.06,0.04,0.072,0.0,0.024444444444444446,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,ESR WES CRP,C REACTIVE PROTEIN QUANT,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,CMP14 LP CBC D PLT TSH,NEUTROPHILS,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,HEMOGLOBIN A1C WITH MPG,HEMOGLOBIN A1C,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.375,0.08833333333333333,0.0,0.0,0.0,0.0,0.048512101434984745,0.0,0.0,0.0,0.0,0.0,0,204552,URINALYSIS W MICRO,GLUCOSE,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,OXYCODONE,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual,Promyelocytes/100 leukocytes
0.0,0.16666666666666666,0.0,0.0,0.16666666666666666,0.0,0.0,0.2276407094521833,0.0,0.0,0.1858678609476695,0.0,0,19711,IMMUNOGLOBULINS A E G M SERUM,IMMUNOGLOBULIN G QN SERUM,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,COMPREHENSIVE METABOLIC PANEL W EGF,EGFR NON AFR AMERICAN,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,URINALYSIS CULTURE IF INDICATED,BILIRUBIN,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.09666666666666668,0.2625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,OBSTETRIC PANEL,NEUTROPHILS,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,CMP,EGFR NON AFRICAN AMERICAN,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,CBC D PLT,HEMOGLOBIN,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.3,0.2,1.0,0.0,0.0,0.0,0.0,0.34003516797720323,1.0,1,45427,NASH FIBROSURE,HAPTOGLOBIN,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.03333333333333333,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,CBC W DIFF PLATELET,EOSINOPHILS,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,20933,CMP14 5AC CBC D PLT TSH T4F,CALCIUM SERUM,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,CMP14 HP4 DBILI CBC D PLT R,WBC,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.5566666666666666,0.14285714285714285,0.0,0.0,0.0,0.0,0.041620163040118285,0.0966660720824497,0.050158741653652195,1,30973,BASIC METABOLIC PANEL W EGFR,BUN CREATININE RATIO,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,TRANSFERRIN,TRANSFERRIN,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.14666666666666667,0.0,0.335,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,LIVER FIBROSIS FIBROTEST ACTITEST P,APOLIPOPROTEIN A1,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,1,305250,LIVER FIBRO HEPSCORE R,AGE,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,FREE T3,FREE T3,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,SUNRISE LABS ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,CBC D WITH PLT CITRATED BLD,LYMPHS,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.08581504994646605,0.11153417675642818,1.0,1,181826,BASIC METABOLIC PANEL,OSMOLALITY,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,HCV RNA QN REAL TIME PCR W RFLX QL,HCV RNA LOG IU ML,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,LIPID PANEL,,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.2375,0.1357142857142857,0.95,0.25,0.14285714285714285,1.0,0.0,0.0,0.0,0.052570301148225806,0.05162000400267441,0.7071067811865476,0,303644,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,HCV FIBROSURE,COMMENT,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Race,Race,Race
0.055,0.033,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,LIVER FIBROSIS PANEL,ALT,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,IFE PE SERUM,M SPIKE,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,RPR REFLEX TITRE TPPA,RPR,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,URINALYSIS W REFLEX MICRO,COLOR,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,LIVER FIBRO HEPSCORE R,AGE,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,HCV FIBROSURE,FIBROSURE STAGE,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,COMP METAB PANEL,CALCIUM PLASMA,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,BASIC METABOLIC PANEL W EGFR,BUN CREATININE RATIO,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,CBC NO DIFF,RBC,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,DIRECT LDL,TRIGLYCERIDES,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,CMP WITH ESTIMATED GFR CALCULATED,UREA NITROGEN,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,IRON BINDING CAPACITY IBC % SATURATION,UNSATURATED IBC,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,HEPATIC FUNCTION PANEL AMA,GLOBULIN,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,MAGNESIUM,HEMOLYSIS,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,CBC W DIFF PLT,MONOCYTES %,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.25,1.0,0.0,0.0,0.0,0.0,0.15505905338492743,1.0,1,7187,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0825,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,URINALYSIS SCREEN,PH,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,FREE T4,FREE T4,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,COCAINE METABOLITE,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,BMP,CHLORIDE,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.0,0.0,0.06200000000000001,0.0,0.0,0.06200000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,HCV RNA NAA QUALITATIVE,HCV RNA NAA QUALITATIVE,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,FREE T4 THYROXINE,FREE T4,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH TOTAL,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,CMP14 CBC D PLT TSH,EGFR IF AFRICN AM,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,COMP METABOLIC PANEL,ANION GAP,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,CBC W DIFF PLT,HEMATOCRIT,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,DRUG ABUSE PANEL 10 WITH OXYCODONE,OPIATES,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0625,0.0,0.0,0.0,0.0,0.0,0.022679367039845966,0.0,0,339143,C4 C3,COMPLEMENT C3 SERUM,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,ARTHRITIS PROFILE,RHEUMATOID FACTOR QUANT,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.036,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN TOTAL RANDOM UR,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.22,0.16666666666666666,0.3333333333333333,0.47,0.16666666666666666,0.3333333333333333,0.0,0.2276407094521833,0.5,0.04524395250155222,0.45528141890436646,0.5,1,19711,BILIRUBIN FRACTIONATED,BILIRUBIN INDIRECT,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0825,0.08833333333333333,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.07163871665340582,0.09716253076254433,1.0,1,57976,URINALYSIS W REFLEX MICRO,KETONES,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.275,0.14285714285714285,0.0,0.275,0.0,0.0,0.0,0.09338639438323382,0.0,0.0,0.09338639438323382,0.0,1,21329,VITAMIN B 12,VITAMIN B 12,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,PROFILE 1236 LIPID PANEL WITH DIRECT LDL,CHOL HDL,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0775,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,HEPATIC FUNCTION PANEL AMA,GLOBULIN,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.2857142857142857,0.0,0.0,0.14285714285714285,0.3333333333333333,0.0,0.028088169076683545,0.0,0.0,0.0,0.0,0,326231,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,CMP13 LP 2AC CBC D PLT,ALBUMIN SERUM,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HCV RNA QUAL TMA,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,CD4 T HELPER PANEL,CD4 CD3 %HELPERS,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,HEPATIC FUNCTION PNL,GLOBULIN,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,BUN CREATININE,BUN,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CBC COMPLETE BLOOD COUNT W O DIFF,HEMATOCRIT,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,CBC W AUTO DIFF,MONOCYTES %,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.14285714285714285,0.3333333333333333,0.0,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,AFP TUMOR MARKER,AFP TUMOR MARKER,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.178,0.12714285714285714,0.178,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,FIBROACT COMPLETE,NECROINFL SCORE,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,LYMPHOCYTE SUBSET PANEL 3,% CD3 CD4 HELPER T4,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.055,0.033,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,COMP METABOLIC PANEL 13,EGFR IF NONAFRICN AM,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.35250000000000004,0.16666666666666666,0.5,0.435,0.3333333333333333,1.0,0.0,0.049077480463630696,0.053150206534941846,0.010451985424486443,0.03938663461739855,0.0426551596547905,1,29918,TESTOSTERONE FR DIALYSIS TOTAL LC MS MS,FREE TESTOSTERONE,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,CBC WITH PLT DIFF,MYELOCYTES,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,RPR W RFLX CONFIRM,RPR SYPHILIS SCREEN,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,HEPATITIS B CORE AB TOTAL REFL,HEPATITIS B CORE AB TOTAL REFL,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,GLYCOHEMOGLOBIN A1C,GLYCOHEMOGLOBIN A1C,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.04666666666666667,0.0,0.0,0.04666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,HCV RNA NAA QUALITATIVE,HCV RNA NAA QUALITATIVE,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.05,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,VITAMIN D 25 OH,25 OH VITAMIN D,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.07333333333333333,0.0,0.0,0.07333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,GLUCOSE,GLUCOSE,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,CBC W AUTO DIFF,MONOS ABSOLUTE,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,COCAINE METABOLITE,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.07833333333333332,0.0,0.0,0.07833333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,HEPATITIS PANEL ACUTE,HEPATITIS C AB CIA,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,CMP,C02 BICARBONATE,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,PTH INTACT MOLECULE,PTH,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.4375,0.2857142857142857,1.0,0.0,0.0,0.0,0.0,0.10343053687972403,0.17358784764553015,1,134585,CMP14 LP 5AC,VLDL CHOLESTEROL CAL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,HB S AG W RFX CONF,HEPATITIS B SURFACE ANTIGEN,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,COMP METABOLIC PANEL,CREATININE,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,HEMOGLOBIN A1C WITH MPG,HEMOGLOBIN A1C,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,HCV RNA QT REALTIME PCR,HCV RNA QN PCR,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,DIRECT LDL,LDL CHOLESTEROL DIRECT,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.066,0.07571428571428572,0.0,0.176,0.14285714285714285,1.0,0.0,0.0,0.0,0.0,0.07582142074137055,1.0,1,505511,URINALYSIS COMPLETE,BILIRUBIN,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,CREATINE KINASE CK,CREATINE KINASE CK,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,MAGNESIUM,HEMOLYSIS,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0834655896020069,0.34003516797720323,1.0,1,28233,CMP14 CBC D PLT ESR WES ANA,POTASSIUM,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.125,0.2573333333333333,0.715,0.25,0.26666666666666666,0.965,0.018878981028615627,0.08614448942962882,0.22524969726717137,0.22848423004998408,0.011147902332567239,0.04372412516808821,1,426171,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,BMP8 CBC D PLT UA,EOS ABSOLUTE,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A RESIST ASSAY INTERP,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.08333333333333333,0.022,0.0,0.08333333333333333,0.022,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,PSA TOTAL,PSA TOTAL,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HCV RNA QUAL TMA,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,DIFFERENTIAL MANUAL,EOSINOPHILS,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,CMP14 HP5 LP 6AC CBC D PLT,HDL CHOLESTEROL,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.09666666666666668,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,ANA CRP ASO PE,P E INTERPRETATION S,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,GLUCOSE,GLUCOSE,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,CMP14 LP 5AC,VLDL CHOLESTEROL CAL,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,PE INTERP RFX IFE S,BETA GLOBULIN,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,HEPATITIS BC AB IGM,HEPATITIS B CORE AB IGM,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,DRUG ABUSE SCREEN 9 NO THC W CONF,PHENCYCLIDINE,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,PHOSPHATE AS PHOSPHORUS,LIPEMIA,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,LIVER PANEL II,LD,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,ANEMIA PROFILE B,EOS,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,PTT,PTT,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,LYMPHOCYTE SUBSET PANEL 1,ABSOLUTE CD8 CELLS,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODY IGG,CCP ANTIBODY IGG,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,MAGNESIUM,ICTERUS,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,RPR SCREEN W TITER,RPR SCREEN,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,HEMATOPATH CONSULTATION SMEAR,WBC,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.033,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.041666666666666664,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,PROTEIN ELECTROPHORESIS,BETA GLOBULINS,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,SUNRISE LABS ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,CMP14 CBC D PLT RPR UA TSH,HCV AB,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,BUN CREATININE RATIO,BUN CREATININE RATIO,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,CBC W O DIFF WITH PLATELETS,MCV,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,CBC W AUTO DIFF,% LYMPHOCYTES,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.23666666666666666,0.125,0.0,0.125,0.125,0.0,0.0,0.0816748825802307,0.0,0.0,0.0666872623744319,0.0,0,109009,IMMUNOGLOBULINS A E G M SERUM,IMMUNOGLOBULIN G QN SERUM,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.1,0.07142857142857142,0.16666666666666666,0.05,0.03571428571428571,0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,HEMOGLOBIN A1C,AVERAGE WHOLE BLOOD GLUCOSE,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,URINALYSIS CULTURE IF INDICATED,APPEARANCE,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,CEA,CEA,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,OBSTETRIC PANEL,NEUTROPHILS,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.19,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.0,0.06444628140908037,0.0946521642027649,1,7138,CBC INCLUDES DIFF PLT,EOSINOPHILS,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,MORPHOLOGICAL REVIEW,PLATELET ESTIMATE,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.0769832768017027,0.08055537486383768,0.09169555407390673,1,301804,CBC W AUTO DIFF WITH PLATELETS,BASOPHILS,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.25,0.2,0.0,0.0,0.0,0.0,0.06725870151848445,0.21223170681007852,0.0,1,7864,CBC WITH DIFFERENTIAL,MCHC,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,URINE DRUG SCREEN,OPIATES,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,PROTEIN ELECTROPHORESIS SERUM,ALPHA 2,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,AMYLASE,AMYLASE,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,CMP14 LP CBC D PLT TSH,NEUTROPHILS,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.2,0.17666666666666664,0.2,0.2,0.5655555555555556,0.884,0.016978337224787476,0.0,0.0,0.03796471617953978,0.13817876011426722,0.14369156469154098,1,139501,HAV HBV IMMUNE STATUS PRO IV,HEP A AB IGM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.08833333333333333,0.0,0.0,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,CERULOPLASMIN,CERULOPLASMIN,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,CBC PLATELET HEM REVIEW,EOS,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.047619047619047616,0.0,0.0,0.0,0.0,0.0,0.01845920271835222,0.0,0.0,0.0,0.0,0,882944,IFE PE SERUM,BETA GLOBULIN,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,CBC INCLUDES DIFF PLT,LYMPHOCYTES ABSOLUTE,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,HEMOGRAM W O DIFFERENTIAL,MEAN PLATELET VOLUME,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.26666666666666666,0.0,0.0,0.26666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,PTH INTACT MOLECULE,PTH,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,TSH 3RD GENERATION,TSH 3RD GENERATION,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,EIA 10 ALCOHOL W GCMS,URINE CREATININE MG DL,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.05357142857142857,0.1875,0.0,0.0,0.0,0.0,0.03979805087390864,0.0,0.0,0.0,0.0,0,110114,CBC D WITH PLT CITRATED BLD,LYMPHS,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,FERRITIN,FERRITIN,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,CBC INCLUDES DIFF PLT,RDW,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,FERRITIN,FERRITIN SERUM,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,RPR,RPR RESULT,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,HCV RNA NAA QUALITATIVE,HCV RNA NAA QUALITATIVE,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,CBC WITH PLT DIFF,NO CELLS DIFF,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.3333333333333333,0.42857142857142855,1.0,0.0,0.42857142857142855,0.6666666666666666,0.050078247894864814,0.0,0.0,0.0,0.6736085929872226,0.7002224033044667,1,28571,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.09090909090909091,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,CBC W AUTO DIFF WITH PLATELETS,RBC,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,RENAL FUNCTION PANEL,ANION GAP,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A RESIST ASSAY INTERP,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.10333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.06285714285714286,0.0,0.0,0.06285714285714286,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,HEPATITIS A IGM,HEPATITIS A IGM,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,HEPATITIS A IGM,HEPATITIS A IGM,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,CMP14 LP 2AC CBC D PLT MG T,WBC,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,UA W RFLX MICROSCOPIC,BILIRUBIN,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,RPR REFLEX TP PA,RPR,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,IRON BINDING CAPACITY % SATURATION,IRON SERUM,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,PROTEIN ELECTRO S,M SPIKE,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,IMMUNOFIXATION SERUM,IGG SERUM NR,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.030763983977592058,0.0,0.0,0.0,0.0,0,7310,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,CMP14 HP4 DBILI CBC D PLT R,WBC,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,PT PROTIME,INR,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.266,0.19,0.44333333333333336,0.0,0.19,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,HEPATITIS C VIRUS RNA QN REAL TIME PCR,HCV RNA PCR QN,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,UA MICROSCOPIC REFLEX CULTURE,PH,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CEA,CEA,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,EIA 10 ALCOHOL W GCMS,URINE CREATININE MG DL,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,HEPATIC FUNCTION PNL,GLOBULIN,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.065,0.21666666666666667,0.0,0.078,0.26,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,CARETC CMP LIPID URIC ACID DIR BILI PROFILE,RISK RATIO LDL HDL,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,CBC W AUTO DIFF WITH PLATELETS,RDW,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,PROTEIN ELECTRO S,GAMMA GLOBULIN,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.5,0.5,1.0,0.5,0.5,1.0,0.0850700205153394,0.04403271978274104,0.04504617029593683,0.4900689862175951,0.011465317579597123,0.011729201619518514,1,108860,PSA TOTAL % FREE,PSA FREE,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,CBC WITH PLT DIFF,BASOPHILS ABSOLUTE,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,COMP METABOLIC PANEL W GFR,GLOBULIN,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,HIV ANTIGEN ANTIBODY FOURTH GEN,HIV AG AB 4TH GEN,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CBC DIFF PLT,PLATELET COUNT,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.08581504994646605,0.11153417675642818,1.0,1,181826,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,LIVER FIBROSIS PANEL,ALT,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.2375,0.15833333333333333,0.95,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp,Daclatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,HBSAB AG,HEP B SURFACE AB QUAL,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,CBC W AUTO DIFF ABS WBC MPV PLT,BASOPHILS,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,CMP13 LP TP TSH 2AC CBC D P,LDL CHOLESTEROL CALC,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.27999999999999997,0.2857142857142857,1.0,0.0,0.0,0.0,0.011862808335706188,0.6345756122357417,1.0,1,28712,PE INTERP RFX IFE S,BETA GLOBULIN,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,GLYCOHEMOGLOBIN A1C,GLYCOHEMOGLOBIN A1C,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.040203715080026736,0.0,0.0,0.0,0.0,1,143149,DRUG ABUSE SCREEN W ETOH NO GCMS,COCAINE METABOLITE,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,HEPATIC LIVER PANEL,DIRECT BILIRUBIN,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.1111111111111111,0.2,0.28833333333333333,0.4444444444444444,0.8,0.0,0.055446852762574106,0.07759701258884111,0.033947326516491017,0.11089370552514821,0.15519402517768222,1,51961,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,HEPATITIS A IGM,HEPATITIS A IGM,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,PSA FREE TOTAL,INTERNAL %,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.009090909090909092,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,CMP14 CBC D PLT TSH,ALBUMIN,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.24333333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,ASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.09666666666666668,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,PE RFX IFE S,GAMMA GLOBULIN,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.09494317394815022,0.0,0.0,0,66902,CBC WITH MANUAL DIFFERENTIAL,WBC,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,FIBROACT COMPLETE,HEIGHT INCHES,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,URINALYSIS COMPLETE W REFLEX CULTURE,PROTEIN,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,NASH FIBROSURE,AST SGOT P5P,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,PROTEIN TOTAL URINE,PROTEIN CR RATIO,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,HEPATITIS C REFLEX PCR,HEPATITIS C ANTIBODY,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,LIVER PANEL II,LD,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.033,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,CMP14,EGFR IF AFRICN AM,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,DIFFERENTIAL MANUAL,NEUTROPHILS,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.465,0.465,0.0,0.0,0.0,0.0,0.7071067811865476,0.7071067811865476,1,82511,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.015,0.0225,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,CMP14 LP CBC D PLT TSH,NEUTROPHILS,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,HIV AB AG COMBO RFLX CONF,HIV AB AG COMBO RFLX CONF,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,HEPATITIS C ANTIBODY W REFL HCV RIBA,SIGNAL CUT OFF,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,ASH FIBROSURE,AST SGOT P5P,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,CBC W DIFF PLT,HEMATOCRIT,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.05,0.0,0.1075,0.0,0.0,0.0,0.033468231804587356,0.0,0.0,0.0,0.0,1,882936,CREATININE,EGFR IF AFRICN AM,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,UREA NITROGEN BUN,ICTERUS,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.042260315089851286,0.0,0,7328,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,HEMOGLOBIN A1C W EAG INT CHART,ESTIMATED AVERAGE GLUCOSE,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.2222222222222222,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,HCV FIBROSURE,INTERPRETATION,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,CBC W DIFF PLATELET,EOSINOPHILS,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.06666666666666667,0.05,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,CBC W AUTO DIFF,MONOS ABSOLUTE,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,RPR,TREPONEMA PALLIDUM ANTIBODIES,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,LYMPHOCYTE SUBSET PANEL 4,HELPER SUPPRESSOR RATIO,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,PE RFX IFE S,GAMMA GLOBULIN,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,PE INTERP RFX IFE S,ALBUMIN,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.142,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,1,7369,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,PHOSPHORUS,PHOSPHORUS,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,CBC PLT DIFF,POLYS,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,CBC WITH PLT DIFF,BANDS ABSOLUTE,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,URINALYSIS CULTURE IF INDICATED,GLUCOSE,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,PROTEIN TOTAL URINE,URINE TOTAL PROTEIN,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.047142857142857146,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,MICROALBUMIN CONC,ALB CREAT RATIO,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,TRANSFERRIN SATURATION,TRANSFERRIN,Specimen source identified,Specimen source XXX,Specimen source
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,EIA 10 ALCOHOL W GCMS,URINE CREATININE MG DL,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,HEPATITIS C ANTIBODY W REFL HCV RIBA,SIGNAL CUT OFF,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.21818181818181817,0.34285714285714286,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,HCV FIBROSURE,INTERPRETATION,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.14285714285714285,0.2,0.0,0.0,0.0,0.0,0.10609682943574561,0.05565150370408234,0.0,0.0,0.0,0,223149,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,IRON BINDING CAPACITY,TIBC,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,CHEM SCREEN PANEL HDL,URIC ACID,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,RPR REFLEX TP PA,RPR TITER,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,T3 FREE,T3 FREE,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,CBC WITH PLT DIFF,BASOPHILS ABSOLUTE,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.0,0.047142857142857146,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,APOLIPOPROTEIN A1,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,HEPATITIS C AB,HEPATITIS C AB,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.06200000000000001,0.0,0.0,0.06200000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,HCV QUANT GT1A NS5A PROFILE,HCV NS5A DRUG RESISTANCE ASSAY,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,COMP METABOLIC PANEL W GFR,GLOBULIN,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,ANA AUTOIMMUNE PROFILE,RHEUMATOID FACTOR QUANT,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.375,0.5,0.3333333333333333,0.0,0.0,0.0,0.23353187788891705,0.24209923748073692,0.06538932921065,0.0,0.0,1,25015,IRON BINDING CAPACITY,UIBC NR,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,NASH FIBROSURE,APOLIPOPROTEIN A 1,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0.0,0.0,0.0,0,27771,IGA SERUM,IMMUNOGLOBULIN A,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,URINALYSIS,LEUKOCYTE ESTERASE,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,URINALYSIS W REFLEX MICRO,PROTEIN,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.156,0.78,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,NMR LIPOPROFILE,LDL P,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,T4,T4,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,7062,CBC,BA%,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,CBC PLT DIFF,POLYS,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,LYMPHOCYTE SUBSET PANEL 1,% CD8,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.06333800979436033,0.0,0,134585,CMP14 3AC CBC D PLT RPR MG,MAGNESIUM SERUM,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,CREATINE KINASE TOTAL,HEMOLYSIS,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.15333333333333335,0.25,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,264499,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE EOS,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,HEPATITIS B CORE AB,HEPATITIS B CORE AB,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,CBCI COMPLETE BLOOD COUNT W DIFF,BASOPHILS,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,PSA FREE TOTAL,FREE PSA,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.2,0.5,0.0,0.0,0.0,0.0,0.01791252113618602,0.01814018390164096,0.0,0.0,0.0,0,205070,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0335,0.067,0.1075,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,BUN CREAT RATIO,EGFR AFRICAN AMERICAN,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,COMPREHENSIVE METABOLIC PANEL,ALBUMIN,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,HCV FIBROSURE,INTERPRETATION,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,CBC W AUTO DIFF,MCV,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,CBC W AUTO DIFF WITH PLATELETS,MCHC,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.028571428571428574,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,COMP METABOLIC PANEL,ANION GAP,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,CMP13 LP 2AC CBC D PLT,CHOLESTEROL TOTAL,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,RPR,TREPONEMA PALLIDUM ANTIBODIES,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,STOOL CULTURE,RESULT 2,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0.0,0.0,0.0,0,29512,PROTEIN ELECTROPHORESIS SERUM,ALPHA 2,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.033,0.047142857142857146,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,MANUAL DIFFERENTIAL,BLASTS %,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,GLUCOSE,GLUCOSE FASTING,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,HEP A AB TOTAL,HEP A AB TOTAL,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,HEP B SURFACE AB,HEP B SURFACE AB,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,GGTP,GGTP,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.010338633511861373,0.0,0.0,0.0,0.0,0,273532,COMPLETE BLOOD COUNT,WBC,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,CBC D PLT,HEMOGLOBIN,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.25,0.09090909090909091,1.0,0.0,0.0,0.0,0.058854483963441506,0.04322678270641078,1.0,1,611517,COMPREHENSIVE METABOLIC PANEL,ALBUMIN,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.14285714285714285,0.06142857142857143,0.215,0.14285714285714285,0.06142857142857143,0.215,0.017169721434868168,0.024318641681776887,0.09518537001083005,0.02271340649845821,0.03217053905643563,0.12591840875016092,0,296095,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,LIVER FIBROSIS PANEL,ALT,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.07142857142857142,0.16666666666666666,0.0,0.07142857142857142,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,RPR W RFLX CONFIRM,RPR SYPHILIS SCREEN,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,OBSTETRIC PANEL,NEUTROPHILS,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,HEPASCORE R,SEX,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,VITAMIN D 25 OH TOTAL IA,VITAMIN D 25 OH TOTAL IA,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,URINALYSIS REFLEX,NITRITE,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,TRANSFERRIN,TRANSFERRIN,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,HIV AB EIA WITH REFLEX,HIV AB,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.06899999999999999,0.11499999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,CLR CBC W DIFF PLT,ABSOLUTE BLASTS,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.165,0.265,0.0,0.5,0.5,1.0,0.0,0.0,0.0,0.1503314858492919,0.7071067811865476,1.0,1,57786,URINALYSIS WITH MICROSCOPIC,COLOR,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,VIT B 12 FOLATE PANEL,FOLIC ACID,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,LD,LIPEMIA,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,PROTEIN ELECTROPHORESIS SERUM,ALPHA 1,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.3333333333333333,1.0,0.0,0.0,0.0,0.0,0.530776546300907,1.0,1,30940,CMP WITH ESTIMATED GFR CALCULATED,UREA NITROGEN,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,HIV 1 RNA QN RT PCR,LOGCOPIES ML,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,RPR,TREPONEMA PALLIDUM ANTIBODIES,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.16666666666666666,0.5,0.0,0.0,0.0,0.0,0.01159552909648498,0.011888453674722133,0.0,0.0,0.0,0,205088,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,HEPATITIS C REFLEX PCR,HEPATITIS C ANTIBODY,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,CMP14 LP 3AC,ALKALINE PHOSPHATASE S,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.09,0.12666666666666668,0.19,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,COMP METABOLIC PANEL W GFR,GLOBULIN,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,TRICHOMONAS MALE,SOURCE,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.05,0.07142857142857142,0.0,0.022,0.03142857142857143,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,COMMENTS,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,NASH FIBROSURE,WEIGHT,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.25666666666666665,0.1325,0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.08466774310592073,0.09762443806815091,1.0,1,58032,URINALYSIS CULTURE IF INDICATED,PH,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,HAPTOGLOBIN,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,STOOL CULTURE,RESULT 2,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,URINALYSIS COMPLETE,GLUCOSE,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.03818181818181818,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,PE INTERP RFX IFE S,ALBUMIN,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CBC,MCHC,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,MA COMP METABOLIC PNL,ALKALINE PHOSPHATASE,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,IRON TOTAL BINDING CAPACITY,LIPEMIA,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,NASH FIBROSURE,HEIGHT,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,CMP14 HP4 1AC PT AFP,PROTHROMBIN TIME,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,CMP14 TP TSH 2AC CBC D PLT,AMYLASE SERUM,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0633025934653415,0.0,0.0,0.0,0.0,0,303768,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,URINALYSIS W MICRO W REFLEX CULTURE,WBC,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,ASH FIBROSURE,COMMENT,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,COMP METABOLIC PANEL W O EGFR,CREATININE,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.22,0.16666666666666666,0.5,0.0,0.0,0.0,0.0,0.09805016057751559,1.0,1,151522,FSRC NEW PATIENT PANEL,D BILIRUBIN,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,PTT,PTT,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,COMPREHENSIVE METABOLIC PANEL WITH GFR,ALBUMIN,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.25,0.16699999999999998,0.5,0.0,0.0,0.0,0.049020432311290385,0.0,0.0,1,302398,NASH FIBROSURE,AST SGOT P5P,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.134,0.0,0.1325,0.134,0.0,0.1325,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,TSH 3RD GENERATION REFL,TSH 3RD GENERATION REFL,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.047142857142857146,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.2783333333333333,0.0,0.0,0.0,0.0,0.0,0.024920686683550963,0.04503052695530496,0.061702657454847154,0,134999,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,HEPATIC FUNCTION PANEL 6,AST SGOT,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.16666666666666666,0.2727272727272727,0.715,0.3333333333333333,0.3509090909090909,0.965,0.026355222038017434,0.08088757789668977,0.22524969726717137,0.31896597628999945,0.015701413246755114,0.04372412516808821,1,112599,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HCV RNA QUAL TMA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,HEPATIC FUNCTION PANEL,BILIRUBIN INDIRECT,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,VITAMIN D 25 OH,VITAMIN D 25 OH,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.14285714285714285,0.3333333333333333,0.0,0.14285714285714285,0.3333333333333333,0.0,0.4596659728295528,0.8660254037844386,0.0,0.530776546300907,1.0,1,18259,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.19999999999999998,0.27999999999999997,0.0,0.0,0.0,0.0,0.04813180165558817,0.12210584428057858,0.0,0.0,0.0,0,487967,COMP METABOLIC PANEL W EGFR,UREA NITROGEN,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.596,0.548,0.435,0.348,0.148,0.185,0.0074752449497415,0.0224257348492245,0.05956676211255352,0.024494182533464692,0.0,0.0,1,345355,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,DRGABU2,METHAQUALONE,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,CBC H H RBC INDICES WBC PLT,MPV,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,CMP14 HP4 DBILI CBC D PLT R,AMYLASE,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,CMP14 LP CBC D PLT,HEMATOCRIT,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,HEPATITIS B CORE TOTAL AB,HEPATITIS B CORE TOTAL AB,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,CBC WITH PLT DIFF,OTHERS,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.07870803013413097,0.08411277379800186,0.09704900074164846,1,264788,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,CBC INCLUDES DIFF PLT,ABSOLUTE NEUTROPHILS,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,DRUG ABUSE SCREEN III,METHAQUALONE,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,DRUG ABUSE SCREEN III,METHADONE,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,COMP METABOLIC PANEL CLARIFICATION,EGFR NON AFR AMERICAN,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.15,0.0,0.0,0.15,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,VITAMIN B 12,VITAMIN B 12,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,CHEM SCREEN PANEL HDL,URIC ACID,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,SPECIAL CUM 50 PLUS PROFILE # 10190,SEDIMENTATION RATE,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,URINALYSIS W REFLEX MICRO,PROTEIN,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,BMP,CHLORIDE,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.011764705882352941,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,CBC W AUTO DIFF,% MONOCYTES,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,URINALYSIS W MICRO,GLUCOSE,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.0,0.03125,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,DRUG ABUSE SCREEN 9 NO THC W CONF,BARBITURATES,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,APTT,PARTIAL THROMBOPLASTIN,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,MAGNESIUM,MAGNESIUM,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,DRUG ABUSE SCREEN W ETOH NO GCMS,COCAINE METABOLITE,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.11399999999999999,0.13249999999999998,0.1875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,HIV AB EIA WITH REFLEXES,HIV EIA AB SCREEN,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,REFLEX ANA PATTERN,PATTERN 1,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,OXYCODONE,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.07142857142857142,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,RPR,RPR RESULT,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.186,0.16909090909090907,0.2657142857142857,0.386,0.24181818181818182,0.38,0.019803931122492457,0.0228095548399192,0.02456821931404507,0.05423529901533852,0.062466538562374274,0.06728283958018277,1,568881,HIV ANTIGEN ANTIBODY FOURTH GEN,HIV AG AB 4TH GEN,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.172,0.2866666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,IRON BINDING CAPACITY,IRON TOTAL,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,LIVER PANEL II,LD,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,FREE T4,FREE T4,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.2,0.34375,0.4583333333333333,0.2,0.375,0.89,0.03628551739281716,0.1524643612967882,0.11313616447240271,0.03628551739281716,0.2286965419451823,0.16970424670860396,0,519132,HEP A AB IGM,HEPATITIS A AB IGM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,BMP,CHLORIDE,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,HEPATITIS B SURFACE ANTIGEN,HBS AG SCREEN,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,HEMOGLOBIN A1C W EAG INT CHART,ESTIMATED AVERAGE GLUCOSE,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,URINALYSIS CULTURE IF INDICATED,COLOR,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,ACCUTYPE R IL28B,IL28B GENOTYPE,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,COMP METABOLIC PANEL W O EGFR,CREATININE,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,CBC INCLUDES DIFF PLT,BLASTS,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,SED RATE WESTERGREN,SED RATE WESTERGREN,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,IRON BINDING CAPACITY,UIBC NR,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.06818181818181818,0.10714285714285714,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,HEPATIC FUNCTION PNL,PROTEIN TOTAL,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,CBC WITH DIFFERENTIAL,IMMATURE GRANS,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.14285714285714285,0.3333333333333333,0.0,0.14285714285714285,0.3333333333333333,0.0,0.4596659728295528,0.8660254037844386,0.0,0.4596659728295528,0.8660254037844386,1,18259,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,FSRC NEW PATIENT PANEL,D BILIRUBIN,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,HEP C VIRUS ANTIBODY,HEP C VIRUS ANTIBODY,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,CMP14 HP5 LP 6AC CBC D PLT,BILIRUBIN INDIRECT,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.045454545454545456,0.125,0.0,0.030000000000000002,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,CBC INC DIFF PLT,RBC,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.25,0.25,0.3333333333333333,0.25,0.25,0.3333333333333333,0.04685168357877478,0.04198853313366668,0.048694979833627805,0.04685168357877478,0.04198853313366668,0.048694979833627805,1,45484,GLYCOHEMOGLOBIN A1C,GLYCOHEMOGLOBIN A1C,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,NASH FIBROSURE,HAPTOGLOBIN,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,PSA TOTAL,PSA TOTAL,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,BMP8 ANION GAP,EGFR IF NONAFRICN AM,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,MAGNESIUM,MAGNESIUM,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.4,0.25,0.6666666666666666,0.0,0.0,0.0,0.43159805011496677,0.036870751523516376,0.02890669461985995,1,141358,LYMPHOCYTE SUBSET PANEL 1,ABSOLUTE CD8 CELLS,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,T LYMPHOCYTE HELPER SUPPRESSOR,LYMPHS,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.0,0.0,0.0,0.0,0.08779161868611507,1.0,0.0,1,285395,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCH,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,FE TIBC FER,IRON BIND CAP TIBC,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.1063004130698838,0.10964330813284906,0.7071067811865476,1,264846,CBC WITH PLT DIFF,MONOCYTES ABSOLUTE,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.15,0.0,0.0,0.15,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,IMMUNOGLOBULIN M IGM,IMMUNOGLOBULIN M,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,UA W MICRO HOLD SPEC 24 HR,GLUCOSE,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,SEGMENTED NEUTROPHILS,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,COMMENTS,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,SPECIAL CUM 50 PLUS PROFILE # 10190,SEDIMENTATION RATE,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.11142857142857143,0.26,0.0,0.10571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,C REACTIVE PROTEIN INFLAMMATORY,C REACTIVE PROTEIN,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,CBC WITH PLT DIFF,MONOCYTES ABSOLUTE,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,CBC PLT DIFF,POLYS,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,ARTHRITIS PROFILE,RHEUMATOID FACTOR QUANT,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,TSH 3RD GENERATION REFL,TSH 3RD GENERATION REFL,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.2,0.16666666666666666,0.0,0.2,0.16666666666666666,0.3333333333333333,0.009814692540447978,0.007890678365173986,0.0,0.048918155723576384,0.039328530307136456,0.07241200273157788,1,237610,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,DRUG ABUSE SCREEN 9 NO THC W CONF,BARBITURATES,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,MA CBC DIFF PLT,MONOCYTES %,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESISTANCE ASSAY PDF,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual,Promyelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,ANA TITER PATTERN,ANA TITER,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,IFE PE SERUM,ALBUMIN,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,IRON TOTAL BINDING CAPACITY,IRON TOTAL,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,CBC,MO%,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,URINALYSIS REFLEX,NITRITE,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CHEM SCREEN PANEL HDL,TRIGLYCERIDES,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.02666666666666667,0.1,0.0,0.011333333333333334,0.0425,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,CHEM 20,CHOLESTEROL,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,CYSTIC FIBROSIS SCREEN,ETHNICITY,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,COMPREHENSIVE METABOLIC PANEL AMA,SODIUM,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,VITAMIN D 25 OH TOTAL IA,VITAMIN D 25 OH TOTAL IA,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,CBC WITH DIFF PLATELET,EOS ABSOLUTE,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.3333333333333333,0.0,0.0,0.3333333333333333,0.14285714285714285,0.3333333333333333,0.04814691864430287,0.0,0.0,0.04814691864430287,0.1353392877707238,0.20412414523193145,1,25007,FE TIBC FER,IRON BIND CAP TIBC,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,FREE T4 THYROXINE,FREE T4,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,CMP14 LP 7AC CBC D PLT T B,IRON SATURATION,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.10357142857142858,0.2625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,CBCI COMPLETE BLOOD COUNT W DIFF,ABS BASOPHILS,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,CMP14 TP TSH 2AC CBC D PLT,AMYLASE SERUM,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,CMP,ALT SGPT,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.11399999999999999,0.08142857142857142,0.1425,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,CD4 T HELPER PANEL,CD4 CD3 %HELPERS,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,DRUG ABUSE PANEL 10 WITH OXYCODONE,COCAINE METABOLITE,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,CBCI COMPLETE BLOOD COUNT W DIFF,BASOPHILS,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.06625,0.0,0.0,0.06625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,CERULOPLASMIN,CERULOPLASMIN,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.014350566291898903,0.0,0.0,0.0,0.0,0,111252,CBC COMPLETE BLOOD COUNT W O DIFF,HEMATOCRIT,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,CMP14 6AC,PHOSPHORUS,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,CBC W AUTO DIFF WITH PLATELETS,MCV,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,PE INTERP RFX IFE S,BETA GLOBULIN,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.024800713330996538,0.0,0.0,0.0,0.0,0,264531,COMPLETE BLOOD COUNT,WBC,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,PSA FREE TOTAL,INTERNAL %,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,TSH 3RD GENERATION,TSH 3RD GENERATION,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,COMP METABOLIC PANEL W GFR,ANION GAP,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHADONE,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,PT PROTIME,INR,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.25,0.2,0.3333333333333333,0.0,0.0,0.0,0.033955663578360995,0.04983141571783456,0.05851014153708933,1,112821,CBC WITH PLT DIFF,NO CELLS DIFF,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.134,0.0,0.0,0.11399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.022,0.044,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,BMP8 ANION GAP,EGFR IF NONAFRICN AM,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.45,0.0,0.0,0.45,0.0,0.0,0.02574435456713875,0.0,0.0,0.04459053011835212,0.0,0.0,1,422543,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,LIPID PANEL,,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.22,0.16666666666666666,0.5,0.0,0.0,0.0,0.0,0.05660928660351461,0.5773502691896257,0,151522,CHEM SCREEN PANEL,BILIRUBIN DIRECT,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.0,0.01,0.035,0.0,0.015714285714285715,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,HEMATOPATH CONSULTATION SMEAR,HEMATOLOGY COMMENTS,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,COMPREHENSIVE METABOLIC PANEL WITH GFR,ALBUMIN,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,TESTOSTERONE,TESTOSTERONE,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.4766666666666666,0.25,0.5,0.0,0.0,0.0,0.010626391791545897,0.6369705461296918,0.9870524497488843,1,312017,AAA MALE PANEL,HIV 1 HIV 2 AB SCREEN,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.016666666666666666,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,AUTOMATED BLD CNT,HEMOGLOBIN,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.3333333333333333,0.16666666666666666,0.5,0.0,0.0,0.0,0.09173176111477566,0.11030835743396694,0.0,0.0,0.0,0.0,0,205088,RPR,TREPONEMA PALLIDUM ANTIBODIES,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,TRANSFERRIN,TRANSFERRIN,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.2,0.16666666666666666,0.0,0.2,0.16666666666666666,0.3333333333333333,0.009413595328285118,0.0075011219466417645,0.0,0.06635350960296393,0.05287307875068503,0.08777198612321668,1,7096,MANUAL DIFFERENTIAL,BLASTS %,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,IRON TOTAL BINDING CAPACITY,IRON TOTAL,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.03666666666666667,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,IRON BINDING CAPACITY,TIBC,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,HCV FIBROSURE LABCORP,RESULT,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,FOLLOW UP PNL ARAKAWA,SODIUM,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,CMP14 LP 2AC CBC D PLT MG T,WBC,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,UREA NITROGEN BUN,ICTERUS,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,COMP METABOLIC PANEL CLARIFICATION,ALT,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,CMP14 LP 3AC,ALKALINE PHOSPHATASE S,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,URINALYSIS CULTURE IF INDICATED,BACTERIA,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.08333333333333333,0.125,0.0,0.055,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.2,0.0,0.22333333333333336,0.4,0.6666666666666666,0.0,0.014350566291898903,0.0,0.0,0.05336825693147673,0.05352091133427317,1,111252,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.06738029520353905,0.0,0.0,0.0,0.0,0,205674,PROTEIN ELEC INTERP SERUM,ALPHA 2 GLOBULIN,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.0,0.0,0.0,0.19333333333333336,0.11600000000000002,0.29000000000000004,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,HEPATITIS PANEL ACUTE,HEPATITIS C AB CIA,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Sex,Sex,Sex
0.534,0.0,0.0,0.534,0.0,0.0,0.09169367941772788,0.0,0.0,0.09169367941772788,0.0,0.0,1,19893,VITAMIN D 25 OH,VITAMIN D 25 OH,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,URINALYSIS SCREEN,BACTERIA,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.11,0.182,0.33,0.0,0.11600000000000002,0.29000000000000004,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,HCV AB WITH RFL RNA QT,HCV SIGNAL CUTOFF,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.0,0.03571428571428571,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,PROTHROMBIN PTT,CONTROL,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,HEP A AB IGM,HEPATITIS A AB IGM,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,CBC W AUTO DIFF WITH PLATELETS,MCV,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,CBC INCLUDES DIFF PLT,MCHC,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,CREATINE KINASE TOTAL,HEMOLYSIS,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.25,0.3333333333333333,1.0,0.46499999999999997,0.16666666666666666,0.5,0.019466308975503166,0.21462171910367378,0.4714045207910318,0.033716636181405524,0.1858678609476695,0.40824829046386313,1,25023,IRON BINDING CAPACITY % SATURATION,CALCULATED % IRON SAT,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,HCV FIBROSURE,INTERPRETATION,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,PROTIME PTT,PTT,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,CBC INCLUDES DIFF PLT,RDW,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,IRON BINDING CAPACITY IBC % SATURATION,UNSATURATED IBC,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.25,0.0,0.0,0.0,0.0,0.0,0.01352557406596222,0.0,0.0,0.0,0.0,0.0,0,192955,HCV RNA QN REAL TIME PCR W RFLX QL,HCV RNA LOG IU ML,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,ALPHA FETOPROTEIN TUMOR MARKER,AFP TUMOR MARKER,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,CBC WITH PLT DIFF,PROMYELOCYTES,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,DRUG ABUSE SCREEN II,METHAQUALONE,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,COMP METABOLIC PANEL W EGFR,UREA NITROGEN,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,DRUG ABUSE PANEL 10 WITH OXYCODONE,OPIATES,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.057999999999999996,0.0,0.0,0.08,0.05,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,CBCI COMPLETE BLOOD COUNT W DIFF,BASOPHILS,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,HEPATIC FUNCTION PNL,PROTEIN TOTAL,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,URINALYSIS ROUTINE,WBC,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.03775254682189788,0.13881877602428572,0.4082482904638629,0.06538932921065,0.24044117311858715,0.7071067811865476,1,24984,IRON BINDING CAPACITY,IRON TOTAL,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.34375,0.6875,0.0,0.34375,0.6875,0.0,0.05345799931322692,0.07240860968350848,0.0,0.05345799931322692,0.07240860968350848,1,139550,HEP C VIRUS ANTIBODY,HEP C VIRUS ANTIBODY,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.066,0.08833333333333333,0.0,0.4,0.3333333333333333,1.0,0.0,0.0,0.0,0.11277316640103974,0.16750164273558021,1.0,1,57992,URINALYSIS,LEUKOCYTE ESTERASE,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.06,0.05142857142857143,0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,COMP METABOLIC PANEL,ANION GAP,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,URINALYSIS RX ALB CREA,KETONES,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,PSA FREE TOTAL,FREE PSA,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.08,0.1285714285714286,0.3,0.08,0.05714285714285715,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,IRON BINDING CAPACITY % SATURATION,CALCULATED % IRON SAT,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.2,0.09090909090909091,0.25,0.4,0.09090909090909091,0.25,0.02772918502773436,0.08470578227256831,0.04946429335601732,0.08318755508320308,0.12705867340885235,0.09892858671203453,0,542183,CD4 T HELPER PANEL,CD4 CD3 %HELPERS,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,CMP14 HP5 LP 6AC CBC D PLT,BILIRUBIN INDIRECT,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,CMP13 LP TP TSH 2AC CBC D P,LDL CHOLESTEROL CALC,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.14285714285714285,0.3333333333333333,0.3333333333333333,0.14285714285714285,0.3333333333333333,0.0,0.043196238761996186,0.044151771767438786,0.0834655896020069,0.0,0.0,1,544346,LIPOPROTEIN ANALYSIS NMR,LDL P,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,COMP METABOLIC PANEL,,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,HEMATOPATH CONSULTATION SMEAR,HEMATOLOGY COMMENTS,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.392,0.45,0.98,0.392,0.392,0.98,0.032370385903997545,0.0449917128842755,0.05839673124596356,0.03737810203089009,0.05195195509007766,0.06743073700930258,1,172841,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.31,0.0,0.0,0.31,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,LIVER FIBROSIS,NECROINFLAM ACT GRADE,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.2,0.0,0.0,0.2,0.0,0.0,0.17001758398860156,0.0,0.0,0.1963193957655779,0.0,1,24653,IFE PE FLC SERUM,IMMUNOGLOBULIN G QN SERUM,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,HIV AB EIA WITH REFLEX,HIV AB,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,CBC WITH AUTO DIFF,RDW,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,CMP,ALT SGPT,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.1111111111111111,0.2,0.0,0.0,0.0,0.0,0.055446852762574106,0.07759701258884111,0.0,0.0,0.0,0,139527,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS C ANTIBODY,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,AMYLASE,AMYLASE,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,PTT,PTT,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,CBC INCLUDES DIFF PLT,EOSINOPHILS,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.24333333333333332,0.186,0.7,0.0,0.0,0.0,0.0,0.06679361170328513,0.1964314811924487,1,28852,HEPATIC FUNCTION PNL,PROTEIN TOTAL,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,HEPATIC FUNCTION PNL,PROTEIN TOTAL,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.0,0.0,0.0,0.43,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,CBC WITH AUTO DIFF,NRBC,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,COMP METABOLIC PANEL W EGFR,UREA NITROGEN,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD4 CELLS,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.11399999999999999,0.08142857142857142,0.11399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,DRUG ABUSE SCREEN III,METHAQUALONE,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.11399999999999999,0.285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,DRUG ABUSE SCREEN III,METHADONE,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.16,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,LD,LIPEMIA,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,ALPHA 2 MACROGLOBULIN,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06691275831255872,0.06348916544989514,0.09169555407390673,1,7062,CBC INC DIFF PLT,BASOPHILS,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.2866666666666667,0.172,0.0,0.2866666666666667,0.172,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,121855,PROTIME PTT,PTT,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,TSH 3RD GENERATION REFL,TSH 3RD GENERATION REFL,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,CMP14 CBC D PLT TSH,ALBUMIN,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,BUN CREAT RATIO,EGFR AFRICAN AMERICAN,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.0,0.125,0.1875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,HEPATIC FUNCTION PNL,PROTEIN TOTAL,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.14500000000000002,0.11600000000000002,0.19333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,T LYMPHOCYTE HELPER SUPPRESSOR,LYMPHS,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06635350960296393,0.05287307875068503,0.08777198612321668,1,7492,CBC WITH DIFFERENTIAL,MYELOCYTES,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,PSA WITH FREE RATIO,PSA ROCHE E170,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,COMPREHENSIVE METABOLIC PANEL E GFR,ALT,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,PROTEIN TOTAL 24HR URINE W CREAT,UR CREAT RANDOM MG DL,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.012393511558828618,0.012678758772981302,0,108860,URINALYSIS W REFLEX MICRO,SPECIFIC GRAVITY,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0382616086406824,0,7856,HEMOGRAM W O DIFFERENTIAL,MEAN PLATELET VOLUME,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.19999999999999998,0.0,0.0,0.19999999999999998,0.0,0.0,0.0,0.0329295894158842,0.033780845966761563,0.0,0.04656947195532102,0.04777333051463073,0,433961,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,ASH FIBROSURE,HEIGHT,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,CBC WITH DIFFERENTIAL PLATELETS,EOS,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,CBC WITH DIFFERENTIAL,HEMATOCRIT,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,MICROALBUMIN CONC,ALB CREAT RATIO,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.08,0.07272727272727274,0.1142857142857143,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,CBC INCLUDES DIFF PLT WITH PATHOLOGIST REVIEW,ABSOLUTE LYMPHOCYTES,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,STOOL CULTURE,RESULT 1,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0825,0.10600000000000001,0.0,0.21000000000000002,0.2,0.5,0.0,0.0,0.0,0.0,0.38075107277079945,1.0,1,58115,URINALYSIS W REFLEX MICRO,SPECIFIC GRAVITY,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.148,0.37,0.0,0.0,0.0,0.0,0.06755685946200152,0.08775968141298807,1,473835,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.011764705882352941,0.025,0.0,0.039411764705882354,0.08375,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,TESTOSTERONE FREE TOTAL LC MS MS,FREE TESTOSTERONE,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.03,0.024444444444444446,0.03666666666666667,0.055,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.04020134008575915,0.0,0,481598,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.06916666666666667,0.0,0.0,0.0,0.0,0.0,0.031811089746947796,0.0,0.0,0.0,0.0,0,115790,PROTEIN ELECTROPHORESIS SERUM,ALPHA 1,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,HEPATITIS BE AG,HB E AG,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.072,0.0625,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,COMPREHENSIVE METABOLIC PANEL E GFR,ALT,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.07142857142857142,0.125,0.0,0.05896036458680387,0.0,0.0,0.0,0.0,0,327692,IGA SERUM,IMMUNOGLOBULIN A,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,CBC W AUTO DIFF,% EOSINOPHILS,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06797427042040116,0.05720402135206337,0.7071067811865476,0,7310,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,PROTEIN ELECTROPHORESIS SERUM,ALPHA 2,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,PHOSPHATE AS PHOSPHORUS,LIPEMIA,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.0,0.0,0.0,0.205,0.42857142857142855,0.3333333333333333,0.0,0.0,0.0,0.0,0.9309084648501563,1.0,1,18358,LIVER FIBROSIS FIBROTEST,ALPHA 2 MACROGLOBULIN,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,URINALYSIS CULTURE IF INDICATED,GLUCOSE,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,PROFILE 1236 LIPID PANEL WITH DIRECT LDL,CHOL HDL,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,VITAMIN D 25 OH,VITAMIN D 25 OH,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,HBSAB AG,HEP B SURFACE AB QUAL,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,CBC WITH PLT DIFF,OTHERS,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,FREE T4 THYROXINE,FREE T4 THYROXINE,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.03125,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,CBC H H RBC INDICES WBC PLT,MPV,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,LIPID PROFILE,FASTING NON FASTING,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,VITAMIN D 25 OH TOTAL IA,VITAMIN D 25 OH TOTAL IA,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,HIV AB AG COMBO RFLX CONF,HIV AB AG COMBO RFLX CONF,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.047142857142857146,0.030000000000000002,0.0,0.14285714285714285,0.09090909090909091,0.5,0.0,0.0,0.0,0.0872369085792638,0.0,0.0,1,17442,COMPREHENSIVE METABOLIC PANEL E GFR,ALT,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,HEPATITIS C ANTIBODY W REFL HCV RIBA,SIGNAL CUT OFF,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,IRON BINDING CAPACITY,UIBC,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.2,0.3814285714285714,0.534,0.2,0.3814285714285714,0.534,0.035890626697693606,0.13654320214078375,0.1378341405618373,0.035890626697693606,0.13654320214078375,0.1378341405618373,1,223222,HEPATITIS BS AB QUANT,HEPATITIS BS AB INTERP,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,HEPATIC FUNCTION PANEL,ALK PHOS,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,VITAMIN B 12,VITAMIN B 12,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.25,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,HEPATITIS B SURFACE ANTIGEN,HBS AG SCREEN,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,IMMUNOGLOBULIN M,IMMUNOGLOBULIN M,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,CMP,EGFR NON AFRICAN AMERICAN,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.06,0.0,0.0,0.15,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,COMP METABOLIC PANEL W EGFR,PROTEIN TOTAL,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.5,0.16666666666666666,0.2,0.0,0.0,0.0,0.11136168435129556,0.05936451274361987,0.17946985244079683,1,63016,PROTIME PTT,INR,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,CBC WITH AUTO DIFF,RDW,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.4,0.14285714285714285,0.0,0.4,0.2857142857142857,0.0,0.039530984740405506,0.1524993434381573,0.0,0.04841537082187086,0.18677278876646775,0.0,1,21329,VITAMIN B12 FOLATE,VITAMIN B12,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.07142857142857142,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCH,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,URINALYSIS,BILIRUBIN,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,HEMATOPATH CONSULTATION SMEAR,HEMATOLOGY COMMENTS,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,HCV GENOTYPE REFLEX NS5A,PLEASE NOTE,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.25,0.0,0.0,0.5,0.5,0.0,0.017075759171271132,0.0,0.0,0.0,0.0,0,81240,COMPLETE BLOOD COUNT,RBC,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,CBC INCLUDES DIFF PLT,RDW,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.11,0.0825,0.0,0.15333333333333335,0.25,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,264499,SPECIAL NEW ANNUAL COMM INSURANCE #6925,ABSOLUTE EOS,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,CLR CBC W DIFF PLT,ABSOLUTE BLASTS,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,URINALYSIS,LEUKOCYTE ESTERASE,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,UA W RFLX MICROSCOPIC,BILIRUBIN,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.16666666666666666,0.1111111111111111,0.3333333333333333,0.0,0.0,0.0,0.029460354621337115,0.03630345171580529,0.09932291697899664,0,273532,URINALYSIS COMPLETE,GLUCOSE QL,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.2857142857142857,0.4,0.0,0.2857142857142857,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,HCV GENOTYPE REFLEX NSA,HCV GENOSURE R NSA INTERP,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,COMP METABOLIC PANEL,CARBON DIOXIDE,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,TSH 3RD GENERATION,TSH 3RD GENERATION,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,HEPATITIS BE AG,HBEAG INS NR,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,DRGABU2,METHAQUALONE,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,DIRECT LDL,LDL CHOLESTEROL DIRECT,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,T LYMPHOCYTE HELPER SUPPRESSOR,LYMPHS,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,COMPREHENSIVE METABOLIC PANEL WITH GFR,T BILIRUBIN,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,SUNRISE LABS ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,IMMUNOGLOBULIN M,IMMUNOGLOBULIN M,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,CBC WITH DIFFERENTIAL,IMMATURE GRANS,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,DRUG ABUSE SCREEN I NO GCMS,BARBITURATES,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,NASH FIBROSURE,HAPTOGLOBIN,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,BMP8 CBC D PLT UA,EOS ABSOLUTE,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,URINALYSIS W REFLEX MICRO,BACTERIA,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,REFLEXED LDL,LDL DIRECT,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,TSH 3RD GENERATION,TSH 3RD GENERATION,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,HEPATIC FUNCTION PANEL AMA,GLOBULIN,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,CBC W AUTO DIFF WITH PLATELETS,RDW,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,CMP14 LP 3AC,ALKALINE PHOSPHATASE S,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,HEPATITIS PANEL ACUTE,HEPATITIS C AB CIA,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,COMPLETE BLOOD COUNT,BASOPHILS %,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,TESTOSTERONE FREE TOTAL LC MS MS,FREE TESTOSTERONE,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CARETC CMP LIPID URIC ACID DIR BILI PROFILE,RISK RATIO LDL HDL,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE AG,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0618006251322335,0.0,0.0,1,7880,CBC INCLUDES DIFF PLT,RDW,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,24588,CMP12 7AC MG,PHOSPHORUS SERUM,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,HCV GENOTYPE REFLEX NSA,HEPATITIS C GENOTYPE,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,CBC W AUTO DIFF,% MONOCYTES,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,HIV 1 RNA QN RT PCR,RACE NR,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,RPR SCREEN W TITER,RPR SCREEN,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,DIFFERENTIAL MANUAL,EOSINOPHILS,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,CBC WITH DIFFERENTIAL,HEMATOCRIT,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.021862468942030144,0.0,0.0,0.0,0.0,0,81224,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.29000000000000004,0.3333333333333333,0.3333333333333333,0.0,0.0,0.0,0.0,0.09061940958216264,0.09061940958216264,0,487934,HCV FIBROSURE,NECROINFLAMMAT ACTIVITY SCORE,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.022000000000000002,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,URINALYSIS W REFLEX MICRO,COLOR,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.021294371112735133,0.0,0.0,0.0,0.0,0,7492,COMPLETE BLOOD COUNT,WBC,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.25,0.0,0.0,0.0,0.0,0.0,0.03721434112743194,0.05557781728487099,0.14099568413003705,0.0,0.0,0.0,0,487967,ASH FIBROSURE,FIBROSIS STAGE,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.15000000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,IMMUNOGLOBULINS A E G M SERUM,IMMUNOGLOBULIN G QN SERUM,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,AUTOMATED BLD CNT,HEMOGLOBIN,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,CBC WITH PLT DIFF,PROMYELOCYTES,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,CBC WITH DIFFERENTIAL,MYELOCYTES,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,BUN CREATININE RATIO,HEMOLYSIS,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,CBC WITH DIFFERENTIAL PLATELETS,EOS,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,HEPATITIS B CORE TOTAL AB,HEPATITIS B CORE TOTAL AB,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.055,0.2,0.4,0.04833333333333333,0.1,0.2,0.0,0.0,0.0,0.0,0.04430299837876139,0.09503654320349175,0,79053,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,CMP14 1AC,EGFR IF NONAFRICN AM,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,URINALYSIS SCREEN,BACTERIA,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,HCV QUANT GT1A NS5A PROFILE,HCV NS5A DRUG RESISTANCE ASSAY,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.115,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,7112,CBC WITH DIFF PLATELET,EOS ABSOLUTE,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.04125,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,CBC W AUTO DIFF WITH PLATELETS,RBC,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN TOTAL RANDOM UR,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,GENERAL HEALTH PANEL,HEMATOCRIT,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,LYMPHOCYTE SUBSET PANEL 4,%CD8 SUPPRESSOR T CELLS,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,PROTEIN ELECTROPHORESIS SERUM,ALPHA 2,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,PROTHROMBIN TIME PT,PT CONTROL,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,HCV GENOTYPE REFLEX NSA,HCV GENOSURE R NSA INTERP,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,RPR REFLEX PER CDC,RPR,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,ASH FIBROSURE,WEIGHT,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.025714285714285714,0.015,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,LYMPHOCYTE SUBSET PANEL 4,COMMENT S,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,COMPLETE BLOOD COUNT,MCV,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,HEPATIC FUNCTION PNL,PROTEIN TOTAL,Race,Race,Race
0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.06650223739152306,0.0,0.0,0,7856,CBC NO DIFF,RBC,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,25718,FE TIBC FER,FERRITIN SERUM,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,CBC WITH PLT DIFF,BANDS ABSOLUTE,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,CMP,EGFR NON AFRICAN AMERICAN,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,LIVER FIBROSIS FIBROTEST ACTITEST P,NECROINFLAMMATION ACT GRADE,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.05142857142857143,0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,COMP METABOLIC PANEL CLARIFICATION,ALBUMIN GLOBULIN RATIO,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,FE TIBC FER,IRON BIND CAP TIBC,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,LIPID PROFILE,CHOLESTEROL NON HDL,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,FREE T4 THYROXINE,FREE T4 THYROXINE,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,CBC WITH MANUAL DIFFERENTIAL,MCHC,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,CMP13 LP 2AC CBC D PLT,NEUTROPHILS ABSOLUTE,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,CBC,MCH,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,CBC PLATELET HEM REVIEW,EOS,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,AUTOMATED BLD CNT,HEMOGLOBIN,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.04125,0.0165,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,CBC PLATELET NO DIFFERENTIAL,HEMATOCRIT,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.25,0.16666666666666666,0.0,0.0,0.0,0.0,0.013234788163202671,0.010181580650666988,0.0,0.0,0.0,0.0,0,7534,CBC WITH MANUAL DIFFERENTIAL,MCHC,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,ANA TITER PATTERN,ANA TITER,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.3333333333333333,0.375,0.75,0.0,0.1,0.0,0.31324120943733813,0.38519704454404224,0.8263051464980926,0.0,0.06265390116103764,0.0,1,79053,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,LIPID PROFILE,CHOLESTEROL NON HDL,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,ANA IFA SCREEN WITH REFLEX TITER,ANTI NUCLEAR AB IFA,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.3333333333333333,0.29666666666666663,0.0,0.5766666666666667,0.1111111111111111,0.0,0.010857222961510482,0.30494157177919345,0.0,0.04786359231046444,0.06917196297270611,0.0,1,59014,PROTHROMBIN TIME PT,PT CONTROL,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.2276407094521833,0.0,0,19711,VITAMIN B12 FOLATE,FOLATE SERUM,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,CMP WITH EGFR,CARBON DIOXIDE,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.25,0.4,0.0,0.25,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,ALPHA 2 MACROGLOBULIN,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.1425,0.13857142857142857,0.2425,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,DRUG ABUSE SCREEN I NO GCMS,BARBITURATES,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,LYMPHOCYTE SUBSET PANEL 1,ABSOLUTE CD8 CELLS,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0.0,0.0,0.0,0,24729,PROTEIN ELECTROPHORESIS SERUM,ALPHA 2,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,HEPATIC FUNCTION PANEL,ALK PHOS,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.125,0.0,0.316,0.375,1.0,0.0,0.06192203894113468,0.0,0.0,0.624939177332759,1.0,1,28654,IFE PE SERUM,ALPHA 1 GLOBULIN,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.0,0.0,0.0,0.23249999999999998,0.05,0.1,0.0,0.0,0.0,0.016390301665365148,0.014313075633483385,0.023626567714950197,1,486423,CMP,EGFR NON AFRICAN AMERICAN,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,COMP METABOLIC PANEL W GFR,ANION GAP,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,LYMPHOCYTE SUBSET PANEL 4,%CD8 SUPPRESSOR T CELLS,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,CBC W AUTO DIFF,% LYMPHOCYTES,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.07142857142857142,0.25,0.0,0.07142857142857142,0.25,0.0,0.044495573563027246,0.12591840875016092,0.0,0.044495573563027246,0.12591840875016092,0,110114,HEPATITIS BS AB QUANT,HEPATITIS BS AB QUANT,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,IRON TOTAL BINDING CAPACITY,LIPEMIA,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.06666666666666667,0.06666666666666667,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,ASH FIBROSURE,AST SGOT P5P,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,DRUG ABUSE PANEL 10 WITH OXYCODONE,AMPHETAMINES,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,IRON TIBC,TIBC,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.22333333333333336,0.25,1.0,0.0,0.0,0.0,0.0,0.15505905338492743,1.0,0.0,0.0,0.0,0,384834,CREATININE,EGFR IF AFRICN AM,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Body weight Measured,Weight Measured,Body weight
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,LIPID PROFILE,FASTING NON FASTING,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HEPATITIS BE AG,HBEAG INS NR,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,CBC WITH DIFFERENTIAL,IMMATURE GRANS,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,LYMPHOCYTE SUBSET PANEL 1,ABSOLUTE CD8 CELLS,Appearance of Urine,Appearance Ur,Appearance
0.0,0.2,0.25,0.0,0.0,0.0,0.0,0.031621853677024414,0.08399329824424573,0.0,0.0,0.0,0,345355,HEPATITIS PANEL CHRONIC,HAV AB TOTAL,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,CBC WITH DIFFERENTIAL PLATELETS,EOS,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,UREA NITROGEN BUN,ICTERUS,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0762496717190787,0.0,0.0,0.0,0.0,0,18358,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,LIPID PANEL STANDARD,LDL CHOL CALCULATED,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.0,0.0,0.0,0.02,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,UA W RFLX MICROSCOPIC,BILIRUBIN,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,CBC WITH ABSOLUTE WBCS MPV,MCHC,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.045454545454545456,0.125,0.0,0.0,0.0,0.0,0.04521753067807699,0.0,0.0,0.0,0.0,0,112599,CBC WITH PLT DIFF,MYELOCYTES,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CMP14 HP5 LP 6AC CBC D PLT,INR,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,FOLLOW UP PNL ARAKAWA,SODIUM,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,URINALYSIS SCREEN,BACTERIA,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL AB,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.07825794037235023,0.0,0,427682,ANA CRP ASO PE,P E INTERPRETATION S,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.15000000000000002,0.10714285714285714,0.0,0.15000000000000002,0.10714285714285714,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,IMMUNOGLOBULIN M,IMMUNOGLOBULIN M,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.14285714285714285,0.08333333333333333,1.0,0.0,0.0,0.0,0.032809221376370656,0.0,0.0,1,115790,SPECIAL PROFILE # 5144,TSH ULTRASENSITIVE,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.182,0.25,0.6666666666666666,0.0,0.12384407788226937,0.0,0.0,0.10725211755430386,0.17162008951344032,1,28688,PROTEIN ELECTROPHORESIS SERUM,ALPHA 2,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,RENAL FUNCTION PANEL,CREATININE,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHADONE,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,BUN CREATININE RATIO,BUN CREATININE RATIO,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,CBC WITH PLT DIFF,NRBC,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.12571428571428572,0.29333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,LIPID PANEL STANDARD,LDL CHOL CALCULATED,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,TRANSFERRIN,TRANSFERRIN,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0625,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,CMP WITH EGFR,ANION GAP,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,GLUCOSE,GLUCOSE FASTING,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.0,0.14285714285714285,0.0,0.0,0.14285714285714285,0.0,0.0,0.11961484711383386,0.0,0.0,0.11961484711383386,0.0,0,17426,AFP SERUM TUMOR MARKER,AFP SERUM TUMOR MARKER,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.028571428571428574,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,COMP METABOLIC PANEL W GFR,ANION GAP,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,DIFFERENTIAL MANUAL,NEUTROPHILS,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,LIVER FIBROSIS PNL HEPASCORE TM,GGT,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,OBSTETRIC PANEL,NEUTROPHILS,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.03288659407583738,0.0,0.0,0.0,0.0,0,301804,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.2,0.14285714285714285,0.0,0.0,0.0,0.0,0.03367976760134472,0.0,0.0,0,632117,CMP14 LP 2AC CBC D PLT TSH,EGFR IF AFRICN AM,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,COMPREHENSIVE METABOLIC PANEL W EGF,EGFR NON AFR AMERICAN,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,CBC W AUTO DIFF,MCV,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,CBC WITH DIFFERENTIAL,IMMATURE GRANS,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,CBC WITH DIFFERENTIAL PLATELETS,POLYS,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.386,0.5714285714285714,0.6,0.33399999999999996,0.6828571428571429,0.9560000000000001,0.024069722185166675,0.025720888368633732,0.0,0.019652845868068813,0.021001017411413248,0.02834076815216946,1,728626,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,PE FLC SERUM,ALBUMIN,Specimen source identified,Specimen source XXX,Specimen source
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.0,0.0,0.5,0.5,1.0,0.0,0.0,0.0,0.12460215794786256,0.16901735079974012,1.0,1,330373,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CBC W AUTO DIFF ABS WBC MPV PLT,BASOPHILS,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,DRUG ABUSE SCREEN II,OPIATES,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,FASTING,FASTING STATUS,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,SPECIAL PROFILE # 5144,TSH ULTRASENSITIVE,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,CMP14 LP TP TSH 4AC CBC D PLT,URIC ACID,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CBC W AUTO DIFF,% LYMPHOCYTES,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,CREATINE KINASE CPK TOTAL,CREATINE KINASE CPK TOTAL,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,PROTEIN ELECTROPHORESIS,BETA GLOBULINS,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,URINALYSIS W REFLEX MICRO,PROTEIN,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.023971401232802836,0.0,0.0,0.0,0.0,0,747741,COMPLETE BLOOD COUNT,MCV,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,LYMPHOCYTE SUBSET PANEL 4,COMMENT S,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.07132561100505608,0.0,0,196592,RPR W RFLX CONFIRM,RPR SYPHILIS SCREEN,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,URINALYSIS,LEUKOCYTE ESTERASE,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.25,1.0,0.0,0.0,0.0,0.0,0.15505905338492743,1.0,1,7187,CBC D PLT,HEMOGLOBIN,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,COMP METABOLIC PANEL W O EGFR,CREATININE,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESISTANCE ASSAY PDF,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,CBC W AUTO DIFF WITH PLATELETS,BASOPHILS,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.04608914025403921,0.0,0.0,0.0,0.0,0,304519,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,CBC WITH MANUAL DIFFERENTIAL,MCH,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,CMP14 HP4 DBILI CBC D PLT R,WBC,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.3333333333333333,0.16666666666666666,0.5,0.3333333333333333,0.16666666666666666,0.5,0.09173176111477566,0.11030835743396694,0.0,0.06486415033444226,0.07799978756310755,0.0,1,205088,RPR,RPR RESULT,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,VITAMIN B 12,VITAMIN B 12,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.13833333333333334,0.0,0.0,0.0,0.0,0.0,0.08557545277410739,0.0,0.0,0.0,0.0,0,20859,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,CBC WITH PLT DIFF,OTHERS,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,T3 FREE,T3 FREE,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,FASTING,FASTING STATUS,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,LP WITHOUT VLDL CHOL HDL LD,LDL HDL RATIO,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,URINALYSIS W REFLEX MICRO,NITRITE,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.041999999999999996,0.022,0.16999999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,486423,BMP8 ANION GAP,EGFR IF NONAFRICN AM,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,CMP14 LP CBC D PLT TSH,NEUTROPHILS,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0725,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.03720100626985978,0.0,0,57703,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH TOTAL,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.16,0.0,0.3225,0.2,1.0,0.0,0.061769791070825475,0.0,0.08103461702415493,0.12353958214165095,1.0,1,192708,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,CMP14 CBC D PLT TSH,ALBUMIN,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,TSH 3RD GENERATION REFL,TSH 3RD GENERATION REFL,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.08333333333333333,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,HB S AG W RFX CONF,HEPATITIS B SURFACE ANTIGEN,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,COMP METABOLIC PANEL,CREATININE,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,BILIRUBIN FRACTIONATED,BILIRUBIN INDIRECT,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,TRANSFERRIN SATURATION,TRANSFERRIN,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,MORPHOLOGICAL REVIEW,PLATELET ESTIMATE,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,PHOSPHORUS,PHOSPHORUS,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,CHEM 20,CHOLESTEROL,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.14285714285714285,0.0,0.23400000000000004,0.24714285714285714,0.365,0.0,0.06743111765690757,0.0,0.0,0.0778627478619458,0.0,0,28746,IFE PE FLC SERUM,IMMUNOGLOBULIN G QN SERUM,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,CREATININE,EGFR IF AFRICN AM,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.013888888888888888,0.03125,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,CMP,TCO2,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,CBC COMPLETE BLOOD COUNT W O DIFF,HEMATOCRIT,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,ANA TITER PATTERN,ANA TITER,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.11399999999999999,0.05142857142857143,0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,COMP METAB PANEL,GLUCOSE FASTING,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,ASH FIBROSURE,WEIGHT,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,ASH FIBROSURE,AST SGOT P5P,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,CBC W AUTO DIFF WITH PLATELETS,RBC,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,CMP14,EGFR IF AFRICN AM,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,CBC INC DIFF PLT,RBC,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,CMP14 1AC,EGFR IF NONAFRICN AM,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.06666666666666667,0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,CBC WITH PLT DIFF,MONOCYTES ABSOLUTE,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.25,0.3,1.0,0.0,0.022,0.07333333333333333,0.06380059491394674,0.0,0.0,0.0,0.35622065033847605,0.9888882125258499,1,305227,CRP,C REACTIVE PROTEIN ULTRA,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.027777777777777776,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,ALB ALP ALT AST GGT LD PROT,LDH,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.5,0.4,1.0,0.0,0.0,0.0,0.5980553435796393,0.7141611687807009,0.042181184586030485,1,81224,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,LIPID PROFILE,CHOLESTEROL NON HDL,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,URINALYSIS COMPLETE WITH REFLEX CULTURE,PROTEIN,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,NASH FIBROSURE,ALT SGPT P5P,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,COMPREHENSIVE METABOLIC PANEL E GFR,ALT,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,FOLATE,FOLATE,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,TESTOSTERONE FR DIALYSIS TOTAL LC MS MS,FREE TESTOSTERONE,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,LP WITHOUT VLDL CHOL HDL LD,LDL HDL RATIO,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,URINALYSIS,BILIRUBIN,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,CD4 T HELPER PANEL,CD4 CD3 %HELPERS,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.0,0.0,0.115,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,7112,BMP8 CBC D PLT UA,EOS ABSOLUTE,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,PE FLC SERUM,ALBUMIN,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,PROTEIN TOTAL 24HR URINE W CREAT,UR CREAT RANDOM MG DL,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,CBC WITH DIFFERENTIAL,HEMATOCRIT,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CBC W AUTO DIFF WITH PLATELETS,BASOPHILS,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,LIVER FIBROSIS FIBROMETER,FIBROMETER PATIENT SCORE,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,CBC INCLUDES DIFF PLT,MCHC,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,CMP CBC TSH,ABSOLUTE BLASTS,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,LIPOPROTEIN ANALYSIS NMR,LDL P,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.11833333333333333,0.355,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,CARETC CMP LIPID URIC ACID DIR BILI PROFILE,RISK RATIO LDL HDL,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.03571428571428571,0.022727272727272728,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,TRANSFERRIN,TRANSFERRIN,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.2,0.0,0.22400000000000003,0.376,0.47,0.0,0.013131984011779396,0.0,0.0,0.42501189506304327,0.054596653825419894,1,265058,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,SEGMENTED NEUTROPHILS,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,CBC COMPLETE BLOOD COUNT W O DIFF,HEMATOCRIT,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,24588,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,HEMATOPATH CONSULTATION SMEAR,WBC,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,CBC WITH PLT MAN DIFF,BANDS,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,CULTURE ROUTINE,CULTURE ROUTINE,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.134,0.0,0.0,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,RPR REFLEX TP PA,RPR TITER,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.16666666666666666,0.21428571428571427,0.75,0.0,0.014285714285714287,0.05,0.028539992607010012,0.0,0.0,0.0,0.0,0.0,1,204164,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,LIVER FIBROSIS FIBROMETER,FIBROMETER PATIENT SCORE,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,TRICHOMONAS MALE,SOURCE,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,LYMPHOCYTE SUBSET PANEL 5,CD4 % POS,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.32,0.16666666666666666,0.3333333333333333,0.12,0.16666666666666666,0.3333333333333333,0.0309504251567585,0.03920811077406172,0.053158992087206314,0.0,0.06791043992946355,0.09207407517419319,1,130682,REFLEX ANA PATTERN,PATTERN 1,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.04777777777777778,0.0,0.21,0.1111111111111111,0.25,0.0,0.0,0.0,0.0,0.006076686051585067,0.009744924678454114,1,32896,MCCARJUH MCCARTHY PROFILE 1,PROTHROMBIN TIME PT,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,29512,COMP METABOLIC PANEL 13,ALBUMIN SERUM,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,CBC WITH AUTO DIFF,NRBC,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.10444444444444444,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,CBC W AUTO DIFF WITH PLATELETS,MCHC,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.2,0.16666666666666666,0.0,0.142,0.16666666666666666,0.3333333333333333,0.03042664053714239,0.0,0.0,0.0,0.0,0.0,1,7369,CBC D WITH PLT CITRATED BLD,LYMPHS,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,PSA FREE TOTAL,INTERNAL %,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,HEPATITIS PANEL CHRONIC,HAV AB TOTAL,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,BUN CREATININE RATIO,HEMOLYSIS,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CBC ESR,ABSOLUTE NEUTROPHILS,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,DRUG ABUSE SCREEN II,OPIATES,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.146,0.4716666666666667,0.5,0.0,0.0,0.0,0.0,0.12820999839172398,0.40824829046386313,0.0,0.07402207708426334,0.0,1,128512,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,HEPATITIS PANEL CHRONIC,HAV AB TOTAL,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.14285714285714285,0.25,0.0,0.14285714285714285,0.25,0.0,0.011746428970376033,0.011847065581821359,0.0,0.03754678212513474,0.0378684612442336,0,142513,HIV AB EIA WITH REFLEXES,HIV EIA AB SCREEN,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,CYSTIC FIBROSIS SCREEN,ETHNICITY,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.15,0.0,0.0,0.15,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,VIT B 12 FOLATE PANEL,VITAMIN B 12,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.25,0.2,0.3333333333333333,0.0,0.0,0.0,0.033955663578360995,0.04983141571783456,0.05851014153708933,1,112821,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,PTH INTACT WITHOUT CALCIUM,PARATHYROID HORMONE INTACT,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.05555555555555555,0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,CMP WITH EGFR,ANION GAP,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,CD4 CD8 RATIO PROFILE,HEMATOLOGY COMMENTS,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,ALPHA FETOPROTEIN TUMOR MARKER,AFP TUMOR MARKER,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.009473684210526315,0.02,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,CBC WITH PLT DIFF,MYELOCYTES,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,DRUG ABUSE SCREEN III,METHADONE,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,CBC WITH DIFFERENTIAL PLATELETS,MCH,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD LOG IU ML,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,RPR REFLEX TP PA,RPR,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.5,0.5,0.9,0.0,0.0,0.0,0.08506391669557933,0.14687247901289302,0.5773502691896257,1,81240,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,ACCUTYPE R IL28B,IL28B GENOTYPE,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.06,0.045,0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.25,0.2,0.3333333333333333,0.0,0.0,0.0,0.009948042129484636,0.014599185251935265,0.01714180468509552,0,112821,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD4 CELLS,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,DRUG ABUSE SCREEN 9 NO THC W CONF,PHENCYCLIDINE,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,GENERAL HEALTH PANEL,HEMATOCRIT,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,COMP METABOLIC PANEL CLARIFICATION,EGFR NON AFR AMERICAN,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.14285714285714285,0.5,0.0,0.0,0.0,0.0,0.16743054821491843,1.0,1,20289,COMP METABOLIC PANEL,CARBON DIOXIDE,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,HCV GENOTYPE REFLEX NSA,HCV GENOSURE R NSA INTERP,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,DRUG ABUSE SCREEN III,AMPHETAMINES,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,HAPTOGLOBIN,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,LIPID PANEL STANDARD,LDL CHOL CALCULATED,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,CBC INC DIFF PLT,BASOPHILS,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,IMMUNOGLOBULIN M,IMMUNOGLOBULIN M,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,LD,LIPEMIA,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A RESIST ASSAY INTERP,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,HEP B SURFACE AB,HEP B SURFACE AB,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,HB S AG W RFX CONF,HEPATITIS B SURFACE ANTIGEN,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,RENAL FUNCTION PANEL,CHLORIDE,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.182,0.14285714285714285,0.2,0.0,0.0,0.0,0.0,0.025720888368633732,0.03471021044566758,0.0,0.0,0.0,0,728626,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,CMP13 LP 2AC CBC D PLT,CHOLESTEROL TOTAL,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,BASIC METABOLIC PANEL,BUN,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.05043482321394899,0.0,0.0,0.0,0.0,0,192708,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,COCAINE METABOLITE,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,1,27771,CMP12 7AC MG,PHOSPHORUS SERUM,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,COMP METABOLIC PANEL,,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,LIPID PANEL W REFL DLDL,NON HDL CHOLESTEROL,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.27666666666666667,0.1925,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,825208,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,FREE T4 THYROXINE,FREE T4 THYROXINE,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,HEPATIC FUNCTION PANEL,ALT,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.3166666666666667,0.0,0.0,0.3333333333333333,0.4,1.0,0.0,0.0,0.0,0.06696411491014109,0.4808823462371743,0.7071067811865476,1,22764,FE TIBC FER,FERRITIN SERUM,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.05102520497901342,0.0,0.0,0.03952395382410778,0.0,0.0,1,30163,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.1,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.030526286249592305,0.0,0,7492,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,CBC INCLUDES DIFF PLT,EOSINOPHILS,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,CBC W AUTO DIFF WITH PLATELETS,RBC,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,CMP14 LP 5AC,VLDL CHOLESTEROL CAL,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,URINALYSIS W REFLEX MICRO,PROTEIN,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,FSRC NEW PATIENT PANEL,D BILIRUBIN,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,HEPATIC FUNCTION PANEL 6,AST SGOT,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.22166666666666668,0.033,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,COMP METABOLIC PANEL W EGFR,UREA NITROGEN,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.09090909090909091,0.0,0.0,0.0,0.0,0.0,0.03540360693747757,0.0,0.0,0.0,0.0,0,322867,PROTEIN ELEC INTERP SERUM,ALPHA 2 GLOBULIN,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.5,0.5,1.0,0.0,0.0,0.0,0.12460215794786256,0.16901735079974012,1.0,1,330373,COMP METABOLIC PANEL,ANION GAP,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,URINE DRUG SCREEN,OPIATES,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,HEMOGLOBIN A1C W EAG INT CHART,ESTIMATED AVERAGE GLUCOSE,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.0,0.0,0.041999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.016322738984926533,0.0,0.0,0.0,0.0,0,81232,CBCI COMPLETE BLOOD COUNT W DIFF,MCH,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,URINALYSIS SCREEN,PH,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,BASIC METABOLIC PANEL,AFRICAN AMERICAN,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.25,0.14285714285714285,0.2,0.0,0.0,0.0,0.008880378964203572,0.0,0.0,0.0,0.0,0.0,0,487967,LIVER FIBROSIS PNL HEPASCORE TM,F2,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,CBC COMPLETE BLOOD COUNT W O DIFF,RED BLOOD CELL COUNT,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0,0.2,0.0,0.0,0.2,0.0,0.0,0.13881877602428572,0.0,0.0,0.13881877602428572,0.0,0,21600,AFP SERUM TUMOR MARKER,AFP SERUM TUMOR MARKER,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,CHEM SCREEN PANEL HDL,TRIGLYCERIDES,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.2,0.42857142857142855,0.6,0.33399999999999996,0.6828571428571429,0.9560000000000001,0.008003935205086354,0.0,0.0,0.019652845868068813,0.021001017411413248,0.02834076815216946,1,728626,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,CBC WITH AUTO DIFF,RDW,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,AAA MALE PANEL,HIV 1 HIV 2 AB SCREEN,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,CMP14 HP4 DBILI CBC D PLT R,WBC,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,PROTEIN ELECTRO S,GAMMA GLOBULIN,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,COMPREHENSIVE METABOLIC PANEL AMA,SODIUM,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.26666666666666666,0.0,0.0,0.26666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,25320,LD,LD,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.072,0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,BASIC METABOLIC PANEL,BUN,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,CMP14 HP4 1AC PT AFP,EGFR IF NONAFRICN AM,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.31,0.09857142857142856,0.45999999999999996,0.31,0.09857142857142856,0.45999999999999996,0.02488757391749208,0.0843257732197713,0.6324555320336758,0.02488757391749208,0.0843257732197713,0.6324555320336758,1,295410,HIV 1 RNA QN RT PCR,HIV 1 RNA QN RT PCR,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,IRON BINDING CAPACITY,UIBC NR,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,HEP A AB TOTAL,HEP A AB TOTAL,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,COMPREHENSIVE METABOLIC PANEL WITH GFR,ALBUMIN,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,COMPLETE BLOOD COUNT,RBC,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,HAPTOGLOBIN,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,CEA,CEA CENTAUR,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,URINALYSIS,BILIRUBIN,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,25718,CMP13 LP 2AC CBC D PLT,ALBUMIN SERUM,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,COMP METABOLIC PANEL W EGFR,UREA NITROGEN,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.07761546026945332,0.0,0,30841,C4 C3,COMPLEMENT C3 SERUM,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.05609681329090033,0.0,0,57927,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.5,0.42857142857142855,1.0,0.5,0.5714285714285714,0.8,0.4335293647738059,0.013881484946973388,0.01569188635480001,0.09320436823828604,0.03301366825316199,0.037319258880631256,1,128413,PSA FREE TOTAL,% FREE PSA,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.3333333333333333,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.0834655896020069,0.0,0.0,1,544346,NMR LIPOPROFILE,LDL P,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.05181818181818181,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.06666666666666667,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,CLR CBC W DIFF PLT,ABSOLUTE BLASTS,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.24333333333333332,0.365,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.011506432237226139,0.011605012695431793,0,142513,HEPATITIS PANEL ACUTE,HEPATITIS B CORE AB IGM,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,COMP METAB PANEL,EGFR NON AFR AMERICAN,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual,Promyelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,IRON TOTAL BINDING CAPACITY,LIPEMIA,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,CBC W DIFF PLT,MONOCYTES %,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,27771,PHOSPHORUS,PHOSPHORUS,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,RPR W RFLX CONFIRM,RPR SYPHILIS SCREEN,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,VIT B 12 FOLATE PANEL,FOLIC ACID,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,DRUG ABUSE PANEL 10 WITH OXYCODONE,AMPHETAMINES,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,FOLATE,FOLATE,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.25,0.5,0.0,0.0,0.0,0.0,0.041408388212339164,0.05608746788525232,0.0,0.0,0.0,0,139550,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,CMP14 LP 7AC CBC D PLT T B,IRON SATURATION,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,PSA TOTAL % FREE,% FREE PSA,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,ANEMIA PROFILE B,EOS,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,URINALYSIS ROUTINE,WBC,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.215,0.16666666666666666,0.5,0.0,0.0,0.0,0.0,0.0,0.0,1,203943,LD,LIPEMIA,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.31,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.0840117798597445,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,823773,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,MORPHOLOGICAL REVIEW,PLATELET ESTIMATE,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,FOLLOW UP PNL ARAKAWA,SODIUM,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,CBC WITH PLT DIFF,MPV,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,DIRECT LDL,LDL CHOLESTEROL DIRECT,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.16666666666666666,0.267,0.534,0.16666666666666666,0.267,0.534,0.026867474523124324,0.09635841428201697,0.1378341405618373,0.026867474523124324,0.09635841428201697,0.1378341405618373,1,51938,HEPATITIS BS AB QUANT,HEPATITIS BS AB QUANT,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,CYSTIC FIBROSIS SCREEN,ETHNICITY,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,SPECIAL PROFILE # 5144,TSH ULTRASENSITIVE,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,ALB ALP ALT AST GGT LD PROT,LDH,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.11166666666666668,0.08375,0.0,0.14833333333333334,0.11125,0.178,0.0,0.0,0.0,0.0,0.0,0.0,1,7641,CBC WITH PLT MAN DIFF,BANDS,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.14285714285714285,0.2,0.0,0.02142857142857143,0.1,0.0,0.05557781728487099,0.14099568413003705,0.0,0.0,0.0,0,487967,LYMPHOCYTE SUBSET PANEL 1,CD4 ABSOLUTE,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,COMP METAB PANEL,EGFR NON AFR AMERICAN,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.3575,0.10857142857142857,0.0,0.0,0.0,0.0,0.0,0.05249109809053998,0.09061940958216264,1,134577,LIPID PANEL STANDARD,LDL CHOL CALCULATED,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,LIVER FIBROSIS,NECROINFLAM ACT GRADE,Age,Age,Age
0.0,0.0,0.0,0.09166666666666667,0.10444444444444444,0.3133333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,MORPHOLOGICAL REVIEW,PLATELET ESTIMATE,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,RBC,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.2,0.3055555555555556,0.55,0.2,0.5933333333333333,0.9339999999999999,0.03796471617953978,0.13817876011426722,0.14369156469154098,0.03796471617953978,0.20726814017140072,0.21553734703731142,1,139501,HEP A AB IGM,HEPATITIS A AB IGM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,HEP A AB TOTAL,HEP A AB TOTAL,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.14666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,UROGRAM,SPECIFIC GRAVITY,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,CBC H H RBC INDICES WBC PLT,MPV,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.044444444444444446,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,GENERAL HEALTH PANEL,HEMATOCRIT,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,CMP13 LP TP TSH 2AC CBC D P,LDL CHOLESTEROL CALC,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.088,0.0,0.0,0.088,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,CBC INCLUDES DIFF PLT WITH PATHOLOGIST REVIEW,ABSOLUTE LYMPHOCYTES,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,URINALYSIS W REFLEX MICRO,BACTERIA,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,PROTHROMBIN TIME,PT POP MEAN,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,MA CBC DIFF PLT,MONOCYTES %,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,IRON BINDING CAPACITY,UIBC,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.07132561100505608,0.0,0,196592,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,HEPATITIS BE AG,HBEAG INS NR,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,CMP14 LP CBC D PLT TSH T4F,NEUTROPHILS ABSOLUTE,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,DIRECT LDL,LDL CHOLESTEROL DIRECT,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,VITAMIN B 12,VITAMIN B 12,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,COMP METABOLIC PANEL CLARIFICATION,ALBUMIN GLOBULIN RATIO,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,SPECIAL NEW ANNUAL COMM INSURANCE #6925,ABSOLUTE EOS,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,CMP12 7AC MG,PHOSPHORUS SERUM,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,CMP14 HP5 LP 6AC CBC D PLT,HDL CHOLESTEROL,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,CBC W O DIFF WITH PLATELETS,MCV,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CBC INCLUDES DIFF PLT,RDW,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,CBC W AUTO DIFF,% LYMPHOCYTES,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,HEPATITIS PANEL ACUTE,HEPATITIS B CORE AB IGM,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.2,0.125,0.0,0.0,0.0,0.0,0.009558757760744996,0.007650482697687866,0.0,0.0,0.0,0.0,0,7633,MANUAL DIFFERENTIAL,BLASTS %,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.16666666666666666,0.3333333333333333,0.6,0.16666666666666666,0.3333333333333333,0.6,0.00936102477107581,0.030419354890964145,0.04257141653334451,0.009480677768291423,0.03080817631544297,0.04311556610120715,0,139527,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,82644,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.47,0.3333333333333333,0.25,0.0,0.0,0.0,0.03694153252517385,0.530776546300907,0.08679392382276507,1,19687,HEPATIC FUNCT PANEL W O TP,BILIRUBIN DIRECT,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,IFE PE SERUM,ALBUMIN,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.372,0.49714285714285716,0.62,0.0,0.0,0.0,0.07351377561058281,0.18661673850657123,0.09866725380717944,1,81018,LYMPHOCYTE SUBSET PANEL 4,%CD8 SUPPRESSOR T CELLS,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.465,0.465,0.0,0.0,0.0,0.0,0.7071067811865476,0.7071067811865476,1,82511,LYMPHOCYTE SUBSET PANEL 4,COMMENT S,Service comment,Service Cmnt XXX-Imp,Service comment
0.22,0.0,0.0,0.21000000000000002,0.2,0.5,0.0,0.0,0.0,0.0,0.38075107277079945,1.0,1,58115,UROGRAM,SPECIFIC GRAVITY,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.09571428571428572,0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,HB S AG W REFLEX CONF,HFLAG,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A RESIST ASSAY INTERP,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,BUN CREATININE RATIO,BUN CREATININE RATIO,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,PHOSPHORUS,PHOSPHORUS,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,NASH FIBROSURE,AST SGOT P5P,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,30916,COMPREHENSIVE METABOLIC PANEL E GFR,BUN,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,PROTHROMBIN PTT,APTT,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,CMP,TCO2,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,STOOL CULTURE,RESULT 1,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,HEPATIC FUNCTION PNL,GLOBULIN,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.09499999999999999,0.285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,DRUG ABUSE SCREEN I NO GCMS,BARBITURATES,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,ASH FIBROSURE,ALT SGPT P5P,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.06714285714285714,0.1175,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,CMP14 LP 2AC CBC D PLT TSH,EGFR IF AFRICN AM,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,FREE T4 THYROXINE,FREE T4 THYROXINE,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,FREE T4 THYROXINE,FREE T4 THYROXINE,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,HCV RNA QN PCR W RFL GENO,HCV RNA QN REAL TIME PCR,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,ASH FIBROSURE,AST SGOT P5P,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,PHOSPHATE AS PHOSPHORUS,LIPEMIA,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,URINALYSIS COMPLETE,BILIRUBIN,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,OBSTETRIC PANEL,RPR RESULT,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,ASH FIBROSURE,COMMENT,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,CBC WITH PLT DIFF,OTHERS,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.007272727272727273,0.02,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,CMP14 HP4 1AC PT AFP,EGFR IF NONAFRICN AM,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,CREATINE KINASE TOTAL,HEMOLYSIS,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,CMP14 5AC CBC D PLT TSH T4F,CALCIUM SERUM,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,DRUG ABUSE SCREEN II,OPIATES,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.16666666666666666,0.23076923076923078,0.6666666666666666,0.0,0.0,0.0,0.028275241940297513,0.08470305693504976,0.3162277660168379,0.0,0.0,0.0,0,204479,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,CHOL HDL RATIO,CHOL HDL RATIO,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,HEPATITIS C GENO TYPE 1 NS5A RESIST,VELPATASVIR RESISTANCE,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,PE RFX IFE S,GAMMA GLOBULIN,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,30916,BASIC METABOLIC PANEL,BUN,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,MICROALBUMIN RANDOM SPEC,MICROALBUMIN,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,COMP METABOLIC PANEL W GFR,GLOBULIN,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,MAGNESIUM,ICTERUS,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,HEPATIC LIVER PANEL,DIRECT BILIRUBIN,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CBC W DIFF PLT,PLATELET SUFFICIENCY,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,URINE DRUG SCREEN,OPIATES,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,COMP METABOLIC PANEL 13,ALBUMIN SERUM,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CYSTIC FIBROSIS SCREEN,ETHNICITY,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0625,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,LIPID PANEL WITH REFLEX DIRECT L,HDL CHOLESTEROL,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,CCP IGG,CCP IGG,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,UROGRAM,KETONES,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,HEPATITIS BE AG,HBEAG INS NR,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.04777777777777778,0.086,0.0,0.04777777777777778,0.086,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,HCV GENOTYPE PCR PROBE,HCV GENOTYPE,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,HCV FIBROSURE LABCORP,RESULT,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,URINALYSIS W REFLEX MICRO,COLOR,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.25,0.2,1.0,0.0,0.0,0.0,0.06591673023183264,0.13909830811578938,1.0,1,108340,COMP METABOLIC PANEL,GLOBULIN,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.045000000000000005,0.0,0.0,0.21166666666666667,0.125,0.25,0.0,0.0,0.0,0.04684598319891731,0.07415191298821733,0.11490614097199336,0,312017,MITOCHONDRIAL ANTIBODY W RFX,MITOCHONDRIAL AB,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.31,0.22,0.9533333333333333,0.31,0.22,0.9533333333333333,0.023896941029320717,0.07158714895716911,0.5345224838248488,0.03161268152937924,0.09470089660440306,0.7071067811865476,1,204479,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,CMP14 HP5 LP 6AC CBC D PLT,INR,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,ESR WES CRP,C REACTIVE PROTEIN QUANT,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.25,0.0,0.0,0.25,0.0,0.0,0.031224633643310185,0.0,0.0,0.0,0.0,0,264994,COMPLETE BLOOD COUNT,RBC,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,URINALYSIS COMPLETE,GLUCOSE,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE EOS,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,HB S AG W REFLEX CONF,HFLAG,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,ASH FIBROSURE,ALT SGPT P5P,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,CMP14 4AC,EGFR IF AFRICN AM,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,PROFILE 1236 LIPID PANEL WITH DIRECT LDL,CHOL HDL,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,CMP14 LP CBC D PLT TSH UA M,HDL CHOLESTEROL,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.195,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.0,0.0762496717190787,0.08190888212768821,1,18358,ASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,HCV RNA QUANT BDNA,HCV RNA QN BDNA,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,CBC,NEUTROPHIL,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,HEPATIC FUNCTION PANEL 6,AST SGOT,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06635350960296393,0.05287307875068503,0.08777198612321668,1,7096,CBC INCLUDES DIFF PLT,BLASTS,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.25,0.33999999999999997,0.85,0.0,0.148,0.37,0.01305909802814298,0.6981845870116105,0.9069761000074495,0.0,0.06755685946200152,0.08775968141298807,1,473835,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,CBC COMPLETE BLOOD COUNT W O DIFF,RED BLOOD CELL COUNT,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,HAV AB TOTAL,HAV AB TOTAL,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,CBC INC DIFF PLT,MONOCYTES,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,T4 THYROXINE,T4 THYROXINE,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,HEMOGRAM W O DIFFERENTIAL,MEAN PLATELET VOLUME,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,HEPATITIS B SURFACE ANTIGEN,HBS AG SCREEN,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,HEMOGLOBIN A1C,AVERAGE WHOLE BLOOD GLUCOSE,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,LIPID PROFILE,CHOLESTEROL NON HDL,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,CRP,C REACTIVE PROTEIN ULTRA,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,URINALYSIS COMPLETE WITH REFLEX CULTURE,PROTEIN,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,IRON BINDING CAPACITY,UIBC,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,OBSTETRIC PANEL,NEUTROPHILS,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,PE RFX IFE S,GAMMA GLOBULIN,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.16,0.0,0.25,0.2,1.0,0.0,0.05524858071613015,0.0,0.07962607175736813,0.12353958214165095,1.0,1,195503,DRUG ABUSE SCREEN I NO GCMS,METHADONE,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,LIPID PANEL AMA,CHOL HDLC RATIO,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,ASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,24588,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,STOOL CULTURE,RESULT 1,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,DIFFERENTIAL MANUAL,EOSINOPHILS,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,CMP14 4AC,EGFR IF AFRICN AM,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.2,0.3333333333333333,0.0,0.0,0.0,0.0,0.3694836435770804,0.5387102392856749,1,45377,SPECIAL CUM 50 PLUS PROFILE # 10190,SEDIMENTATION RATE,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,CMP WITH ESTIMATED GFR CALCULATED,CHEMISTRY SODIUM,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,RPR,RPR RESULT,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.3333333333333333,0.5,0.0,0.3333333333333333,0.5,0.0,0.07184578234577044,0.07240860968350848,0.0,0.08799275345909874,0.08868207335447242,1,161281,HEPATITIS C REFLEX PCR,HEPATITIS C ANTIBODY,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,COMP METABOLIC PANEL CLARIFICATION,ALBUMIN GLOBULIN RATIO,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.26666666666666666,0.12,0.0,0.0,0.0,0.0,0.0,0.04972639190343808,0.0,0.0,0.0,0.0,0,302398,CBC W O DIFF WITH PLATELETS,MCH,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,HEPATITIS B CORE TOTAL AB,HEPATITIS B CORE TOTAL AB,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,RENAL FUNCTION PANEL,CREATININE,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,COMPREHENSIVE METABOLIC PANEL E GFR,ALT,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,CBC W DIFF PLT,PLATELET SUFFICIENCY,Appearance of Urine,Appearance Ur,Appearance
0.0,0.2857142857142857,0.4,0.0,0.2857142857142857,0.4,0.0,0.8311519417552347,0.435968309432466,0.0,0.8311519417552347,0.435968309432466,0,223149,HEPATITIS C VIRUS RNA QUALITATIVE PCR,HEPATITIS C VIRUS RNA QUALITATIVE PCR,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,PROTEIN ELECTRO S,M SPIKE,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.2866666666666667,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,AUTOMATED BLD CNT,MCH,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.04894736842105263,0.02,0.0,0.04894736842105263,0.02,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,IMMUNOGLOBULIN M,IMMUNOGLOBULIN M,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,LYMPHOCYTE SUBSET PANEL 1,ABSOLUTE CD8 CELLS,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.235,0.94,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,CBC WITH PLT DIFF,WBC MORPHOLOGY,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,RENAL FUNCTION PANEL,CREATININE,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,VITAMIN B12 FOLATE,VITAMIN B12,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.2857142857142857,0.24000000000000002,0.9,0.2857142857142857,0.23066666666666666,0.865,0.28137051682367653,0.015163057868296748,0.0430796451476837,0.2855798754616614,0.01538990021601927,0.04372412516808821,1,381806,HCV RNA QT REALTIME PCR,HCV RNA QN PCR,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.20750000000000002,0.0,0.0,0.20750000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,VITAMIN B 12,VITAMIN B 12,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,PE FLC SERUM,ALBUMIN,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,LIVER FIBROSIS FIBROTEST ACTITEST P,GGT,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,CBC PLT DIFF,ABSOLUTE EOS,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,CBC PLT DIFF,ABSOLUTE EOS,Body height Measured,Body height Measured,Body height
0.0,0.06666666666666667,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,COMMENTS,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,DRUG ABUSE PANEL 10 WITH OXYCODONE,COCAINE METABOLITE,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,FOLLOW UP PNL ARAKAWA,SODIUM,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CBC,NEUTROPHIL,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,HCV QUANT GT1A NS5A PROFILE,HCV NS5A DRUG RESISTANCE ASSAY,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,HCV FIBROSURE,LIMITATIONS,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual,Promyelocytes/100 leukocytes
0.09499999999999999,0.045,0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,COMP METAB PANEL,EGFR NON AFR AMERICAN,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,ASH FIBROSURE,WEIGHT,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,MAGNESIUM,MAGNESIUM,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,MITOCHONDRIAL ANTIBODY W RFX,MITOCHONDRIAL AB,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,REFLEXED LDL,LDL DIRECT,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,FIBROACT COMPLETE,HEIGHT INCHES,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,URINALYSIS W REFLEX MICRO,KETONES,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.16666666666666666,0.0,0.0,0.16666666666666666,0.0,0.0,0.13142842488073536,0.0,0.0,0.13142842488073536,0.0,0,17988,AFP SERUM TUMOR MARKER,AFP SERUM TUMOR MARKER,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CMP14 LP 6AC CBC D PLT ESR,CREATININE,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.3333333333333333,0.235,0.94,0.0,0.0,0.0,0.11098565713428754,0.0,0.0,1,265157,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,CBC WITH DIFF PLATELET,EOS ABSOLUTE,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.29333333333333333,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.14397756228354264,1.0,1,19752,COMPREHENSIVE METABOLIC PANEL WITH GFR,T BILIRUBIN,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,CMP14 LP CBC D PLT,HEMATOCRIT,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.23399999999999999,0.16714285714285712,0.38999999999999996,0.23399999999999999,0.16714285714285712,0.22,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,HEPATITIS BC AB IGM,HEPATITIS B CORE AB IGM,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.3333333333333333,0.0,0.25,0.0,0.0,0.0,0.03258155267402285,0.0,0.09494317394815022,0.0,0.0,1,66902,COMPLETE BLOOD COUNT,WBC,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,CMP13 LP TP TSH 2AC CBC D P,LDL CHOLESTEROL CALC,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,MITOCHONDRIAL ANTIBODY W RFX,MITOCHONDRIAL AB,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,LIPID PANEL WITH DIRECT LDL,TRIGLYCERIDES,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,ALPHA 2 MACROGLOBULIN,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,NASH FIBROSURE,HEIGHT,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,ALPHA 2 MACROGLOBULIN,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,HEPATITIS BE AG,HBEAG INS NR,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,URINE DRUG SCREEN,OPIATES,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.16,0.0,0.1875,0.2,1.0,0.0,0.05043482321394899,0.0,0.0,0.12353958214165095,1.0,1,143164,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.25,0.2573333333333333,0.965,0.25,0.2573333333333333,1.0,0.22848423004998408,0.011147902332567239,0.04372412516808821,0.22848423004998408,0.011147902332567239,0.04372412516808821,1,426171,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,TSH 3RD GENERATION,TSH 3RD GENERATION,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,LYMPHOCYTE SUBSET PANEL 1,CD4 ABSOLUTE,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESISTANCE ASSAY PDF,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,FREE T4,FREE T4,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.07692307692307693,0.0,0.0,0.0,0.0,0.0,0.03866147914414264,0.0,0.0,0.0,0.0,0,204479,DRUG ABUSE PANEL 10 WITH OXYCODONE,OPIATES,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,HCV RNA QN PCR W RFL GENO,HCV RNA QN REAL TIME PCR,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.0,0.15666666666666665,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,CBC W AUTO DIFF WITH PLATELETS,MCV,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.09666666666666668,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,PE INTERP RFX IFE S,ALBUMIN,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,C4 SERUM,C4 SERUM,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.14285714285714285,0.0,0.0,0.0,0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.03896046902095196,0.0,0,115790,CMP13 LP 2AC CBC D PLT,ALBUMIN SERUM,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,BUN CREAT RATIO,EGFR AFRICAN AMERICAN,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.04,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,COMP METABOLIC PANEL 14,EGFR IF NONAFRICN AM,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.057549248626998395,0.0,0,303925,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CMP12 7AC MG,PHOSPHORUS SERUM,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,URINALYSIS C,BILIRUBIN,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.032694664605325,0.12022058655929357,0.35355339059327373,0.09247447620418048,0.34003516797720323,1.0,1,30346,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.3,1.0,0.0,0.022,0.38333333333333336,0.0,0.35622065033847605,0.9888882125258499,0.0,0.3602233759350876,1.0,0,305227,C REACTIVE PROTEIN INFLAMMATORY,C REACTIVE PROTEIN,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,HB S AB QL,HB S AB QL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.037852329877889224,0.0,0,121855,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,CEA,CEA,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,ACCUTYPE R IL28B,IL28B GENOTYPE,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.19499999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,CBCI COMPLETE BLOOD COUNT W DIFF,ABS BASOPHILS,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,URINALYSIS CULTURE IF INDICATED,BILIRUBIN,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,COMP METABOLIC PANEL,CREATININE,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,PSA FREE TOTAL,FREE PSA,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.335,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,CMP WITH ESTIMATED GFR CALCULATED,UREA NITROGEN,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,PROTEIN TOTAL URINE,PROTEIN CR RATIO,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,HIV AB AG COMBO RFLX CONF,HIV AB AG COMBO RFLX CONF,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,CMP14 LP CBC D PLT,HEMATOCRIT,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,CBC,MCHC,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.15166666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,7302,CBC WITH PLT DIFF,OTHERS,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,ASH FIBROSURE,ALT SGPT P5P,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,HCV FIBROSURE,FIBROSURE STAGE,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,HEP A AB TOTAL,HEP A AB TOTAL,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.08952338621207645,0.0,0,264440,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.08428571428571428,0.185,0.3333333333333333,0.14285714285714285,0.5,0.0,0.0,0.0,0.061685809626148336,0.0,0.0,1,17426,CMP14 LP CBC D PLT TSH HB A,ALT SGPT,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,CBC INCLUDES DIFF PLT,BLASTS,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,IRON TOTAL BINDING CAPACITY,LIPEMIA,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,CBC W AUTO DIFF,MONOS ABSOLUTE,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,CMP14 LP TP TSH 4AC CBC D PLT,URIC ACID,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,UA W RFLX MICROSCOPIC,BILIRUBIN,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,PSA FREE TOTAL,FREE PSA,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,LYMPHOCYTE SUBSET PANEL 4,HELPER SUPPRESSOR RATIO,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.06292624359840293,0.0,0,110114,FERRITIN,FERRITIN SERUM,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,URINALYSIS W REFLEX MICRO,NITRITE,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.14333333333333334,0.15384615384615385,0.6666666666666666,0.14333333333333334,0.07692307692307693,0.3333333333333333,0.0,0.04235152846752488,0.3162277660168379,0.0,0.05467558814705109,0.40824829046386313,0,204479,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.10714285714285714,0.125,0.0,0.0,0.0,0.0,0.03995658192873952,0.0,0.0,0.0,0.0,0,204164,CMP WITH ESTIMATED GFR CALCULATED,UREA NITROGEN,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,VITAMIN D 25 OH TOTAL IA,VITAMIN D 25 OH TOTAL IA,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.14285714285714285,0.3333333333333333,0.3333333333333333,0.14285714285714285,0.3333333333333333,0.0,0.6051276557179278,0.6596810992114517,0.04623723810209024,0.0,0.0,1,18341,ALPHA FETOPROTEIN TUMOR MARKER,AFP TUMOR MARKER,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,URINALYSIS W REFLEX MICRO,COLOR,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.3333333333333333,0.42857142857142855,0.0,0.3333333333333333,0.42857142857142855,1.0,0.07082133735279972,0.0,0.0,0.07082133735279972,0.0,0.0,1,28571,PSA TOTAL,PSA TOTAL,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.14285714285714285,0.5,0.0,0.0,0.0,0.0,0.03995658192873952,0.11262484863358568,0.0,0.0,0.0,0,204164,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.04666666666666667,0.0,0.0,0.04666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,HCV GENOTYPE REFLEX NSA,HCV GENOSURE R NSA INTERP,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.036330483680629855,0.0,0.0,0.0,0.0,0,110114,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Body weight Measured,Weight Measured,Body weight
0.0,0.0,0.0,0.4,0.2885714285714286,0.3333333333333333,0.0,0.0,0.0,0.37922385977021555,0.5353776024807763,0.6367157804962068,1,81232,LYMPHOCYTE SUBSET PANEL 3,% CD3 CD4 HELPER T4,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,MITOCHONDRIAL M2 ANTIBODY,MITOCHONDRIAL M2 ANTIBODY,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CBC WITH AUTO DIFF,RDW,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,HEMATOPATH CONSULTATION SMEAR,HEMATOLOGY COMMENTS,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,GLUCOSE,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,326231,CBC WITH PLT DIFF,MPV,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,LIVER FIBROSIS FIBROTEST ACTITEST P,GGT,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,COMPREHENSIVE METABOLIC PANEL AMA,SODIUM,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,CBC W AUTO DIFF WITH PLATELETS,RDW,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0,0.0,0.0,0.0,0.0,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,C REACTIVE PROTEIN INFLAMMATORY,C REACTIVE PROTEIN,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,NASH FIBROSURE,ALT SGPT P5P,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,CBC W AUTO DIFF,MONOCYTES %,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,FASTING,FASTING STATUS,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CBC WITH AUTO DIFF,MONOCYTES #,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,HCV RNA QN PCR W RFL GENO,HCV RNA QN REAL TIME PCR,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,URINALYSIS COMPLETE,GLUCOSE,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,AFP TUMOR MARKER,AFP TUMOR MARKER,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,CMP12 LP TP TSH 6AC CBC D PLT,URIC ACID,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,LIVER FIBROSIS PNL HEPASCORE TM,F2,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,BMP8 CBC D PLT UA,EOS ABSOLUTE,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,CMP14 CBC D PLT TSH,EGFR IF AFRICN AM,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,LIPID PROFILE WRFL LDL DIRECT,NON HDL CHOLESTEROL,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,URINALYSIS ROUTINE,WBC,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,CREATINE KINASE CPK TOTAL,CREATINE KINASE CPK TOTAL,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,T4 THYROXINE,T4 THYROXINE,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,AUTOMATED BLD CNT,MCH,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.2,0.23857142857142857,0.4175,0.2,0.07142857142857142,0.125,0.011333963723054508,0.016878028292801384,0.019617965872839815,0.04183290768824732,0.06229568196836488,0.07240860968350848,0,139519,HIV AB AG RFLX CONF,HIV AG AB,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,URINALYSIS,BILIRUBIN,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,ESR WES CRP,C REACTIVE PROTEIN QUANT,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,CBC,MCHC,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,X HEPATITIS COMPLEX PROFILE,ANTI HCV,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,PSA WITH FREE RATIO,PSA ROCHE E170,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,HAV HBV IMMUNE STATUS PRO IV,HEP A AB IGM,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CMP14 CBC D PLT TSH,EGFR IF AFRICN AM,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.3333333333333333,0.1325,0.265,0.0,0.0,0.0,0.010713541722103481,0.014232105164471598,0.01954574209274329,1,453530,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,CHOL HDL RATIO,CHOL HDL RATIO,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,COMP METABOLIC PANEL,ANION GAP,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.1925,0.08833333333333333,0.0,0.3225,0.16666666666666666,1.0,0.0,0.0,0.0,0.07097576385288318,0.09716253076254433,1.0,1,204057,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,CBC W O DIFF WITH PLATELETS,MCV,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,HEPATITIS A IGM,HEPATITIS A IGM,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,VITAMIN B12 FOLATE,FOLATE SERUM,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,MANUAL DIFFERENTIAL,BLASTS %,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.045454545454545456,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,CBC INC DIFF PLT,BASOPHILS,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,RENAL FUNCTION PANEL,BUN,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp,Daclatasvir
0.0,0.0,0.0,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,CMP,TCO2,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.055,0.033,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,VIT B 12 FOLATE PANEL,VITAMIN B 12,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0275,0.055,0.0,0.0275,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,CREATINE KINASE CK,CREATINE KINASE CK,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,NASH FIBROSURE,ALT SGPT P5P,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,CMP14 HP4 DBILI CBC D PLT R,WBC,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,HIV AB AG RFLX CONF,HIV AG AB,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,BASIC METABOLIC PANEL,OSMOLALITY,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.3333333333333333,0.0,0.16666666666666666,0.0,0.0,0.0,0.020543378257532607,0.0,0.0555987435097689,0.0,0.0,0,7302,COMPLETE BLOOD COUNT,WBC,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,AFP SERUM TUMOR MARKER,AFP SERUM TUMOR MARKER,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,COMP METAB PANEL,CALCIUM PLASMA,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,CBC W AUTO DIFF,MONOS ABSOLUTE,Body weight Measured,Weight Measured,Body weight
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,LYMPHOCYTE SUBSET PANEL 5,CD4 % POS,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,CBC,MO%,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.14285714285714285,0.2,0.0,0.0,0.0,0.0,0.0769055150490483,0.07759701258884111,0.0,0.0,0.0,1,169334,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.041875,0.08375,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,CARETC CMP LIPID URIC ACID DIR BILI PROFILE,RISK RATIO LDL HDL,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,COMPREHENSIVE METABOLIC PANEL,CALCIUM,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.31,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.0840117798597445,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,728592,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.088,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,UROGRAM,APPEARANCE,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,CMP14 1AC,EGFR IF NONAFRICN AM,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,RPR REFLEX PER CDC,RPR,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,CMP14 LP 6AC CBC D PLT ESR,CREATININE,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,URINALYSIS SCREEN,PH,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,HEPATITIS C VIRUS RNA QUALITATIVE PCR,HEPATITIS C VIRUS RNA QUALITATIVE PCR,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,DIRECT LDL,TRIGLYCERIDES,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,CBC WITH PLT MAN DIFF,BANDS,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,URINALYSIS C,BILIRUBIN,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.07692307692307693,0.0,0.0,0.0,0.0,0.0,0.04235152846752488,0.0,0.0,0.0,0.0,0,204479,CBC W AUTO DIFF WITH PLATELETS,MCHC,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,LIVER FIBROSIS PNL HEPASCORE TM,GGT,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,NASH FIBROSURE,APOLIPOPROTEIN A 1,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,COMPREHENSIVE METABOLIC PANEL E GFR,AST,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.29333333333333333,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.917303309798122,0.1569574215481997,1,19752,CMP12 2AC,BILIRUBIN TOTAL,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,OXYCODONE,Specimen source identified,Specimen source XXX,Specimen source
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,FREE T4 THYROXINE,FREE T4,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,CBC INCLUDES DIFF PLT WITH PATHOLOGIST REVIEW,ABSOLUTE LYMPHOCYTES,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,PROTEIN TOTAL URINE,PROTEIN CR RATIO,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,PROTEIN ELECTRO S,GAMMA GLOBULIN,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.47,0.3333333333333333,0.3333333333333333,0.0,0.0,0.0,0.04524395250155222,0.45528141890436646,0.5,1,19711,HEPATIC FUNCTION PANEL,BILIRUBIN INDIRECT,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.192,0.192,0.48,0.392,0.2,0.5,0.0,0.0,0.0,0.04577863876468413,0.0636278905553388,0.0825854493262983,1,172841,MITOCHONDRIAL ANTIBODY W RFX,MITOCHONDRIAL AB,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,CBC W DIFF PLT,ABSOLUTE NEUTROPHILS,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.14333333333333334,0.125,0.25,0.31,0.125,0.25,0.0,0.04689778758027785,0.07267302452237867,0.027046541010347647,0.08562325384934599,0.13268218284344302,0,312017,HIV ANTIGEN ANTIBODY FOURTH GEN,HIV AG AB 4TH GEN,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.15,0.022,0.0,0.0,0.0,0.0,0.0,0.06462795662709708,0.0,0.0,0.0,0.0,0,17434,CBC WITH PLT DIFF,BANDS,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,PTT,PTT,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.5519999999999999,0.5866666666666667,0.0,0.5519999999999999,0.5866666666666667,0.0,0.06052798441972773,0.044125153490629065,0.0,0.06052798441972773,0.044125153490629065,1,45377,WESTERGREN SED RATE,WESTERGREN SED RATE,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.16666666666666666,0.5,0.0,0.16666666666666666,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,PSA TOTAL % FREE,PSA FREE,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,LIVER FIBROSIS FIBROTEST ACTITEST P,APOLIPOPROTEIN A1,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,HEMATOPATH CONSULTATION SMEAR,WBC,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,T3 FREE,T3 FREE,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,CMP13 LP 2AC CBC D PLT,NEUTROPHILS ABSOLUTE,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,ARTHRITIS PROFILE,RHEUMATOID FACTOR QUANT,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.16,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,ALB ALP ALT AST GGT LD PROT,LDH,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.11,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,URINALYSIS W REFLEX MICRO,COLOR,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,MA COMP METABOLIC PNL,ALKALINE PHOSPHATASE,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,BASIC METABOLIC PANEL,OSMOLALITY,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.27999999999999997,0.0,0.0,0.0,0.0,0.0,0.009815853763028959,0.0,0.0,0.0,0.0,0.0,0,602797,HCV RNA QN REAL TIME PCR W RFLX QL,HCV RNA LOG IU ML,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,HEPATIC FUNCTION PNL,GLOBULIN,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.1425,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.008181756297874987,0.0,0.0,0.0,0.0,0,57703,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0125,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,CBC WITH AUTO DIFF,MONOCYTES #,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,CBC W DIFF PLATELET,EOSINOPHILS,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,DRUG ABUSE PANEL 10 WITH OXYCODONE,OPIATES,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.061769791070825475,0.0,0.0,0.12353958214165095,1.0,1,196592,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,NMR LIPOPROFILE,LDL P,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.25,0.0,0.0,0.0,0.0,0.0,0.037164269392726657,0.0,0.0,0.0,0.0,0.0,0,45443,CBC W AUTO DIFF,MONOS ABSOLUTE,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,LIVER FIBROSIS,NECROINFLAM ACT GRADE,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,IMMUNOFIXATION SERUM,IGG SERUM NR,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.25,0.3333333333333333,1.0,0.0,0.0,0.0,0.041294277243752564,0.45528141890436646,1.0,1,25023,CMP14 LP 7AC CBC D PLT T B,IRON SATURATION,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,PTT,PTT,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,DRUG ABUSE PANEL 10 WITH OXYCODONE,COCAINE METABOLITE,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,PTH INTACT,PTH INTACT,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,ESR WES CRP,C REACTIVE PROTEIN QUANT,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,LIPID CASCADE,LDL CHOLESTEROL CALC,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,ALPHA 1 ANTITRYPSIN SERUM,ALPHA 1 ANTITRYPSIN SERUM,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,EIA 10 ALCOHOL W GCMS,URINE CREATININE MG DL,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp,Daclatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,CBC INCLUDES DIFFERENTIAL PLATELETS,MEAN PLATELET VOLUME,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.03928571428571429,0.1375,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,COMPLETE BLOOD COUNT,BASOPHILS %,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,LD,LIPEMIA,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,DRUG ABUSE PANEL 10 WITH OXYCODONE,AMPHETAMINES,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,LYMPHOCYTE SUBSET PANEL 1,ABSOLUTE CD8 CELLS,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.13636363636363635,0.125,0.0,0.0,0.0,0.0,0.03166594870435313,0.0,0.0,0.0,0.0,0,322867,CBC WITH ABSOLUTE WBCS MPV,MCHC,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.026965410719833605,0.0,0.0,0,505511,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,CMP13 LP TP TSH 2AC CBC D P,NEUTROPHILS ABSOLUTE,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.10833333333333334,0.125,0.0,0.0,0.0,0.0,0.0,0.009829574994514534,0.0,0.0,0.0,0.0,0,302398,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,772020,HCV GENOTYPE REFLEX NSA,HCV GENOSURE R NSA INTERP,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.16666666666666666,0.3,0.42857142857142855,0.0,0.0,0.0,0.006899525398215922,0.0,0.0,0.0,0.0,0.0,0,736553,HCV FIBROSURE LABCORP,RESULT,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.10444444444444444,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,CBC W O DIFF WITH PLATELETS,MCH,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,PROTHROMBIN PTT,CONTROL,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,FIBROACT COMPLETE,WEIGHT LBS,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,IRON TOTAL BINDING CAPACITY,IRON TOTAL,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,BUN CREATININE RATIO,EGFR NON AFR AMERICAN,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,CBC WITH DIFFERENTIAL,MYELOCYTES,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.47,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.04524395250155222,0.45528141890436646,0.5,1,19711,CMP14 HP5 LP 6AC CBC D PLT,BILIRUBIN INDIRECT,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.07571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,URINALYSIS,LEUKOCYTE ESTERASE,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,CMP14 1AC,ALT SGPT,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.0,0.0,0.0,0.25,0.152,0.0,0.0,0.0,0.0,0.00925891548283142,0.0,0.0,0,108340,LIPID CASCADE,LDL CHOLESTEROL CALC,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE EOS,Sex,Sex,Sex
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0834655896020069,0.34003516797720323,1.0,1,28233,COMPREHENSIVE METABOLIC PNL W O CO2 ALT,POTASSIUM,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.14666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.08399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0825,0.10600000000000001,0.0,0.25,0.2,1.0,0.0,0.0,0.0,0.0763206923693498,0.09762443806815091,1.0,1,254284,URINALYSIS COMPLETE,GLUCOSE,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,MICROALBUMIN CREATININE RANDOM RATIO,MICROALBUMIN RANDOM,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,PTH INTACT MOLECULE,PTH,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,VITAMIN B 12,VITAMIN B 12,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.022727272727272728,0.03571428571428571,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,IRON BINDING CAPACITY,IRON TOTAL,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.2375,0.2375,0.31666666666666665,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.08312548434166944,0.0,0.0,0.0,0.0,0,19752,PE FLC SERUM,ALBUMIN,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.02666666666666667,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,COMP METABOLIC PANEL,GLOBULIN,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,ANA AUTOIMMUNE PROFILE,RHEUMATOID FACTOR QUANT,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.19999999999999998,0.0,0.0,0.19999999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,23457,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,FREE T4 THYROXINE,FREE T4 THYROXINE,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,FIBROACT,FIBROSIS SCORE,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,LIVER FIBROSIS FIBROTEST ACTITEST P,GGT,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.09247447620418048,0.34003516797720323,1.0,0.09247447620418048,0.34003516797720323,1.0,1,191239,MAGNESIUM,MAGNESIUM,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,CBC INCLUDES DIFF PLT,BLASTS,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,DRUG ABUSE SCREEN III,METHAQUALONE,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,MITOCHONDRIAL ANTIBODY W RFX,MITOCHONDRIAL AB,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,PSA FREE TOTAL,% FREE PSA,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.07142857142857142,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,CBC,MO%,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,HAPTOGLOBIN,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,HEPATITIS BE AG,HB E AG,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,FOLATE,FOLATE,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,ASH FIBROSURE,FIBROSIS STAGE,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,HCV FIBROSURE,COMMENT,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.2,0.5,0.0,0.2,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,PSA FREE TOTAL,PSA FREE,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.006666666666666666,0.01,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.8,0.8,0.0,0.8,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,PSA FREE TOTAL,PSA FREE,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,PROTIME PTT,INR,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.3333333333333333,0.16666666666666666,0.5,0.3333333333333333,0.16666666666666666,0.5,0.09247447620418048,0.0,0.0,0.09247447620418048,0.0,0.0,1,20396,CEA,CEA,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCH,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,LIVER FIBRO HEPSCORE R,AGE,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,LIVER FIBRO HEPSCORE R,AGE,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,UA W MICRO HOLD SPEC 24 HR,GLUCOSE,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,HEPASCORE R,AGE,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,HCV FIBROSURE,LIMITATIONS,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CALCIUM,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,BMP,CHLORIDE,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,URINALYSIS RX ALB CREA,KETONES,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,CMP14 HP5 LP 6AC CBC D PLT,INR,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,CBC W AUTO DIFF,% LYMPHOCYTES,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.0,0.05555555555555555,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,LP WITHOUT VLDL CHOL HDL LD,LDL HDL RATIO,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,VITAMIN D 25 OH TOTAL IA,VITAMIN D 25 OH TOTAL IA,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.1425,0.36,0.0,0.25,0.2,1.0,0.0,0.14265122201011204,0.0,0.08356777192520215,0.12353958214165095,1.0,1,192955,URINE DRUG SCREEN,OPIATES,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,CARDIO IQ R VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.24333333333333332,0.335,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,823781,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,ANA AUTOIMMUNE PROFILE,RHEUMATOID FACTOR QUANT,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,URINALYSIS,BILIRUBIN,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,CCP IGG,CCP IGG,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.2,0.0,0.1825,0.2,0.0,0.0,0.048791106490973624,0.0,0.0,0.0,0.0,0,104661,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.028571428571428574,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,PROFILE 104 LIVER,BILIRUBIN TOTAL,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.17692551543363566,0.0,0,30510,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,HIV 1 RNA QN RT PCR,RACE NR,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,FE TIBC FER,FERRITIN SERUM,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,DRUG ABUSE SCREEN III,AMPHETAMINES,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.11,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,URINALYSIS ROUTINE,WBC,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.007000000000000001,0.015555555555555557,0.0,0.007000000000000001,0.015555555555555557,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,MITOCHONDRIAL ANTIBODY W RFX,MITOCHONDRIAL AB,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,CBC INCLUDES DIFF PLT,RDW,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,CMP14 LP 3AC,ALKALINE PHOSPHATASE S,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.16743054821491843,1.0,1,20289,CMP WITH EGFR,CARBON DIOXIDE,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,HEPATITIS BE ANTIGEN,HEPATITIS BE ANTIGEN,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,CBC WITH DIFFERENTIAL,IMMATURE GRANS,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,CBC INC DIFF PLT,MONOCYTES,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.25,0.2,0.25,0.0,0.0,0.0,0.0746172002260781,0.0,0.0,1,349993,CBC WITH DIFFERENTIAL PLATELETS,POLYS,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.028894352326416572,0.0,0,30916,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,CBC W DIFF PLT,ABSOLUTE NEUTROPHILS,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.06200000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,HCV FIBROSURE,COMMENT,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0525,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,CMP14 LP 2AC CBC D PLT TSH,EGFR IF AFRICN AM,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,URINALYSIS W REFLEX MICRO,COLOR,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,CBC WITH PLT DIFF,NO CELLS DIFF,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,CMP,TCO2,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.06200000000000001,0.0,0.0,0.06200000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,HCV AB WITH RFL RNA QT,HCV SIGNAL CUTOFF,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,HEPATITIS B SURFACE ANTIGEN,HBS AG SCREEN,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.1925,0.10600000000000001,0.0,0.1825,0.2,1.0,0.0,0.0,0.0,0.0,0.09762443806815091,1.0,1,204545,URINALYSIS COMPLETE W REFLEX CULTURE,PROTEIN,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,HIV AB EIA WITH REFLEXES,HIV EIA AB SCREEN,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.33399999999999996,0.3457142857142857,0.484,0.33399999999999996,0.3457142857142857,0.484,0.04144292597059562,0.07883325451199508,0.0795785781568974,0.04144292597059562,0.07883325451199508,0.0795785781568974,0,223222,HEP A AB TOTAL,HEP A AB TOTAL,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,GLYCOHEMOGLOBIN A1C,GLYCOHEMOGLOBIN A1C,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE EOS,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.04,0.06666666666666667,0.0,0.04,0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,VITAMIN B 12,VITAMIN B 12,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,COMP METABOLIC PANEL 14,EGFR IF NONAFRICN AM,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,CMP14 LP 6AC CBC D PLT ESR,CREATININE,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,C REACTIVE PROTEIN INFLAMMATORY,C REACTIVE PROTEIN,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,PSA WITH FREE RATIO,PSA ROCHE E170,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,1.0,1,205708,CBC WITH DIFFERENTIAL,HEMATOCRIT,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,LIPID PROFILE,FASTING NON FASTING,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.21668861764565872,0.0,0,18259,CMP14 5AC CBC D PLT TSH T4F,CALCIUM SERUM,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,TRANSFERRIN SATURATION,TRANSFERRIN,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,OXYCODONE,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.23399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,FOLATE,FOLATE,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.01125,0.0225,0.0,0.01125,0.0225,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,URINALYSIS CULTURE IF INDICATED,BILIRUBIN,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,CBC PLATELET HEM REVIEW,NEUTROPHILS,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,REFLEX ANA PATTERN,PATTERN 1,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,BMP8 CBC D PLT UA,EOS ABSOLUTE,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.047142857142857146,0.030000000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,AAA MALE PANEL,HIV 1 HIV 2 AB SCREEN,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,1.0,0.6666666666666666,0.0,0.0,0.056709193968798366,0.0,1.0,0.9870524497488843,0.0,1,59022,FE ANA TIBC FER PTT PT A1A,PROTHROMBIN TIME,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,HEPATIC FUNCTION PANEL 6,AST SGOT,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,PTT,PTT,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.3333333333333333,0.0,0.0,0.3333333333333333,0.0,0.0,0.06538932921065,0.0,0.0,0.09247447620418048,0.0,0.0,1,30940,BUN CREATININE,BUN,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.16,0.0,0.3225,0.2,1.0,0.0,0.05524858071613015,0.0,0.08103461702415493,0.12353958214165095,1.0,1,192708,DRUG ABUSE SCREEN I NO GCMS,BARBITURATES,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,TRICHOMONAS MALE,SOURCE,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,CMP14 LP CBC D PLT TSH HB A,ALT SGPT,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,COMP METABOLIC PANEL 13,EGFR IF NONAFRICN AM,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.16,0.0,0.3225,0.2,1.0,0.0,0.05043482321394899,0.0,0.08103461702415493,0.12353958214165095,1.0,1,192708,DRUG ABUSE SCREEN 9 NO THC W CONF,BARBITURATES,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.011728328363332818,0.0,0.0,0.0,0.0,0,7765,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,SEGMENTED NEUTROPHILS,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,DRUG ABUSE SCREEN I NO GCMS,BARBITURATES,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.0,0.14285714285714285,0.0,0.0,0.14285714285714285,0.0,0.0,0.09338639438323382,0.0,0.0,0.0762496717190786,0.0,0,19901,IMMUNOGLOBULINS A E G M SERUM,IMMUNOGLOBULIN G QN SERUM,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.1416666666666667,0.42500000000000004,0.0,0.1416666666666667,0.42500000000000004,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,HCV RNA GENO W REFL NS5A,HCV RNA GENOTYPE LIPA R,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,UROGRAM,SPECIFIC GRAVITY,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,FREE T4,FREE T4,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.1111111111111111,0.2,0.0,0.0,0.0,0.0,0.042948947469812815,0.06010638749440578,0.0,0.0,0.0,0,51961,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,CBC WITH DIFFERENTIAL PLATELETS,EOS,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,NASH FIBROSURE,ALT SGPT P5P,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,COMPLETE BLOOD COUNT,WBC,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,IFE PE SERUM,BETA GLOBULIN,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,COMP METABOLIC PANEL 14,EGFR IF NONAFRICN AM,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.07583869961926504,0.0,0,28688,VITAMIN B12 FOLATE,FOLATE SERUM,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.028571428571428574,0.05,0.2,0.07142857142857142,0.125,0.0,0.0,0.0,0.029580332703110557,0.044049699158471345,0.05120061892349881,0,139519,HIV ANTIGEN ANTIBODY FOURTH GEN,HIV AG AB 4TH GEN,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Body weight Measured,Weight Measured,Body weight
0.0,0.09090909090909091,0.0,0.0,0.09090909090909091,0.0,0.0,0.03711528845941925,0.0,0.0,0.03711528845941925,0.0,0,17442,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,RPR,RPR RESULT,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,COMPREHENSIVE METABOLIC PANEL W EGF,EGFR NON AFR AMERICAN,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,CBC DIFF PLT,PLATELET COUNT,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.16,0.0,0.25,0.2,1.0,0.0,0.061769791070825475,0.0,0.08356777192520215,0.12353958214165095,1.0,1,192955,DRUG ABUSE SCREEN II,OPIATES,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,HEPATITIS B CORE AB TOTAL REFL,HEPATITIS B CORE AB TOTAL REFL,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,CBC W O DIFF WITH PLATELETS,MCV,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,FERRITIN,FERRITIN,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,CMP13 LP TP TSH 2AC CBC D P,NEUTROPHILS ABSOLUTE,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,CBC W AUTO DIFF,MCV,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,URINALYSIS CULTURE IF INDICATED,GLUCOSE,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,DRUG ABUSE SCREEN II,METHAQUALONE,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.09499999999999999,0.10714285714285714,0.1875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,DRUG ABUSE SCREEN 9 NO THC W CONF,BARBITURATES,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,CBC,MCH,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.31,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.05153731836902975,0.0,0.0,1,7732,CBC WITH PLT DIFF,NRBC,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,CLR CBC W DIFF PLT,ABSOLUTE BLASTS,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.072,0.09857142857142856,0.13799999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,BASIC METABOLIC PANEL,AFRICAN AMERICAN,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.027777777777777776,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,DRUG ABUSE SCREEN 9 NO THC W CONF,BARBITURATES,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.01611111111111111,0.03625,0.0,0.08333333333333333,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,RBC,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.25,0.25,0.0,0.0,0.0,0.0,0.032132418748037184,0.0,0.0,0.0,0.0,0.0,0,265116,AUTOMATED BLD CNT,MCH,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,BASIC METABOLIC PANEL W EGFR,BUN CREATININE RATIO,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,MICROALBUMIN RANDOM SPEC,MICROALBUMIN,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,LIPID PANEL STANDARD,LDL CHOL CALCULATED,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,COMP METABOLIC PANEL W GFR,ANION GAP,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,LYMPHOCYTE SUBSET PANEL 3,ANALYZED DATE TIME,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,HB S AG W RFX CONF,HEPATITIS B SURFACE ANTIGEN,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.14833333333333334,0.11125,0.178,0.0,0.0,0.0,0.0,0.0,0.0,1,7641,CBC WITH PLT DIFF,BANDS,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,CBC,BA%,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,CBC PLT DIFF,ABSOLUTE EOS,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,RPR REFLEX TP PA,RPR TITER,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.072,0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.09090909090909091,0.0,0.0,0.09090909090909091,0.0,0.0,0.04521753067807699,0.0,0.0,0.052212707018155835,0.0,0,112599,IFE PE FLC SERUM,IMMUNOGLOBULIN G QN SERUM,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,CMP14 4AC,EGFR IF AFRICN AM,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CBC,MO%,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,HIV 1 RNA QN RT PCR,LOGCOPIES ML,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,HCV RNA QT REALTIME PCR,HCV RNA QN PCR,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.21668861764565872,0.0,0.0,0.21668861764565872,0.0,0,18259,C4 SERUM,C4 SERUM,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,MCCARJUH MCCARTHY PROFILE 1,PROTHROMBIN TIME PT,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,CBC W AUTO DIFF,MONOCYTES %,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,URINALYSIS W MICRO W REFLEX CULTURE,WBC,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.07333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,HEMATOPATH CONSULTATION SMEAR,WBC,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,VITAMIN B 12,VITAMIN B 12,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.13636363636363635,0.125,0.0,0.0,0.0,0.0,0.03166594870435313,0.0,0.0,0.0,0.0,0,322867,CBC W AUTO DIFF WITH PLATELETS,MCHC,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.4,0.5357142857142857,0.75,0.6,0.5714285714285714,0.8,0.43773540378221376,0.8284997221788247,0.8359491946807684,0.4485192921815444,0.8489103365948751,0.8565433315613047,1,169334,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,COMPLETE BLOOD COUNT,BASOPHILS %,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESISTANCE ASSAY PDF,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.2,0.0,0.0,0.2,0.0,0.0,0.013486072589692144,0.0,0.0,0.013486072589692144,0.0,0,30841,ALPHA 1 ANTITRYPSIN SERUM,ALPHA 1 ANTITRYPSIN SERUM,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,RENAL FUNCTION PANEL,BUN,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.08030844563447248,0.0,0,303503,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.04818181818181819,0.0,0.0,0.04818181818181819,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,CERULOPLASMIN,CERULOPLASMIN,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,FREE T4 THYROXINE,FREE T4,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,IMMUNOFIXATION SERUM,IGG SERUM NR,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,CMP14 HP5 LP 6AC CBC D PLT,INR,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,IRON BINDING CAPACITY,UIBC,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,HCV FIBROSURE,LIMITATIONS,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA PATTERN,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,T4,T4,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.04,0.05714285714285715,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,COMP METABOLIC PANEL,ANION GAP,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,CBC INC DIFF PLT,RBC,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,CBC W AUTO DIFF,% EOSINOPHILS,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,CCP IGG,CCP IGG,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,CBC INCLUDES DIFF PLT WITH PATHOLOGIST REVIEW,ABSOLUTE LYMPHOCYTES,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,UA MICROSCOPIC REFLEX CULTURE,LEUKOCYTE ESTERASE,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.0,0.03636363636363637,0.05714285714285715,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,LYMPHOCYTE SUBSET PANEL 1,ABSOLUTE CD8 CELLS,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,VITAMIN B12 FOLATE,VITAMIN B12,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.21,0.1111111111111111,0.25,0.0,0.0,0.0,0.0,0.021872967314701564,0.03507675354076545,1,32896,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,ASH FIBROSURE,COMMENT,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,RENAL FUNCTION PANEL,CHLORIDE,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE AG,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,OBSTETRIC PANEL,RPR RESULT,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,CBC,BA%,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,RENAL FUNCTION PANEL,CREATININE,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,URINALYSIS W REFLEX MICRO,SPECIFIC GRAVITY,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.0,0.0,0.0,0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,CHEM SCREEN PANEL HDL,URIC ACID,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,COMP METAB PANEL,CALCIUM PLASMA,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,MITOCHONDRIAL M2 ANTIBODY,MITOCHONDRIAL M2 ANTIBODY,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,CCP IGG,CCP IGG,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,CEA,CEA CENTAUR,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,COMP METABOLIC PANEL,,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,PROTEIN TOTAL 24HR URINE W CREAT,UR CREAT RANDOM MG DL,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,DRUG ABUSE SCREEN I NO GCMS,AMPHETAMINES,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.1,0.16666666666666666,0.0,0.0,0.0,0.0,0.015218253751563937,0.0212050347766235,0.0,0.0,0.0,0,241133,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CBC WITH MANUAL DIFFERENTIAL,MCHC,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.05555555555555555,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,ASH FIBROSURE,WEIGHT,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,FIBROACT,FIBROSIS SCORE,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.15,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.037657557511435735,0.0,0.0,0.0,0.0,0,632117,PROTEIN ELECTROPHORESIS SERUM,ALPHA 1,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.016666666666666666,0.03,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,DRUG ABUSE SCREEN I NO GCMS,BARBITURATES,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.11,0.0,0.0,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,MITOCHONDRIAL ANTIBODY W RFX,MITOCHONDRIAL AB,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,CHOLESTEROL TOTAL,ICTERUS,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,PT PROTIME,INR,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CMP WITH EGFR,CARBON DIOXIDE,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,CMP14 HP4 DBILI CBC D PLT R,AMYLASE,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.08312548434166944,0.0,0.0,0.0,0.0,0,19752,IFE PE SERUM,GAMMA GLOBULIN,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,CMP WITH EGFR,CARBON DIOXIDE,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.02,0.04666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CMP CBC TSH,ABSOLUTE BLASTS,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,DRUG ABUSE SCREEN II,METHAQUALONE,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,IRON TIBC,TIBC,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.3333333333333333,0.24714285714285714,0.865,0.3333333333333333,0.2621428571428571,0.9175,0.30304972032715427,0.015005024364675101,0.04246284832312519,0.2988315713654016,0.014796169435270734,0.04187180795069423,1,110114,HCV RNA QN PCR W RFL GENO,HCV RNA QN REAL TIME PCR,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,LYMPHOCYTE SUBSET PANEL 4,COMMENT S,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.066,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,URINALYSIS WITH MICROSCOPIC,COLOR,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.3333333333333333,0.46875,0.75,0.3333333333333333,0.46875,0.75,0.3858852398421331,0.7015934244403738,0.837218460816585,0.3858852398421331,0.7015934244403738,0.837218460816585,1,109009,HEP B SURFACE AB,HEP B SURFACE AB,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.030763983977592058,0.0,0.0,0.0,0.0,0,7518,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,COMPREHENSIVE METABOLIC PANEL WITH GFR,T BILIRUBIN,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,UROGRAM,NITRITE,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,HCV FIBROSURE,COMMENT,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,HIV AB EIA WITH REFLEXES,HIV EIA AB SCREEN,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,CBC PLATELET HEM REVIEW,NEUTROPHILS,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,HCV RNA QT REALTIME PCR,HCV RNA QN PCR,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,SPECIAL CUM 50 PLUS PROFILE # 10190,SEDIMENTATION RATE,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.02,0.03,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.5,0.3333333333333333,1.0,0.25,0.16666666666666666,0.5,0.11620501087019508,0.04902508028875774,0.05093349536754144,0.07747000724679676,0.0,0.0,1,27318,PTH INTACT MOLECULE,PTH,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,LIPID PROFILE WRFL LDL DIRECT,NON HDL CHOLESTEROL,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,URINALYSIS C,BILIRUBIN,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,PROTHROMBIN TIME PT,PT CONTROL,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,TSH 3RD GENERATION REFL,TSH 3RD GENERATION REFL,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.43,0.0,0.0,0.0,0.0,0.0,0.0,0.046144390603046204,0.04691479279731581,1,20958,PROFILE 1236 LIPID PANEL WITH DIRECT LDL,CHOL HDL,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,30916,RENAL FUNCTION PANEL,BUN,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,CBC,BA%,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,HCV RNA QT REALTIME PCR,HCV RNA QN PCR,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.66,0.514,0.7849999999999999,0.66,0.548,0.37,0.0,0.03869667864135018,0.019733925021995558,0.0,0.04216763877231289,0.014335993873441866,1,93187,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,COMP METABOLIC PANEL W EGFR,UREA NITROGEN,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,DIRECT LDL,LDL CHOLESTEROL DIRECT,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CD4 CD8 RATIO PROFILE,HEMATOLOGY COMMENTS,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,CMP WITH ESTIMATED GFR CALCULATED,CHEMISTRY SODIUM,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,SEGMENTED NEUTROPHILS,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,ALPHA 2 MACROGLOBULIN,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,CMP14 1AC,ALT SGPT,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,CBC WITH DIFF PLATELET,EOS ABSOLUTE,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.5,0.4,1.0,0.0,0.0,0.0,0.5980553435796393,0.7141611687807009,0.042181184586030485,1,81224,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,TSH SML,TSH,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,CBC W DIFF PLT,MONOCYTES %,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,URINALYSIS,LEUKOCYTE ESTERASE,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.09090909090909091,0.25,0.0,0.09090909090909091,0.25,0.0,0.01135732291885827,0.01663689182775463,0.0,0.01135732291885827,0.01663689182775463,0,322867,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,CBC INCLUDES DIFF PLT,MCHC,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,MICROALBUMIN CONC,ALB CREAT RATIO,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,REFLEXED LDL,LDL DIRECT,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,DRUG ABUSE SCREEN I NO GCMS,METHADONE,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,HEPATITIS BC AB IGM,HEPATITIS B CORE AB IGM,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.1,0.0,0.0,0.04,0.08,0.0,0.05563255642440801,0.0,0.0,0.0,0.0,0,51938,IFE PE SERUM,BETA GLOBULIN,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.03133333333333333,0.1175,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,URINALYSIS COMPLETE W REFLEX CULTURE,PROTEIN,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,LIVER FIBROSIS FIBROTEST ACTITEST P,APOLIPOPROTEIN A1,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.5,0.41111111111111115,0.74,0.5,0.41111111111111115,0.74,0.013012224336779066,0.9457662360035409,0.7072472090959524,0.013012224336779066,0.9457662360035409,0.7072472090959524,1,339358,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,LIPOPROTEIN ANALYSIS NMR,LDL P,pH of Urine by Test strip,pH Ur Strip,pH
0.3333333333333333,0.4444444444444444,0.8,0.3333333333333333,0.4444444444444444,0.8,0.059107272304839475,0.14405514915685358,0.20160295247915183,0.059107272304839475,0.14405514915685358,0.20160295247915183,1,139527,HEPATITIS B CORE TOTAL AB,HEPATITIS B CORE TOTAL AB,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,CBC WITH PLT DIFF,NRBC,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,CBC WITH PLT MAN DIFF,BANDS,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,CBC WITH MANUAL DIFFERENTIAL,RDW,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,DRUG ABUSE SCREEN III,METHAQUALONE,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,WESTERGREN SED RATE,WESTERGREN SED RATE,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.16916093904956808,0.0,0,17426,CBC INCLUDES DIFFERENTIAL PLATELETS,MEAN PLATELET VOLUME,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,Color of Urine,Color Ur,Color
0.0,0.028571428571428574,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,COMP METABOLIC PANEL,,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.007894736842105263,0.016666666666666666,0.0,0.04315789473684211,0.09111111111111111,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,URINALYSIS REFLEX,NITRITE,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,LIVER FIBROSIS PANEL HEPASCORE,FIBROSIS SCORE,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.3333333333333333,0.6,0.4666666666666666,0.2222222222222222,0.4,0.0,0.3463455259430688,0.4847052050325502,0.36763357933547924,0.5973264996689122,0.8359491946807684,1,139527,HEPATITIS B VIRUS PNL 6 TESTS,HB CORE AB TOTAL,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.4,0.3333333333333333,1.0,0.0,0.0,0.0,0.11277316640103974,0.16750164273558021,1.0,1,57992,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,COMPREHENSIVE METABOLIC PNL W O CO2 ALT,POTASSIUM,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CBC,MCHC,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,DRUG ABUSE SCREEN W ETOH NO GCMS,COCAINE METABOLITE,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.20285714285714285,0.0,0.0,0.0,0.0,0.0,0.05581018273830618,0.0,0.0,0.0,0.0,0,30973,IFE PE SERUM,ALBUMIN,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,LYMPHOCYTE SUBSET PANEL 4,HELPER SUPPRESSOR RATIO,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.43,0.2857142857142857,0.6666666666666666,0.43,0.2857142857142857,0.6666666666666666,0.0,0.11303021146914194,0.11491730374182318,0.0,0.11303021146914194,0.11491730374182318,1,20958,HDL AS % CHOLESTEROL,HDL AS % CHOLESTEROL,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.08333333333333333,0.033,0.0,0.0,0.081,0.405,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,LIVER FIBROSIS PNL HEPASCORE TM,GGT,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,CBC W AUTO DIFF,MCV,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.1416666666666667,0.42500000000000004,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,LIPID PANEL AMA,CHOL HDLC RATIO,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.06666666666666667,0.08,0.16,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,HIV AB EIA WITH REFLEX,HIV AB,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,AUTOMATED BLD CNT,HEMOGLOBIN,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.036,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.04555555555555556,0.10250000000000001,0.0,0.008333333333333333,0.01875,0.0,0.00570307938854131,0.0,0.0,0.0,0.0,0,622381,MICROALBUMIN CREATININE RANDOM RATIO,MICROALBUMIN RANDOM,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.134,0.08375,0.0,0.178,0.11125,0.2966666666666667,0.0,0.0,0.0,0.0,0.0,0.0,1,7633,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.045454545454545456,0.125,0.0,0.045454545454545456,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,CD4 T HELPER PANEL,CD4 CD3 %HELPERS,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.11166666666666668,0.1675,0.25,0.16666666666666666,0.25,0.0,0.0,0.0,0.012816665455167797,0.01747939389314279,0.017616324418623153,0,161281,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CALCIUM,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,CMP14 LP CBC D PLT TSH HB A,ALT SGPT,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0475,0.095,0.0,0.0475,0.095,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,BMP8 ANION GAP,EGFR IF NONAFRICN AM,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,CBC INCLUDES DIFF PLT,ABSOLUTE NEUTROPHILS,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,CBC INC DIFF PLT,MONOCYTES,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,URINALYSIS,LEUKOCYTE ESTERASE,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,COMP METABOLIC PANEL CLARIFICATION,ALBUMIN GLOBULIN RATIO,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,COMPREHENSIVE METABOLIC PANEL WITH GFR,ALBUMIN,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.3333333333333333,0.14285714285714285,0.5,0.0,0.0,0.0,0.060037523066651444,0.0,0.0,1,19208,HEPATIC FUNCTION PANEL 6,AST SGOT,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,FIBROACT,FIBROSIS SCORE,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,203927,CHOLESTEROL TOTAL,ICTERUS,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.405,0.3333333333333333,0.6666666666666666,0.0,0.0,0.0,0.04707567369242904,0.0818901804741462,0.12900463674079643,1,265074,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.025714285714285714,0.036,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,ESR WES CRP,C REACTIVE PROTEIN QUANT,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.235,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.08089870281836808,1.0,1,7773,CMP14 LP CBC D PLT TSH,PLATELETS,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.2,0.2775,0.37000000000000005,0.2,0.24625,0.3283333333333333,0.00963012475658398,0.04046382484576627,0.03002617729150281,0.00963012475658398,0.020231912422883136,0.01501308864575146,0,519132,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,TESTOSTERONE TOTAL LC MS MS,TESTOSTERONE TOTAL LC MS MS,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,DIRECT LDL,TRIGLYCERIDES,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.5,0.3333333333333333,0.0,0.0,0.0,0.0,0.1503314858492919,0.7071067811865476,0.0,1,304287,CBC W O DIFF WITH PLATELETS,MCV,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,HEMOGLOBIN A1C W EAG INT CHART,ESTIMATED AVERAGE GLUCOSE,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,AAA MALE PANEL,HIV 1 HIV 2 AB SCREEN,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,CBC W DIFF PLT,BASOPHILS ABSOLUTE,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,X HEPATITIS COMPLEX PROFILE,ANTI HCV,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.3333333333333333,0.14285714285714285,0.5,0.0,0.0,0.0,0.084905879372146,0.0,0.0,1,19208,COMPREHENSIVE METABOLIC PANEL E GFR,AST,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,CBC COMPLETE BLOOD COUNT W O DIFF,RED BLOOD CELL COUNT,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,CMP14 LP TP TSH 4AC CBC D PLT,URIC ACID,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,CBC WITH DIFFERENTIAL PLATELETS,EOS,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.31,0.10615384615384614,0.45999999999999996,0.31,0.22,0.9533333333333333,0.028275241940297513,0.08470305693504976,0.6324555320336758,0.03161268152937924,0.09470089660440306,0.7071067811865476,1,204479,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.06625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,BUN CREAT RATIO,EGFR AFRICAN AMERICAN,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,PROTIME PTT,PROTHROMBIN TIME PT,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,SPECIAL CUM 50 PLUS PROFILE # 10190,SEDIMENTATION RATE,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,CBC W AUTO DIFF,MCV,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,CMP14 LP CBC D PLT TSH T4F,NEUTROPHILS ABSOLUTE,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,CMP14 LP CBC D PLT TSH,PLATELETS,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,CMP14 HP5 LP 6AC CBC D PLT,HDL CHOLESTEROL,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,PSA FREE TOTAL,% FREE PSA,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.04666666666666666,0.0,0.0,0.0,0.0,0.0,0.00516483365805831,0.0,0.0,0.0,0.0,0,58214,PROTEIN TOTAL URINE,PROTEIN CR RATIO,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,COMPREHENSIVE METABOLIC PANEL WITH GFR,T BILIRUBIN,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,IFE PE SERUM,ALBUMIN,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,CBC WITH PLT DIFF,BANDS ABSOLUTE,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,HCV FIBROSURE,LIMITATIONS,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.04833333333333333,0.05555555555555555,0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,CBC W DIFF PLT,PLATELET SUFFICIENCY,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.05339253570354541,0,7864,CBC INCLUDES DIFF PLT,HEMOGLOBIN,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,CBC PLATELET HEM REVIEW,NEUTROPHILS,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,BMP,CHLORIDE,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,CLR CBC W DIFF PLT,ABSOLUTE BLASTS,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0,0.0,0.0,0.094,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,IFE PE SERUM,M SPIKE,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,URINALYSIS RX ALB CREA,KETONES,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,UA W RFLX MICROSCOPIC,BILIRUBIN,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.10031748330730439,0.10964330813284906,0.7071067811865476,1,303768,CLR CBC W DIFF PLT,ABSOLUTE BLASTS,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.125,0.125,0.0,0.0,0.0,0.0,0.0,0.0666872623744319,0.0,0.0,0.0,0.0,0,109009,IFE PE SERUM,GAMMA GLOBULIN,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.06,0.0,0.0,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,BUN CREATININE RATIO,EGFR NON AFR AMERICAN,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.06090909090909091,0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,UA W MICRO HOLD SPEC 24 HR,GLUCOSE,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,HEPATITIS A IGM,HEPATITIS A IGM,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,HIV AB EIA WITH REFLEX,HIV AB,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,HELPER T LYMPH CD4,NEUTROPHILS,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,LIPID PANEL,VLDL CHOL CALC,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,30916,CMP13 LP 2AC CBC D PLT,ALBUMIN SERUM,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,AUTOMATED BLD CNT,MCH,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,PROTIME PTT,PROTHROMBIN TIME PT,Body weight Measured,Weight Measured,Body weight
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,VITAMIN D 25 OH,25 OH VITAMIN D,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,URINALYSIS W REFLEX MICRO,COLOR,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,CBC WITH DIFFERENTIAL,MCHC,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,LIVER FIBROSIS FIBROTEST ACTITEST P,APOLIPOPROTEIN A1,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,CBC D WITH PLT CITRATED BLD,LYMPHS,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,AFP TUMOR MARKER,AFP TUMOR MARKER,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.16666666666666666,0.0,0.0,0.16666666666666666,0.3333333333333333,0.0,0.017831508061623147,0.0,0.0,0.044274927162410105,0.04848838326247262,1,7880,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,CBC INC DIFF PLT,BASOPHILS,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,ESR WES CRP,C REACTIVE PROTEIN QUANT,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,CREATININE,EGFR IF AFRICN AM,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,HEPATITIS A IGM,HEPATITIS A IGM,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,LYMPHOCYTE SUBSET PANEL 1,% CD8,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,CBC WITH PLT DIFF,NRBC,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,STOOL CULTURE,RESULT 2,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.05181818181818181,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,DRUG ABUSE SCREEN III,METHADONE,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1858678609476695,0.0,0.0,0.0,0.0,0,44859,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,CBC WITH DIFFERENTIAL,MCHC,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,DRUG ABUSE SCREEN I NO GCMS,METHADONE,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,NASH FIBROSURE,APOLIPOPROTEIN A 1,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CMP14 HP4 DBILI CBC D PLT R,AMYLASE,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,CBC WITH PLT DIFF,NO CELLS DIFF,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,FIBROACT,FIBROSIS SCORE,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,RENAL FUNCTION PANEL,BUN,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.0,0.0,0.0,0.2,0.25,0.0,0.0,0.0,0.0,0.009242572384373537,0.009863562863192121,0,349993,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,STOOL CULTURE,RESULT 2,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.09499999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,URINALYSIS ROUTINE,WBC,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,CBC PLATELET HEM REVIEW,NEUTROPHILS,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,PSA FREE TOTAL,FREE PSA,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL AB,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,PTH INTACT,PTH INTACT,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.06636363636363636,0.1825,0.0,0.06636363636363636,0.1825,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,HIV AB AG COMBO RFLX CONF,HIV AB AG COMBO RFLX CONF,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.4,0.23285714285714285,0.5433333333333333,0.4,0.23285714285714285,0.5433333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,HEPATITIS A IGM,HEPATITIS A IGM,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.5,0.5714285714285714,1.0,0.0,0.2857142857142857,0.5,0.02835463752905909,0.041329352180867085,0.04229321806927422,0.0,0.08666100167154711,0.08868207335447242,1,223271,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,HCV GENOTYPE REFLEX NS5A,PLEASE NOTE,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,AAA MALE PANEL,HIV 1 HIV 2 AB SCREEN,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,CHOLESTEROL TOTAL,ICTERUS,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,URINALYSIS ROUTINE,WBC,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,DIRECT LDL,LDL CHOLESTEROL DIRECT,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,PROFILE 104 LIVER,BILIRUBIN TOTAL,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,FOLATE,FOLATE,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.4,0.25,0.6666666666666666,0.0,0.0,0.0,0.43159805011496677,0.036870751523516376,0.02890669461985995,1,141358,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.2333333333333333,0.1325,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,ANEMIA PROFILE B,EOS,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,UA MICROSCOPIC REFLEX CULTURE,PH,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,REFLEXED LDL,LDL DIRECT,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,DRUG ABUSE SCREEN III,METHADONE,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,CHEM SCREEN PANEL HDL,TRIGLYCERIDES,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.0,0.0,0.06666666666666667,0.044444444444444446,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,CBC W AUTO DIFF ABS WBC MPV PLT,BASOPHILS,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,COMPLETE BLOOD COUNT,MCV,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,HIV AG AB 4TH GEN RFL,RACE NR,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,IRON TOTAL BINDING CAPACITY,IRON TOTAL,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.1111111111111111,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,PSA FREE TOTAL,INTERNAL %,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,HIV 1 RNA QN RT PCR,HIV 1 RNA QN RT PCR,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.286,0.16909090909090907,0.2657142857142857,0.286,0.16909090909090907,0.2657142857142857,0.025566765142283954,0.029447008676470543,0.03171743474975597,0.025566765142283954,0.029447008676470543,0.03171743474975597,0,568881,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,ALPHA FETOPROTEIN TUMOR MARKER,AFP TUMOR MARKER,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CBC W O DIFF WITH PLATELETS,MCV,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE EOS,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.16666666666666666,0.0,0.0,0.16666666666666666,0.0,0.0,0.06546569326404728,0.0,0.0,0.0,0.0,0,115725,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH TOTAL,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CALCIUM,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.044444444444444446,0.0,0.0,0.1111111111111111,0.0,0.0,0.06790824855576716,0.0,0.0,0.055446852762574106,0.0,0,51961,IMMUNOFIXATION SERUM,IGG SERUM NR,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,CMP14 HP4 DBILI CBC D PLT R,WBC,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.14285714285714285,0.2757142857142857,0.715,0.2857142857142857,0.2757142857142857,0.965,0.020315488372455226,0.08632261464360236,0.22524969726717137,0.2458696638252934,0.011170953400621464,0.04372412516808821,1,296095,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,PROTHROMBIN PTT,CONTROL,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.072,0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,COMP METAB PANEL,CALCIUM PLASMA,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CBC NO DIFF,RBC,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,CBC D PLT,HEMOGLOBIN,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.024444444444444446,0.03666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,PROFILE 1236 LIPID PANEL WITH DIRECT LDL,CHOL HDL,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,LYMPHOCYTE SUBSET PANEL 3,ANALYZED DATE TIME,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,CMP14 LP 7AC CBC D PLT T B,IRON SATURATION,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,MORPHOLOGICAL REVIEW,PLATELET ESTIMATE,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,DRUG ABUSE SCREEN III,AMPHETAMINES,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,CBC,MCH,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Specimen source identified,Specimen source XXX,Specimen source
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,URINALYSIS REFLEX,NITRITE,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.09499999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,RPR REFLEX TP PA,RPR,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.134,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.05957327454539674,0.0,0,52217,FE TIBC FER,FERRITIN SERUM,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,LIVER FIBROSIS PNL HEPASCORE TM,GGT,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,PROTEIN ELECTROPHORESIS SERUM,ALPHA 1,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,RENAL FUNCTION PANEL,BUN,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06797427042040116,0.05720402135206337,0.7071067811865476,1,7310,CBC INCLUDES DIFF PLT,LYMPHOCYTES ABSOLUTE,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,LIPID PANEL W REFL DLDL,NON HDL CHOLESTEROL,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.11857142857142858,0.049999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,CUSTOM HEPATITIS PANEL,HEP B SURFACE AB,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.178,0.11125,0.2966666666666667,0.0,0.0,0.0,0.0,0.0,0.0,1,7633,CBC WITH PLT DIFF,BANDS ABSOLUTE,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,CBC WITH MANUAL DIFFERENTIAL,RDW,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESIST ASSAY INTERP,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.22200000000000003,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,SPECIAL A 2 PANEL #9633,POLYS,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.2225,0.2966666666666667,0.2966666666666667,0.2225,0.2966666666666667,0.2966666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,HEPATITIS B CORE AB,HEPATITIS B CORE AB,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,LD,LIPEMIA,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,AMYLASE,AMYLASE,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,PSA FREE TOTAL,INTERNAL %,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.015454545454545455,0.0425,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,DIRECT LDL,LDL CHOLESTEROL DIRECT,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,CBC WITH AUTO DIFF,NRBC,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.008571428571428572,0.018,0.0,0.008571428571428572,0.018,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.028571428571428574,0.05,0.0,0.04714285714285714,0.08249999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.03630345171580529,0.0,0,273532,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,FIBROACT COMPLETE,NECROINFL SCORE,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,URINALYSIS COMPLETE,BILIRUBIN,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.3333333333333333,0.142,0.71,0.0,0.0,0.0,0.04623723810209024,0.17001758398860156,0.5,0.0,0.0,0.0,1,22848,VIT B 12 FOLATE PANEL,FOLIC ACID,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.765,0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,149799,PT PTT,PARTIAL THROMBOPLASTIN,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,IRON BINDING CAPACITY,UIBC NR,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,BASIC METABOLIC PANEL W EGFR,BUN CREATININE RATIO,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,HAV AB TOTAL,HAV AB TOTAL,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp,Daclatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,CBC WITH PLT DIFF,OTHERS,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.14285714285714285,0.0,0.0,0.14285714285714285,0.3333333333333333,0.0,0.06603415273894597,0.0,0.0,0.022665574408004208,0.02434780138308501,0,18358,PROTEIN ELEC INTERP SERUM,ALPHA 2 GLOBULIN,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,CHEM SCREEN PANEL,BILIRUBIN DIRECT,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.03882352941176471,0.0,0.0,0.03882352941176471,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,HEP B SURFACE AB,HEP B SURFACE AB,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HCV AB WITH RFL RNA QT,HCV SIGNAL CUTOFF,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,GLUCOSE,GLUCOSE FASTING,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,LIVER FIBROSIS,NECROINFLAM ACT GRADE,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,MANUAL DIFFERENTIAL,BLASTS %,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,CMP WITH EGFR,CARBON DIOXIDE,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.01,0.022222222222222223,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,PATHOLOGIST SMEAR REVIEW,MONOCYTES,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.3333333333333333,0.3283333333333333,0.985,0.3333333333333333,0.16666666666666666,0.5,0.03775254682189788,0.05391665993580863,0.057918325991897945,0.06538932921065,0.0,0.0,1,20396,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,CBC W DIFF PLT,ABSOLUTE NEUTROPHILS,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.155,0.2316666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,327767,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,URINALYSIS RX ALB CREA,KETONES,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.26,0.2,1.0,0.0,0.0,0.0,0.0,0.05111799204302647,0.1503314858492919,1,20933,CMP13 LP 2AC CBC D PLT,CHOLESTEROL TOTAL,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,COMP METABOLIC PANEL,GLOBULIN,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,MICROALBUMIN CREATININE RANDOM RATIO,MICROALBUMIN RANDOM,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.335,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,LIPID PROFILE,FASTING NON FASTING,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,HEPATITIS C GENO TYPE 1 NS5A RESIST,VELPATASVIR RESISTANCE,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,HEPATIC FUNCT PANEL W O TP,BILIRUBIN DIRECT,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CBC WITH AUTO DIFF,MONOCYTES #,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,CMP14 CBC D PLT TSH,ALBUMIN,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,MITOCHONDRIAL ANTIBODY W RFX,MITOCHONDRIAL AB,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.25,0.16666666666666666,0.0,0.0,0.0,0.0,0.06812389033458222,0.051758104169687846,0.0,0.0,0.0,0.0,0,7328,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,CBC W DIFF PLT,BASOPHILS ABSOLUTE,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,DIRECT LDL,LDL CHOLESTEROL DIRECT,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,CBC WITH MANUAL DIFFERENTIAL,PLATELET COUNT,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.044444444444444446,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,PE FLC SERUM,ALBUMIN,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,PROTEIN ELECTRO S,GAMMA GLOBULIN,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.2,0.0,0.0,0.2,0.0,0.0,0.13881877602428572,0.0,0.0,0.13881877602428572,0.0,0,27771,AFP SERUM TUMOR MARKER,AFP SERUM TUMOR MARKER,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,CBC WITH DIFFERENTIAL,MYELOCYTES,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH TOTAL,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,DRGABU2,METHAQUALONE,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,COMP METAB PANEL,EGFR NON AFR AMERICAN,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.5733333333333334,0.14285714285714285,0.0,0.5733333333333334,0.14285714285714285,0.0,0.0,0.08055416307669028,0.05461391574666674,0.0,0.11392078992866939,0.07723574034323777,1,110544,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.16666666666666666,0.03538461538461539,0.15333333333333335,0.16666666666666666,0.05153846153846154,0.2866666666666667,0.010660589775500773,0.015967759791800873,0.11922707845424241,0.010512205029774346,0.015745504548289713,0.11756755678680242,0,204479,HCV RNA QN PCR W RFL GENO,HCV RNA QN REAL TIME PCR,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CBC DIFF PLT,PLATELET COUNT,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,CBC WITH PLT DIFF,PROMYELOCYTES,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,RPR,RPR RESULT,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,DRGABU2,METHAQUALONE,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,CBC WITH DIFFERENTIAL PLATELETS,MCH,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,HCV GENOTYPE REFLEX NS5A,PLEASE NOTE,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHADONE,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,CBC W AUTO DIFF WITH PLATELETS,RBC,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,CBC WITH PLT DIFF,MYELOCYTES,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,COMP METABOLIC PANEL,POTASSIUM,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,CBC WITH DIFFERENTIAL,MYELOCYTES,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.03571428571428571,0.125,0.0,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.051583725460460195,0.0,0,204164,CBC INCLUDES DIFFERENTIAL PLATELETS,MEAN PLATELET VOLUME,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.13799999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.0,0.0,0.0,0.41333333333333333,0.5,1.0,0.0,0.0,0.0,0.0,0.5773502691896257,0.5,1,21618,EIA 10 ALCOHOL W GCMS,URINE CREATININE MG DL,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,HEPATITIS A IGM,HEPATITIS A IGM,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.03666666666666667,0.0,0.0,0.03666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,HEP B SURFACE AB,HEP B SURFACE AB,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,PSA FREE TOTAL,% FREE PSA,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,CBC INCLUDES DIFF PLT,LYMPHOCYTES ABSOLUTE,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CD4 T HELPER PANEL,CD4 CD3 %HELPERS,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,RPR SCREEN W TITER,RPR SCREEN,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,HIV AB AG COMBO RFLX CONF,HIV AB AG COMBO RFLX CONF,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,HCV FIBROSURE,FIBROSURE STAGE,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,HCV FIBROSURE,FIBROSURE STAGE,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,CBC WITH PLT DIFF,BANDS ABSOLUTE,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,CBC WITH MANUAL DIFFERENTIAL,MCH,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,COMP METABOLIC PANEL,ANION GAP,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,LIVER FIBRO HEPSCORE R,AGE,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,CBC WITH PLT DIFF,BANDS ABSOLUTE,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.05,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,CBC WITH MANUAL DIFFERENTIAL,RDW,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,TRANSFERRIN,TRANSFERRIN,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,CMP14 HP4 1AC PT AFP,EGFR IF NONAFRICN AM,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.073,0.10428571428571429,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,GENERAL HEALTH PANEL,HEMATOCRIT,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,URINALYSIS CULTURE IF INDICATED,PH,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,CBC INC DIFF PLT,RBC,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.06,0.05142857142857143,0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,CBC INCLUDES DIFF PLT,LYMPHOCYTES ABSOLUTE,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp,Daclatasvir
0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,ASH FIBROSURE,WEIGHT,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,CHEM SCREEN PANEL HDL,TRIGLYCERIDES,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.25,1.0,0.0,0.0,0.0,0.0,0.15505905338492743,1.0,1,7187,CBC INCLUDES DIFF PLT,HEMOGLOBIN,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.25,0.16666666666666666,0.0,0.0,0.0,0.0,0.02861478805067552,0.13704591495872687,0.0,0.0,0.0,0.0,0,19687,LIPID PANEL WITH DIRECT LDL,TRIGLYCERIDES,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,CBC WITH MANUAL DIFFERENTIAL,WBC,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,URINALYSIS W REFLEX MICRO,SPECIFIC GRAVITY,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,IRON TIBC,TIBC,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.0,0.14285714285714285,0.2,0.4,0.5714285714285714,0.8,0.0,0.06660212972360224,0.06720098415971731,0.3866542573725118,0.8590550279997561,0.8667792391701724,1,51953,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE AG,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.020543378257532607,0.0,0.0,0.0,0.0,0,7302,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,URINALYSIS W MICRO W REFLEX CULTURE,WBC,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,PE INTERP RFX IFE S,ALBUMIN,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,HEPATIC FUNCTION PANEL AMA,GLOBULIN,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.5,0.16666666666666666,0.2,0.0,0.0,0.0,0.11136168435129556,0.05936451274361987,0.17946985244079683,1,63016,PT PROTIME,INR,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,HCV FIBROSURE,FIBROSURE STAGE,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,MICROALBUMIN CONC,ALB CREAT RATIO,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,LIPID PANEL WITH DIRECT LDL,TRIGLYCERIDES,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,IFE PE FLC SERUM,IMMUNOGLOBULIN G QN SERUM,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,COMPREHENSIVE METABOLIC PANEL WITH GFR,T BILIRUBIN,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.14285714285714285,0.5,0.0,0.0,0.0,0.0,0.012707819480527238,0.021327579827395304,0,134585,CMP14 LP CBC D PLT TSH UA M,HDL CHOLESTEROL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.044444444444444446,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,PROTEIN ELECTROPHORESIS,BETA GLOBULINS,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,IRON BINDING CAPACITY,TIBC,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,FE TIBC FER,FERRITIN SERUM,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,ASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,RPR SCREEN W TITER,RPR SCREEN,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,DRGABU2,METHAQUALONE,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.22333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.316,0.125,1.0,0.0,0.0,0.0,0.0,0.624939177332759,1.0,1,28654,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.0,0.0,0.0,0.25,0.2,1.0,0.0,0.0,0.0,0.08356777192520215,0.12353958214165095,1.0,1,192955,DRUG ABUSE PANEL 10 WITH OXYCODONE,OPIATES,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,MAGNESIUM,HEMOLYSIS,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,IRON BINDING CAPACITY,IRON TOTAL,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,MICROALBUMIN CREATININE RANDOM RATIO,MICROALBUMIN RANDOM,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.25,0.2,0.0,0.0,0.0,0.0,0.06725870151848445,0.21223170681007852,0.0,1,7864,CBC,MCHC,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,UREA NITROGEN BUN,ICTERUS,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,URINALYSIS REFLEX,NITRITE,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.10333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,HAPTOGLOBIN,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CHEM SCREEN PANEL,BILIRUBIN DIRECT,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.027424832592389037,0.0,0.0,0.0,0.0,0,622381,IGA SERUM,IMMUNOGLOBULIN A,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.04,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,BASIC METABOLIC PANEL,AFRICAN AMERICAN,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.25,0.2,0.5,0.0,0.0,0.0,0.014270065960565903,0.017040441314305155,0.02226760361383817,0,81224,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,MA CBC DIFF PLT,MONOCYTES %,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,URINALYSIS WITH MICROSCOPIC,COLOR,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,PROTHROMBIN PTT,APTT,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHADONE,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.0,0.01,0.0225,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,CBC WITH PLT DIFF,WBC MORPHOLOGY,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,HCV FIBROSURE,FIBROSURE STAGE,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.25,0.10857142857142857,0.0,0.1825,0.0,0.0,0.022269798661496143,0.0,0.0,0.0,0.0,0.0,0,134585,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CALCIUM,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.5,0.7142857142857143,1.0,0.0,0.0,0.0,0.4335293647738059,0.013881484946973388,0.01569188635480001,0.0,0.0,0.0,1,128413,PSA FREE TOTAL,INTERNAL %,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,HCV RNA QT REALTIME PCR,HCV RNA QN PCR,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.01431921834184502,0.0,0.0,0.015466523512897123,0.0,0,32896,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,DRUG ABUSE SCREEN I NO GCMS,METHADONE,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,CBC W DIFF PLT,HEMATOCRIT,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,COMPLETE BLOOD COUNT,RBC,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,URINALYSIS W REFLEX MICRO,BACTERIA,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,CULTURE ROUTINE,CULTURE ROUTINE,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.047142857142857146,0.0275,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,LIPID PANEL,,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,COMP METABOLIC PANEL,POTASSIUM,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,HEP A AB TOTAL,HEP A AB TOTAL,Body weight Measured,Weight Measured,Body weight
0.25,0.2,0.0,0.25,0.0,0.0,0.04221452135443238,0.06312481184311647,0.0,0.051702018527091775,0.07731178956241591,0.0,1,50484,ANA TITER PATTERN,ANA TITER,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.2,0.2727272727272727,0.75,0.0,0.18181818181818182,0.5,0.033101371371618726,0.0,0.0,0.0,0.05006826108790696,0.07334300958724782,0,322867,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,LIVER FIBRO HEPSCORE R,AGE,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,19638,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.5566666666666666,0.14285714285714285,0.0,0.5566666666666666,0.2857142857142857,0.0,0.041620163040118285,0.0966660720824497,0.050158741653652195,0.041620163040118285,0.0966660720824497,0.050158741653652195,1,30973,BUN CREATININE RATIO,BUN CREATININE RATIO,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.066,0.0,0.0,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,SPECIAL A 2 PANEL #9633,POLYS,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,HB S AG W REFLEX CONF,HFLAG,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,CBC WITH PLT DIFF,BANDS ABSOLUTE,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,CHEM SCREEN PANEL,BILIRUBIN DIRECT,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,LD,LD,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,COMP METABOLIC PANEL CLARIFICATION,ALT,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.3333333333333333,0.2783333333333333,0.5566666666666666,0.3333333333333333,0.2783333333333333,0.5566666666666666,0.04183290768824732,0.06972447331798648,0.08489650403181737,0.04183290768824732,0.06972447331798648,0.08489650403181737,0,241109,HEP A AB TOTAL,HEP A AB TOTAL,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.05,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,CBC WITH PLT DIFF,OTHERS,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,URINALYSIS W REFLEX MICRO,PROTEIN,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CBC WITH PLT DIFF,BANDS ABSOLUTE,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,SPECIAL NEW ANNUAL COMM INSURANCE #6925,ABSOLUTE EOS,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,COMP METABOLIC PANEL,,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,COMP METABOLIC PANEL,GLOBULIN,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN TOTAL RANDOM UR,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,FASTING,FASTING STATUS,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,COMP METABOLIC PANEL W O EGFR,CREATININE,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,DIFFERENTIAL MANUAL,NEUTROPHILS,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,LYMPHOCYTE SUBSET PANEL 1,% CD8,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,PROTEIN ELECTROPHORESIS,BETA GLOBULINS,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,UROGRAM,KETONES,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,CBC D PLT,HEMOGLOBIN,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,URINALYSIS CULTURE IF INDICATED,COLOR,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.041666666666666664,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,X HEPATITIS COMPLEX PROFILE,ANTI HCV,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,RPR REFLEX TP PA,RPR,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.24,0.39999999999999997,0.0,0.24,0.39999999999999997,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,HCV RNA QN PCR W RFL GENO,HCV RNA QN REAL TIME PCR,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,VITAMIN B12 FOLATE,VITAMIN B12,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.05181818181818181,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,DRUG ABUSE SCREEN W ETOH NO GCMS,BENZODIAZEPINES,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.25,0.5,0.75,0.25,0.5,0.75,0.06452018247650781,0.17598550691819748,0.17736414670894485,0.06452018247650781,0.17598550691819748,0.17736414670894485,1,161281,HEPATITIS C AB,HEPATITIS C AB,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.11857142857142858,0.030000000000000002,0.0,0.047142857142857146,0.01,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,SPECIAL A 2 PANEL #9633,POLYS,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.09499999999999999,0.09777777777777777,0.11399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,DRUG ABUSE PANEL NO CONFIRM,CREATININE,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,OBSTETRIC PANEL,RPR RESULT,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,CMP14 LP CBC D PLT,HEMATOCRIT,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,PROTEIN ELEC INTERP SERUM,ALPHA 2 GLOBULIN,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,PE FLC SERUM,ALBUMIN,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.3225,0.0,0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,ALPHA 2 MACROGLOBULIN,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,PROTEIN ELECTRO S,M SPIKE,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.08333333333333333,0.0,0.0,0.11166666666666668,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,CBC INCLUDES DIFF PLT,BLASTS,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.04833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCH,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,FSRC NEW PATIENT PANEL,D BILIRUBIN,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,C REACTIVE PROTEIN INFLAMMATORY,C REACTIVE PROTEIN,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,HEPATITIS C GENO TYPE 1 NS5A RESIST,VELPATASVIR RESISTANCE,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,LYMPHOCYTE SUBSET PANEL 4,HELPER SUPPRESSOR RATIO,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.044,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,CBC W AUTO DIFF,% EOSINOPHILS,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,DRUG ABUSE SCREEN 9 NO THC W CONF,BARBITURATES,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.01459672907953935,0.0,0.0,0.0,0.0,0.0,0,285395,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.06666666666666667,0.05,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,LYMPHOCYTE SUBSET PANEL 4,HELPER SUPPRESSOR RATIO,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,FREE T4,FREE T4,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.125,0.05714285714285715,0.0,0.0,0.0,0.0,0.0,0.05533672031898129,0.0,0.0,0.0,0.0,0,427682,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,HEPATITIS BE AG,HB E AG,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.63,0.2,0.5,0.3333333333333333,0.2,0.5,0.03821366308112262,0.04963429477595027,0.0,0.08544834831866432,0.11098565713428754,0.0,1,311472,RPR REFLEX TITRE TPPA,RPR,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,CBC WITH AUTO DIFF,LYMPHOCYTES #,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,PATHOLOGIST SMEAR REVIEW,MONOCYTES,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,HEPATITIS PANEL CHRONIC,HAV AB TOTAL,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.09333333333333332,0.1275,0.0,0.09333333333333332,0.1275,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,HEPATITIS A IGM,HEPATITIS A IGM,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,LIPID CASCADE,LDL CHOLESTEROL CALC,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,PATHOLOGIST SMEAR REVIEW,MONOCYTES,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.1775,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,7328,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,CBC WITH DIFFERENTIAL PLATELETS,POLYS,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,23366,HEPATIC FUNCTION PANEL,,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,RENAL FUNCTION PANEL,CHLORIDE,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,COMP METAB PANEL,CALCIUM PLASMA,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,CARDIO IQ R VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,LIPID PANEL,VLDL CHOL CALC,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.036,0.03272727272727272,0.05142857142857143,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,MAGNESIUM,HEMOLYSIS,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,URINALYSIS CULTURE IF INDICATED,GLUCOSE,Body weight Measured,Weight Measured,Body weight
0.0,0.0,0.0,0.0,0.07545454545454545,0.20750000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD4 CELLS,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,DRUG ABUSE SCREEN II,METHAQUALONE,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,TESTOSTERONE FR DIALYSIS TOTAL LC MS MS,FREE TESTOSTERONE,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.08333333333333333,0.25,0.0,0.08333333333333333,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,PSA TOTAL % FREE,PSA FREE,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,CMP14 LP 3AC,ALKALINE PHOSPHATASE S,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,PTH INTACT WITHOUT CALCIUM,PARATHYROID HORMONE INTACT,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,ASH FIBROSURE,WEIGHT,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,PSA TOTAL,PSA TOTAL,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,IMMUNOGLOBULINS A E G M SERUM,IMMUNOGLOBULIN G QN SERUM,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,PROTHROMBIN PTT,CONTROL,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.05339016372965322,0.1963193957655779,0.5773502691896257,0.06538932921065,0.4808823462371743,0.7071067811865476,1,22848,VITAMIN B12 FOLATE,FOLATE SERUM,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,URINALYSIS,BILIRUBIN,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0825,0.10600000000000001,0.0,0.1825,0.2,1.0,0.0,0.0,0.0,0.0,0.09762443806815091,1.0,1,204545,URINALYSIS W REFLEX MICRO,PROTEIN,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,FERRITIN,FERRITIN,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHADONE,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,UA W RFLX MICROSCOPIC,BILIRUBIN,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,HCV GENOTYPE REFLEX NSA,HEPATITIS C GENOTYPE,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.25,0.2,1.0,0.0,0.0,0.0,0.07962607175736813,0.12353958214165095,1.0,1,195586,DRGABU2,METHAQUALONE,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,UROGRAM,APPEARANCE,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,C REACTIVE PROTEIN INFLAMMATORY,C REACTIVE PROTEIN,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,CMP14 6AC,PHOSPHORUS,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.125,0.0,0.3333333333333333,0.375,1.0,0.0,0.0,0.0,0.08176255116563813,0.0,0.0,1,23242,LIVER FIBROSIS FIBROTEST ACTITEST P,GGT,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,CBC,MCH,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.03333333333333333,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,CBC INCLUDES DIFF PLT,EOSINOPHILS,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,PSA FREE TOTAL,PSA FREE,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.2,0.0,0.25,0.2,0.0,0.0,0.04129421566871461,0.0,0.06650223739152306,0.21717918485032472,0.0,1,7856,CBCI COMPLETE BLOOD COUNT W DIFF,MCH,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.26666666666666666,0.0,0.0,0.3333333333333333,0.14285714285714285,0.5,0.0,0.0,0.0,0.084905879372146,0.0,0.0,1,25320,ALB ALP ALT AST GGT LD PROT,LDH,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA PATTERN,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,DRUG ABUSE SCREEN W ETOH NO GCMS,BENZODIAZEPINES,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,HEPATIC FUNCTION PANEL,ALT,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,DRUG ABUSE SCREEN III,AMPHETAMINES,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,CMP14 LP CBC D PLT,NEUTROPHILS,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.13333333333333333,0.0,0.0,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,CBC WITH PLT DIFF,BANDS,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,CMP14 CBC D PLT ESR WES ANA,POTASSIUM,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,CBC WITH AUTO DIFF,MONOCYTES #,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,PROTEIN TOTAL URINE,URINE TOTAL PROTEIN,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,FIBROACT COMPLETE,NECROINFL SCORE,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,CBC INCLUDES DIFF PLT W SMEAR RVW,WHITE BLOOD CELL COUNT,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,HB S AG W REFLEX CONF,HFLAG,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,CHEM SCREEN PANEL HDL,URIC ACID,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,CBC PLT DIFF,POLYS,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,DRUG ABUSE SCREEN I NO GCMS,BARBITURATES,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,COMPREHENSIVE METABOLIC PANEL WITH GFR,ALBUMIN,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,HEPATITIS PANEL ACUTE,HEPATITIS B CORE AB IGM,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp,Daclatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,CBC WITH MANUAL DIFFERENTIAL,RDW,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.1,0.0,0.2,0.125,0.5,0.0,0.02509091837088262,0.0,0.05623518965539054,0.07096783410499707,0.7071067811865476,1,196444,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,CMP14 HP5 LP 6AC CBC D PLT,BILIRUBIN INDIRECT,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,GLUCOSE,GLUCOSE FASTING,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.046508667362307854,0.0,0,301804,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,HAPTOGLOBIN,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,URINALYSIS COMPLETE WITH REFLEX CULTURE,PROTEIN,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.18181818181818182,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,CBC WITH PLT DIFF,NUCLEATED RBCS,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0825,0.08833333333333333,0.0,0.22,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.08318397885080242,1.0,1,57703,URINALYSIS,BILIRUBIN,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,SPECIAL A 2 PANEL #9633,POLYS,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,TRANSFERRIN,TRANSFERRIN,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,LIPID PANEL WITH REFLEX DIRECT L,HDL CHOLESTEROL,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.2,0.0,0.0,0.2,0.0,0.0,0.1963193957655779,0.0,0.0,0.1963193957655779,0.0,0,17517,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.06999999999999999,0.06999999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,NASH FIBROSURE,WEIGHT,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.18666666666666668,0.2,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,25718,LIPID PANEL WITH DIRECT LDL,TRIGLYCERIDES,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.14285714285714285,0.09090909090909091,0.5,0.0,0.0,0.0,0.061685809626148336,0.0,0.0,1,17442,CMP,ALT SGPT,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,LIVER FIBROSIS PANEL,ALT,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,RBC,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,CMP14 HP4 1AC PT AFP,EGFR IF NONAFRICN AM,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,LIVER PANEL II,LD,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCH,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,CBC W AUTO DIFF,% EOSINOPHILS,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,CMP13 LP TP TSH 2AC CBC D P,AST SGOT,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.31,0.25,0.0,0.0,0.0,0.0,0.0,0.13283428732072688,0.0,0,728592,ACCUTYPE R IL28B,IL28B GENOTYPE,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,HEPASCORE R,AGE,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,COMPREHENSIVE METABOLIC PANEL E GFR,ALT,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.25,0.2,0.0,0.0,0.548,0.87,0.04221452135443238,0.06312481184311647,0.0,0.0,0.6143530535007152,0.9567642781036875,1,50484,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,COMPREHENSIVE METABOLIC PANEL,ALBUMIN,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,ASH FIBROSURE,ALT SGPT P5P,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,CMP14 4AC,EGFR IF AFRICN AM,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,URINE DRUG SCREEN,OPIATES,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,URINALYSIS COMPLETE W REFLEX CULTURE,PROTEIN,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,HEPATITIS C VIRUS RNA QUALITATIVE PCR,HEPATITIS C VIRUS RNA QUALITATIVE PCR,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.006666666666666666,0.01,0.3333333333333333,0.4766666666666667,0.715,0.0,0.0,0.0,0.32833234626123065,0.009757165067065143,0.016126063426601833,1,481598,CMP14 CBC D PLT RPR UA TSH,HCV AB,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,ASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.5,0.16666666666666666,1.0,0.5,0.3333333333333333,1.0,0.13418198861418107,0.05660928660351461,0.05881293452243719,0.13418198861418107,0.05660928660351461,0.05881293452243719,1,27318,PTH INTACT,PTH INTACT,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,COMP METABOLIC PANEL,GLUCOSE NON FASTING,Race,Race,Race
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0130693498781973,0.0,0.0,0.0,0.0,0,192526,CBCI COMPLETE BLOOD COUNT W DIFF,MCH,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.047142857142857146,0.0275,0.0,0.07142857142857142,0.014166666666666668,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,LIPID CASCADE,LDL CHOLESTEROL CALC,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.07166666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,CHOLESTEROL TOTAL,ICTERUS,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.20750000000000002,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,HCV FIBROSURE,NECROINFLAMMAT ACTIVITY SCORE,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.07142857142857142,0.125,0.0,0.10428571428571429,0.1825,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,CBC INCLUDES DIFF PLT W SMEAR RVW,WHITE BLOOD CELL COUNT,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,CMP14 LP 2AC CBC D PLT MG T,WBC,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,COMP METABOLIC PANEL CLARIFICATION,ALT,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.5,0.38333333333333336,0.6900000000000001,0.5,0.4166666666666667,0.75,0.013012224336779066,0.9457662360035409,0.7072472090959524,0.07601041756762406,0.05504399149282735,0.04116208411637334,1,339358,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODY IGG,CCP ANTIBODY IGG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,WESTERGREN SED RATE,WESTERGREN SED RATE,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA PATTERN,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,LIVER FIBROSIS PANEL HEPASCORE,FIBROSIS SCORE,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,CMP14 LP 2AC CBC D PLT MG T,WBC,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.19,0.44333333333333336,0.0,0.19,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,HCV RNA QUANT BDNA,HCV RNA QN BDNA,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,CBC DIFF PLT,PLATELET COUNT,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,CULTURE ROUTINE,CULTURE ROUTINE,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.3333333333333333,0.1325,0.265,0.0,0.0,0.0,0.010713541722103481,0.014232105164471598,0.01954574209274329,1,453530,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,LIPID PANEL,,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,FREE T4 THYROXINE,FREE T4,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.05290437188716146,0.0,0,544346,CMP14 TP TSH 2AC CBC D PLT,AMYLASE SERUM,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.04833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,MANUAL DIFFERENTIAL,BLASTS %,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,HEPATITIS B SURFACE ANTIGEN,HBS AG SCREEN,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.15444444444444447,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,URINALYSIS WITH MICROSCOPIC,COLOR,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.1925,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,URINALYSIS CULTURE IF INDICATED,APPEARANCE,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,URINALYSIS COMPLETE,GLUCOSE,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,UROGRAM,NITRITE,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,HEMOGLOBIN A1C W EAG INT CHART,ESTIMATED AVERAGE GLUCOSE,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,ASH FIBROSURE,AST SGOT P5P,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.2857142857142857,0.4,0.0,0.2857142857142857,0.4,0.0,0.4783690785249981,0.4828917864535487,0.0,0.4783690785249981,0.4828917864535487,0,223222,HEPATITIS C VIRUS RNA QUALITATIVE PCR,HEPATITIS C VIRUS RNA QUALITATIVE PCR,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,DRUG ABUSE SCREEN 9 NO THC W CONF,PHENCYCLIDINE,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,SED RATE WESTERGREN,SED RATE WESTERGREN,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,CBC WITH DIFFERENTIAL,HEMATOCRIT,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,TESTOSTERONE FREE TOTAL LC MS MS,FREE TESTOSTERONE,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,RENAL FUNCTION PANEL,ANION GAP,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,LIVER FIBROSIS FIBROTEST ACTITEST P,GGT,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.5,0.4444444444444444,0.8,0.5,0.4444444444444444,0.8,0.4639937427612,0.01352577543307043,0.010114620888054038,0.4639937427612,0.01352577543307043,0.010114620888054038,1,339358,CCP IGG,CCP IGG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,PSA TOTAL % FREE,% FREE PSA,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,UROGRAM,KETONES,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,CBC W AUTO DIFF,MONOS ABSOLUTE,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CMP14 HP4 1AC PT AFP,PROTHROMBIN TIME,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,FIBROACT COMPLETE,NECROINFL SCORE,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual,Promyelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.07571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,URINALYSIS CULTURE IF INDICATED,BACTERIA,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.05,0.0,0.0,0.0,0.0,0.0,0.0193228926416793,0.0,0,882936,C4 C3,COMPLEMENT C3 SERUM,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,URINALYSIS W REFLEX MICRO,UROBILINOGEN,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.1075,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,882936,CMP14,EGFR IF AFRICN AM,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.4,0.25,0.6666666666666666,0.0,0.0,0.0,0.42720853174042706,0.03748184864782589,0.036362498104970165,1,244673,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD4 CELLS,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,PROTEIN ELECTROPHORESIS SERUM,ALPHA 2,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.43,0.14333333333333334,0.0,0.5,0.16666666666666666,0.0,0.0,0.0,0.0,0.11136168435129556,0.05936451274361987,0.0,1,149799,PROTHROMBIN PTT,APTT,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.0,0.025,0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,CBC ESR,ABSOLUTE NEUTROPHILS,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,HIV ANTIGEN ANTIBODY FOURTH GEN,HIV AG AB 4TH GEN,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,DRGABU2,METHAQUALONE,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,COMP METABOLIC PANEL CLARIFICATION,ALBUMIN GLOBULIN RATIO,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.12,0.072,0.36,0.12,0.072,0.36,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,HEPATITIS BE AG,HB E AG,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.31,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.0840117798597445,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,728600,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.053000000000000005,0.07571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,COMP METABOLIC PANEL CLARIFICATION,EGFR NON AFR AMERICAN,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,CMP13 LP 2AC CBC D PLT,CHOLESTEROL TOTAL,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.11,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,SPECIAL NEW ANNUAL COMM INSURANCE #6925,ABSOLUTE EOS,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,HIV 1 RNA QN RT PCR,RACE NR,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,DRUG ABUSE SCREEN I NO GCMS,AMPHETAMINES,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,CBC WITH PLT DIFF,BLASTS,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,PROTHROMBIN TIME PT,PT CONTROL,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,CBC INCLUDES DIFF PLT,HEMOGLOBIN,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.3333333333333333,0.0,0.25,0.16666666666666666,1.0,0.0,0.03258155267402285,0.0,0.06605502583691747,0.05720402135206337,0.7071067811865476,1,7047,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,FE TIBC FER,FERRITIN SERUM,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,CMP14 HP4 DBILI CBC D PLT R,AMYLASE,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.08857142857142856,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,CBC D PLT,HEMOGLOBIN,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,NASH FIBROSURE,WEIGHT,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,HEMATOPATH CONSULTATION SMEAR,WBC,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.2,0.4,0.3333333333333333,0.2,0.4,0.6666666666666666,0.007806566737586396,0.37372692636381444,0.46844093359181893,0.007806566737586396,0.37372692636381444,0.46844093359181893,1,178566,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,CBC INCLUDES DIFF PLT,EOSINOPHILS,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,ANA TITER PATTERN,ANA TITER,Body weight Measured,Weight Measured,Body weight
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,COMP METABOLIC PANEL,,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,RENAL FUNCTION PANEL,CREATININE,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,ANA REFLEX AUTOIMMUNE AB PROFILE,ANTI NUCLEAR ANTIBODIES,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.24333333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,PROTEIN ELECTRO S,GAMMA GLOBULIN,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,CBC W O DIFF WITH PLATELETS,MCH,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,APOLIPOPROTEIN A1,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,LIVER FIBROSIS FIBROTEST,ALPHA 2 MACROGLOBULIN,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.25,0.16666666666666666,0.0,0.0,0.0,0.0,0.09341591340147393,0.0,0.0,1,7898,CBC INC DIFF PLT,RBC,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,ALB ALP ALT AST GGT LD PROT,LDH,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.04785714285714286,0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.25,0.2,0.0,0.0,0.0,0.0,0.06650223739152306,0.21717918485032472,0.0,1,7856,CBC,MCH,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,NASH FIBROSURE,APOLIPOPROTEIN A 1,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.05555555555555555,0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,CBC WITH PLT DIFF,BLASTS,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.047619047619047616,0.0,0.0,0.0,0.0,0.0,0.02260781385927957,0.0,0,882944,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,CBC PLATELET HEM REVIEW,PLATELETS,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,UREA NITROGEN BUN,ICTERUS,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,HIV 1 RNA QN RT PCR,LOGCOPIES ML,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.1,0.16666666666666666,0.3333333333333333,0.32199999999999995,0.8333333333333334,0.0,0.055192913156707046,0.0769055150490483,0.017692205955941787,0.0585924829043345,0.8693209510109255,1,241133,HEPATITIS PANEL ACUTE,HEPATITIS B CORE AB IGM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.14285714285714285,0.0,0.27999999999999997,0.0,0.0,0.0,0.0633130619441763,0.0,0.0,0.0,0.0,1,333583,IFE PE SERUM,M SPIKE,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,FERRITIN,FERRITIN,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.14333333333333334,0.2866666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.16666666666666666,0.21428571428571427,0.75,0.16666666666666666,0.21428571428571427,0.75,0.02578387657415615,0.0,0.0,0.02578387657415604,0.0,0.0,0,110114,HCV QUANT GT1A NS5A PROFILE,HCV NS5A DRUG RESISTANCE ASSAY,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.11249999999999999,0.15,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,HEPATITIS B VIRUS PNL 6 TESTS,HB CORE AB TOTAL,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.16999999999999998,0.09,0.0,0.16999999999999998,0.09,0.0,0.05345799931322692,0.0,0.0,0.05345799931322692,0.0,0,139550,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.07142857142857142,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CBC WITH PLT DIFF,OTHERS,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0825,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,URINALYSIS WITH MICROSCOPIC,COLOR,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,CMP12 2AC,BILIRUBIN TOTAL,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp,Daclatasvir
0.0,0.0,0.0,0.0,0.10857142857142857,0.25333333333333335,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,PROTEIN ELECTRO S,GAMMA GLOBULIN,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.0,0.0,0.0,0.0,0.08287539106540942,0.7071067811865476,0.0,1,285403,CBC WITH MANUAL DIFFERENTIAL,MCHC,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,FIBROACT,FIBROSIS SCORE,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,CMP14 CBC D PLT RPR UA TSH,HCV AB,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.016117066729945173,0.0,0.0,0.0,0.0,0,7732,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,IFE PE SERUM,BETA GLOBULIN,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.3333333333333333,0.0,0.0,0.3333333333333333,0.0,0.0,0.02783520196223732,0.0,0.0,0.020363161301333976,0.0,0,7534,CBC COMPLETE BLOOD COUNT W O DIFF,RED BLOOD CELL COUNT,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.03258155267402285,0.0,0.0,0.0,0.0,0,66902,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.2,0.125,0.0,0.0,0.0,0.0,0.036291544283745814,0.0714561518627298,0.0,0,182626,HEPATIC LIVER PANEL,DIRECT BILIRUBIN,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,PATHOLOGIST SMEAR REVIEW,MONOCYTES,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,CMP14 HP4 1AC PT AFP,PROTHROMBIN TIME,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CMP14 LP 5AC CBC D PLT RPR,CHOLESTEROL TOTAL,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,OBSTETRIC PANEL,RPR RESULT,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.041875,0.08375,0.14333333333333334,0.0,0.0,0.0,0.019640907998258128,0.0,0.0,0.0,0.0,1,339143,BUN CREATININE RATIO,EGFR NON AFR AMERICAN,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,CBC,BA%,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.015714285714285715,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,CREATINE KINASE TOTAL,HEMOLYSIS,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,HEPATIC FUNCTION PANEL,BILIRUBIN INDIRECT,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,CMP,C02 BICARBONATE,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,HCV RNA QN REAL TIME PCR W RFLX QL,HCV RNA LOG IU ML,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,COMPLETE BLOOD COUNT,BASOPHILS %,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,IFE PE SERUM,ALPHA 1 GLOBULIN,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HCV RNA QUAL TMA,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.45,0.32,0.96,0.0,0.0,0.0,0.008516468395054266,0.913744925535582,0.9900858126069512,1,115725,ARTHRITIS PROFILE,RHEUMATOID FACTOR QUANT,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,FE ANA TIBC FER PTT PT A1A,PROTHROMBIN TIME,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,COMP METABOLIC PANEL CLARIFICATION,EGFR NON AFR AMERICAN,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.07886657271852937,0.0,0,181826,FERRITIN,FERRITIN SERUM,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,PE FLC SERUM,ALBUMIN,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,HCV GENOTYPE PCR PROBE,HCV GENOTYPE,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.14285714285714285,0.25,0.0,0.0,0.0,0.0,0.04814093609537751,0.061372572100865885,0,327692,ASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,CMP,C02 BICARBONATE,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.047142857142857146,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,CBC PLATELET HEM REVIEW,PLATELETS,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,CMP,ALT SGPT,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.1,0.0,0.0,0.1,0.0,0.155,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,UA MICROSCOPIC REFLEX CULTURE,PH,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,APTT,PARTIAL THROMBOPLASTIN,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.14285714285714285,0.08333333333333333,1.0,0.14285714285714285,0.08333333333333333,1.0,0.032809221376370656,0.0,0.0,0.04639924584136457,0.0,0.0,1,115790,TSH SML,TSH,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,HEPATIC FUNCTION PANEL,BILIRUBIN INDIRECT,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH TOTAL,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.21,0.32125,0.4,0.14333333333333334,0.25,0.2,0.0,0.034880496193767985,0.04779467294787276,0.0,0.04503052695530496,0.061702657454847154,1,134999,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,VIT B 12 FOLATE PANEL,VITAMIN B 12,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,C4 SERUM,C4 SERUM,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.07142857142857142,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,CBC WITH PLT DIFF,PROMYELOCYTES,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,HAV AB TOTAL,HAV AB TOTAL,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,AAA MALE PANEL,HIV 1 HIV 2 AB SCREEN,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,HEMOGLOBIN A1C WITH MPG,HEMOGLOBIN A1C,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,FIBROACT COMPLETE,HEIGHT INCHES,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.047142857142857146,0.030000000000000002,0.0,0.14285714285714285,0.09090909090909091,0.5,0.0,0.0,0.0,0.0872369085792638,0.0,0.0,1,17442,HEPATIC FUNCTION PANEL,ALT,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1216962121474966,1.0,1,45443,CBC PLATELET NO DIFFERENTIAL,HEMATOCRIT,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,REFLEX ANA PATTERN,PATTERN 1,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,CMP13 LP TP TSH 2AC CBC D P,AST SGOT,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,PE INTERP RFX IFE S,ALBUMIN,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,CBC,MCH,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.38999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,LIPOPROTEIN ANALYSIS NMR,LDL P,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.16666666666666666,0.14285714285714285,0.25,0.3333333333333333,0.14285714285714285,0.25,0.03095373581683858,0.034998014890340046,0.07267302452237867,0.03095373581683858,0.034998014890340046,0.07267302452237867,1,427682,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.3333333333333333,0.2,0.5,0.3333333333333333,0.2,0.5,0.04272417415933216,0.05549282856714377,0.0,0.08544834831866432,0.11098565713428754,0.0,1,311472,RPR REFLEX TP PA,RPR,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.011063663610396235,0.0,0.0,0.0,0.0,0,178566,COMPLETE BLOOD COUNT,BASOPHILS %,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,CMP14 LP CBC D PLT TSH,PLATELETS,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.5,0.48625,0.75,0.5,0.5,1.0,0.48462344379507305,0.011337917407329035,0.011598869223880981,0.10418907133533917,0.05392884772733497,0.055170066045780786,1,108860,PSA FREE TOTAL,FREE PSA,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.25,0.25,0.4,0.0,0.0,0.0,0.01152336042659885,0.013264257264103407,0.0,0,81240,LYMPHOCYTE SUBSET PANEL 3,% CD3 CD4 HELPER T4,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,CMP14 LP CBC D PLT TSH,PLATELETS,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.0,0.06714285714285714,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.16666666666666666,0.21428571428571427,0.75,0.0,0.14285714285714285,0.5,0.04036164461486136,0.0,0.0,0.0,0.06317690320497038,0.17807552140691663,1,204164,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0834655896020069,0.34003516797720323,1.0,1,28233,COMP METABOLIC PANEL,POTASSIUM,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,7427,CBC,MO%,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,CHEM 20,CHOLESTEROL,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.0,0.1416666666666667,0.42500000000000004,0.0,0.1416666666666667,0.42500000000000004,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.11,0.0,0.0,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,HEP B SURFACE AB,HEP B SURFACE AB,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,CBC W AUTO DIFF,MONOS ABSOLUTE,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,PROTEIN TOTAL URINE,URINE TOTAL PROTEIN,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,CBC WITH AUTO DIFF,NRBC,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.16,0.0,0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,CBC WITH PLT DIFF,WBC MORPHOLOGY,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.25,0.14285714285714285,1.0,0.0,0.0,0.0,0.052570301148225806,0.05162000400267441,0.7071067811865476,1,303644,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,CBC WITH PLT DIFF,NUCLEATED RBCS,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,MCCARJUH MCCARTHY PROFILE 1,PROTHROMBIN TIME PT,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,SPECIAL NEW ANNUAL COMM INSURANCE #6925,ABSOLUTE EOS,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,CMP13 LP 2AC CBC D PLT,NEUTROPHILS ABSOLUTE,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.7071067811865476,0.7071067811865476,0.7071067811865476,1,326249,HIV AG AB 4TH GEN RFL,RACE NR,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,PHOSPHORUS,PHOSPHORUS,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.072,0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,GLUCOSE,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.1425,0.36,0.0,0.0,0.0,0.0,0.0,0.14265122201011204,0.0,0.0,0.0,0.0,0,195586,URINE DRUG SCREEN,OPIATES,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,URINALYSIS CULTURE IF INDICATED,APPEARANCE,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,HCV GENOTYPE PCR PROBE,HCV GENOTYPE,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.09247447620418048,0.34003516797720323,1.0,0.09247447620418048,0.34003516797720323,1.0,1,30346,TRANSFERRIN,TRANSFERRIN,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,FE ANA TIBC FER PTT PT A1A,PROTHROMBIN TIME,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,PROTHROMBIN PTT,APTT,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,MICROALBUMIN CREATININE RANDOM RATIO,MICROALBUMIN RANDOM,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,CARETC CMP LIPID URIC ACID DIR BILI PROFILE,RISK RATIO LDL HDL,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,IRON BINDING CAPACITY,UIBC NR,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0375,0.15,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,PE FLC SERUM,ALBUMIN,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.009,0.045,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,RENAL FUNCTION PANEL,CREATININE,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,IMMUNOFIXATION SERUM,IGG SERUM NR,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,HEMATOPATH CONSULTATION SMEAR,HEMATOLOGY COMMENTS,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA PATTERN,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,CMP14 HP4 DBILI CBC D PLT R,AMYLASE,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,CHOLESTEROL TOTAL,ICTERUS,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,LYMPHOCYTE SUBSET PANEL 5,CD4 % POS,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,PTH INTACT,PTH INTACT,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,RPR REFLEX TP PA,RPR,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,URINALYSIS CULTURE IF INDICATED,COLOR,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.24333333333333332,0.186,0.0,0.24333333333333332,0.186,0.0,0.0,0.04357905440832277,0.0,0.0,0.04357905440832277,0.0,1,64634,CULTURE ROUTINE,CULTURE ROUTINE,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,MICROALBUMIN CONC,ALB CREAT RATIO,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,MCCARJUH MCCARTHY PROFILE 1,PROTHROMBIN TIME PT,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,CBC INCLUDES DIFF PLT,RDW,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,C REACTIVE PROTEIN INFLAMMATORY,C REACTIVE PROTEIN,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,LYMPHOCYTE SUBSET PANEL 1,CD4 ABSOLUTE,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,PROTEIN ELECTROPHORESIS SERUM,ALPHA 1,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,MITOCHONDRIAL M2 ANTIBODY,MITOCHONDRIAL M2 ANTIBODY,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,URINALYSIS W REFLEX MICRO,COLOR,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.2857142857142857,1.0,0.0,0.2857142857142857,1.0,0.0,0.39309449986067113,0.7745966692414834,0.0,0.39309449986067113,0.7745966692414834,1,21576,CREATINE KINASE CPK TOTAL,CREATINE KINASE CPK TOTAL,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.32125,0.4283333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,HCV FIBROSURE LABCORP,RESULT,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.03333333333333333,0.125,0.06571428571428571,0.03066666666666667,0.0,0.0,0.04432042353220711,0.0,0.0,0.0,0.0,0,381806,CBC WITH PLT DIFF,WBC MORPHOLOGY,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.3333333333333333,0.14285714285714285,0.3333333333333333,0.3333333333333333,0.14285714285714285,0.3333333333333333,0.03775254682189788,0.0,0.0,0.04623723810209024,0.0,0.0,1,18341,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.014666666666666666,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,IRON BINDING CAPACITY,UIBC,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,VITAMIN B12 FOLATE,VITAMIN B12,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,FE ANA TIBC FER PTT PT A1A,PROTHROMBIN TIME,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,PSA TOTAL % FREE,PSA FREE,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,MICROALBUMIN RANDOM SPEC,MICROALBUMIN,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.06666666666666667,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,PT PTT,PARTIAL THROMBOPLASTIN,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.09499999999999999,0.2,0.4,0.06666666666666667,0.1,0.2,0.0,0.010564234126925531,0.02266185878508542,0.0,0.04430299837876139,0.09503654320349175,0,79053,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,CMP13 LP TP TSH 2AC CBC D P,LDL CHOLESTEROL CALC,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.14285714285714285,0.0,0.26799999999999996,0.2857142857142857,1.0,0.0,0.07507973713479688,0.0,0.0,0.07507973713479688,0.11831487956222486,1,28712,PROTEIN ELECTROPHORESIS,BETA GLOBULINS,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,LYMPHOCYTE SUBSET PANEL 4,COMMENT S,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.057999999999999996,0.0,0.0,0.08,0.05,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,HIV AB AG RFLX CONF,HIV AG AB,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.08,0.06666666666666667,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,CBC INCLUDES DIFF PLT WITH PATHOLOGIST REVIEW,ABSOLUTE LYMPHOCYTES,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,NMR LIPOPROFILE,LDL P,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,CMP12 2AC,BILIRUBIN TOTAL,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,CMP13 LP TP TSH 2AC CBC D P,LDL CHOLESTEROL CALC,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.26666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,LD,LIPEMIA,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,HIV 1 RNA QN RT PCR,LOGCOPIES ML,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.18,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.2276407094521833,0.0,0,15586,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.125,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,IMMUNOGLOBULIN M IGM,IMMUNOGLOBULIN M,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.3333333333333333,0.25,0.0,0.0,0.0,0.0,0.1503314858492919,0.0,0.0,1,264531,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,RBC,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,CMP,C02 BICARBONATE,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.04833333333333333,0.0,0.0,0.06666666666666667,0.05,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,HEPATITIS BE ANTIGEN,HEPATITIS BE ANTIGEN,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.558,0.6666666666666666,0.6666666666666666,0.0,0.0,0.0,0.3757978134029263,0.022046838418816495,0.022046838418816495,1,487934,LIVER FIBROSIS,NECROINFLAM ACT GRADE,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,HBSAB AG,HEP B SURFACE AB QUAL,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.10357142857142858,0.2625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,CBCI COMPLETE BLOOD COUNT W DIFF,BASOPHILS,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,LMG CBC DIFF PLT,LYMPHOCYTES #,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.04367783813865689,0.0,0.0,0.0,0.0,0,196592,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,ANA TITER PATTERN,ANA TITER,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,NASH FIBROSURE,WEIGHT,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,LIPID PANEL AMA,CHOL HDLC RATIO,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.16666666666666666,0.0,0.25,0.16666666666666666,1.0,0.0,0.07858063232628809,0.0,0.07257572557143144,0.13610564768002043,1.0,1,28621,PE FLC SERUM,ALBUMIN,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,CBC INCLUDES DIFF PLT,EOSINOPHILS,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.06803609835483304,0.0,0,23242,VITAMIN B12 FOLATE,FOLATE SERUM,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,TRICHOMONAS MALE,SOURCE,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,HAV AB TOTAL,HAV AB TOTAL,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.0769832768017027,0.08055537486383768,0.09169555407390673,1,264853,CBC W AUTO DIFF,% MONOCYTES,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,FASTING,FASTING STATUS,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,CMP14 LP CBC D PLT,NEUTROPHILS,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,LIPID PANEL AMA,CHOL HDLC RATIO,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.45,0.32,0.96,0.0,0.0,0.0,0.008516468395054266,0.913744925535582,0.9900858126069512,1,115725,ANA AUTOIMMUNE PROFILE,RHEUMATOID FACTOR QUANT,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.14285714285714285,0.0,0.0,0.14285714285714285,0.0,0.0,0.08312548434166944,0.0,0.0,0.08312548434166944,0.0,0,18341,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,HCV GENOTYPE REFLEX NS5A,PLEASE NOTE,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,COMP METABOLIC PANEL 13,EGFR IF NONAFRICN AM,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,CEA,CEA,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.3333333333333333,0.5322222222222223,0.7983333333333333,0.215,0.6755555555555556,0.9166666666666666,0.3105481402104584,0.009228665709630435,0.01525259105011434,0.007914915047499527,0.39676809220551035,0.6557547583319097,1,481598,HCV AB WITH RFL RNA QT,HCV SIGNAL CUTOFF,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,CBCI COMPLETE BLOOD COUNT W DIFF,BASOPHILS,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,HEMATOPATH CONSULTATION SMEAR,HEMATOLOGY COMMENTS,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.172,0.1075,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,BILIRUBIN FRACTIONATED,BILIRUBIN INDIRECT,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,ACCUTYPE R IL28B,IL28B GENOTYPE,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.025,0.03333333333333333,0.0,0.041249999999999995,0.05499999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,MITOCHONDRIAL AB SCREEN,MITOCHONDRIAL AB SCREEN,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.066,0.07571428571428572,0.0,0.176,0.14285714285714285,1.0,0.0,0.0,0.0,0.0,0.07582142074137055,1.0,1,505511,URINALYSIS,BILIRUBIN,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.13636363636363635,0.125,0.0,0.0,0.0,0.0,0.04521753067807699,0.0,0.0,0.0,0.0,0,112599,CBC WITH AUTO DIFF,BASOPHILS #,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,DRUG ABUSE SCREEN 9 NO THC W CONF,BARBITURATES,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,CHOL HDL RATIO,CHOL HDL RATIO,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,RPR SCREEN W TITER,RPR SCREEN,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,HEPATITIS PANEL ACUTE,HEPATITIS C AB CIA,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,CBC INC DIFF PLT,MONOCYTES,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,FERRITIN,FERRITIN,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,HEPATIC FUNCTION PANEL,BILIRUBIN INDIRECT,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.115,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,7120,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.7071067811865476,0.7071067811865476,0.7071067811865476,1,326249,HIV 1 RNA QN RT PCR,RACE NR,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,COMMENTS,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0825,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,URINALYSIS,BILIRUBIN,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,CYSTIC FIBROSIS SCREEN,ETHNICITY,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.15555555555555556,0.27999999999999997,0.0,0.02,0.036,0.0,0.03920684558386822,0.054869373801387455,0.0,0.0,0.0,0,139527,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,CBC WITH PLT DIFF,BANDS,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.25,0.2,0.5,0.0,0.148,0.37,0.036686586362187024,0.06042469204137413,0.07849464532926642,0.0,0.06755685946200152,0.08775968141298807,1,473835,ANA REFLEX AUTOIMMUNE AB PROFILE,ANTI NUCLEAR ANTIBODIES,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06803603656800117,0.06673966886790239,0.10240603634159506,1,7708,CMP14 LP CBC D PLT TSH,NEUTROPHILS,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,HIV AB EIA WITH REFLEXES,HIV EIA AB SCREEN,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,PTH INTACT MOLECULE,PTH,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,HEP B SURFACE AB,HEP B SURFACE AB,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,LIPID PANEL W REFL DLDL,NON HDL CHOLESTEROL,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HEPATITIS PANEL CHRONIC,HAV AB TOTAL,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,COMP METABOLIC PANEL CLARIFICATION,EGFR NON AFR AMERICAN,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,BUN CREATININE,BUN,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,FREE T4 THYROXINE,FREE T4,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.5242857142857142,0.734,0.0,0.1742857142857143,0.244,0.0,0.0800031898919874,0.04196447568029116,0.0,0.1677538167696766,0.08799275345909874,0,223149,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,LIVER FIBROSIS FIBROMETER,FIBROMETER PATIENT SCORE,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.14666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,CHEM 20,CHOLESTEROL,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CBC WITH PLT DIFF,NRBC,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,UROGRAM,KETONES,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,BMP8 CBC D PLT UA,EOS ABSOLUTE,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,ANEMIA PROFILE B,EOS,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,COMP METABOLIC PANEL W O EGFR,CREATININE,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.15,0.14285714285714285,0.0,0.15,0.14285714285714285,0.0,0.0,0.05438041120182613,0.0,0.0,0.05438041120182613,0.0,0,51953,AFP SERUM TUMOR MARKER,AFP SERUM TUMOR MARKER,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,DRUG ABUSE SCREEN II,METHAQUALONE,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,TSH SML,TSH,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.013880466255054902,0.0,0.0,0.0,0.0,0,303644,CBCI COMPLETE BLOOD COUNT W DIFF,MCH,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,ASH FIBROSURE,HEIGHT,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,CBC D PLT,HEMOGLOBIN,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.19999999999999998,0.27999999999999997,0.0,0.19999999999999998,0.27999999999999997,0.0,0.007976513205319447,0.010764264748993724,0.0,0.007976513205319447,0.010764264748993724,0,728626,HEPATITIS B CORE AB,HEPATITIS B CORE AB,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,CBC WITH PLT DIFF,RBC MORPHOLOGY,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD4 CELLS,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,CBC WITH PLT DIFF,RBC MORPHOLOGY,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.11,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,SPECIAL A 2 PANEL #9633,POLYS,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,LIPID PROFILE WRFL LDL DIRECT,NON HDL CHOLESTEROL,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1216962121474966,1.0,1,45443,CBC W DIFF PLT,HEMATOCRIT,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,PROTIME PTT,PTT,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,HEPATITIS C VIRUS RNA QN REAL TIME PCR,HCV RNA PCR QN,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.16,0.0,0.25,0.2,1.0,0.0,0.061769791070825475,0.0,0.07962607175736813,0.12353958214165095,1.0,1,195586,DRUG ABUSE SCREEN III,METHAQUALONE,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,DRUG ABUSE SCREEN 9 NO THC W CONF,PHENCYCLIDINE,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.004666666666666667,0.0175,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,CMP14 LP CBC D PLT TSH T4F,NEUTROPHILS ABSOLUTE,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,COMP METABOLIC PANEL CLARIFICATION,EGFR NON AFR AMERICAN,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,CBC W AUTO DIFF,MONOS ABSOLUTE,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.25,0.0,0.0,0.0,0.0,0.0,0.04245987818953023,0.0,0.0,0.0,0.0,0.0,0,7518,CBC W AUTO DIFF WITH PLATELETS,BASOPHILS,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.03968462988854371,0.0,0,192526,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,LIVER FIBROSIS FIBROTEST,ALPHA 2 MACROGLOBULIN,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,URINALYSIS C,BILIRUBIN,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,LIPID PROFILE WRFL LDL DIRECT,NON HDL CHOLESTEROL,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,IFE PE SERUM,M SPIKE,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,ACCUTYPE R IL28B,IL28B GENOTYPE,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.405,0.3333333333333333,0.6666666666666666,0.0,0.0,0.0,0.04707567369242904,0.0818901804741462,0.12900463674079643,1,265074,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,ALPHA FETOPROTEIN TUMOR MARKER,AFP TUMOR MARKER,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,FREE T4 THYROXINE,FREE T4,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.31,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.05153731836902975,0.0,0.0,1,7732,CBC WITH AUTO DIFF,NRBC,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,HEPATIC FUNCTION PANEL,BILIRUBIN INDIRECT,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,VIT B 12 FOLATE PANEL,VITAMIN B 12,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,HEPATIC FUNCTION PANEL,ALT,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.134,0.2783333333333333,0.0,0.19,0.16666666666666666,0.3333333333333333,0.0,0.022155855810859326,0.0,0.0,0.05427054155128297,0.0946521642027649,1,7146,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,URINALYSIS COMPLETE W REFLEX CULTURE,PROTEIN,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,CMP14 LP CBC D PLT,HEMATOCRIT,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,HEPATITIS BE ANTIGEN,HEPATITIS BE ANTIGEN,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.0,0.11399999999999999,0.18999999999999997,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,ANA IFA SCREEN WITH REFLEX TITER,ANTI NUCLEAR AB IFA,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,COMPLETE BLOOD COUNT,WBC,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.44333333333333336,0.25,0.5,0.44333333333333336,0.25,0.5,0.010363119229323314,0.621189378727853,0.9625978811059088,0.033125112391305556,0.10486664102384657,0.1625018229625479,1,312017,HIV AB EIA WITH REFLEXES,HIV EIA AB SCREEN,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.05,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,CBC WITH MANUAL DIFFERENTIAL,MCH,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,CBC WITH PLT DIFF,BANDS,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,CBC WITH MANUAL DIFFERENTIAL,RDW,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,ANA IFA SCREEN WITH REFLEX TITER,ANTI NUCLEAR AB IFA,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,COMP METABOLIC PANEL,ANION GAP,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,CMP,EGFR NON AFRICAN AMERICAN,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.14333333333333334,0.07692307692307693,0.3333333333333333,0.14333333333333334,0.15384615384615385,0.3333333333333333,0.0,0.05467558814705109,0.40824829046386313,0.0,0.10935117629410207,0.40824829046386313,1,204479,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,LIVER FIBROSIS FIBROTEST,ALPHA 2 MACROGLOBULIN,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,HDL AS % CHOLESTEROL,HDL AS % CHOLESTEROL,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,HCV GENOTYPE REFLEX NS5A,PLEASE NOTE,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,CREATININE,EGFR IF AFRICN AM,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,DRUG ABUSE SCREEN 9 NO THC W CONF,BARBITURATES,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,CBC W AUTO DIFF,% MONOCYTES,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CREATINE KINASE CPK TOTAL,CREATINE KINASE CPK TOTAL,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,ANA CRP ASO PE,P E INTERPRETATION S,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.06090909090909091,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,COMPREHENSIVE METABOLIC PANEL WITH GFR,T BILIRUBIN,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,CBC W DIFF PLT,BASOPHILS ABSOLUTE,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD4 CELLS,Color of Urine,Color Ur,Color
0.25,0.5242857142857142,0.734,0.25,0.5242857142857142,0.734,0.05489961348405459,0.3355076335393532,0.17598550691819748,0.05489961348405459,0.3355076335393532,0.17598550691819748,1,223149,HEPATITIS A IGM,HEPATITIS A IGM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,HCV QUANT GT1A NS5A PROFILE,HCV NS5A DRUG RESISTANCE ASSAY,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,CMP14 HP5 LP 6AC CBC D PLT,INR,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.07571428571428572,0.0,0.0,0.07571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,TSH 3RD GENERATION,TSH 3RD GENERATION,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CALCIUM,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,VIT B 12 FOLATE PANEL,VITAMIN B 12,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.08,0.05714285714285715,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.5425,0.7233333333333333,0.0,0.33375,0.445,0.0,0.1524643612967882,0.11313616447240271,0.0,0.09336497228411789,0.06928146860324524,1,519132,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.5,0.41428571428571426,1.0,0.5,0.41428571428571426,1.0,0.08384227635677743,0.226779813772099,0.16381776425537642,0.08384227635677743,0.226779813772099,0.16381776425537642,1,30247,FREE T4 THYROXINE,FREE T4 THYROXINE,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,LYMPHOCYTE SUBSET PANEL 3,% CD3 CD4 HELPER T4,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,HEPATIC FUNCTION PANEL AMA,GLOBULIN,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.05515090694457048,0.0,0,134999,CMP14 TP TSH 2AC CBC D PLT,AMYLASE SERUM,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.14285714285714285,0.3333333333333333,0.0,0.14285714285714285,0.3333333333333333,0.0,0.04402276849263065,0.047290115145442124,0.0,0.04402276849263065,0.047290115145442124,0,18358,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,PROFILE 104 LIVER,BILIRUBIN TOTAL,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,NASH FIBROSURE,HAPTOGLOBIN,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,PHOSPHORUS,PHOSPHORUS,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.025714285714285714,0.015,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.13,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,LIVER FIBROSIS FIBROTEST ACTITEST P,NECROINFLAMMATION ACT GRADE,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,VITAMIN D 25 OH TOTAL IA,VITAMIN D 25 OH TOTAL IA,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,HIV AB AG RFLX CONF,HIV AG AB,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.10714285714285714,0.15,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,HEPATIC FUNCTION PNL,PROTEIN TOTAL,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,CHEM SCREEN PANEL,BILIRUBIN DIRECT,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,BMP8 CBC D PLT UA,EOS ABSOLUTE,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,COMP METABOLIC PANEL W O EGFR,CREATININE,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,RPR REFLEX PER CDC,RPR,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,CBC,BA%,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,PT PROTIME,INR,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.3333333333333333,0.2857142857142857,1.0,0.0,0.2857142857142857,1.0,0.05781485437633482,0.0,0.0,0.0,0.439493011634871,0.8660254037844386,1,21576,CK TOTAL,CREATINE KINASE TOTAL,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,LIVER FIBROSIS,NECROINFLAM ACT GRADE,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,CEA,CEA CENTAUR,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.005,0.0175,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.11098565713428754,0.10964330813284906,0.7071067811865476,1,264994,CBC ESR,ABSOLUTE NEUTROPHILS,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,PROTEIN ELECTRO S,M SPIKE,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.10333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,UA MICROSCOPIC REFLEX CULTURE,PH,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,CBC,HEMOGLOBIN,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.16666666666666666,0.125,0.25,0.0,0.0,0.0,0.006964172316456629,0.011023500082217974,0.017082065767519583,0.0,0.0,0.0,0,312017,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.05555555555555555,0.0,0.025,0.05555555555555555,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,CBC H H RBC INDICES WBC PLT,MPV,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,PE RFX IFE S,GAMMA GLOBULIN,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0825,0.10600000000000001,0.0,0.25,0.2,1.0,0.0,0.0,0.0,0.0763206923693498,0.09762443806815091,1.0,1,58024,URINALYSIS W REFLEX MICRO,NITRITE,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,CBCI COMPLETE BLOOD COUNT W DIFF,MCH,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,CHEM SCREEN PANEL HDL,URIC ACID,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.1425,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,CMP WITH ESTIMATED GFR CALCULATED,UREA NITROGEN,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,IFE PE SERUM,ALBUMIN,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,CBC WITH DIFFERENTIAL,MYELOCYTES,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.088,0.08833333333333333,0.0,0.4,0.3333333333333333,1.0,0.0,0.0,0.0,0.11277316640103974,0.16750164273558021,1.0,1,57992,UA MICROSCOPIC REFLEX CULTURE,LEUKOCYTE ESTERASE,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,HIV 1 RNA QN RT PCR,HIV 1 RNA QN RT PCR,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,MAGNESIUM,MAGNESIUM,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.020830287582650375,0.0,0,17830,CBC INCLUDES DIFF PLT W SMEAR RVW,WHITE BLOOD CELL COUNT,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.1569574215481997,0.0,0.0,1,303842,CBC W AUTO DIFF WITH PLATELETS,RDW,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,CBC PLATELET HEM REVIEW,PLATELETS,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.5,0.16666666666666666,0.0,0.0,0.0,0.0,0.11136168435129556,0.05936451274361987,0.0,0.0,0.0,0.0,1,149799,APTT,PARTIAL THROMBOPLASTIN,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,DIFFERENTIAL MANUAL,NEUTROPHILS,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,HEPATITIS C GENO TYPE 1 NS5A RESIST,VELPATASVIR RESISTANCE,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,HEPATITIS B VIRUS PNL 6 TESTS,HB CORE AB TOTAL,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,VITAMIN D 25 OH,25 OH VITAMIN D,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,CBC PLATELET NO DIFFERENTIAL,HEMATOCRIT,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,COMPREHENSIVE METABOLIC PANEL W EGF,EGFR NON AFR AMERICAN,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.2375,0.15833333333333333,0.95,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06797427042040116,0.05720402135206337,0.7071067811865476,1,7310,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,HIV AB EIA WITH REFLEXES,HIV EIA AB SCREEN,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.16666666666666666,0.2757142857142857,0.965,0.3333333333333333,0.2757142857142857,0.965,0.012651487590124022,0.30790499772601176,0.8713430180861237,0.3120512265900537,0.015450719614443886,0.04372412516808821,1,110114,HEPATITIS C VIRUS RNA QN REAL TIME PCR,HCV RNA PCR QN,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,CBC WITH MANUAL DIFFERENTIAL,WBC,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,LP WITHOUT VLDL CHOL HDL LD,LDL HDL RATIO,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,CREATINE KINASE CK,CREATINE KINASE CK,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.039411764705882354,0.08375,0.0,0.0,0.0,0.0,0.019421521791069485,0.0,0.0,0.0,0.0,0,771477,BUN CREATININE RATIO,HEMOLYSIS,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.015316711982292452,0.0,0.0,0.0,0.0,0,301804,CBCI COMPLETE BLOOD COUNT W DIFF,MCH,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.057549248626998395,0.1125015497193188,0,303925,CBC WITH PLT DIFF,NUCLEATED RBCS,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,IRON BINDING CAPACITY,UIBC,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,HEPATITIS B VIRUS PNL 6 TESTS,HB CORE AB TOTAL,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,NMR LIPOPROFILE,LDL P,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,HCV GENOTYPE PCR PROBE,HCV GENOTYPE,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,HEMATOPATH CONSULTATION SMEAR,HEMATOLOGY COMMENTS,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,COMPREHENSIVE METABOLIC PANEL WITH GFR,T BILIRUBIN,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.058363114168254904,0.0,0,264507,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,CMP WITH ESTIMATED GFR CALCULATED,CHEMISTRY SODIUM,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0,19638,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,DRUG ABUSE SCREEN W ETOH NO GCMS,COCAINE METABOLITE,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.08333333333333333,0.022,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,PROFILE 1236 LIPID PANEL WITH DIRECT LDL,CHOL HDL,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,ASH FIBROSURE,COMMENT,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,183145,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,COMMENTS,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.11,0.1325,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,URINALYSIS SCREEN,PH,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.21857142857142858,0.0,0.0,0.0,0.0,0.0,0.032629011509134775,0.0,0.0,0.0,0.0,0,20958,PROTEIN ELEC INTERP SERUM,M SPIKE,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,AUTOMATED BLD CNT,MCH,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,CBC INCLUDES DIFF PLT W SMEAR RVW,PLATELET COUNT,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,BUN CREATININE RATIO,BUN CREATININE RATIO,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp,Daclatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,AFP TUMOR MARKER,AFP TUMOR MARKER,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.017142857142857144,0.04,0.0,0.017142857142857144,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CEA,CEA CENTAUR,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,URINALYSIS W MICRO,GLUCOSE,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.5,0.5714285714285714,0.6,0.0,0.03571428571428571,0.05,0.4543382861631333,0.013656950654702071,0.034646396615759856,0.0,0.0,0.0,1,487967,HCV FIBROSURE,COMMENT,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.06200000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,HEPATIC LIVER PANEL,DIRECT BILIRUBIN,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.16,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,TESTOSTERONE FR DIALYSIS TOTAL LC MS MS,FREE TESTOSTERONE,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.22199999999999998,0.19428571428571426,0.072,0.0,0.0,0.0,0.0,0.09418963513805056,0.0,0,51953,CMP14 3AC CBC D PLT RPR MG,MAGNESIUM SERUM,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.07692307692307693,0.0,0.0,0.0,0.0,0.0,0.012925030213119637,0.0,0.0,0.0,0.0,0,204479,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCH,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,HEMOGLOBIN A1C WITH MPG,HEMOGLOBIN A1C,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,CBC WITH AUTO DIFF,LYMPHOCYTES #,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.25,0.42857142857142855,0.75,0.25,0.42857142857142855,0.75,0.014383252316800266,0.0,0.0,0.014598428619085002,0.0,0.0,0,223271,HCV RNA QT REALTIME PCR,HCV RNA QN PCR,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.2,0.17333333333333334,0.26,0.0,0.0,0.0,0.0360154199639221,0.07165999577194615,0.10031748330730439,1,495416,LIPID PROFILE,FASTING NON FASTING,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS C ANTIBODY,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,NMR LIPOPROFILE,LDL P,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.02125,0.028333333333333335,0.0,0.0275,0.03666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,HEPATITIS BS AB QUANT,HEPATITIS BS AB INTERP,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,URINALYSIS C,BILIRUBIN,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.16285714285714287,0.22800000000000004,0.0,0.0,0.0,0.0,0.04305039215257289,0.10921478730455103,0.0,0.0,0.0,0,487967,COMPREHENSIVE METABOLIC PANEL WITH GFR,ALBUMIN,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,CMP14 CBC D PLT ESR WES ANA,POTASSIUM,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,CBC INC DIFF PLT,BASOPHILS,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,URINALYSIS CULTURE IF INDICATED,APPEARANCE,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.385,0.265,0.0,0.5,0.5,1.0,0.0,0.0,0.0,0.14187034543632637,0.7071067811865476,1.0,1,57679,URINALYSIS CULTURE IF INDICATED,APPEARANCE,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,TESTOSTERONE FREE TOTAL LC MS MS,FREE TESTOSTERONE,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.21400000000000002,0.0,0.0,0.21400000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,HEPATITIS A IGM,HEPATITIS A IGM,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,PTH INTACT MOLECULE,PTH,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.43,0.14285714285714285,0.3333333333333333,0.43,0.2857142857142857,0.6666666666666666,0.0,0.037676737156380646,0.038305767913941025,0.0,0.11303021146914194,0.11491730374182318,1,20958,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.2857142857142857,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,CBC INC DIFF PLT,RBC,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,TESTOSTERONE TOTAL LC MS MS,TESTOSTERONE TOTAL LC MS MS,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,CBC INCLUDES DIFF PLT,HEMOGLOBIN,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,FE ANA TIBC FER PTT PT A1A,PROTHROMBIN TIME,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,CBC WITH DIFFERENTIAL PLATELETS,EOS,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,MCCARJUH MCCARTHY PROFILE 1,PROTHROMBIN TIME PT,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,T4 THYROXINE,T4 THYROXINE,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,CBC,BA%,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,LYMPHOCYTE SUBSET PANEL 4,COMMENT S,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,CARDIO IQ R VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,PTT,PTT,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,UROGRAM,NITRITE,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,HEPATIC FUNCTION PANEL AMA,GLOBULIN,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,TSH SML,TSH,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,PROTEIN ELECTRO S,M SPIKE,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,C4 C3,COMPLEMENT C3 SERUM,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.3333333333333333,0.4444444444444444,0.8,0.3333333333333333,0.4444444444444444,0.8,0.3633923216427376,0.6049811048159087,0.8466616961548833,0.3633923216427376,0.6049811048159087,0.8466616961548833,1,139527,HEPATITIS B CORE AB TOTAL REFL,HEPATITIS B CORE AB TOTAL REFL,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.27999999999999997,0.09090909090909091,0.2,0.2,0.09090909090909091,0.2,0.03501471280402846,0.02619755394479084,0.0413729178490605,0.04288408992998327,0.032085319836887005,0.0506712689501424,1,602797,ACCUTYPE R IL28B,IL28B GENOTYPE,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.036,0.03272727272727272,0.05142857142857143,0.134,0.09090909090909091,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,HIV AG AB 4TH GEN RFL,RACE NR,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,DRUG ABUSE PANEL 10 WITH OXYCODONE,AMPHETAMINES,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,COMPLETE BLOOD COUNT,WBC,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,URINE DRUG SCREEN,OPIATES,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,PROTEIN ELEC INTERP SERUM,M SPIKE,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,CBC INCLUDES DIFF PLT,HEMOGLOBIN,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.12285714285714286,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,622381,CMP14 LP 2AC CBC D PLT TSH,EGFR IF AFRICN AM,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,URINALYSIS REFLEX,NITRITE,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,CRP,C REACTIVE PROTEIN ULTRA,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.02948276095739455,0.0,0.0,0.0,0.0,0,264648,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.04833333333333333,0.031,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,CBC PLATELET NO DIFFERENTIAL,HEMATOCRIT,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.12,0.072,0.36,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,CBC WITH DIFFERENTIAL,MCHC,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,FIBROACT COMPLETE,NECROINFL SCORE,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,MAGNESIUM,MAGNESIUM,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.2857142857142857,0.0,0.0,0.0,0.0,0.0,0.02082089594569836,0.0,0.0,0.0,0.0,0,716951,CBCI COMPLETE BLOOD COUNT W DIFF,BASOPHILS,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,CBC W DIFF PLT,BASOPHILS ABSOLUTE,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,LIVER FIBROSIS,NECROINFLAM ACT GRADE,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.5233333333333333,0.5,0.74,0.5233333333333333,0.5,0.74,0.012181305892681737,0.16061689126894507,0.0,0.008849284997959672,0.11668245250939069,0.0,0,149575,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,URINALYSIS W REFLEX MICRO,BACTERIA,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.11,0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,DIFFERENTIAL MANUAL,EOSINOPHILS,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.013636363636363636,0.0375,0.0,0.051818181818181826,0.14250000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,CMP14 LP 5AC,VLDL CHOLESTEROL CAL,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,LYMPHOCYTE SUBSET PANEL 3,ANALYZED DATE TIME,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,DRUG ABUSE SCREEN III,METHAQUALONE,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,EIA 10 ALCOHOL W GCMS,URINE CREATININE MG DL,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.041666666666666664,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,SPECIAL PROFILE # 5144,TSH ULTRASENSITIVE,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.08,0.08857142857142856,0.155,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,CMP13 LP TP TSH 2AC CBC D P,NEUTROPHILS ABSOLUTE,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,CBC WITH PLT DIFF,NUCLEATED RBCS,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,RENAL FUNCTION PANEL,CHLORIDE,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.03666666666666667,0.066,0.0,0.03666666666666667,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,CBC COMPLETE BLOOD COUNT W O DIFF,RED BLOOD CELL COUNT,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESIST ASSAY INTERP,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,PSA FREE TOTAL,PSA FREE,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.6166666666666667,0.425,0.7,0.5666666666666667,0.4325,0.73,0.0,0.40824829046386313,0.0,0.0,0.33333333333333337,0.0,0,23366,IMMUNOGLOBULINS A E G M SERUM,IMMUNOGLOBULIN G QN SERUM,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.16666666666666666,0.1,0.2,0.0,0.0,0.0,0.00902374526857963,0.016181531766538138,0.02314657770817119,0,51938,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,URINALYSIS CULTURE IF INDICATED,APPEARANCE,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,LIPID PANEL,VLDL CHOL CALC,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.16666666666666666,0.0,0.0,0.16666666666666666,0.0,0.0,0.16096628932775536,0.0,0.0,0.0,0.0,0,44859,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,CMP14 6AC,PHOSPHORUS,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,CBC PLATELET NO DIFFERENTIAL,HEMATOCRIT,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,HIV 1 RNA QN RT PCR,LOGCOPIES ML,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp,Daclatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,PSA FREE TOTAL,% FREE PSA,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.2857142857142857,0.2573333333333333,0.965,0.5714285714285714,0.324,1.0,0.2662211635159746,0.014346659179958254,0.04076018121777358,0.3450229873156683,0.016153304496081544,0.02294651354950772,1,381806,HCV RNA QN REAL TIME PCR W RFLX QL,HCV RNA LOG IU ML,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,CMP WITH ESTIMATED GFR CALCULATED,UREA NITROGEN,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,CBC INCLUDES DIFF PLT,ABSOLUTE NEUTROPHILS,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,LIVER FIBROSIS PANEL,ALT,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,COMPREHENSIVE METABOLIC PANEL E GFR,BUN,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,CBC INC DIFF PLT,RBC,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.2,0.0,0.0,0.19,0.16666666666666666,0.3333333333333333,0.048918155723576384,0.03837506794957857,0.0,0.0,0.05427054155128297,0.0946521642027649,1,7146,DIFFERENTIAL MANUAL,EOSINOPHILS,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.31,0.386,0.5514285714285714,0.31,0.386,0.5514285714285714,0.021966949517961187,0.0,0.0,0.021966949517961187,0.0,0.0,1,736553,HCV QUANT GT1A NS5A PROFILE,HCV NS5A DRUG RESISTANCE ASSAY,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0260399547305894,0.0,0,19687,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.09505913690571055,0.0,0,30841,CMP14 3AC CBC D PLT RPR MG,MAGNESIUM SERUM,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,HEPATITIS C VIRUS RNA QUALITATIVE PCR,HEPATITIS C VIRUS RNA QUALITATIVE PCR,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,COMP METABOLIC PANEL W EGFR,UREA NITROGEN,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,CBC,MCH,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,CMP14 1AC,ALT SGPT,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,LIVER FIBROSIS PNL HEPASCORE TM,F2,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,BUN CREATININE RATIO,HEMOLYSIS,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESIST ASSAY INTERP,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CBC WITH PLT DIFF,BASOPHILS ABSOLUTE,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,CMP12 2AC,BILIRUBIN TOTAL,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,HCV QUANT GT1A NS5A PROFILE,HCV NS5A DRUG RESISTANCE ASSAY,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,CMP14 LP 2AC CBC D PLT TSH,EGFR IF AFRICN AM,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.0,0.0,0.0,0.041428571428571426,0.0725,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,HEPATITIS C ANTIBODY W REFL HCV RIBA,SIGNAL CUT OFF,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,COMPREHENSIVE METABOLIC PANEL E GFR,BUN,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A RESIST ASSAY INTERP,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,URINALYSIS COMPLETE,GLUCOSE QL,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.17692551543363566,0.0,0,19687,C4 C3,COMPLEMENT C3 SERUM,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,COCAINE METABOLITE,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual,Promyelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,CBC,MO%,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,PROTEIN TOTAL URINE,URINE TOTAL PROTEIN,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,PATHOLOGIST SMEAR REVIEW,MONOCYTES,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,CMP14 LP 2AC CBC D PLT TSH,EGFR IF AFRICN AM,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,DRUG ABUSE SCREEN 9 NO THC W CONF,PHENCYCLIDINE,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,DIRECT LDL,LDL CHOLESTEROL DIRECT,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.0,0.0,0.0,0.0275,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,X HEPATITIS COMPLEX PROFILE,ANTI HCV,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,CREATINE KINASE CPK TOTAL,CREATINE KINASE CPK TOTAL,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,URINALYSIS,LEUKOCYTE ESTERASE,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,WESTERGREN SED RATE,WESTERGREN SED RATE,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.01636363636363636,0.045,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.25,0.2,1.0,0.0,0.0,0.0,0.06591673023183264,0.13909830811578938,1.0,1,108340,HEPATIC FUNCTION PNL,GLOBULIN,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.08952338621207645,0.0,0,264499,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,CBC WITH MANUAL DIFFERENTIAL,MCHC,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.0,0.0,0.0,0.3,0.2,1.0,0.0,0.0,0.0,0.0,0.34003516797720323,1.0,1,45427,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,CBC INCLUDES DIFF PLT,HEMOGLOBIN,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,CMP14 LP CBC D PLT,HEMATOCRIT,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,CMP14 LP TP TSH 4AC CBC D PLT,URIC ACID,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,COMP METABOLIC PANEL W O EGFR,CREATININE,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,REFLEX ANA PATTERN,PATTERN 1,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CALCIUM,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.14285714285714285,0.2573333333333333,0.715,0.2857142857142857,0.2573333333333333,1.0,0.023596626558496703,0.1189241757715156,0.22524969726717137,0.2855798754616614,0.01538990021601927,0.04372412516808821,0,381806,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,IRON TIBC,TIBC,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,HIGH SENSITIVITY CRP,HIGH SENSITIVITY CRP,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,LIPID PANEL AMA,CHOL HDLC RATIO,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,CBC WITH AUTO DIFF,MONOCYTES #,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,PROTEIN TOTAL 24HR URINE W CREAT,UR CREAT RANDOM MG DL,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CBC WITH ABSOLUTE WBCS MPV,MCHC,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,ASH FIBROSURE,HEIGHT,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.44333333333333336,0.25,0.5,0.31,0.25,0.5,0.010363119229323314,0.621189378727853,0.9625978811059088,0.010765782298852833,0.6453259361159007,1.0,1,312017,HIV AB EIA WITH REFLEX,HIV AB,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.0,0.09428571428571428,0.08,0.0,0.017857142857142856,0.0625,0.0,0.031588451602485135,0.0,0.0,0.0,0.0,0,204164,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CALCIUM,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,LIVER FIBROSIS PNL HEPASCORE TM,GGT,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,HIV 1 RNA QN RT PCR,HIV 1 RNA QN RT PCR,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,IRON TOTAL BINDING CAPACITY,IRON TOTAL,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,URINALYSIS COMPLETE W REFLEX CULTURE,PROTEIN,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,URINALYSIS,LEUKOCYTE ESTERASE,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,MITOCHONDRIAL AB SCREEN,MITOCHONDRIAL AB SCREEN,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,HEP A AB TOTAL,HEP A AB TOTAL,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,DRUG ABUSE SCREEN 9 NO THC W CONF,PHENCYCLIDINE,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.2857142857142857,0.4,0.0,0.2857142857142857,0.4,0.0,0.036374829167206246,0.04908765036508733,0.0,0.036374829167206246,0.04908765036508733,0,728626,HEPATITIS C AB,HEPATITIS C AB,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.14666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,CEA,CEA CENTAUR,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,CBC WITH PLT MAN DIFF,BANDS,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,RPR REFLEX PER CDC,RPR,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,AFP TUMOR MARKER,AFP TUMOR MARKER,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,BMP,CHLORIDE,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,CBCI COMPLETE BLOOD COUNT W DIFF,MCH,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,DRUG ABUSE PANEL 10 WITH OXYCODONE,COCAINE METABOLITE,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,RENAL FUNCTION PANEL,CREATININE,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,FREE T4,FREE T4,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,LIPID PROFILE,CHOLESTEROL NON HDL,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.125,0.2,0.3333333333333333,0.46875,0.75,0.0,0.0666872623744319,0.0795785781568974,0.3858852398421331,0.7015934244403738,0.837218460816585,1,109009,CUSTOM HEPATITIS PANEL,HEP B SURFACE AB,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,UA MICROSCOPIC REFLEX CULTURE,LEUKOCYTE ESTERASE,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,UA W RFLX MICROSCOPIC,BILIRUBIN,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,BASIC METABOLIC PANEL W EGFR,BUN CREATININE RATIO,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,DIFFERENTIAL MANUAL,NEUTROPHILS,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,PT PTT,PARTIAL THROMBOPLASTIN,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.015364635222253398,0.0,0.0,0.0,0.0,0,81018,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,HB S AG W REFLEX CONF,HFLAG,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,URINALYSIS COMPLETE W REFLEX CULTURE,PROTEIN,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.02823933563163694,0.0,0,59014,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0825,0.08833333333333333,0.0,0.3225,0.16666666666666666,1.0,0.0,0.0,0.0,0.07097576385288318,0.09716253076254433,1.0,1,204057,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,CMP14 LP 2AC CBC D PLT TSH,EGFR IF AFRICN AM,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,COMP METABOLIC PANEL W GFR,GLOBULIN,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,CBC WITH DIFFERENTIAL,IMMATURE GRANS,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS C ANTIBODY,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,TSH SML,TSH,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,HCV RNA QUANT BDNA,HCV RNA QN BDNA,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,FOLLOW UP PNL ARAKAWA,SODIUM,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,COMPREHENSIVE METABOLIC PANEL E GFR,BUN,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.16666666666666666,0.14307692307692307,0.2866666666666667,0.16666666666666666,0.07692307692307693,0.2866666666666667,0.028275241940297513,0.08470305693504976,0.3162277660168379,0.01097724199193173,0.0164420512368324,0.12276848839929855,0,204479,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,CBC W DIFF PLT,PLATELET SUFFICIENCY,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.2,0.25,0.0,0.0,0.0,0.0,0.027385328599057512,0.07274033002715963,0.0,0.0,0.0,0,345355,VIT B 12 FOLATE PANEL,VITAMIN B 12,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,HCV FIBROSURE,NECROINFLAMMAT ACTIVITY SCORE,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,HEMOGRAM W O DIFFERENTIAL,MEAN PLATELET VOLUME,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,NASH FIBROSURE,AST SGOT P5P,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,CBC PLT DIFF,POLYS,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.1675,0.134,0.0,0.25,0.2,0.5,0.0,0.0,0.0,0.06428788335820634,0.07676866432248541,0.10031748330730439,1,81224,IMMUNODEF PROFILE #1,ABSOLUTE CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,CBC WITH MANUAL DIFFERENTIAL,PLATELET COUNT,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.0,0.011111111111111112,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,COMP METABOLIC PANEL,CARBON DIOXIDE,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,ANA TITER PATTERN,ANA TITER,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,IRON BINDING CAPACITY,IRON TOTAL,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,RENAL FUNCTION PANEL,ANION GAP,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,GGTP,GGTP,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.03666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,CBC PLATELET HEM REVIEW,EOS,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.055,0.033,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,CBC WITH MANUAL DIFFERENTIAL,MCH,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.11399999999999999,0.0,0.0,0.4,0.5357142857142857,0.75,0.0,0.0,0.0,0.4305038496827379,0.8189098321511491,0.826652159481457,1,223222,HBSAB AG,HEP B SURFACE AB QUAL,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,CBC WITH PLT DIFF,NO CELLS DIFF,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.1075,0.172,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,HEMOGLOBIN A1C W EAG INT CHART,ESTIMATED AVERAGE GLUCOSE,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,COMP METABOLIC PANEL 13,EGFR IF NONAFRICN AM,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.20750000000000002,0.20750000000000002,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,T4 THYROXINE,T4 THYROXINE,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.25,0.4,0.0,0.25,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD LOG IU ML,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,HEMATOPATH CONSULTATION SMEAR,WBC,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL AB,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual,Promyelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,HIV 1 RNA QN RT PCR,RACE NR,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,MORPHOLOGICAL REVIEW,PLATELET ESTIMATE,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,FIBROACT COMPLETE,HEIGHT INCHES,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,NASH FIBROSURE,HEIGHT,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,LMG CBC DIFF PLT,LYMPHOCYTES #,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,ASH FIBROSURE,COMMENT,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,CMP14 CBC D PLT TSH,EGFR IF AFRICN AM,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,RPR W RFLX CONFIRM,RPR SYPHILIS SCREEN,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.088,0.14666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,BUN CREATININE RATIO,EGFR NON AFR AMERICAN,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.3333333333333333,0.16666666666666666,0.5,0.3333333333333333,0.16666666666666666,0.5,0.06538932921065,0.45528141890436646,0.5,0.06538932921065,0.45528141890436646,0.5,1,44982,C4 SERUM,C4 SERUM,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,CBC W AUTO DIFF ABS WBC MPV PLT,BASOPHILS,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE AG,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,TRANSFERRIN SATURATION,TRANSFERRIN,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,COMP METABOLIC PANEL CLARIFICATION,ALT,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.18999999999999997,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,URINALYSIS SCREEN,PH,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,APTT,PARTIAL THROMBOPLASTIN,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,GGTP,GGTP,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,CMP13 LP TP TSH 2AC CBC D P,AST SGOT,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,CMP14 1AC,EGFR IF NONAFRICN AM,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,CBC INCLUDES DIFF PLT,EOSINOPHILS,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.048562532594562446,0.0,0,264788,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,HCV FIBROSURE,LIMITATIONS,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,CREATINE KINASE CPK TOTAL,CREATINE KINASE CPK TOTAL,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,PT PTT,PARTIAL THROMBOPLASTIN,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,HEMOGLOBIN A1C,AVERAGE WHOLE BLOOD GLUCOSE,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.405,0.16666666666666666,0.0,0.0,0.0,0.0,0.03924496332518701,0.03302675712634284,0.0,0.0,0.0,0.0,0,7310,AUTOMATED BLD CNT,HEMOGLOBIN,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD4 CELLS,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,HAV HBV IMMUNE STATUS PRO IV,HEP A AB IGM,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,CBC WITH PLT DIFF,WBC MORPHOLOGY,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.3333333333333333,0.375,1.0,0.0,0.0,0.0,0.08176255116563813,0.0,0.0,1,23242,LIVER FIBROSIS PNL HEPASCORE TM,GGT,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,CD4 CD8 RATIO PROFILE,HEMATOLOGY COMMENTS,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.16666666666666666,0.25,0.6875,0.0,0.0,0.0,0.029466034019553722,0.04521753067807699,0.12591840875016092,0.0,0.0,0.0,0,112599,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.2,0.05,0.13333333333333333,0.0,0.0,0.0,0.052601290786171706,0.07834499240220905,0.07600531298566238,1,244673,LYMPHOCYTE SUBSET PANEL 1,CD4 ABSOLUTE,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,T4,T4,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,COMPLETE BLOOD COUNT,MCV,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.25,0.2,0.0,0.0,0.0,0.0,0.024010279975948068,0.0,0.0,0.0,0.0,0.0,0,112821,AUTOMATED BLD CNT,HEMOGLOBIN,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,HEPATIC FUNCTION PANEL 6,AST SGOT,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,HCV GENOTYPE REFLEX NSA,HCV GENOSURE R NSA INTERP,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,CHEM 20,CHOLESTEROL,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,URINALYSIS W REFLEX MICRO,BACTERIA,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,TESTOSTERONE FREE TOTAL LC MS MS,FREE TESTOSTERONE,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,TESTOSTERONE FREE TOTAL LC MS MS,FREE TESTOSTERONE,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.2,0.0,0.0,0.2,0.0,0.0,0.034111472287449485,0.0,0.0,0.034111472287449485,0.0,0,27771,ALPHA 1 ANTITRYPSIN SERUM,ALPHA 1 ANTITRYPSIN SERUM,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,HCV QUANT GT1A NS5A PROFILE,HCV NS5A DRUG RESISTANCE ASSAY,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.1,0.047142857142857146,0.11,0.1,0.047142857142857146,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,COMP METABOLIC PANEL CLARIFICATION,ALBUMIN GLOBULIN RATIO,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,COMPREHENSIVE METABOLIC PANEL AMA,SODIUM,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,COMP METABOLIC PANEL CLARIFICATION,ALBUMIN GLOBULIN RATIO,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,COMPREHENSIVE METABOLIC PANEL E GFR,BUN,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.148,0.0,0.0,0.148,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,PSA FREE TOTAL,% FREE PSA,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,COMP METABOLIC PANEL,POTASSIUM,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,FE TIBC FER,FERRITIN SERUM,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.017368421052631578,0.03666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,URINALYSIS W REFLEX MICRO,KETONES,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,GLUCOSE,GLUCOSE FASTING,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,RPR REFLEX TP PA,RPR,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,URINALYSIS RX ALB CREA,KETONES,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,ARTHRITIS PROFILE,RHEUMATOID FACTOR QUANT,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,OBSTETRIC PANEL,NEUTROPHILS,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,ARTHRITIS PROFILE,RHEUMATOID FACTOR QUANT,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,CMP14 HP5 LP 6AC CBC D PLT,BILIRUBIN INDIRECT,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,T3 FREE,T3 FREE,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,FREE T3,FREE T3,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,PE INTERP RFX IFE S,BETA GLOBULIN,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.14285714285714285,0.0,0.0,0.14285714285714285,0.0,0.0,0.05171526843986196,0.0,0.0,0.05171526843986196,0.0,0,134585,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0725,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,23457,FE TIBC FER,FERRITIN SERUM,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA PATTERN,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,EIA 10 ALCOHOL W GCMS,URINE CREATININE MG DL,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,RPR,RPR RESULT,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06800077147700478,0.05369526777702294,0.09169555407390673,1,7831,CBC WITH PLT DIFF,PROMYELOCYTES,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual,Promyelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,CBC WITH PLT DIFF,OTHERS,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.1925,0.08833333333333333,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.07065997001469593,0.09716253076254433,1.0,1,57927,URINALYSIS CULTURE IF INDICATED,GLUCOSE,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,HEPATIC FUNCTION PANEL,ALK PHOS,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0,0.14285714285714285,0.25,0.4,0.3814285714285714,0.6675,0.0,0.06229568196836488,0.07240860968350848,0.47662402489215927,0.01604041949885182,0.018644381728446624,1,139519,HEPATITIS PANEL CHRONIC,HAV AB TOTAL,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,CMP14 CBC D PLT TSH,ALBUMIN,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,HEPATITIS PANEL CHRONIC,HAV AB TOTAL,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.20717899254074368,0.0,0,25320,CMP13 LP 2AC CBC D PLT,ALBUMIN SERUM,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,HEPATIC FUNCTION PANEL 6,AST SGOT,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,CBC WITH PLT DIFF,BASOPHILS ABSOLUTE,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,UA W MICRO HOLD SPEC 24 HR,GLUCOSE,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.0,0.71,0.0,0.0,0.0,0.0,0.0,0.0,1,19638,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,PTT,PTT,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,BILIRUBIN FRACTIONATED,BILIRUBIN INDIRECT,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.06666666666666667,0.1,0.0,0.0,0.0,0.0,0.0,0.07462593631165992,0.0,0.0,0.0,0.0,0,17434,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.1416666666666667,0.42500000000000004,0.0,0.1416666666666667,0.42500000000000004,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,VIT B 12 FOLATE PANEL,VITAMIN B 12,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,URINALYSIS COMPLETE,BILIRUBIN,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,URINALYSIS CULTURE IF INDICATED,COLOR,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,WESTERGREN SED RATE,WESTERGREN SED RATE,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.09499999999999999,0.04384615384615384,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,HEPATITIS BE AG,HBEAG INS NR,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,DRUG ABUSE SCREEN II,OPIATES,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,CMP14,EGFR IF AFRICN AM,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.2783333333333333,0.26666666666666666,0.39999999999999997,0.2783333333333333,0.26666666666666666,0.39999999999999997,0.008737333696933414,0.017631231673505443,0.029139853461716658,0.008737333696933414,0.017631231673505443,0.029139853461716658,0,481598,HEPATITIS B CORE AB,HEPATITIS B CORE AB,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,CMP14 3AC CBC D PLT RPR MG,MAGNESIUM SERUM,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual,Promyelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,OXYCODONE,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,CARDIO IQ R VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,T3 FREE,T3 FREE,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,RPR W RFLX CONFIRM,RPR SYPHILIS SCREEN,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,HEPATITIS C GENO TYPE 1 NS5A RESIST,VELPATASVIR RESISTANCE,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,MA COMP METABOLIC PNL,ALKALINE PHOSPHATASE,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.25,0.35,0.0,0.0,0.0,0.0,0.04813180165558817,0.12210584428057858,0.0,0.0,0.0,0,487967,HEPATIC FUNCT PANEL W O TP,BILIRUBIN DIRECT,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,CBC,MO%,Specimen source identified,Specimen source XXX,Specimen source
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1216962121474966,1.0,1,45443,CMP14 LP CBC D PLT,HEMATOCRIT,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,ASH FIBROSURE,HEIGHT,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.051583725460460195,0.0,0,204164,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.25,0.2857142857142857,0.5,0.25,0.2857142857142857,0.5,0.01331639536223761,0.038819610593967324,0.03972494533739679,0.01348660606631813,0.039315804426577006,0.0402327111953118,0,223271,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,TESTOSTERONE,TESTOSTERONE,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,CMP12 7AC MG,PHOSPHORUS SERUM,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,PT PROTIME,INR,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.02783520196223732,0.0,0.0,0.0,0.0,0,7120,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.2857142857142857,0.5,0.0,0.14285714285714285,0.25,0.0,0.0,0.0,0.0,0.07629631700059647,0.08868207335447242,0,139519,HCV GENOTYPE REFLEX NSA,HEPATITIS C GENOTYPE,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0125,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,UA MICROSCOPIC REFLEX CULTURE,LEUKOCYTE ESTERASE,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.25,0.16666666666666666,0.0,0.0,0.0,0.0,0.013234788163202671,0.010181580650666988,0.0,0.0,0.0,0.0,0,7120,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,RPR SCREEN W TITER,RPR SCREEN,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,CMP14 HP4 DBILI CBC D PLT R,AMYLASE,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,FREE T4 THYROXINE,FREE T4 THYROXINE,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,COMP METAB PANEL,CALCIUM PLASMA,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.2,0.3336363636363636,0.9175,0.2,0.36363636363636365,1.0,0.009807526921279508,0.0,0.0,0.009954249465735754,0.012293609461087485,0.018008420843363293,1,322867,HCV RNA GENO W REFL NS5A,HCV RNA GENOTYPE LIPA R,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,HEP B SURFACE AB,HEP B SURFACE AB,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.07545454545454545,0.0,0.0,0.0,0.0,0.0,0.041353268343751526,0.0,0.0,0.0,0.0,0,831008,PROTEIN ELECTROPHORESIS SERUM,ALPHA 2,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.24333333333333332,0.186,0.0,0.0,0.0,0.0,0.0,0.030815044889822563,0.0,0.0,0.0,0.0,0,64634,URINALYSIS CULTURE IF INDICATED,GLUCOSE,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,COMP METABOLIC PANEL W EGFR,PROTEIN TOTAL,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,COMP METABOLIC PANEL,GLOBULIN,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,URINALYSIS W MICRO,GLUCOSE,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.31,0.386,0.5514285714285714,0.31,0.386,0.5514285714285714,0.021966949517961187,0.0,0.0,0.021966949517961187,0.0,0.0,1,736553,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,CMP14 LP CBC D PLT TSH HB A,ALT SGPT,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,COMP METABOLIC PANEL,POTASSIUM,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CMP14 1AC,ALT SGPT,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.46499999999999997,0.4,0.6666666666666666,0.0,0.0,0.0,0.034103916281504665,0.16901735079974012,1.0,1,104661,CMP WITH EGFR,ANION GAP,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,FE TIBC FER,IRON BIND CAP TIBC,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,CMP14 LP CBC D PLT TSH T4F,NEUTROPHILS ABSOLUTE,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,HIV 1 RNA QN RT PCR,HIV 1 RNA QN RT PCR,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,FSRC NEW PATIENT PANEL,D BILIRUBIN,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.09090909090909091,0.25,0.0,0.09090909090909091,0.25,0.0,0.04521753067807699,0.12591840875016092,0.0,0.052212707018155835,0.14539805437566944,0,112599,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,COMP METAB PANEL,EGFR NON AFR AMERICAN,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,X HEPATITIS COMPLEX PROFILE,ANTI HCV,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,CMP13 LP 2AC CBC D PLT,CHOLESTEROL TOTAL,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,LYMPHOCYTE SUBSET PANEL 5,CD4 % POS,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,PROTHROMBIN PTT,CONTROL,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,CMP14 HP5 LP 6AC CBC D PLT,HDL CHOLESTEROL,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,LYMPHOCYTE SUBSET PANEL 4,%CD8 SUPPRESSOR T CELLS,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,PROTEIN ELEC INTERP SERUM,ALPHA 2 GLOBULIN,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.125,0.16666666666666666,0.0,0.5425,0.7233333333333333,0.0,0.0762321806483941,0.056568082236201356,0.0,0.1524643612967882,0.11313616447240271,1,519132,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,DRUG ABUSE SCREEN III,AMPHETAMINES,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,SPECIAL CUM 50 PLUS PROFILE # 10190,SEDIMENTATION RATE,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CBC D WITH PLT CITRATED BLD,LYMPHS,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,PTH INTACT,PTH INTACT,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,AUTOMATED BLD CNT,HEMOGLOBIN,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,COMP METABOLIC PANEL W EGFR,PROTEIN TOTAL,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.06,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.03763610069594081,0.0,0,7369,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,GLUCOSE,GLUCOSE FASTING,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,HBSAB AG,HEP B SURFACE AB QUAL,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,CBC WITH AUTO DIFF,MONOCYTES #,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.007000000000000001,0.023333333333333334,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.09499999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,LIPID PANEL WITH REFLEX DIRECT L,HDL CHOLESTEROL,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,CRP,C REACTIVE PROTEIN ULTRA,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,DRUG ABUSE SCREEN W ETOH NO GCMS,BENZODIAZEPINES,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.07938204106182678,0.0,0,19208,CBC INCLUDES DIFFERENTIAL PLATELETS,MEAN PLATELET VOLUME,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,HEPATITIS BC AB IGM,HEPATITIS B CORE AB IGM,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CBC WITH PLT DIFF,NRBC,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,PTH INTACT MOLECULE,PTH,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.11,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,CBC W AUTO DIFF WITH PLATELETS,RDW,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.3333333333333333,0.2,0.5,0.3333333333333333,0.2,0.5,0.05661369574194264,0.06447593079677061,0.0,0.06933733351046811,0.07896656557154391,0.0,1,205070,RPR SCREEN W TITER,RPR SCREEN,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,CMP14 1AC,ALT SGPT,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.1063004130698838,0.10964330813284906,0.7071067811865476,1,264440,CBC WITH PLT DIFF,BASOPHILS ABSOLUTE,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.035263157894736843,0.07444444444444445,0.0,0.0,0.0,0.0,0.01675289171541816,0.0,0.0,0.0,0.0,0,486431,BUN CREATININE RATIO,HEMOLYSIS,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,PROTHROMBIN TIME PT,PT CONTROL,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,URINALYSIS W MICRO W REFLEX CULTURE,WBC,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.0,0.0,0.0,0.4,0.5171428571428571,0.6666666666666666,0.0,0.0,0.0,0.07351377561058281,0.18661673850657123,0.09866725380717944,1,81018,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.16625,0.44333333333333336,0.0,0.16625,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESISTANCE ASSAY PDF,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,29512,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,ALB ALP ALT AST GGT LD PROT,LDH,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,CHEM SCREEN PANEL HDL,URIC ACID,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.25,0.2,1.0,0.0,0.0,0.0,0.06591673023183264,0.13909830811578938,1.0,1,108340,COMP METABOLIC PANEL W GFR,GLOBULIN,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,HEPATIC FUNCTION PANEL,BILIRUBIN INDIRECT,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,HEMOGLOBIN A1C W EAG INT CHART,ESTIMATED AVERAGE GLUCOSE,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0125,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,MAGNESIUM,ICTERUS,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,PSA FREE TOTAL,PSA FREE,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.25,0.5,0.5,0.0,0.0,0.0,0.04253195834778967,0.14687247901289302,0.5773502691896257,0,81240,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.25,0.20000000000000004,0.0,0.25,0.16666666666666666,1.0,0.03960996495528413,0.0,0.0,0.06860647178857471,0.0793317966039091,1.0,1,251454,URINALYSIS W REFLEX MICRO,BACTERIA,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,COCAINE METABOLITE,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.25,0.2,0.0,0.0,0.0,0.0,0.06725870151848445,0.21223170681007852,0.0,1,7864,CBC INCLUDES DIFF PLT,MCHC,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,COMP METABOLIC PANEL,ANION GAP,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.2,0.16666666666666666,0.3333333333333333,0.2,0.16666666666666666,0.3333333333333333,0.041334701501644866,0.053249518936579365,0.05370835074347102,0.041334701501644866,0.053249518936579365,0.05370835074347102,0,497818,HEPATITIS C AB,HEPATITIS C AB,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.009333333333333334,0.035,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS C ANTIBODY,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,HCV FIBROSURE,COMMENT,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,CK TOTAL,CREATINE KINASE TOTAL,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.235,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.04044935140918404,0.5,0.0,0.0,0.0,0,7773,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE EOS,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,CBC,NEUTROPHIL,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,PROTIME PTT,PTT,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.018181818181818184,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,BMP8 ANION GAP,EGFR IF NONAFRICN AM,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.3333333333333333,0.14285714285714285,0.5,0.0,0.0,0.0,0.060037523066651444,0.0,0.0,1,19208,CMP13 LP TP TSH 2AC CBC D P,AST SGOT,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.2,0.125,0.0,0.0,0.0,0.0,0.009371986993610637,0.007500998156060201,0.0,0.0,0.0,0.0,0,7633,CBC WITH MANUAL DIFFERENTIAL,RDW,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,CBC W O DIFF WITH PLATELETS,MCH,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.051666666666666666,0.10333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,PSA FREE TOTAL,INTERNAL %,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.03775254682189788,0.13881877602428572,0.4082482904638629,0.0,0.0,0.0,0,24984,IRON BINDING CAPACITY,UIBC,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,ANA IFA SCREEN WITH REFLEX TITER,ANTI NUCLEAR AB IFA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.13333333333333333,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,HAV HBV IMMUNE STATUS PRO IV,HEP A AB IGM,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.1425,0.36,0.0,0.0,0.0,0.0,0.0,0.14265122201011204,0.0,0.0,0.0,0.0,0,192708,URINE DRUG SCREEN,OPIATES,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,CBC INCLUDES DIFF PLT,MCHC,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,CRP,C REACTIVE PROTEIN ULTRA,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,DRUG ABUSE PANEL 10 WITH OXYCODONE,AMPHETAMINES,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,ASH FIBROSURE,HEIGHT,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.15,0.09125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE AG,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.05290437188716146,0.0,0,544346,CMP13 LP 2AC CBC D PLT,ALBUMIN SERUM,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,IRON BINDING CAPACITY % SATURATION,CALCULATED % IRON SAT,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,CMP14 CBC D PLT ESR WES ANA,POTASSIUM,Age,Age,Age
0.0,0.0,0.0,0.0,0.09090909090909091,0.0,0.0,0.0,0.0,0.0,0.00631165451019422,0.0,0,602797,CBC INCLUDES DIFF PLT W SMEAR RVW,WHITE BLOOD CELL COUNT,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.0,0.0,0.3333333333333333,0.16666666666666666,0.5,0.0,0.0,0.0,0.06486415033444226,0.07799978756310755,0.0,1,205088,OBSTETRIC PANEL,RPR RESULT,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.11000000000000001,0.0,0.0,0.576,0.96,0.96,0.0,0.0,0.0,0.3757978134029263,0.022046838418816495,0.022046838418816495,1,487934,LIVER FIBROSIS FIBROTEST ACTITEST P,NECROINFLAMMATION ACT GRADE,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.09090909090909091,0.0,0.0,0.0,0.0,0.0,0.013948089075490944,0.0,0.0,0.0,0.0,0,542183,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0085,0.01888888888888889,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,HIV AB AG COMBO RFLX CONF,HIV AB AG COMBO RFLX CONF,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,PSA TOTAL % FREE,PSA FREE,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,LIVER FIBROSIS FIBROMETER,FIBROMETER PATIENT SCORE,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,MANUAL DIFFERENTIAL,BLASTS %,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.16666666666666666,0.2757142857142857,0.75,0.3333333333333333,0.2757142857142857,1.0,0.031263995483780005,0.11986974578621867,0.22524969726717137,0.3783747610938436,0.015512265816446047,0.04372412516808821,0,204164,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HCV RNA QUAL TMA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.13833333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,HCV GENOTYPE PCR PROBE,HCV GENOTYPE,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.09506946003405836,0.0,0.0,0.5,1.0,1,205708,CBC COMPLETE BLOOD COUNT W O DIFF,HEMATOCRIT,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,X HEPATITIS COMPLEX PROFILE,ANTI HCV,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,CBC W DIFF PLATELET,EOSINOPHILS,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.040203715080026736,0.0,0.0,0.0,0.0,1,143149,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,COCAINE METABOLITE,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.2857142857142857,0.0,0.0,0.42857142857142855,1.0,0.0,0.029747647799953647,0.0,0.0,0.12793313413942875,0.15892726613090935,1,326231,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.5,0.5,1.0,0.0,0.0,0.0,0.12460215794786256,0.16901735079974012,1.0,1,330373,COMP METABOLIC PANEL W GFR,ANION GAP,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.5,0.0,0.0,0.0,0.059630238727867435,0.059630238727867435,0.1063004130698838,1,31377,FIBROACT COMPLETE,HEIGHT INCHES,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,COMP METABOLIC PANEL,CARBON DIOXIDE,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,ANA IFA SCREEN WITH REFLEX TITER,ANTI NUCLEAR AB IFA,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.3333333333333333,0.0,0.0,0.0,0.03142857142857143,0.07333333333333333,0.05467597086898157,0.0,0.0,0.0,0.9131129509166843,0.9888882125258499,1,19885,ESR WES CRP,C REACTIVE PROTEIN QUANT,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,IRON BINDING CAPACITY,UIBC NR,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,PE RFX IFE S,GAMMA GLOBULIN,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,HEPATIC FUNCTION PANEL,ALK PHOS,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.26666666666666666,0.0,0.0,0.0,0.14285714285714285,0.5,0.0,0.0,0.0,0.0,0.5074828171487041,1.0,1,67686,CMP14 LP 3AC,ALKALINE PHOSPHATASE S,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,LIVER FIBROSIS FIBROTEST ACTITEST P,GGT,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,COMP METABOLIC PANEL,ANION GAP,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,STOOL CULTURE,RESULT 1,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,CEA,CEA,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,CMP14 6AC,PHOSPHORUS,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,CMP14 CBC D PLT ESR WES ANA,POTASSIUM,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,PROTEIN TOTAL 24HR URINE W CREAT,UR CREAT RANDOM MG DL,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,CMP14 LP 5AC CBC D PLT RPR,CHOLESTEROL TOTAL,Body weight Measured,Weight Measured,Body weight
0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,AMYLASE,AMYLASE,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESISTANCE ASSAY PDF,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,CMP14 4AC,EGFR IF AFRICN AM,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCH,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.392,0.09571428571428572,0.1675,0.0,0.0,0.0,0.03321870600293453,0.043355289534301455,0.043726732586310324,1,142513,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,COMP METABOLIC PANEL,GLOBULIN,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.11399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.06666666666666667,0.25,0.0,0.06666666666666667,0.25,0.0,0.04432042353220711,0.12591840875016092,0.0,0.04432042353220711,0.12591840875016092,0,381806,HEPATITIS BS AB QUANT,HEPATITIS BS AB INTERP,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,UROGRAM,NITRITE,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.21666666666666667,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.09338639438323382,0.0,1,17590,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.03666666666666667,0.0,0.0,0.0,0.044444444444444446,0.03666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,LIPID PANEL STANDARD,LDL CHOL CALCULATED,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.1675,0.11166666666666668,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.5,0.5,0.6666666666666666,0.25,0.5,0.6666666666666666,0.4265260514383984,0.008638751144131596,0.010018540333668557,0.009960706634886463,0.40392557361123926,0.46844093359181893,1,45484,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.0769832768017027,0.08055537486383768,0.09169555407390673,0,264853,CBC W DIFF PLT,MONOCYTES %,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.07692307692307693,0.0,0.0,0.0,0.0,0.0,0.05467558814705109,0.0,0.0,0.0,0.0,0,204479,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.00875,0.0175,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,CMP14 LP 7AC CBC D PLT T B,IRON SATURATION,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,HEPATIC FUNCTION PANEL AMA,GLOBULIN,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,COMPREHENSIVE METABOLIC PANEL AMA,SODIUM,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,GLYCOHEMOGLOBIN A1C,GLYCOHEMOGLOBIN A1C,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,ANEMIA PROFILE B,EOS,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,HEPATIC FUNCTION PANEL 6,AST SGOT,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,STOOL CULTURE,RESULT 1,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,COMP METABOLIC PANEL W GFR,ANION GAP,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,URINALYSIS SCREEN,BACTERIA,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,HELPER T LYMPH CD4,NEUTROPHILS,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,COMP METABOLIC PANEL W EGFR,UREA NITROGEN,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,HEPATITIS B VIRUS PNL 6 TESTS,HB CORE AB TOTAL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.014370478260188557,0.0,0.0,0.0,0.0,0,20289,PSA FREE TOTAL,% FREE PSA,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.07,0.2625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,CBC COMPLETE BLOOD COUNT W O DIFF,HEMATOCRIT,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,COMP METABOLIC PANEL,CREATININE,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,FREE T3,FREE T3,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.18666666666666668,0.2,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,25718,DIRECT LDL,TRIGLYCERIDES,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.16666666666666666,0.94,0.25,0.16666666666666666,0.94,0.0,0.0,0.0,0.05026217761451124,0.056942591518096664,0.0,1,93179,CBC W DIFF PLT,PLATELET SUFFICIENCY,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,PROTHROMBIN TIME,PT POP MEAN,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.11857142857142856,0.0,0.0,0.0,0.0,0.0,0.17692551543363566,0.0,0.0,0.0,0.0,0,30510,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.04220940476841939,0.04274587362976634,0.0,0.0,0.0,0,205070,HIV AG AB 4TH GEN RFL,RACE NR,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0725,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,URINALYSIS COMPLETE,GLUCOSE QL,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.25,0.16699999999999998,0.5,0.0,0.0,0.0,0.049020432311290385,0.0,0.0,1,302398,ASH FIBROSURE,AST SGOT P5P,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.08142857142857142,0.18999999999999997,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,URINALYSIS COMPLETE W REFLEX CULTURE,PROTEIN,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,LYMPHOCYTE SUBSET PANEL 3,ANALYZED DATE TIME,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,LIVER FIBROSIS PNL HEPASCORE TM,F2,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,HAV HBV IMMUNE STATUS PRO IV,HEP A AB IGM,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,30841,CMP12 LP TP TSH 6AC CBC D PLT,URIC ACID,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.11600000000000002,0.19333333333333336,0.14500000000000002,0.11600000000000002,0.19333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,HCV GENOTYPE REFLEX NSA,HEPATITIS C GENOTYPE,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,ALPHA FETOPROTEIN TUMOR MARKER,AFP TUMOR MARKER,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.7666666666666666,0.386,0.465,0.4666666666666666,0.454,0.635,0.010152652931362582,0.03360193723570992,0.017176466887497077,0.0,0.9783777508095268,0.9781387946600695,1,28902,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.2,0.5,0.0,0.0,0.0,0.0,0.01635194213270963,0.02609289002227677,0,422543,HEPATITIS PANEL CHRONIC,HAV AB TOTAL,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,COMPLETE BLOOD COUNT,WBC,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.08417404545937612,0.0,0,747741,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.33399999999999996,0.5842857142857143,0.855,0.33399999999999996,0.5842857142857143,0.855,0.04183290768824732,0.06229568196836488,0.07240860968350848,0.04183290768824732,0.06229568196836488,0.07240860968350848,1,139519,HEP A AB TOTAL,HEP A AB TOTAL,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,T3 FREE,T3 FREE,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,TSH 3RD GENERATION REFL,TSH 3RD GENERATION REFL,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.31,0.386,0.5514285714285714,0.31,0.386,0.5514285714285714,0.018565460848511406,0.0,0.0,0.020052989617607597,0.0,0.0,1,736553,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,HCV RNA QT REALTIME PCR,HCV RNA QN PCR,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,HB S AB QL,HB S AB QL,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,PROTIME PTT,INR,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,FIBROACT COMPLETE,NECROINFL SCORE,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,ANA REFLEX AUTOIMMUNE AB PROFILE,ANTI NUCLEAR ANTIBODIES,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,BASIC METABOLIC PANEL,BUN,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,FIBROACT COMPLETE,HEIGHT INCHES,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.09090909090909091,0.0,0.0,0.09090909090909091,0.0,0.0,0.01076763726734975,0.0,0.0,0.01076763726734975,0.0,0,831008,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.19999999999999998,0.0,0.0,0.19999999999999998,0.0,0.0,0.04159198942540121,0.0,0.0,0.04159198942540121,0.0,0,57703,HEPATITIS B CORE TOTAL AB,HEPATITIS B CORE TOTAL AB,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,CMP14 LP CBC D PLT TSH,NEUTROPHILS,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,CBC WITH ABSOLUTE WBCS MPV,MCHC,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,HCV RNA QN PCR W REFL GENOTYPE LIPA R,HCV RNA QUANTITATIVE REAL TIME PCR,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,IRON TOTAL BINDING CAPACITY,LIPEMIA,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.31,0.25,0.0,0.0,0.0,0.0,0.0,0.032615729323927534,0.0,0.0,0.0,0.0,0,728600,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0125,0.025,0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,339143,COMP METABOLIC PANEL CLARIFICATION,EGFR NON AFR AMERICAN,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,CBC W AUTO DIFF,% MONOCYTES,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.5,0.42857142857142855,0.6,0.0,0.0,0.0,0.4543382861631333,0.013656950654702071,0.034646396615759856,0.0,0.0,0.0,1,487967,HCV FIBROSURE,INTERPRETATION,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.266,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,URINALYSIS C,BILIRUBIN,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.08142857142857142,0.1425,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,CMP14 HP5 LP 6AC CBC D PLT,HDL CHOLESTEROL,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.12166666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,FIBROACT COMPLETE,WEIGHT LBS,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,PROTEIN ELECTROPHORESIS,BETA GLOBULINS,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.0846168638925987,0.0,0,139501,CMP12 7AC MG,PHOSPHORUS SERUM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.08375,0.012380952380952381,0.026000000000000002,0.0,0.0,0.0,0.0,0.02260781385927957,0.037356883635721205,0,882944,LIPID PROFILE,FASTING NON FASTING,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,COMPREHENSIVE METABOLIC PANEL E GFR,AST,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,CMP14 1AC,EGFR IF NONAFRICN AM,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,UROGRAM,SPECIFIC GRAVITY,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,ASH FIBROSURE,COMMENT,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,CBCI COMPLETE BLOOD COUNT W DIFF,MCH,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,CMP14 LP CBC D PLT TSH,PLATELETS,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,MAGNESIUM,ICTERUS,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.04,0.0,0.0,0.075,0.0,0.0,0.0913977327705009,0.0,0.0,0.0,0.0,0,17434,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,COMPREHENSIVE METABOLIC PNL W O CO2 ALT,POTASSIUM,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.09499999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,CBC DIFF PLT,PLATELET COUNT,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,CMP13 LP 2AC CBC D PLT,NEUTROPHILS ABSOLUTE,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE AG,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,LIPOPROTEIN ANALYSIS NMR,LDL P,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,CMP14 LP CBC D PLT TSH UA M,HDL CHOLESTEROL,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.010211152348914676,0.0,0.0,0,45377,HCV RNA QT REALTIME PCR,HCV RNA QN PCR,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,DRUG ABUSE SCREEN W ETOH NO GCMS,BENZODIAZEPINES,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.3333333333333333,0.4,1.0,0.0,0.0,0.0,0.06538932921065,0.4808823462371743,0.7071067811865476,1,191239,CMP14 3AC CBC D PLT RPR MG,MAGNESIUM SERUM,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.04833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,DIFFERENTIAL MANUAL,EOSINOPHILS,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.041875,0.08375,0.0,0.104375,0.08375,0.0,0.019640907998258128,0.0,0.0,0.019640907998258128,0.0,0,339143,BUN CREATININE RATIO,BUN CREATININE RATIO,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,DRUG ABUSE PANEL 10 WITH OXYCODONE,OPIATES,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,HIGH SENSITIVITY CRP,HIGH SENSITIVITY CRP,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,CBCI COMPLETE BLOOD COUNT W DIFF,ABS BASOPHILS,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,CMP14 LP TP TSH 4AC CBC D PLT,URIC ACID,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,COMPREHENSIVE METABOLIC PANEL WITH GFR,ALBUMIN,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.08333333333333333,0.1,0.0,0.08333333333333333,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,BUN CREATININE RATIO,BUN CREATININE RATIO,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.2,0.16666666666666666,0.0,0.0,0.0,0.0,0.03928062402713073,0.0,0.0,0.0,0.0,0.0,0,7708,CBC W AUTO DIFF,% LYMPHOCYTES,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,CMP14 CBC D PLT ESR WES ANA,POTASSIUM,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,HIGH SENSITIVITY CRP,HIGH SENSITIVITY CRP,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,VITAMIN B 12,VITAMIN B 12,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.08,0.0,0.0,0.15,0.0,0.0,0.24044117311858715,0.0,0.0,0.0,0.0,0,30916,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.017287103660211245,0.0,0.0,0.0,0.0,0,81232,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,COMP METABOLIC PANEL,,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,COMP METABOLIC PANEL,GLUCOSE NON FASTING,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.05,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,CBC,MCHC,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,CBC W AUTO DIFF,% EOSINOPHILS,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,COMP METABOLIC PANEL,POTASSIUM,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.02142196630047022,0.0,0.0,0.0,0.0,0.0,0,264648,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.06200000000000001,0.0,0.0,0.06200000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,HEPATITIS C VIRUS RNA QN REAL TIME PCR,HCV RNA PCR QN,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.14666666666666667,0.1325,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.592,0.49333333333333335,0.9866666666666667,0.0,0.0,0.0,0.40795382993965124,0.5255474069833806,0.530075858529406,1,497818,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,ASH FIBROSURE,FIBROSIS STAGE,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.11399999999999999,0.0,0.0,0.11399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.4,0.36363636363636365,1.0,0.2,0.36363636363636365,1.0,0.05733325701584957,0.07080721387495514,0.051861339431772846,0.04054073482341847,0.05006826108790696,0.07334300958724782,1,322867,HCV GENOTYPE PCR PROBE,HCV GENOTYPE,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,CMP14 LP 5AC CBC D PLT RPR,CHOLESTEROL TOTAL,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,BUN CREATININE RATIO,BUN CREATININE RATIO,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Sex,Sex,Sex
0.0,0.03571428571428571,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,LD,LD,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.13,0.0,0.0,0.0,0.0,0.0,0.013317865042417165,0.0,0.0,0.013317865042417165,0.0,0,20289,TESTOSTERONE TOTAL LC MS MS,TESTOSTERONE TOTAL LC MS MS,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,PT PTT,PARTIAL THROMBOPLASTIN,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,LIVER PANEL II,LD,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,CD4 T HELPER PANEL,CD4 CD3 %HELPERS,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,BMP8 CBC D PLT UA,EOS ABSOLUTE,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,URINALYSIS CULTURE IF INDICATED,GLUCOSE,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,CBC W AUTO DIFF,% LYMPHOCYTES,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,COMP METABOLIC PANEL,GLUCOSE NON FASTING,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,COMP METABOLIC PANEL 14,EGFR IF NONAFRICN AM,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.2866666666666667,0.3333333333333333,1.0,0.0,0.0,0.0,0.0,0.042056338045787456,0.046108379515458875,1,20859,LIPID PANEL WITH REFLEX DIRECT L,HDL CHOLESTEROL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,HAPTOGLOBIN,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06691275831255872,0.06348916544989514,0.09169555407390673,1,59055,CBC W DIFF PLT,MONOCYTES %,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,LIPID CASCADE,LDL CHOLESTEROL CALC,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,DRUG ABUSE SCREEN I NO GCMS,AMPHETAMINES,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL AB,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,PROTIME PTT,PROTHROMBIN TIME PT,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,T4,T4,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,LIPID PANEL,,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CBC W AUTO DIFF,MONOCYTES %,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.172,0.14285714285714285,0.3333333333333333,0.252,0.2857142857142857,0.6666666666666666,0.0,0.037677447047597123,0.07267302452237867,0.0,0.048641374980985086,0.09382047123123194,1,52217,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,BASIC METABOLIC PANEL,BUN,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,CBC W AUTO DIFF,MONOCYTES %,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.16625,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,HCV FIBROSURE,FIBROSURE STAGE,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.05524858071613015,0.0,0.0,0.0,0.0,0,192708,DRUG ABUSE SCREEN I NO GCMS,AMPHETAMINES,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,IFE PE SERUM,GAMMA GLOBULIN,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,CMP WITH EGFR,ANION GAP,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,IFE PE SERUM,M SPIKE,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,BMP8 ANION GAP,EGFR IF NONAFRICN AM,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,AMYLASE,AMYLASE,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,HEMOGLOBIN A1C WITH MPG,HEMOGLOBIN A1C,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.42857142857142855,0.6666666666666666,0.0,0.0,0.0,0.0,0.10683799300987995,0.15892726613090935,1,7765,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.07761546026945332,0.0,0.0,0.0,0.0,0,19893,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,HEPATIC FUNCTION PANEL,,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,CMP,C02 BICARBONATE,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,MAGNESIUM,HEMOLYSIS,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,UA MICROSCOPIC REFLEX CULTURE,PH,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,COMP METABOLIC PANEL,POTASSIUM,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,HEPATITIS PANEL ACUTE,HEPATITIS C AB CIA,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,COMPREHENSIVE METABOLIC PANEL E GFR,ALT,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,NASH FIBROSURE,AST SGOT P5P,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,HEPATIC FUNCTION PANEL,ALK PHOS,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,HEMOGLOBIN A1C,AVERAGE WHOLE BLOOD GLUCOSE,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,COMP METABOLIC PANEL,CARBON DIOXIDE,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,COMP METABOLIC PANEL 14,EGFR IF NONAFRICN AM,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,IFE PE FLC SERUM,IMMUNOGLOBULIN G QN SERUM,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.2916666666666667,0.14285714285714285,0.0,0.2916666666666667,0.14285714285714285,0.0,0.0,0.007850639626967304,0.0,0.0,0.007850639626967304,0.0,0,427682,ALPHA 1 ANTITRYPSIN SERUM,ALPHA 1 ANTITRYPSIN SERUM,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,PROTEIN ELECTRO S,GAMMA GLOBULIN,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.09375,0.0,0.0,0.09375,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,IMMUNOGLOBULIN M IGM,IMMUNOGLOBULIN M,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD LOG IU ML,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.0825,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,URINALYSIS W REFLEX MICRO,KETONES,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.05137906274872117,0.0,0.0,0.0,0.0,0,110114,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.33399999999999996,0.5714285714285714,0.8,0.33399999999999996,0.6828571428571429,0.9560000000000001,0.021528614002227053,0.023005461933579552,0.031045756027934357,0.021528614002227053,0.023005461933579552,0.031045756027934357,1,728626,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESISTANCE ASSAY PDF,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,LIVER FIBROSIS FIBROTEST ACTITEST P,GGT,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,MAGNESIUM,MAGNESIUM,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,PROTIME PTT,INR,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,CBC WITH DIFFERENTIAL PLATELETS,MCH,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,24588,CMP14 3AC CBC D PLT RPR MG,MAGNESIUM SERUM,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,ASH FIBROSURE,HEIGHT,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.155,0.0,0.0,0.25,0.2,0.0,0.0,0.08866303093948036,0.0,0.06650223739152306,0.21717918485032472,0.0,1,7856,AUTOMATED BLD CNT,MCH,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,LYMPHOCYTE SUBSET PANEL 4,%CD8 SUPPRESSOR T CELLS,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.125,0.2,0.12166666666666666,0.375,0.6,0.0,0.0666872623744319,0.0795785781568974,0.0,0.0666872623744319,0.0795785781568974,0,109009,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,VIT B 12 FOLATE PANEL,VITAMIN B 12,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,FIBROACT COMPLETE,HEIGHT INCHES,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0.0,0.0,0.0,0,23457,IFE PE SERUM,GAMMA GLOBULIN,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,CHOL HDL RATIO,CHOL HDL RATIO,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,TRANSFERRIN,TRANSFERRIN,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.5916666666666667,0.125,0.2,0.5916666666666667,0.125,0.2,0.0733576722338849,0.0666872623744319,0.0795785781568974,0.0733576722338849,0.0666872623744319,0.0795785781568974,1,109009,HB S AB QL,HB S AB QL,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,REFLEXED LDL,LDL DIRECT,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,CBC PLATELET HEM REVIEW,PLATELETS,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,DRUG ABUSE PANEL 10 WITH OXYCODONE,AMPHETAMINES,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,URINALYSIS W REFLEX MICRO,NITRITE,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCH,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL AB,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,COMP METABOLIC PANEL,,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,HEMATOPATH CONSULTATION SMEAR,WBC,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.47250000000000003,0.25142857142857145,0.5,0.0,0.0,0.0,0.036366428930120875,0.05171526843986196,0.08679392382276507,1,134585,LIPID PANEL,VLDL CHOL CALC,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.175,0.08833333333333333,0.0,0.175,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.04833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,HEMOGRAM W O DIFFERENTIAL,MEAN PLATELET VOLUME,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,URINALYSIS SCREEN,PH,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,MORPHOLOGICAL REVIEW,PLATELET ESTIMATE,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,SUNRISE LABS ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,LYMPHOCYTE SUBSET PANEL 1,% CD8,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,BASIC METABOLIC PANEL W EGFR,BUN CREATININE RATIO,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,PROTIME PTT,PTT,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.11,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,UA MICROSCOPIC REFLEX CULTURE,LEUKOCYTE ESTERASE,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,FREE T3,FREE T3,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.06888888888888889,0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,LYMPHOCYTE SUBSET PANEL 1,CD4 ABSOLUTE,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,LD,LIPEMIA,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,CHEM 20,CHOLESTEROL,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,LIVER FIBROSIS FIBROTEST ACTITEST P,NECROINFLAMMATION ACT GRADE,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,LP WITHOUT VLDL CHOL HDL LD,LDL HDL RATIO,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,DRGABU2,METHAQUALONE,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,NASH FIBROSURE,HEIGHT,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,COMPREHENSIVE METABOLIC PANEL W EGF,EGFR NON AFR AMERICAN,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.18666666666666668,0.2,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,25718,CHEM SCREEN PANEL HDL,TRIGLYCERIDES,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,T4,T4,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,IRON TOTAL BINDING CAPACITY,IRON TOTAL,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,ANA REFLEX AUTOIMMUNE AB PROFILE,ANTI NUCLEAR ANTIBODIES,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL AB,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,CMP14 LP 5AC CBC D PLT RPR,CHOLESTEROL TOTAL,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CBC W AUTO DIFF WITH PLATELETS,RBC,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,HEPATITIS BE ANTIGEN,HEPATITIS BE ANTIGEN,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,CMP14 LP 5AC CBC D PLT RPR,CHOLESTEROL TOTAL,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,HEPATITIS BE AG,HB E AG,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.047142857142857146,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,URINALYSIS WITH MICROSCOPIC,COLOR,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,STOOL CULTURE,RESULT 2,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,CRP,C REACTIVE PROTEIN ULTRA,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,CMP14 CBC D PLT RPR UA TSH,HCV AB,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE EOS,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,HEP A AB IGM,HEPATITIS A AB IGM,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,BASIC METABOLIC PANEL,AFRICAN AMERICAN,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,RPR,RPR RESULT,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,PROFILE 104 LIVER,BILIRUBIN TOTAL,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,HEPATITIS C ANTIBODY W REFL HCV RIBA,SIGNAL CUT OFF,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,COMPREHENSIVE METABOLIC PANEL E GFR,BUN,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CREATINE KINASE CPK TOTAL,CREATINE KINASE CPK TOTAL,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,APOLIPOPROTEIN A1,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.17500000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,ALPHA 2 MACROGLOBULIN,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06713496212611103,0.05720402135206337,0.7071067811865476,1,7518,CMP14 LP CBC D PLT TSH T4F,NEUTROPHILS ABSOLUTE,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,RPR REFLEX TP PA,RPR,Specimen source identified,Specimen source XXX,Specimen source
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,PROTIME PTT,PROTHROMBIN TIME PT,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,BASIC METABOLIC PANEL,OSMOLALITY,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,CARETC CMP LIPID URIC ACID DIR BILI PROFILE,RISK RATIO LDL HDL,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,HCV GENOTYPE REFLEX NS5A,PLEASE NOTE,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,NASH FIBROSURE,APOLIPOPROTEIN A 1,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.0,0.028999999999999998,0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,CBC,BA%,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,BASIC METABOLIC PANEL,BUN,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,ALB ALP ALT AST GGT LD PROT,LDH,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,TESTOSTERONE,TESTOSTERONE,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0085,0.01888888888888889,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,UA MICROSCOPIC REFLEX CULTURE,PH,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,HCV FIBROSURE,INTERPRETATION,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.25,0.0,0.0,0.0,0.0,0.0,0.04459053011835212,0.0,0.0,0.0,0.0,0.0,0,422543,ANA AUTOIMMUNE PROFILE,RHEUMATOID FACTOR QUANT,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0382616086406824,0,285395,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,FOLLOW UP PNL ARAKAWA,SODIUM,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.25,0.20000000000000004,0.0,0.0,0.0,0.0,0.03960996495528413,0.0,0.0,0.0,0.0,0.0,1,327767,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.326,0.08285714285714285,0.19333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,CBC WITH AUTO DIFF,LYMPHOCYTES #,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,CBC W DIFF PLATELET,EOSINOPHILS,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH TOTAL,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,CBC WITH PLT DIFF,MPV,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,CBC W DIFF PLT,HEMATOCRIT,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,FREE T4,FREE T4,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,CMP14 LP CBC D PLT TSH HB A,ALT SGPT,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,IRON BINDING CAPACITY,TIBC,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,LIVER FIBROSIS FIBROTEST ACTITEST P,APOLIPOPROTEIN A1,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,LIPOPROTEIN ANALYSIS NMR,LDL P,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0834655896020069,0.34003516797720323,1.0,1,20750,BMP,CHLORIDE,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,HEP A AB IGM,HEPATITIS A AB IGM,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,CMP13 LP 2AC CBC D PLT,NEUTROPHILS ABSOLUTE,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,SPECIAL NEW ANNUAL COMM INSURANCE #6925,ABSOLUTE EOS,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,BUN CREAT RATIO,EGFR AFRICAN AMERICAN,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,NASH FIBROSURE,AST SGOT P5P,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.03238095238095238,0.0,0.0,0.03238095238095238,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,HCV RNA QN PCR W RFL GENO,HCV RNA QN REAL TIME PCR,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CBC INCLUDES DIFF PLT,EOSINOPHILS,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,LIVER FIBROSIS FIBROTEST ACTITEST P,GGT,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,CBC NO DIFF,RBC,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.09090909090909091,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,RBC,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,FREE T4 THYROXINE,FREE T4,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,CMP14 LP 2AC CBC D PLT TSH,EGFR IF AFRICN AM,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06713496212611103,0.05720402135206337,0.7071067811865476,1,7518,CMP13 LP 2AC CBC D PLT,NEUTROPHILS ABSOLUTE,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,17517,FERRITIN,FERRITIN SERUM,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.05,0.25,0.0,0.05,0.25,0.0,0.013050320015445815,0.09518537001083005,0.0,0.019934693104725842,0.14539805437566944,0,347047,SUNRISE LABS ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,COMP METABOLIC PANEL CLARIFICATION,ALT,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,HIGH SENSITIVITY CRP,HIGH SENSITIVITY CRP,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.015454545454545455,0.0425,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,LIPID PROFILE WRFL LDL DIRECT,NON HDL CHOLESTEROL,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.10031748330730439,0.10964330813284906,0.7071067811865476,1,303768,CMP CBC TSH,ABSOLUTE BLASTS,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,HCV RNA NAA QUALITATIVE,HCV RNA NAA QUALITATIVE,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.12285714285714286,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,486431,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.11,0.1325,0.0,0.3333333333333333,0.0,1.0,0.0,0.0,0.0,0.08466774310592073,0.09762443806815091,1.0,1,58032,URINALYSIS SCREEN,PH,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,LIVER FIBROSIS PNL HEPASCORE TM,GGT,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,HCV GENOTYPE PCR PROBE,HCV GENOTYPE,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,DRUG ABUSE SCREEN 9 NO THC W CONF,PHENCYCLIDINE,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,CMP14 CBC D PLT TSH,ALBUMIN,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,RPR REFLEX TITRE TPPA,RPR,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,T3 FREE,T3 FREE,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.158,0.10333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,HEPATITIS PANEL ACUTE,HEPATITIS B CORE AB IGM,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,CMP14 LP 5AC CBC D PLT RPR,CHOLESTEROL TOTAL,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.105,0.05555555555555555,0.08333333333333333,0.07333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.5,0.0,0.0,0.0,0.07776291418096726,0.1106775195057691,0.14187034543632637,1,312082,TRICHOMONAS MALE,SOURCE,Specimen source identified,Specimen source XXX,Specimen source
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,CBC INCLUDES DIFF PLT WITH PATHOLOGIST REVIEW,ABSOLUTE LYMPHOCYTES,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,LYMPHOCYTE SUBSET PANEL 1,% CD8,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,LIVER FIBROSIS FIBROTEST ACTITEST P,APOLIPOPROTEIN A1,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,LIPOPROTEIN ANALYSIS NMR,LDL P,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.22,0.16666666666666666,0.5,0.0,0.0,0.0,0.0,0.05660928660351461,0.5773502691896257,1,151522,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CMP CBC TSH,ABSOLUTE BLASTS,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,PTH INTACT MOLECULE,PTH,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,HEPATITIS C VIRUS RNA QN REAL TIME PCR,HCV RNA PCR QN,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,COMP METABOLIC PANEL W O EGFR,CREATININE,Sex,Sex,Sex
0.0,0.0,0.0,0.25,0.09090909090909091,1.0,0.0,0.0,0.0,0.058854483963441506,0.04322678270641078,1.0,1,611517,COMPREHENSIVE METABOLIC PANEL WITH GFR,ALBUMIN,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,DRUG ABUSE SCREEN I NO GCMS,BARBITURATES,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,COMP METABOLIC PANEL 14,EGFR IF NONAFRICN AM,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.066,0.10600000000000001,0.0,0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,CBC H H RBC INDICES WBC PLT,MPV,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,URINALYSIS CULTURE IF INDICATED,APPEARANCE,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,LIPID PANEL,VLDL CHOL CALC,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CBC INCLUDES DIFF PLT,HEMOGLOBIN,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,LIVER FIBROSIS FIBROTEST ACTITEST P,NECROINFLAMMATION ACT GRADE,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,ALPHA 1 ANTITRYPSIN SERUM,ALPHA 1 ANTITRYPSIN SERUM,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,LIPID PROFILE,CHOLESTEROL NON HDL,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,LYMPHOCYTE SUBSET PANEL 4,%CD8 SUPPRESSOR T CELLS,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,HEPATIC FUNCTION PANEL,BILIRUBIN INDIRECT,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,BMP8 CBC D PLT UA,EOS ABSOLUTE,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,GLUCOSE,GLUCOSE,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,PROTEIN TOTAL URINE,PROTEIN CR RATIO,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,CBC INC DIFF PLT,BASOPHILS,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,CREATININE,EGFR IF AFRICN AM,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.43333333333333335,0.22428571428571425,0.5,0.43333333333333335,0.22428571428571425,0.5,0.0,0.530776546300907,0.16381776425537642,0.0,0.530776546300907,0.16381776425537642,1,30510,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,HEPATITIS B SURFACE ANTIGEN,HBS AG SCREEN,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,HIV AB AG RFLX CONF,HIV AG AB,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.0,0.0,0.0,0.0,0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,RPR,TREPONEMA PALLIDUM ANTIBODIES,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,RBC,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,HDL AS % CHOLESTEROL,HDL AS % CHOLESTEROL,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,HEPATITIS A IGM,HEPATITIS A IGM,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,IRON TOTAL BINDING CAPACITY,LIPEMIA,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,VITAMIN D 25 OH,25 OH VITAMIN D,Body weight Measured,Weight Measured,Body weight
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,GLUCOSE,GLUCOSE FASTING,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,CMP WITH ESTIMATED GFR CALCULATED,UREA NITROGEN,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,AUTOMATED BLD CNT,MCH,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.072,0.045,0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,BASIC METABOLIC PANEL W EGFR,BUN CREATININE RATIO,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.235,0.2571428571428572,0.45,0.33499999999999996,0.1142857142857143,0.2,0.0,0.12507382086168062,0.15945061960482576,0.0,0.05896036458680387,0.07516574292464595,1,327692,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,CMP14 CBC D PLT RPR UA TSH,HCV AB,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.5,0.5714285714285714,0.8,0.5,0.5714285714285714,0.8,0.07610104799408934,0.05391109450517806,0.06094209455758426,0.09320436823828604,0.03301366825316199,0.037319258880631256,1,128413,PSA TOTAL % FREE,% FREE PSA,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,ACCUTYPE R IL28B,IL28B GENOTYPE,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,HEP C VIRUS ANTIBODY,HEP C VIRUS ANTIBODY,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,CMP14 CBC D PLT ESR WES ANA,POTASSIUM,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.4175,0.18142857142857144,0.0,0.4175,0.18142857142857144,0.0,0.034234837021806186,0.0,0.0,0.039530984740405506,0.0,0.0,1,19901,VITAMIN D 25 OH,25 OH VITAMIN D,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0825,0.10600000000000001,0.0,0.5,0.2,1.0,0.0,0.0,0.0,0.1079337582384392,0.06903090216751562,0.7071067811865476,1,254284,URINALYSIS REFLEX,GLUCOSE QL,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.035263157894736843,0.07444444444444445,0.12285714285714286,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,486431,BUN CREAT RATIO,EGFR AFRICAN AMERICAN,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,UROGRAM,KETONES,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,PHOSPHORUS,PHOSPHORUS,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.2,0.14285714285714285,0.0,0.27999999999999997,0.0,0.0,0.03776245386391519,0.10966144007006884,0.09102369686139644,0.0,0.0,0.0,1,333583,PROTEIN ELEC INTERP SERUM,M SPIKE,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,CHEM 20,CHOLESTEROL,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,CBC INCLUDES DIFFERENTIAL PLATELETS,MEAN PLATELET VOLUME,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,ASH FIBROSURE,FIBROSIS STAGE,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,VITAMIN B12 FOLATE,FOLATE SERUM,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.2,0.0,0.3333333333333333,0.2,0.0,0.0,0.04273763542324893,0.0,0.08719609088829028,0.21223170681007852,0.0,1,7872,COMPLETE BLOOD COUNT,MCV,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,CBC WITH AUTO DIFF,LYMPHOCYTES #,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.16,0.0,0.1875,0.2,1.0,0.0,0.061769791070825475,0.0,0.0,0.12353958214165095,1.0,1,143164,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,GLYCOHEMOGLOBIN A1C,GLYCOHEMOGLOBIN A1C,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,CMP14 LP 6AC CBC D PLT ESR,CREATININE,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,PTT,PTT,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.05720402135206337,0.0,0,7427,CBC DIFF PLT,PLATELET COUNT,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.386,0.26,0.40857142857142853,0.386,0.24181818181818182,0.38,0.2692418785170825,0.3101044613442048,0.3340141651179731,0.07670029542685186,0.08834102602941163,0.0951523042492678,1,568881,HIV AB AG RFLX CONF,HIV AG AB,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,COMP METABOLIC PANEL 14,EGFR IF NONAFRICN AM,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,COMP METABOLIC PANEL,ANION GAP,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,NMR LIPOPROFILE,LDL P,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,ANA TITER PATTERN,ANA TITER,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A RESIST ASSAY INTERP,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,CBC W AUTO DIFF WITH PLATELETS,BASOPHILS,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,CMP14 LP CBC D PLT,NEUTROPHILS,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,HIV AB EIA WITH REFLEXES,HIV EIA AB SCREEN,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.05142857142857143,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,COMP METABOLIC PANEL W GFR,GLOBULIN,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,URINALYSIS W REFLEX MICRO,SPECIFIC GRAVITY,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.044444444444444446,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD4 CELLS,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,IRON BINDING CAPACITY % SATURATION,CALCULATED % IRON SAT,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.094,0.028571428571428574,0.06666666666666667,0.268,0.07142857142857142,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,HIV ANTIGEN ANTIBODY FOURTH GEN,HIV AG AB 4TH GEN,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,SPECIAL PROFILE # 5144,TSH ULTRASENSITIVE,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,BMP8 CBC D PLT UA,EOS ABSOLUTE,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.0,0.18555555555555556,0.2783333333333333,0.0,0.18555555555555556,0.2783333333333333,0.0,0.06958943805011741,0.14539805437566944,0.0,0.06958943805011741,0.14539805437566944,1,139543,HEPATITIS BE ANTIGEN,HEPATITIS BE ANTIGEN,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,CBC WITH PLT DIFF,MONOCYTES ABSOLUTE,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.6666666666666666,0.5,1.0,0.0,0.0,0.0,0.1503314858492919,0.15505905338492743,1.0,1,264846,CBC WITH AUTO DIFF,MONOCYTES #,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,IRON TIBC,TIBC,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,ASH FIBROSURE,WEIGHT,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.1,0.125,0.0,0.0,0.0,0.0,0.05117681691383591,0.0,0.0,0.0,0.0,0,381806,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,GENERAL HEALTH PANEL,HEMATOCRIT,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,URINALYSIS W REFLEX MICRO,KETONES,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,CBC INCLUDES DIFF PLT W SMEAR RVW,WHITE BLOOD CELL COUNT,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0,28852,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0335,0.067,0.0,0.0,0.0,0.0,0.016002505041782356,0.0,0.0,0.0,0.0,0,486423,BUN CREATININE RATIO,HEMOLYSIS,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,LIPID PANEL,VLDL CHOL CALC,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,CMP14 LP 6AC CBC D PLT ESR,CREATININE,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,CMP13 LP TP TSH 2AC CBC D P,LDL CHOLESTEROL CALC,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,TESTOSTERONE FREE TOTAL LC MS MS,FREE TESTOSTERONE,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.2,0.0,0.0,0.2,0.0,0.0,0.24044117311858715,0.0,0.0,0.1963193957655779,0.0,0,19638,IMMUNOGLOBULINS A E G M SERUM,IMMUNOGLOBULIN G QN SERUM,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,URINALYSIS C,BILIRUBIN,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.3333333333333333,0.4,1.0,0.0,0.0,0.0,0.06809002533324715,0.4808823462371743,0.7071067811865476,1,17517,CMP13 LP 2AC CBC D PLT,ALBUMIN SERUM,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,COCAINE METABOLITE,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,HIV ANTIGEN ANTIBODY FOURTH GEN,HIV AG AB 4TH GEN,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,BUN CREAT RATIO,EGFR AFRICAN AMERICAN,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,CBC WITH AUTO DIFF,NRBC,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,ASH FIBROSURE,AST SGOT P5P,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.125,0.0,0.0,0.125,0.0,0.0,0.013919488560328985,0.0,0.0,0.013919488560328985,0.0,0,139550,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,X HEPATITIS COMPLEX PROFILE,ANTI HCV,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,CRP,C REACTIVE PROTEIN ULTRA,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.39000000000000007,0.0,0.0,0.3333333333333333,0.4,1.0,0.0,0.0,0.0,0.06696411491014109,0.4808823462371743,0.7071067811865476,1,22764,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,HEMOGLOBIN A1C,AVERAGE WHOLE BLOOD GLUCOSE,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,OBSTETRIC PANEL,RPR RESULT,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,FE TIBC FER,IRON BIND CAP TIBC,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.46499999999999997,0.4,0.6666666666666666,0.0,0.0,0.0,0.034103916281504665,0.16901735079974012,1.0,1,104661,COMP METABOLIC PANEL,ANION GAP,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,URINALYSIS COMPLETE,GLUCOSE QL,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,CBC W AUTO DIFF,MCV,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.10428571428571429,0.0,0.0,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.052727272727272734,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,DRUG ABUSE SCREEN I NO GCMS,AMPHETAMINES,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,HCV FIBROSURE,NECROINFLAMMAT ACTIVITY SCORE,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.0,0.0,0.0,0.0,0.33399999999999996,0.0,0.0,0.0,0.0,0.05504399149282735,0.04116208411637334,0,339358,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,CBC INCLUDES DIFF PLT,MCHC,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,HEPATITIS BC AB IGM,HEPATITIS B CORE AB IGM,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,BILIRUBIN FRACTIONATED,BILIRUBIN INDIRECT,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Specimen source identified,Specimen source XXX,Specimen source
0.0,0.19,0.44333333333333336,0.266,0.19,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,HCV GENOTYPE REFLEX NSA,HEPATITIS C GENOTYPE,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.23888888888888887,0.43,0.0,0.23888888888888887,0.43,0.0,0.055446852762574106,0.07759701258884111,0.0,0.055446852762574106,0.07759701258884111,0,139527,HEP C VIRUS ANTIBODY,HEP C VIRUS ANTIBODY,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,UA MICROSCOPIC REFLEX CULTURE,PH,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06713496212611103,0.05720402135206337,0.7071067811865476,1,7518,CMP13 LP TP TSH 2AC CBC D P,NEUTROPHILS ABSOLUTE,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.534,0.0,0.0,0.534,0.0,0.0,0.07486757573725777,0.0,0.0,0.07486757573725777,0.0,0.0,1,19893,VITAMIN D 25 OH TOTAL IA,VITAMIN D 25 OH TOTAL IA,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.09494317394815022,0.0,0.0,1,66902,CMP14 HP4 DBILI CBC D PLT R,WBC,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HCV FIBROSURE LABCORP,RESULT,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,DRUG ABUSE SCREEN W ETOH NO GCMS,COCAINE METABOLITE,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,CBC WITH PLT DIFF,MPV,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,HCV GENOTYPE REFLEX NSA,HEPATITIS C GENOTYPE,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,CBC,HEMOGLOBIN,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,LIPID PROFILE WRFL LDL DIRECT,NON HDL CHOLESTEROL,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,CBC WITH PLT DIFF,BANDS ABSOLUTE,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,CBC,MCH,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.5566666666666666,0.4,0.3333333333333333,0.0,0.0,0.0,0.05352091133427317,0.04991270465467579,0.05003751769211573,1,67421,CBC WITH PLT DIFF,RBC MORPHOLOGY,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,LIVER FIBROSIS PNL HEPASCORE TM,GGT,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,HCV RNA QN PCR W RFL GENO,HCV RNA QN REAL TIME PCR,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,HEPATITIS B CORE AB TOTAL REFL,HEPATITIS B CORE AB TOTAL REFL,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.11399999999999999,0.08142857142857142,0.11399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,DRUG ABUSE PANEL NO CONFIRM,CREATININE,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.134,0.0,0.0,0.11399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,CMP14 LP 2AC CBC D PLT TSH,EGFR IF AFRICN AM,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,CUSTOM HEPATITIS PANEL,HEP B SURFACE AB,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,PATHOLOGIST SMEAR REVIEW,MONOCYTES,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.19,0.266,0.25,0.5242857142857142,0.734,0.0,0.11861986140776393,0.06222027266620478,0.05489961348405459,0.3355076335393532,0.17598550691819748,1,223149,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.12727272727272726,0.35,0.0,0.12727272727272726,0.35,0.0,0.04521753067807699,0.12591840875016092,0.0,0.04521753067807699,0.12591840875016092,0,112599,HEPATITIS B CORE TOTAL AB,HEPATITIS B CORE TOTAL AB,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.22333333333333336,0.25,1.0,0.0,0.0,0.0,0.0,0.5773502691896257,1.0,1,21618,DRUG ABUSE PANEL NO CONFIRM,CREATININE,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,HEPATITIS C ANTIBODY W REFL HCV RIBA,SIGNAL CUT OFF,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,FSRC NEW PATIENT PANEL,D BILIRUBIN,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,URINALYSIS ROUTINE,WBC,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,PSA TOTAL,PSA TOTAL,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.2,0.125,0.25,0.0,0.0,0.0,0.011565571927780516,0.015549030453740564,0.021061088921135673,0,139550,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,CBC W AUTO DIFF WITH PLATELETS,MCHC,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,CMP13 LP TP TSH 2AC CBC D P,AST SGOT,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,HEPATIC FUNCTION PANEL AMA,GLOBULIN,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,FOLATE,FOLATE,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.11,0.0,0.0,0.10333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,IRON BINDING CAPACITY IBC % SATURATION,UNSATURATED IBC,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.030000000000000002,0.047142857142857146,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,COMPLETE BLOOD COUNT,MCV,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.0769832768017027,0.08055537486383768,0.09169555407390673,1,264853,PATHOLOGIST SMEAR REVIEW,MONOCYTES,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,CMP14 HP4 1AC PT AFP,PROTHROMBIN TIME,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,GLUCOSE,GLUCOSE FASTING,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,CLR CBC W DIFF PLT,ABSOLUTE BLASTS,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,LIPID PROFILE,FASTING NON FASTING,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,CBC ESR,ABSOLUTE NEUTROPHILS,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,T4 THYROXINE,T4 THYROXINE,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,UA W MICRO HOLD SPEC 24 HR,GLUCOSE,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.215,0.16666666666666666,0.5,0.0,0.0,0.0,0.0,0.0,0.0,1,203943,PHOSPHATE AS PHOSPHORUS,LIPEMIA,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,CBC INCLUDES DIFF PLT,HEMOGLOBIN,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.06875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,LIPID PANEL,,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.2,0.17142857142857146,0.0,0.292,0.2571428571428572,0.9,0.03285364306619687,0.0,0.0,0.008931533211845588,0.45222488980749964,1.0,1,204537,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.2,0.0,0.0,0.0,0.0,0.0,0.026030835528723872,0.03499647547910856,0.04740256212017002,0.0,0.0,0.0,0,139550,HIV AG AB 4TH GEN RFL,RACE NR,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESISTANCE ASSAY PDF,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.3333333333333333,0.25,0.0,0.0,0.0,0.0,0.1503314858492919,0.0,0.0,1,264531,CBC W AUTO DIFF WITH PLATELETS,RBC,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,CMP14 CBC D PLT TSH,EGFR IF AFRICN AM,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,T3 FREE,T3 FREE,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,CBC WITH AUTO DIFF,MONOCYTES #,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,CBC INCLUDES DIFF PLT,HEMOGLOBIN,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,PROTHROMBIN TIME,PT POP MEAN,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,PE RFX IFE S,GAMMA GLOBULIN,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,URINE DRUG SCREEN,OPIATES,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,CMP14 LP 2AC CBC D PLT TSH,EGFR IF AFRICN AM,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,GGTP,GGTP,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,HEPATITIS B CORE AB TOTAL REFL,HEPATITIS B CORE AB TOTAL REFL,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,URINALYSIS COMPLETE,GLUCOSE,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,CMP13 LP TP TSH 2AC CBC D P,LDL CHOLESTEROL CALC,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.033,0.066,0.0,0.10300000000000001,0.044,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,BASIC METABOLIC PANEL W EGFR,BUN CREATININE RATIO,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,DRUG ABUSE SCREEN III,AMPHETAMINES,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,CBC WITH PLT DIFF,BASOPHILS ABSOLUTE,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.3333333333333333,0.1325,0.265,0.0,0.0,0.0,0.010816689796725898,0.014369129342247433,0.019733925021995558,1,453530,LYMPHOCYTE SUBSET PANEL 3,ANALYZED DATE TIME,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,PROFILE 1236 LIPID PANEL WITH DIRECT LDL,CHOL HDL,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,CMP14 LP CBC D PLT TSH,NEUTROPHILS,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.24333333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0.04357905440832277,0.0,0.0,0.0,0.0,1,64634,STOOL CULTURE,RESULT 1,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,LIVER FIBROSIS PNL HEPASCORE TM,GGT,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,CBC INC DIFF PLT,MONOCYTES,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,ASH FIBROSURE,ALT SGPT P5P,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,PROTEIN ELEC INTERP SERUM,M SPIKE,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,CBC INC DIFF PLT,BASOPHILS,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,HEPATITIS BE ANTIGEN,HEPATITIS BE ANTIGEN,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.10714285714285714,0.15,0.0,0.14285714285714285,0.2,0.0,0.0,0.0,0.0,0.029699923646854032,0.04007989868886952,0,728626,HEP A AB IGM,HEPATITIS A AB IGM,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,COMPREHENSIVE METABOLIC PNL W O CO2 ALT,POTASSIUM,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,DIFFERENTIAL MANUAL,EOSINOPHILS,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,DRUG ABUSE SCREEN W ETOH NO GCMS,BENZODIAZEPINES,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,CBC COMPLETE BLOOD COUNT W O DIFF,RED BLOOD CELL COUNT,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,DRUG ABUSE SCREEN II,OPIATES,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.03666666666666667,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,AUTOMATED BLD CNT,MCH,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.0,0.0,0.0,0.10857142857142857,0.25333333333333335,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,COMP METABOLIC PANEL W GFR,GLOBULIN,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.16666666666666666,0.0,0.0,0.16666666666666666,0.0,0.0,0.04968227056514307,0.0,0.0,0.0860522168542115,0.0,0,45443,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN TOTAL RANDOM UR,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,OBSTETRIC PANEL,NEUTROPHILS,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,TESTOSTERONE FR DIALYSIS TOTAL LC MS MS,FREE TESTOSTERONE,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.25,0.0,0.0,0.0,0.16666666666666666,0.0,0.028787319286399216,0.0,0.0,0.0,0.0,0.0,0,45443,CBC W AUTO DIFF WITH PLATELETS,RBC,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.4175,0.18142857142857144,0.0,0.6675,0.3242857142857143,0.0,0.019765492370202753,0.0,0.0,0.061241138223508074,0.058554296133023875,0.0,1,22368,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.33333333333333337,0.0,0,21618,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,CBC WITH DIFFERENTIAL PLATELETS,EOS,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,CMP14 1AC,EGFR IF NONAFRICN AM,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,IRON TIBC,TIBC,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,CCP IGG,CCP IGG,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,COMP METABOLIC PANEL W EGFR,PROTEIN TOTAL,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,18697,VITAMIN B12 FOLATE,FOLATE SERUM,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,CBC PLATELET HEM REVIEW,NEUTROPHILS,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,APTT,PARTIAL THROMBOPLASTIN,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,URINALYSIS COMPLETE,BILIRUBIN,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,COMP METABOLIC PANEL,CARBON DIOXIDE,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,RPR REFLEX TITRE TPPA,RPR,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.058823529411764705,0.0,0.0,0.014705882352941176,0.03125,0.0,0.022426041668292318,0.0,0.0,0.0,0.0,0,771477,IFE PE SERUM,M SPIKE,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.07858063232628809,0.0,0.0,0.0,0.0,0,28621,IFE PE SERUM,GAMMA GLOBULIN,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.0,0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,URINALYSIS WITH MICROSCOPIC,APPEARANCE,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.1416666666666667,0.42500000000000004,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,CMP14 CBC D PLT RPR UA TSH,HCV AB,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.03476190476190476,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,HAV HBV IMMUNE STATUS PRO IV,HEP A AB IGM,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.07333333333333333,0.0,0.0,0.07333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,HIV AB AG COMBO RFLX CONF,HIV AB AG COMBO RFLX CONF,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,LIPID PROFILE,CHOLESTEROL NON HDL,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,COMP METABOLIC PANEL,GLUCOSE NON FASTING,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,CBC W DIFF PLT,BASOPHILS ABSOLUTE,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.11363636363636363,0.3125,0.16666666666666666,0.0,0.0,0.0,0.052212707018155835,0.14539805437566944,0.04167126493979989,0.0,0.0,0,112599,X HEPATITIS COMPLEX PROFILE,ANTI HCV,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.04833333333333333,0.09666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.0,0.0,0.0,0.06666666666666667,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,HCV QUANT GT1A NS5A PROFILE,HCV NS5A DRUG RESISTANCE ASSAY,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,PROTIME PTT,PTT,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,IGA SERUM,IMMUNOGLOBULIN A,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.3333333333333333,0.31666666666666665,1.0,0.3333333333333333,0.31666666666666665,1.0,0.06538932921065,0.45528141890436646,0.7071067811865476,0.06538932921065,0.45528141890436646,0.7071067811865476,1,30262,T4 THYROXINE,T4 THYROXINE,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,HEPASCORE R,SEX,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.4166666666666667,0.2757142857142857,0.965,0.3333333333333333,0.2757142857142857,0.965,0.2988315713654016,0.014796169435270734,0.04187180795069423,0.2988315713654016,0.014796169435270734,0.04187180795069423,1,110114,HCV RNA QN PCR W REFL GENOTYPE LIPA R,HCV RNA QUANTITATIVE REAL TIME PCR,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.2222222222222222,0.4,0.0,0.2222222222222222,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,HCV RNA QN PCR W REFL GENOTYPE LIPA R,HCV RNA QUANTITATIVE REAL TIME PCR,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,VITAMIN B12 FOLATE,VITAMIN B12,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.34199999999999997,0.2857142857142857,1.0,0.0,0.0,0.0,0.039794905532140934,0.08429511355131847,0.8164965809277261,1,7344,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,CBC W AUTO DIFF WITH PLATELETS,RDW,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,ACCUTYPE R IL28B NY,IL28B GENOTYPE,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.18999999999999997,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,148692,HEMATOPATH CONSULTATION SMEAR,WBC,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.3333333333333333,0.14285714285714285,0.3333333333333333,0.3333333333333333,0.14285714285714285,0.3333333333333333,0.03495206666531736,0.0,0.0,0.03495206666531736,0.0,0.0,1,18341,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,IMMUNOGLOBULIN M IGM,IMMUNOGLOBULIN M,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,COMPREHENSIVE METABOLIC PANEL,ALBUMIN,Sex,Sex,Sex
0.08142857142857142,0.04684210526315789,0.0,0.0,0.04684210526315789,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,CK TOTAL,CREATINE KINASE TOTAL,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,HEPATITIS C REFLEX PCR,HEPATITIS C ANTIBODY,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,CBC WITH AUTO DIFF,BASOPHILS #,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,HB S AB QL,HB S AB QL,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,CMP14 HP4 DBILI CBC D PLT R,WBC,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.03636363636363637,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,COMP METABOLIC PANEL,ANION GAP,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,HEP A AB IGM,HEPATITIS A AB IGM,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.16,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,ALB ALP ALT AST GGT LD PROT,LDH,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.5733333333333334,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0986582980974181,0.06688811321734245,1,110544,CARETC CMP LIPID URIC ACID DIR BILI PROFILE,RISK RATIO LDL HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,URINALYSIS W REFLEX MICRO,NITRITE,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,CULTURE ROUTINE,CULTURE ROUTINE,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.15333333333333335,0.25,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,ANEMIA PROFILE B,EOS,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,HEMOGLOBIN A1C WITH MPG,HEMOGLOBIN A1C,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,OXYCODONE,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.023692166672912185,0.0,0.0,0.023692166672912185,0.0,0,486431,C4 SERUM,C4 SERUM,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,PTH INTACT WITHOUT CALCIUM,PARATHYROID HORMONE INTACT,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,TRANSFERRIN SATURATION,TRANSFERRIN,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,TRICHOMONAS MALE,SOURCE,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.044274927162410105,0.0,0,7880,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,HCV FIBROSURE,INTERPRETATION,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.5,0.16666666666666666,0.5,0.25,0.31,0.9299999999999999,0.10393692145274336,0.04384936485121893,0.045556303189397296,0.044727329538060356,0.05660928660351461,0.05881293452243719,1,27318,PTH INTACT WITHOUT CALCIUM,PARATHYROID HORMONE INTACT,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.072,0.05142857142857143,0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.07571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,HEPATITIS BS AB QUANT,HEPATITIS BS AB INTERP,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,CMP14,EGFR IF AFRICN AM,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.033999999999999996,0.0,0.0,0.0445,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,CRP,C REACTIVE PROTEIN ULTRA,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,CBC W DIFF PLT,PLATELET SUFFICIENCY,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.14333333333333334,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.02446945846686055,0.08969841024226421,1,7732,CBC WITH PLT DIFF,NUCLEATED RBCS,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,GLUCOSE,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,PATHOLOGIST SMEAR REVIEW,MONOCYTES,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,HDL AS % CHOLESTEROL,HDL AS % CHOLESTEROL,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,DRUG ABUSE PANEL NO CONFIRM,CREATININE,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,AMYLASE,AMYLASE,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,CMP WITH EGFR,CARBON DIOXIDE,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.25,0.2,0.0,0.0,0.0,0.0,0.0,0.06407759902266841,0.0,0.0,0.0,0.0,0,311472,IFE PE SERUM,M SPIKE,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,RPR REFLEX TITRE TPPA,RPR,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.025,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,HEPATIC FUNCTION PANEL,BILIRUBIN INDIRECT,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,HCV RNA QT REALTIME PCR,HCV RNA QN PCR,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,REFLEX ANA PATTERN,PATTERN 1,Specimen source identified,Specimen source XXX,Specimen source
0.25,0.42857142857142855,0.75,0.25,0.42857142857142855,0.75,0.014598428619085002,0.0,0.0,0.009237134211083409,0.0,0.0,0,223271,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.25,0.062,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,CBC W DIFF PLT,HEMATOCRIT,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,CBC WITH PLT MAN DIFF,BANDS,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,UREA NITROGEN BUN,ICTERUS,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.1,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.037968287962760416,0.0,0,7831,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual,Promyelocytes/100 leukocytes
0.25,0.4444444444444444,0.6,0.25,0.4444444444444444,0.6,0.027952627376922723,0.16254976929198672,0.12681234287431364,0.027952627376922723,0.16254976929198672,0.12681234287431364,1,539627,AFP SERUM TUMOR MARKER,AFP SERUM TUMOR MARKER,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.16666666666666666,0.333,0.555,0.3333333333333333,0.5,0.5366666666666667,0.028865828635901036,0.14339539470773,0.19980638917080684,0.017692205955941787,0.0585924829043345,0.8693209510109255,1,241133,HEPATITIS BC AB IGM,HEPATITIS B CORE AB IGM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.154,0.178,0.2225,0.154,0.178,0.2225,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,CREATINE KINASE CK,CREATINE KINASE CK,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.24333333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,LIPID PANEL AMA,CHOL HDLC RATIO,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,CMP13 LP TP TSH 2AC CBC D P,NEUTROPHILS ABSOLUTE,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.25,0.16666666666666666,0.0,0.25,0.16666666666666666,1.0,0.013668034462936185,0.010384485502120788,0.0,0.06812389033458222,0.051758104169687846,0.7071067811865476,1,7328,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,CBC INCLUDES DIFF PLT W SMEAR RVW,PLATELET COUNT,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,PSA WITH FREE RATIO,PSA ROCHE E170,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.115,0.25,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,SPECIAL NEW ANNUAL COMM INSURANCE #6925,ABSOLUTE EOS,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,NASH FIBROSURE,HEIGHT,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,UA W MICRO HOLD SPEC 24 HR,GLUCOSE,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.1111111111111111,0.0,0.0,0.1111111111111111,0.0,0.0,0.06908938005713361,0.0,0.0,0.06908938005713361,0.0,0,139501,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.06625,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,IRON BINDING CAPACITY IBC % SATURATION,UNSATURATED IBC,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,URINALYSIS CULTURE IF INDICATED,BACTERIA,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,FE ANA TIBC FER PTT PT A1A,PROTHROMBIN TIME,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,DRUG ABUSE SCREEN III,METHADONE,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.05609681329090033,0.0,0,57976,CBC INCLUDES DIFFERENTIAL PLATELETS,MEAN PLATELET VOLUME,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.09247447620418048,0.34003516797720323,1.0,1,191239,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,CBC WITH PLT DIFF,MPV,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.044,0.0,0.07333333333333333,0.22999999999999998,0.1142857142857143,0.6,0.0,0.0,0.0,0.0,0.24044117311858715,0.7071067811865476,1,18697,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,APOLIPOPROTEIN A1,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.066,0.06285714285714286,0.0,0.176,0.14285714285714285,1.0,0.0,0.0,0.0,0.0,0.07582142074137055,1.0,1,505511,URINALYSIS C,BILIRUBIN,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,PROTHROMBIN PTT,CONTROL,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,PROTEIN ELECTRO S,M SPIKE,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.19,0.15833333333333333,0.31666666666666665,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,CBC,NEUTROPHIL,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,CBC W DIFF PLT,HEMATOCRIT,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,FOLLOW UP PNL ARAKAWA,SODIUM,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,HEP C VIRUS ANTIBODY,HEP C VIRUS ANTIBODY,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,CMP14 CBC D PLT RPR UA TSH,HCV AB,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.0,0.05928571428571429,0.20750000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD4 CELLS,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.16636363636363638,0.4575,0.0,0.16636363636363638,0.4575,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESISTANCE ASSAY PDF,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.05142857142857143,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,RPR REFLEX TP PA,RPR,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,CBC WITH MANUAL DIFFERENTIAL,MCHC,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.25,0.062,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,CBC W DIFF PLT,ABSOLUTE NEUTROPHILS,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,COMP METABOLIC PANEL 13,ALBUMIN SERUM,Age,Age,Age
0.0,0.08833333333333333,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.07065997001469593,0.09716253076254433,1.0,1,57927,UA W MICRO HOLD SPEC 24 HR,GLUCOSE,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,HEPATITIS PANEL ACUTE,HEPATITIS C AB CIA,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,RPR SCREEN W TITER,RPR SCREEN,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.06538932921065,0.24044117311858715,0.7071067811865476,0.09247447620418048,0.34003516797720323,1.0,1,30346,TRANSFERRIN SATURATION,TRANSFERRIN,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.19666666666666666,0.118,0.59,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,DRUG ABUSE SCREEN 9 NO THC W CONF,BARBITURATES,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,HEPATIC FUNCTION PANEL,ALT,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,LP WITHOUT VLDL CHOL HDL LD,LDL HDL RATIO,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,VITAMIN D 25 OH,VITAMIN D 25 OH,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,CBC WITH DIFFERENTIAL PLATELETS,MCH,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,CBC W AUTO DIFF WITH PLATELETS,RBC,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,T4 THYROXINE,T4 THYROXINE,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,NMR LIPOPROFILE,LDL P,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,VIT B 12 FOLATE PANEL,FOLIC ACID,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,COCAINE METABOLITE,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.20750000000000002,0.20750000000000002,0.5,0.20750000000000002,0.20750000000000002,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,HEP C VIRUS ANTIBODY,HEP C VIRUS ANTIBODY,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.24,0.3,0.6,0.0,0.0,0.0,0.022785526138194512,0.0560393528206532,0.12021277498881155,0.0,0.0,0.0,1,79053,HEPATITIS B SURFACE ANTIGEN W REFL CONFIRM,CONFIRMATION,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,UROGRAM,NITRITE,Specimen source identified,Specimen source XXX,Specimen source
0.15,0.14285714285714285,0.0,0.0,0.05714285714285715,0.08,0.0,0.0769055150490483,0.0,0.0,0.0,0.0,0,51953,IFE PE SERUM,BETA GLOBULIN,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.134,0.0,0.0,0.08,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CBC W DIFF PLT,ABSOLUTE NEUTROPHILS,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.4,0.25,0.6666666666666666,0.0,0.0,0.0,0.42720853174042706,0.03748184864782589,0.036362498104970165,1,244673,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD4 CELLS,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.03636363636363637,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,MA COMP METABOLIC PNL,ALKALINE PHOSPHATASE,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,CBC WITH DIFFERENTIAL,HEMATOCRIT,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,CMP WITH ESTIMATED GFR CALCULATED,UREA NITROGEN,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.2,0.0,0.3333333333333333,0.4,1.0,0.0,0.24044117311858715,0.0,0.05467597086898157,0.3926387915311558,0.5773502691896257,1,24653,IMMUNOFIXATION SERUM,IGG SERUM NR,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.041428571428571426,0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,CMP CBC TSH,ABSOLUTE BLASTS,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,CMP14 LP 2AC CBC D PLT MG T,WBC,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,WESTERGREN SED RATE,WESTERGREN SED RATE,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,PSA TOTAL,PSA TOTAL,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.172,0.14285714285714285,0.3333333333333333,0.372,0.2714285714285714,0.44333333333333336,0.0,0.037677447047597123,0.07267302452237867,0.009349256989389043,0.499060427605139,0.9625978811059088,1,52217,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,CBC WITH MANUAL DIFFERENTIAL,MCH,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.2222222222222222,0.0,0.3333333333333333,0.0,0.0,0.0,0.3009933254549282,0.0,0.03908045947241279,0.02823933563163694,0.0,1,59014,PROTHROMBIN TIME,PT POP MEAN,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,HEPATIC LIVER PANEL,DIRECT BILIRUBIN,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,GLYCOHEMOGLOBIN A1C,GLYCOHEMOGLOBIN A1C,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,WESTERGREN SED RATE,WESTERGREN SED RATE,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,AAA MALE PANEL,HIV 1 HIV 2 AB SCREEN,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,TRICHOMONAS MALE,SOURCE,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,VIT B 12 FOLATE PANEL,FOLIC ACID,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,LYMPHOCYTE SUBSET PANEL 3,% CD3 CD4 HELPER T4,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,PE RFX IFE S,GAMMA GLOBULIN,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.021294371112735133,0.0,0.0,0.0,0.0,0,7096,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN TOTAL RANDOM UR,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,LYMPHOCYTE SUBSET PANEL 1,CD4 ABSOLUTE,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,HCV FIBROSURE,COMMENT,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE AG,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,HCV FIBROSURE,COMMENT,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,URINALYSIS CULTURE IF INDICATED,BACTERIA,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.0,0.0,0.0,0.1075,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,882944,CMP14 HP4 1AC PT AFP,EGFR IF NONAFRICN AM,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,HAPTOGLOBIN,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.155,0.2316666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,MORPHOLOGICAL REVIEW,PLATELET ESTIMATE,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,DRUG ABUSE SCREEN II,METHAQUALONE,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,CCP IGG,CCP IGG,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,LIVER FIBROSIS PANEL HEPASCORE,FIBROSIS SCORE,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,LIPOPROTEIN ANALYSIS NMR,LDL P,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,TRANSFERRIN SATURATION,TRANSFERRIN,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.03264735709509192,0.0,0,303644,HEMOGLOBIN A1C,AVERAGE WHOLE BLOOD GLUCOSE,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.01,0.0275,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,CMP14 LP CBC D PLT,NEUTROPHILS,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.182,0.14285714285714285,0.2,0.0,0.03142857142857143,0.044,0.0,0.029699923646854032,0.04007989868886952,0.0,0.0,0.0,0,728626,LYMPHOCYTE SUBSET PANEL 4,COMMENT S,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,BMP8 ANION GAP,EGFR IF NONAFRICN AM,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.007586946436600961,0.00857642404381631,0,128413,UROGRAM,SPECIFIC GRAVITY,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.4,0.14727272727272728,0.25,0.0,0.0,0.0,0.04295786872652774,0.06561281681382569,0.11494463063986393,0.0,0.0,0.0,0,542183,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.072,0.05142857142857143,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,COMPREHENSIVE METABOLIC PANEL E GFR,AST,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.11600000000000002,0.19333333333333336,0.0,0.11600000000000002,0.19333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A RESIST ASSAY INTERP,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,CBC WITH AUTO DIFF,LYMPHOCYTES #,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,HEPATITIS PANEL CHRONIC,HAV AB TOTAL,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,FERRITIN,FERRITIN,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,COMPLETE BLOOD COUNT,MCV,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,HCV FIBROSURE LABCORP,RESULT,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.16666666666666666,0.0,0.25,0.16666666666666666,1.0,0.0,0.07858063232628809,0.0,0.07257572557143144,0.13610564768002043,1.0,1,28621,IFE PE SERUM,ALBUMIN,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.2,0.5,0.0,0.0,0.0,0.0,0.05499740468859693,0.08775968141298807,0,422543,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,CUSTOM HEPATITIS PANEL,HEP B SURFACE AB,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.0,0.06999999999999999,0.0,0.5566666666666666,0.3333333333333333,0.5,0.0,0.0,0.0,0.01112594487153995,0.9402300820764442,0.9900858126069512,1,17590,COMP METABOLIC PANEL CLARIFICATION,ALBUMIN GLOBULIN RATIO,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,FOLATE,FOLATE,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,HCV FIBROSURE,NECROINFLAMMAT ACTIVITY SCORE,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.022222222222222223,0.03333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,UA W RFLX MICROSCOPIC,BILIRUBIN,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.07142857142857142,0.1,0.0,0.047142857142857146,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,CBC WITH PLT DIFF,NUCLEATED RBCS,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.175,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,CUSTOM HEPATITIS PANEL,HEP B SURFACE AB,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.2,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.04526827987678228,0.06070256115709882,0.07600531298566238,1,81232,LYMPHOCYTE SUBSET PANEL 5,CD4 % POS,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,17517,CMP12 7AC MG,PHOSPHORUS SERUM,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,MANUAL DIFFERENTIAL,BLASTS %,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.012142857142857144,0.0425,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,CHEM SCREEN PANEL,BILIRUBIN DIRECT,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,CMP14 HP5 LP 6AC CBC D PLT,INR,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL AB,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,DRUG ABUSE SCREEN I NO GCMS,BARBITURATES,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.0,0.06090909090909091,0.0,0.025714285714285714,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,LIVER FIBRO HEPSCORE R,AGE,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,GLUCOSE,GLUCOSE,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CBC WITH DIFF PLATELET,EOS ABSOLUTE,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,BUN CREATININE,BUN,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.12444444444444445,0.22400000000000003,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,CBC WITH ABSOLUTE WBCS MPV,MCHC,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,CBC WITH AUTO DIFF,NRBC,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.1425,0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.3333333333333333,1.0,0.0,0.0,0.0,0.0,0.530776546300907,1.0,1,30940,COMP METABOLIC PANEL W EGFR,UREA NITROGEN,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,CMP,EGFR NON AFRICAN AMERICAN,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,URINALYSIS W REFLEX MICRO,KETONES,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,LYMPHOCYTE SUBSET PANEL 1,% CD8,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,TSH SML,TSH,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.1825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,PROTEIN ELECTRO S,M SPIKE,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.5566666666666666,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.041620163040118285,0.0966660720824497,0.050158741653652195,1,30973,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,PROTHROMBIN TIME PT,PT CONTROL,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.19,0.2,0.0,0.23857142857142857,0.33399999999999996,0.0,0.13697041783001718,0.07184578234577044,0.0,0.13697041783001718,0.07184578234577044,0,223149,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.1825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,PE INTERP RFX IFE S,ALBUMIN,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.0,0.0,0.0,0.0,0.08779161868611507,1.0,0.0,1,285395,CBC WITH MANUAL DIFFERENTIAL,MCH,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,CREATINE KINASE CK,CREATINE KINASE CK,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,CMP14 LP CBC D PLT TSH,PLATELETS,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,HEPATITIS C ANTIBODY W REFL HCV RIBA,SIGNAL CUT OFF,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,IFE PE FLC SERUM,IMMUNOGLOBULIN G QN SERUM,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,COMP METABOLIC PANEL W EGFR,PROTEIN TOTAL,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,C4 SERUM,C4 SERUM,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.062,0.051666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,URINALYSIS SCREEN,PH,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,REFLEX ANA PATTERN,PATTERN 1,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,LYMPHOCYTE SUBSET PANEL 1,CD4 ABSOLUTE,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,BUN CREATININE RATIO,BUN CREATININE RATIO,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.435,0.3333333333333333,1.0,0.435,0.3333333333333333,1.0,0.010717967407183449,0.8935783031788724,0.9677324695650544,0.010717967407183449,0.8935783031788724,0.9677324695650544,1,29918,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.124,0.3333333333333333,0.0,0.19,0.16666666666666666,0.3333333333333333,0.0,0.036761239048585526,0.0,0.0,0.06444628140908037,0.0946521642027649,1,7138,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.062499999999999986,0.0,0.0,0.033999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.007000000000000001,0.035,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,URINALYSIS SCREEN,BACTERIA,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HCV RNA QUAL TMA,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,CBC PLT DIFF,ABSOLUTE EOS,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,CD4 T HELPER PANEL,CD4 CD3 %HELPERS,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,CBC PLATELET HEM REVIEW,EOS,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,CBC WITH DIFFERENTIAL,HEMATOCRIT,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.0,0.0,0.1075,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,882944,CMP14 1AC,EGFR IF NONAFRICN AM,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,CD4 CD8 RATIO PROFILE,HEMATOLOGY COMMENTS,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,LIVER PANEL II,LD,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.030763983977592058,0.0,0.0,0.0,0.0,0,7310,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,HEPATITIS C VIRUS RNA QN REAL TIME PCR,HCV RNA PCR QN,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,CBC W AUTO DIFF,MCV,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,CBC WITH DIFFERENTIAL,HEMATOCRIT,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS C ANTIBODY,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.3333333333333333,0.2,0.0,0.0,0.0,0.0,0.03384959645284491,0.0,0.0,0.0,0.0,0.0,0,67421,CBC D WITH PLT CITRATED BLD,LYMPHS,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.10333333333333333,0.0775,0.31,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,UROGRAM,KETONES,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,PSA TOTAL % FREE,% FREE PSA,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,HEPATIC FUNCT PANEL W O TP,BILIRUBIN DIRECT,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,CBC WITH DIFFERENTIAL,NEUTROPHILS,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.0,0.01,0.022222222222222223,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,CBC WITH AUTO DIFF,MONOCYTES #,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.5,0.5,1.0,0.0,0.0,0.0,0.4792205357001811,1.0,1.0,1,487942,ASH FIBROSURE,FIBROSIS STAGE,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.088,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,COMPREHENSIVE METABOLIC PANEL E GFR,BUN,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,RPR REFLEX PER CDC,RPR,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.09666666666666668,0.02,0.03,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,HEPATITIS C AB,HEPATITIS C AB,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,CBC INCLUDES DIFF PLT W SMEAR RVW,PLATELET COUNT,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,VIT B 12 FOLATE PANEL,VITAMIN B 12,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD LOG IU ML,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,CBC INCLUDES DIFF PLT WITH PATHOLOGIST REVIEW,ABSOLUTE LYMPHOCYTES,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.018943264239665303,0.09932291697899664,0,28746,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,BILIRUBIN DIRECT,DIRECT BILIRUBIN,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,LYMPHOCYTE SUBSET PANEL 5,CD4 % POS,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,ACCUTYPE R IL28B NY,IL28B GENOTYPE,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH TOTAL,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,LIVER FIBROSIS PANEL HEPASCORE,FIBROSIS SCORE,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual,Promyelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,CMP14 LP 6AC CBC D PLT ESR,CREATININE,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,CBC WITH DIFFERENTIAL PLATELETS,POLYS,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,URINALYSIS CULTURE IF INDICATED,GLUCOSE,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.155,0.2316666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,204552,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,CBC PLATELET HEM REVIEW,NEUTROPHILS,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.14333333333333334,0.125,0.2,0.21,0.125,0.2,0.0,0.034880496193767985,0.04779467294787276,0.0,0.04503052695530496,0.061702657454847154,1,134999,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,HIV 1 RNA QN RT PCR,RACE NR,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.18999999999999997,0.2,0.0,0.0,0.0,0.0,0.0,0.08030844563447248,0.0,0.0,0.0,0.0,0,93187,URINE DRUG SCREEN,OPIATES,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,CMP14 LP 2AC CBC D PLT MG T,WBC,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.3244444444444444,0.584,0.0,0.3244444444444444,0.584,0.0,0.24382465393798014,0.2536246857486273,0.0,0.24382465393798014,0.2536246857486273,1,539627,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,PROTIME PTT,INR,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,COMP METABOLIC PANEL CLARIFICATION,ALBUMIN GLOBULIN RATIO,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,HIV AB EIA WITH REFLEXES,HIV EIA AB SCREEN,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,T4 THYROXINE,T4 THYROXINE,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,UROGRAM,NITRITE,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,COMPLETE BLOOD COUNT,BASOPHILS %,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,STOOL CULTURE,RESULT 1,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.38999999999999996,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,LIVER FIBROSIS FIBROTEST ACTITEST P,NECROINFLAMMATION ACT GRADE,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHADONE,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESIST ASSAY INTERP,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,URINALYSIS CULTURE IF INDICATED,PH,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,ARTHRITIS PROFILE,RHEUMATOID FACTOR QUANT,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.5519999999999999,0.5866666666666667,0.0,0.5519999999999999,0.5866666666666667,0.0,0.3658205134959909,0.010735229171089822,0.0,0.3658205134959909,0.010735229171089822,1,45377,SED RATE WESTERGREN,SED RATE WESTERGREN,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.22333333333333336,0.2,1.0,0.0,0.0,0.0,0.0,0.34003516797720323,1.0,1,21600,RENAL FUNCTION PANEL,CREATININE,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.027777777777777776,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,IRON BINDING CAPACITY,IRON TOTAL,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,LIPID PANEL AMA,CHOL HDLC RATIO,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,CMP14 CBC D PLT TSH,ALBUMIN,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.3333333333333333,0.2,0.5,0.3333333333333333,0.2,0.5,0.05661369574194264,0.06447593079677061,0.0,0.05661369574194264,0.06447593079677061,0.0,1,205070,RPR W RFLX CONFIRM,RPR SYPHILIS SCREEN,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CBC W DIFF PLT,BASOPHILS ABSOLUTE,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,SUNRISE LABS ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.5,0.375,0.75,0.5,0.5,1.0,0.48462344379507305,0.011337917407329035,0.011598869223880981,0.4900689862175951,0.011465317579597123,0.011729201619518514,1,108860,PSA FREE TOTAL,PSA FREE,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.21,0.1111111111111111,0.25,0.0,0.0,0.0,0.0,0.006076686051585067,0.009744924678454114,1,32896,PROTIME PTT,PROTHROMBIN TIME PT,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,HCV AB WITH RFL RNA QT,HCV SIGNAL CUTOFF,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.03571428571428571,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,CMP14 CBC D PLT TSH,ALBUMIN,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,HEPATITIS BS AB QUANT,HEPATITIS BS AB QUANT,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,URINALYSIS CULTURE IF INDICATED,PH,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.006666666666666667,0.014000000000000002,0.0,0.006666666666666667,0.014000000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,MITOCHONDRIAL ANTIBODY W RFX,MITOCHONDRIAL AB,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,RENAL FUNCTION PANEL,CHLORIDE,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.08833333333333333,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06860647178857471,0.0793317966039091,1.0,1,251454,URINALYSIS CULTURE IF INDICATED,BACTERIA,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,LIPID PANEL,,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.046144390603046204,0.0,0,98301,COMP METABOLIC PANEL 13,ALBUMIN SERUM,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,LIPID PANEL STANDARD,LDL CHOL CALCULATED,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,ANEMIA PROFILE B,EOS,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,LIPID PANEL WITH REFLEX DIRECT L,HDL CHOLESTEROL,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.06790824855576716,0.0,0,139527,CMP14 5AC CBC D PLT TSH T4F,CALCIUM SERUM,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CBCI COMPLETE BLOOD COUNT W DIFF,ABS MONOCYTES,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,HEPATITIS C GENO TYPE 1 NS5A RESIST,VELPATASVIR RESISTANCE,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,MAGNESIUM,MAGNESIUM,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CALCIUM,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.052529819653824195,0.0,0,203927,CMP14 5AC CBC D PLT TSH T4F,CALCIUM SERUM,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,HEPATITIS B CORE AB TOTAL REFL,HEPATITIS B CORE AB TOTAL REFL,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1059787103279074,0.0,0,30163,CMP14 3AC CBC D PLT RPR MG,MAGNESIUM SERUM,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,HCV FIBROSURE,NECROINFLAMMAT ACTIVITY SCORE,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.04833333333333333,0.0,0.0,0.06666666666666667,0.04,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,HELPER T LYMPH CD4,NEUTROPHILS,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.3333333333333333,0.0,0.0,0.3333333333333333,0.0,0.0,0.02142196630047022,0.0,0.0,0.1569574215481997,0.0,0.0,1,264648,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.25,0.5,0.5,0.0,0.0,0.0,0.0480741980906203,0.10031748330730439,0.10031748330730439,1,487942,HCV FIBROSURE,FIBROSURE STAGE,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,FIBROACT,FIBROSIS SCORE,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,PTH INTACT,PTH INTACT,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,COMPLETE BLOOD COUNT,MCV,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,FIBROACT COMPLETE,WEIGHT LBS,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp,Daclatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,CEA,CEA,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.007802865833695383,0.0,0.0,0.0,0.0,0,251454,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,PE RFX IFE S,GAMMA GLOBULIN,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0.0,0.0,0.0,0,25718,IFE PE SERUM,BETA GLOBULIN,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,VIT B 12 FOLATE PANEL,FOLIC ACID,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.04802629258177493,0.0,0.0,0.0,0.0,0,57703,PSA TOTAL % FREE,PSA FREE,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.10714285714285714,0.1875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,HEPATIC FUNCTION PANEL,,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,CBC INC DIFF PLT,MONOCYTES,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,T4 THYROXINE,T4 THYROXINE,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,CMP14 HP5 LP 6AC CBC D PLT,BILIRUBIN INDIRECT,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.3333333333333333,0.2,1.0,0.3333333333333333,0.4,1.0,0.03082482540139353,0.11334505599240108,0.33333333333333326,0.06538932921065,0.4808823462371743,0.7071067811865476,1,24984,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CBC WITH PLT DIFF,MONOCYTES ABSOLUTE,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,HDL AS % CHOLESTEROL,HDL AS % CHOLESTEROL,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,DRUG ABUSE PANEL NO CONFIRM,CREATININE,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,DRUG ABUSE SCREEN III,METHAQUALONE,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,HIGH SENSITIVITY CRP,HIGH SENSITIVITY CRP,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH TOTAL,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,ALPHA FETOPROTEIN TUMOR MARKER,AFP TUMOR MARKER,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,ANA AUTOIMMUNE PROFILE,RHEUMATOID FACTOR QUANT,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,PROTEIN TOTAL URINE,URINE TOTAL PROTEIN,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,LYMPHOCYTE SUBSET PANEL 3,ANALYZED DATE TIME,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,UROGRAM,SPECIFIC GRAVITY,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,AMYLASE,AMYLASE,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,CBC WITH PLT DIFF,PROMYELOCYTES,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,CBC PLATELET HEM REVIEW,PLATELETS,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,CBC WITH PLT DIFF,RBC MORPHOLOGY,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.4666666666666666,0.15,0.0,0.0,0.15,0.0,0.06968261318695779,0.24044117311858715,0.7071067811865476,0.0,0.0,0.0,1,24729,IMMUNOGLOBULIN M IGM,IMMUNOGLOBULIN M,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,DRUG ABUSE SCREEN W ETOH NO GCMS,BENZODIAZEPINES,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.11098565713428754,0.10964330813284906,0.7071067811865476,1,264994,CBC W DIFF PLT,ABSOLUTE NEUTROPHILS,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,ESR WES CRP,C REACTIVE PROTEIN QUANT,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,ESR WES CRP,C REACTIVE PROTEIN QUANT,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.124,0.2,0.25,0.0,0.0,0.0,0.0,0.06906520772851166,0.16798781955203945,1,265058,CBC WITH DIFFERENTIAL,NEUTROPHILS,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,CBC W DIFF PLT,PLATELET SUFFICIENCY,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,PSA FREE TOTAL,PSA FREE,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,HEPATITIS B SURFACE ANTIGEN W REFL CONFIRM,CONFIRMATION,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,FE TIBC FER,IRON BIND CAP TIBC,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.06,0.045,0.072,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.05515090694457048,0.0,0,134999,COMP METABOLIC PANEL 13,ALBUMIN SERUM,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,NASH FIBROSURE,HAPTOGLOBIN,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.09499999999999999,0.07125,0.1425,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.2276407094521833,0.0,0,19711,CMP12 7AC MG,PHOSPHORUS SERUM,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,URINALYSIS C,BILIRUBIN,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.3333333333333333,0.38,0.608,0.3333333333333333,0.38,0.608,0.37632479846089595,0.684211202693391,0.8164760814988351,0.37632479846089595,0.684211202693391,0.8164760814988351,0,109009,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,CBC INCLUDES DIFF PLT,MCHC,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.0,0.0,0.092,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,1,7146,CBC PLATELET HEM REVIEW,EOS,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.061769791070825475,0.0,0.0,0.0,0.0,0,192955,DRUG ABUSE SCREEN III,METHADONE,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.11098565713428754,0.10964330813284906,0.7071067811865476,1,264994,CBC INCLUDES DIFF PLT,ABSOLUTE NEUTROPHILS,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,URINALYSIS W MICRO,GLUCOSE,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,LIVER FIBROSIS PANEL,ALT,Sex,Sex,Sex
0.0,0.25,0.0,0.25,0.25,0.3333333333333333,0.0,0.016642660834240153,0.0,0.012790198378587414,0.014223614626308834,0.016641167587878147,0,265116,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,SEGMENTED NEUTROPHILS,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,HEPATITIS B SURFACE ANTIGEN,HBS AG SCREEN,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,CBC INCLUDES DIFF PLT,MCHC,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,TESTOSTERONE FREE TOTAL LC MS MS,FREE TESTOSTERONE,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,CBC D WITH PLT CITRATED BLD,LYMPHS,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,FREE T3,FREE T3,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESIST ASSAY INTERP,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,PTH INTACT MOLECULE,PTH,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,COMP METABOLIC PANEL 13,EGFR IF NONAFRICN AM,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,CBC PLATELET HEM REVIEW,EOS,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,ANEMIA PROFILE B,EOS,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,REFLEXED LDL,LDL DIRECT,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,HEPATITIS BS AB QUANT,HEPATITIS BS AB INTERP,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,HEMATOPATH CONSULTATION SMEAR,HEMATOLOGY COMMENTS,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,RPR REFLEX TITRE TPPA,RPR,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.05,0.0,0.0,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,TESTOSTERONE TOTAL LC MS MS,TESTOSTERONE TOTAL LC MS MS,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,HCV QUANT GT1A NS5A PROFILE,HCV NS5A DRUG RESISTANCE ASSAY,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,HAV AB TOTAL,HAV AB TOTAL,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2276407094521833,0.0,0,44982,CMP13 LP 2AC CBC D PLT,ALBUMIN SERUM,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.08,0.05714285714285715,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.15,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.04801993258748538,0.0,0,130682,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.09090909090909091,0.25,0.0,0.09090909090909091,0.25,0.0,0.04088056399127271,0.059884316562937245,0.0,0.04088056399127271,0.059884316562937245,0,322867,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,PSA TOTAL,PSA TOTAL,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.028571428571428574,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,COMP METABOLIC PANEL W GFR,GLOBULIN,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.2,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.06366479720687357,0.08080741815904413,0.08544834831866432,1,81018,LYMPHOCYTE SUBSET PANEL 1,% CD8,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,COMP METABOLIC PANEL,GLOBULIN,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,COMP METAB PANEL,GLUCOSE FASTING,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,FIBROACT,FIBROSIS SCORE,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,SUNRISE LABS ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,HEPATIC FUNCTION PANEL,ALT,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.09247447620418048,0.34003516797720323,1.0,0.09247447620418048,0.34003516797720323,1.0,1,22848,FOLATE,FOLATE,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.09505913690571055,0.0,0,19893,CMP14 TP TSH 2AC CBC D PLT,AMYLASE SERUM,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.25,0.16666666666666666,0.94,0.0,0.0,0.0,0.05026217761451124,0.056942591518096664,0.0,1,93179,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,HEPATITIS BS AB QUANT,HEPATITIS BS AB INTERP,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,HAV AB TOTAL,HAV AB TOTAL,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,HAV HBV IMMUNE STATUS PRO IV,HEP A AB IGM,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.06666666666666667,0.05,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,IMMUNODEF PROFILE #1,ABSOLUTE CD3,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.03666666666666667,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CBCI COMPLETE BLOOD COUNT W DIFF,ABS MONOCYTES,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.10714285714285714,0.0,0.0,0.10714285714285714,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,IMMUNOGLOBULIN M,IMMUNOGLOBULIN M,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,HEPATIC FUNCTION PANEL,ALK PHOS,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.041428571428571426,0.09666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,COMP METABOLIC PANEL,GLUCOSE NON FASTING,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,CMP13 LP TP TSH 2AC CBC D P,NEUTROPHILS ABSOLUTE,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,URINALYSIS RX ALB CREA,KETONES,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,FIBROACT COMPLETE,WEIGHT LBS,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,HAV HBV IMMUNE STATUS PRO IV,HEP A AB IGM,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,FREE T4 THYROXINE,FREE T4 THYROXINE,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,FASTING,FASTING STATUS,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,T4,T4,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.022,0.03142857142857143,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,IRON BINDING CAPACITY,TIBC,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.1416666666666667,0.42500000000000004,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,TSH 3RD GENERATION,TSH 3RD GENERATION,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,PROTHROMBIN TIME,PT POP MEAN,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.016666666666666666,0.024999999999999998,0.055,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.04020134008575915,0.0,0,481598,CMP12 7AC MG,PHOSPHORUS SERUM,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,HEP C VIRUS ANTIBODY,HEP C VIRUS ANTIBODY,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,DRUG ABUSE SCREEN W ETOH NO GCMS,BENZODIAZEPINES,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,HEPATITIS B VIRUS PNL 6 TESTS,HB CORE AB TOTAL,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.42857142857142855,1.0,0.0,0.2857142857142857,0.3333333333333333,0.0,0.5413571510828952,0.8164965809277259,0.0,0.3827973125745455,0.288675134594813,0,25007,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,CMP14 LP CBC D PLT TSH,PLATELETS,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.07142857142857142,0.1,0.0,0.047142857142857146,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,CBC WITH PLT DIFF,NO CELLS DIFF,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,MCCARJUH MCCARTHY PROFILE 1,PROTHROMBIN TIME PT,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN TOTAL RANDOM UR,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.154,0.07571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,URINALYSIS CULTURE IF INDICATED,BACTERIA,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.04833333333333333,0.0,0.0,0.0,0.04,0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.5,0.0,0.0,0.0,0.08432989233649546,0.08432989233649546,0.1503314858492919,1,31377,ASH FIBROSURE,HEIGHT,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0725,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,DRUG ABUSE SCREEN I NO GCMS,BARBITURATES,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.1562763484527192,0.0,0,25007,CBC INCLUDES DIFFERENTIAL PLATELETS,MEAN PLATELET VOLUME,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCH,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,DRGABU2,METHAQUALONE,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.22333333333333336,0.2,1.0,0.0,0.0,0.0,0.0,0.34003516797720323,1.0,1,21600,CMP14 LP 6AC CBC D PLT ESR,CREATININE,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,SPECIAL NEW ANNUAL COMM INSURANCE #6925,ABSOLUTE EOS,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,CHOLESTEROL TOTAL,ICTERUS,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.0,0.0625,0.0,0.0,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,IMMUNOGLOBULIN M,IMMUNOGLOBULIN M,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,CBC INC DIFF PLT,RBC,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.072,0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,COMP METAB PANEL,CALCIUM PLASMA,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,TSH SML,TSH,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,COCAINE METABOLITE,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,CMP14 HP5 LP 6AC CBC D PLT,BILIRUBIN INDIRECT,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,HCV RNA QN PCR W REFL GENOTYPE LIPA R,HCV RNA QUANTITATIVE REAL TIME PCR,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,BASIC METABOLIC PANEL,AFRICAN AMERICAN,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,CMP12 LP TP TSH 6AC CBC D PLT,URIC ACID,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL AB,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.09629383728860574,0.34003516797720323,1.0,1,17517,CMP14 CBC D PLT TSH,ALBUMIN,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,URINALYSIS W MICRO,GLUCOSE,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.044,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,URINALYSIS W REFLEX MICRO,BACTERIA,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.14285714285714285,0.21428571428571427,0.75,0.0,0.0,0.0,0.0064447176519438765,0.0,0.0,0.0,0.0,0.0,0,296095,HCV FIBROSURE,FIBROSURE STAGE,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,PROTEIN TOTAL 24HR URINE W CREAT,UR CREAT RANDOM MG DL,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,HEPATITIS BE AG,HB E AG,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,ALPHA 1 ANTITRYPSIN SERUM,ALPHA 1 ANTITRYPSIN SERUM,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,HEPASCORE R,AGE,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,CMP14 LP 3AC,ALKALINE PHOSPHATASE S,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,URINALYSIS W REFLEX MICRO,SPECIFIC GRAVITY,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.16666666666666666,0.0,0.16666666666666666,0.0,0.0,0.0,0.020824089356768827,0.0,0.0555987435097689,0.0,0.0,0,7302,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.1,0.0,0.2,0.125,0.5,0.0,0.028972496951288118,0.0,0.05623518965539054,0.07096783410499707,0.7071067811865476,1,196444,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.14666666666666667,0.1325,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.08466774310592073,0.09762443806815091,1.0,1,58032,UA MICROSCOPIC REFLEX CULTURE,PH,pH of Urine by Test strip,pH Ur Strip,pH
0.057999999999999996,0.04428571428571428,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,CBC PLATELET NO DIFFERENTIAL,HEMATOCRIT,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.072,0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,COMPREHENSIVE METABOLIC PANEL E GFR,BUN,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD4 CELLS,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,CMP CBC TSH,ABSOLUTE BLASTS,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,CBC ESR,ABSOLUTE NEUTROPHILS,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,CMP13 LP 2AC CBC D PLT,ALBUMIN SERUM,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.049999999999999996,0.0,1.0,0.6666666666666666,0.0,0.0,0.07173208688547461,0.0,1.0,0.9870524497488843,0.0,1,59022,CMP14 HP4 1AC PT AFP,PROTHROMBIN TIME,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD LOG IU ML,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.3333333333333333,0.0,0.0,0.16666666666666666,0.0,0.0,0.026879071739240423,0.0,0.0,0.0,0.0,0,7708,COMPLETE BLOOD COUNT,RBC,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0825,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,URINALYSIS,BILIRUBIN,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,ALPHA 2 MACROGLOBULIN,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.04,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,COMPREHENSIVE METABOLIC PANEL AMA,SODIUM,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,URINALYSIS COMPLETE WITH REFLEX CULTURE,PROTEIN,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,203935,BUN CREATININE RATIO,HEMOLYSIS,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,IRON BINDING CAPACITY,UIBC,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.2,0.07571428571428572,0.0,0.0,0.0,0.0,0.028452089502192912,0.0,0.0,0.0,0.0,0.0,0,204537,URINALYSIS W MICRO W REFLEX CULTURE,WBC,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.072,0.05142857142857143,0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,COMP METABOLIC PANEL W O EGFR,CREATININE,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,CMP14 LP 3AC,ALKALINE PHOSPHATASE S,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.15,0.2,0.0,0.0,0.0,0.0,0.0,0.0636278905553388,0.0,0,172841,CMP12 7AC MG,PHOSPHORUS SERUM,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.142,0.0,0.0,0.0,0.0,0.0,0.07132561100505608,0.0,0.0,0.0,0.0,0,196592,CHEM SCREEN PANEL,BILIRUBIN DIRECT,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,LIPID PANEL WITH DIRECT LDL,TRIGLYCERIDES,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,HIV AG AB 4TH GEN RFL,RACE NR,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,BILIRUBIN FRACTIONATED,BILIRUBIN INDIRECT,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.03666666666666667,0.055,0.0,0.03666666666666667,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,CULTURE ROUTINE,CULTURE ROUTINE,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,DRUG ABUSE PANEL 10 WITH OXYCODONE,COCAINE METABOLITE,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.08,0.08857142857142856,0.155,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.014499999999999999,0.03222222222222222,0.0,0.025,0.05555555555555555,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,CBC WITH MANUAL DIFFERENTIAL,MCH,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,HEPATITIS B CORE AB TOTAL REFL,HEPATITIS B CORE AB TOTAL REFL,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,COMPREHENSIVE METABOLIC PANEL,ALBUMIN,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.03238095238095238,0.0,0.0,0.03238095238095238,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,HIGH SENSITIVITY CRP,HIGH SENSITIVITY CRP,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,PSA TOTAL,PSA TOTAL,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.134,0.09571428571428572,0.22333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,IFE PE SERUM,BETA GLOBULIN,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.017069280070973192,0.0,0.0,0.0,0.0,0,7732,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.011,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,RENAL FUNCTION PANEL,CHLORIDE,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.07571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.020714285714285713,0.0725,0.0,0.020714285714285713,0.0725,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,CMP14 HP4 1AC PT AFP,EGFR IF NONAFRICN AM,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,LIPID PANEL WITH REFLEX DIRECT L,HDL CHOLESTEROL,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,CBC PLATELET HEM REVIEW,EOS,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,HEPATITIS B VIRUS PNL 6 TESTS,HB CORE AB TOTAL,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,NASH FIBROSURE,WEIGHT,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCH,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,URINALYSIS SCREEN,BACTERIA,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,LIPID PROFILE WRFL LDL DIRECT,NON HDL CHOLESTEROL,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,PSA TOTAL % FREE,% FREE PSA,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0825,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,URINALYSIS REFLEX,NITRITE,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,HCV GENOTYPE PCR PROBE,HCV GENOTYPE,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0825,0.10600000000000001,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.057300127208634755,0.0,0.0,0,192708,URINALYSIS REFLEX,GLUCOSE QL,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,BASIC METABOLIC PANEL,BUN,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp,Daclatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.2,0.14285714285714285,0.0,0.0,0.0,0.0,0.04873860645800243,0.05162000400267441,0.0,0.0,0.0,0.0,0,7344,DIFFERENTIAL MANUAL,EOSINOPHILS,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,HEPATIC FUNCTION PNL,GLOBULIN,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0953620011163746,0.0,0,28746,FE TIBC FER,FERRITIN SERUM,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.04238095238095238,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,CREATINE KINASE TOTAL,HEMOLYSIS,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.009761890689840791,0.0,0.0,0.0,0.0,0,273532,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
1.0,0.89,0.0,1.0,0.89,0.0,0.9870524497488843,1.0,0.0,0.9870524497488843,1.0,0.0,1,59022,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,MITOCHONDRIAL AB SCREEN,MITOCHONDRIAL AB SCREEN,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,HIV 1 RNA QN RT PCR,LOGCOPIES ML,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,CBC W AUTO DIFF WITH PLATELETS,BASOPHILS,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,LYMPHOCYTE SUBSET PANEL 3,% CD3 CD4 HELPER T4,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,CBC W AUTO DIFF,MONOS ABSOLUTE,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,TRANSFERRIN SATURATION,TRANSFERRIN,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,COMMENTS,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,CMP14 3AC CBC D PLT RPR MG,MAGNESIUM SERUM,Service comment,Service Cmnt XXX-Imp,Service comment
0.2,0.17142857142857146,0.0,0.0,0.0,0.0,0.03285364306619687,0.0,0.0,0.0,0.0,0.0,0,204537,URINALYSIS W REFLEX MICRO,KETONES,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.15,0.0,0.0,0.24044117311858715,0.0,0.0,0.0,0.0,1,24729,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,DRUG ABUSE SCREEN III,METHADONE,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,ANA REFLEX AUTOIMMUNE AB PROFILE,ANTI NUCLEAR ANTIBODIES,Specimen source identified,Specimen source XXX,Specimen source
0.0,0.0,0.0,0.14666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,HBSAB AG,HEP B SURFACE AB QUAL,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,MAGNESIUM,ICTERUS,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.25,0.5,0.3333333333333333,0.0,0.0,0.0,0.23353187788891705,0.24209923748073692,0.09247447620418048,0.0,0.0,1,25015,IRON BINDING CAPACITY,UIBC,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,COMP METABOLIC PANEL 13,ALBUMIN SERUM,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,BASIC METABOLIC PANEL,BUN,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,CERULOPLASMIN,CERULOPLASMIN,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,HEPATIC FUNCTION PANEL AMA,GLOBULIN,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.27999999999999997,0.09090909090909091,0.2,0.27999999999999997,0.09090909090909091,0.2,0.03501471280402846,0.02619755394479084,0.0413729178490605,0.03501471280402846,0.02619755394479084,0.0413729178490605,1,602797,ACCUTYPE R IL28B,ACCUTYPE R IL28B,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,CBC,MO%,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,RPR W RFLX CONFIRM,RPR SYPHILIS SCREEN,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD4 CELLS,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.09258247128417263,0.0,0,115725,CMP14 3AC CBC D PLT RPR MG,MAGNESIUM SERUM,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.025,0.041666666666666664,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,IRON BINDING CAPACITY IBC % SATURATION,UNSATURATED IBC,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,SPECIAL CUM 50 PLUS PROFILE # 10190,SEDIMENTATION RATE,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,DRUG ABUSE SCREEN II,OPIATES,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.07257572557143144,0.13610564768002043,1.0,1,28621,PE INTERP RFX IFE S,ALBUMIN,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,DRUG ABUSE SCREEN 9 NO THC W CONF,PHENCYCLIDINE,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,URINALYSIS COMPLETE,GLUCOSE,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,IRON BINDING CAPACITY,IRON TOTAL,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,IFE PE SERUM,ALPHA 1 GLOBULIN,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.05888888888888889,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.06290250689706056,0.0,0.0,1,58214,URINALYSIS ROUTINE,WBC,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.305,0.0,0.0,0.0,0.0,0.0,0.00977856980477887,0.0,0.0,0.0,0.0,0.0,0,45377,HCV RNA QN PCR W REFL GENOTYPE LIPA R,HCV RNA QUANTITATIVE REAL TIME PCR,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,CBC W O DIFF WITH PLATELETS,MCH,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,CBC PLATELET HEM REVIEW,EOS,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,HEPATITIS C ANTIBODY W REFL HCV RIBA,SIGNAL CUT OFF,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,HIV AG AB 4TH GEN RFL,RACE NR,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.05102520497901342,0.0,0.0,0.05102520497901342,0.0,0.0,1,30163,TSH 3RD GENERATION,TSH 3RD GENERATION,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,LIVER FIBROSIS PANEL HEPASCORE,FIBROSIS SCORE,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,HEPATITIS BS AB QUANT,HEPATITIS BS AB QUANT,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.1111111111111111,0.0,0.4166666666666667,0.2222222222222222,1.0,0.0,0.007391290979703591,0.0,0.290759678007509,0.014423058883279771,1.0,1,273532,HEMOGLOBIN A1C W EAG INT CHART,ESTIMATED AVERAGE GLUCOSE,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.1925,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,URINALYSIS CULTURE IF INDICATED,PH,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.5,0.0,0.0,0.0,0.05498668394218953,0.07826082456743577,0.10031748330730439,1,312082,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Specimen source identified,Specimen source XXX,Specimen source
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,PE INTERP RFX IFE S,BETA GLOBULIN,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.5299999999999999,0.14285714285714285,0.0,0.5299999999999999,0.14285714285714285,0.0,0.0,0.0753534743127614,0.038305767913941025,0.0,0.0753534743127614,0.038305767913941025,1,98301,CHOL HDL RATIO,CHOL HDL RATIO,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,HIGH SENSITIVITY CRP,HIGH SENSITIVITY CRP,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.06290250689706056,0.0,0.0,1,58214,CMP14 LP 2AC CBC D PLT MG T,WBC,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,COMPREHENSIVE METABOLIC PANEL E GFR,AST,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.2375,0.0,0.0,0.1775,0.25,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,T LYMPHOCYTE HELPER SUPPRESSOR,LYMPHS,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,LMG CBC DIFF PLT,LYMPHOCYTES #,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.25,0.09090909090909091,1.0,0.0,0.0,0.0,0.058854483963441506,0.04322678270641078,1.0,1,611517,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,IFE PE SERUM,M SPIKE,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,AAA MALE PANEL,HIV 1 HIV 2 AB SCREEN,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,LIVER FIBROSIS PANEL HEPASCORE,FIBROSIS SCORE,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,ANA IFA SCREEN WITH REFLEX TITER,ANTI NUCLEAR AB IFA,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.39999999999999997,0.31428571428571433,0.5333333333333333,0.0,0.0,0.0,0.0,0.41219810878268626,0.4228537636689047,1,433961,LIPID PANEL W REFL DLDL,NON HDL CHOLESTEROL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,BUN CREATININE RATIO,HEMOLYSIS,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,HCV FIBROSURE,INTERPRETATION,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.20750000000000002,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,URINALYSIS W MICRO,GLUCOSE,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.16666666666666666,0.21428571428571427,0.75,0.0,0.14285714285714285,0.5,0.04036164461486136,0.0,0.0,0.0,0.06317690320497038,0.17807552140691663,1,204164,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,CBC,BA%,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HCV RNA QUAL TMA,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,FE TIBC FER,FERRITIN SERUM,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,HEPATITIS PANEL ACUTE,HEPATITIS C AB CIA,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,COMP METABOLIC PANEL 13,ALBUMIN SERUM,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.015795751026077554,0.0,0,143149,AAA MALE PANEL,HIV 1 HIV 2 AB SCREEN,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,CMP14 TP TSH 2AC CBC D PLT,AMYLASE SERUM,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,PROTIME PTT,PROTHROMBIN TIME PT,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,HEPATITIS B VIRUS PNL 6 TESTS,HB CORE AB TOTAL,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,FERRITIN,FERRITIN,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,URINALYSIS WITH MICROSCOPIC,COLOR,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.134,0.0,0.0,0.08,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.022000000000000002,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,COMP METABOLIC PANEL 14,EGFR IF NONAFRICN AM,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.062,0.10333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,UA W MICRO HOLD SPEC 24 HR,GLUCOSE,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.11399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,ANA REFLEX AUTOIMMUNE AB PROFILE,ANTI NUCLEAR ANTIBODIES,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,BASIC METABOLIC PANEL,AFRICAN AMERICAN,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.22333333333333336,0.2,0.3333333333333333,0.0,0.0,0.0,0.0,0.05336825693147673,0.05352091133427317,0,111252,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,LIPID PANEL W REFL DLDL,NON HDL CHOLESTEROL,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,HCV RNA GENO W REFL NS5A,HCV RNA GENOTYPE LIPA R,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,ANA CRP ASO PE,P E INTERPRETATION S,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.0,0.0,0.0,0.0,0.027777777777777776,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,CMP,ALT SGPT,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,COMP METAB PANEL,GLUCOSE FASTING,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,CBC WITH PLT DIFF,WBC MORPHOLOGY,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.034444444444444444,0.062,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,RPR REFLEX TP PA,RPR TITER,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.05181818181818181,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.025,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,CBC WITH MANUAL DIFFERENTIAL,MCHC,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,LMG CBC DIFF PLT,LYMPHOCYTES #,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0834655896020069,0.34003516797720323,1.0,1,20750,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.11,0.1325,0.0,0.09666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,CBC INCLUDES DIFF PLT,ABSOLUTE NEUTROPHILS,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,CBC INCLUDES DIFF PLT,BLASTS,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,CBC W AUTO DIFF,% MONOCYTES,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,ACCUTYPE R IL28B,IL28B GENOTYPE,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,SPECIAL PROFILE # 5144,TSH ULTRASENSITIVE,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.0,0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.07834499240220905,0.0,0,244673,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,LIVER FIBROSIS PANEL HEPASCORE,FIBROSIS SCORE,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.11490614097199336,0.10964330813284906,0.7071067811865476,1,264747,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,DRUG ABUSE SCREEN III,METHADONE,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,CBC PLT DIFF,POLYS,Body weight Measured,Weight Measured,Body weight
0.0,0.0,0.0,0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.0703861147930801,0.0,0,539627,CMP14 TP TSH 2AC CBC D PLT,AMYLASE SERUM,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,HCV FIBROSURE,NECROINFLAMMAT ACTIVITY SCORE,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0816748825802307,0.0,0.0,0.0,0.0,0,109009,IGA SERUM,IMMUNOGLOBULIN A,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.15333333333333335,0.022,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,PT PROTIME,INR,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.055192913156707046,0.0,0.0,0.0,0.0,0,241133,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,CBC WITH PLT DIFF,RBC MORPHOLOGY,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,HB S AG W RFX CONF,HEPATITIS B SURFACE ANTIGEN,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,CBC NO DIFF,RBC,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,CMP14 LP 2AC CBC D PLT MG T,WBC,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,COMPREHENSIVE METABOLIC PNL W O CO2 ALT,POTASSIUM,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.178,0.89,0.25666666666666665,0.178,0.89,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,CK TOTAL,CREATINE KINASE TOTAL,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE AG,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,CBC WITH AUTO DIFF,LYMPHOCYTES #,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,PROTHROMBIN TIME PT,PT CONTROL,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,DRUG ABUSE SCREEN III,AMPHETAMINES,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,CMP,TCO2,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.25,0.5,1.0,0.25,0.5,1.0,0.008961675040387918,0.37792276480678133,0.0,0.008961675040387918,0.37792276480678133,0.0,1,305227,HIGH SENSITIVITY CRP,HIGH SENSITIVITY CRP,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.33399999999999996,0.2857142857142857,1.0,0.0,0.0,0.0,0.04215892569416535,0.1907240022327492,1.0,1,28746,PE RFX IFE S,GAMMA GLOBULIN,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,CMP WITH EGFR,CARBON DIOXIDE,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.392,0.09571428571428572,0.1675,0.392,0.09571428571428572,0.1675,0.03321870600293453,0.043355289534301455,0.043726732586310324,0.03321870600293453,0.043355289534301455,0.043726732586310324,1,142513,MITOCHONDRIAL M2 ANTIBODY,MITOCHONDRIAL M2 ANTIBODY,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,CBC INCLUDES DIFF PLT,BLASTS,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,CBC WITH DIFFERENTIAL,MCHC,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,HEPATITIS BS AB QUANT,HEPATITIS BS AB QUANT,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,HEPATIC FUNCTION PNL,GLOBULIN,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.1425,0.2,0.0,0.25,0.2,0.0,0.0,0.014115296805345068,0.0,0.01581640066742107,0.0,0.0,0,192955,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN TOTAL RANDOM UR,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,CMP14 LP 5AC,VLDL CHOLESTEROL CAL,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.09562499999999999,0.19124999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,MCCARJUH MCCARTHY PROFILE 1,PROTHROMBIN TIME PT,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.1,0.04428571428571428,0.0775,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0825,0.08833333333333333,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.07065997001469593,0.09716253076254433,1.0,1,57927,URINALYSIS W MICRO,GLUCOSE,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,LYMPHOCYTE SUBSET PANEL 1,ABSOLUTE CD8 CELLS,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,PSA WITH FREE RATIO,PSA ROCHE E170,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0,27771,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.03571428571428571,0.022727272727272728,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,PROTEIN ELECTROPHORESIS,BETA GLOBULINS,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Race,Race,Race
0.0,0.0,0.0,0.3333333333333333,0.16666666666666666,1.0,0.0,0.0,0.0,0.084905879372146,0.3219325786555107,1.0,1,17988,CMP14 HP4 DBILI CBC D PLT R,AMYLASE,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,CBC WITH PLT DIFF,MONOCYTES ABSOLUTE,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,CBC WITH PLT DIFF,RBC MORPHOLOGY,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,TESTOSTERONE,TESTOSTERONE,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0825,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,URINALYSIS W REFLEX MICRO,PROTEIN,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,LIPID PANEL WITH REFLEX DIRECT L,HDL CHOLESTEROL,Body weight Measured,Weight Measured,Body weight
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,HEPATITIS C REFLEX PCR,HEPATITIS C ANTIBODY,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,VITAMIN B12 FOLATE,FOLATE SERUM,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.1875,0.14285714285714285,0.0,0.1875,0.14285714285714285,0.0,0.0,0.11861986140776393,0.0,0.0,0.13697041783001718,0.0,0,223149,IFE PE FLC SERUM,IMMUNOGLOBULIN G QN SERUM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,GLUCOSE,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,CMP14 3AC CBC D PLT RPR MG,MAGNESIUM SERUM,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.031224633643310185,0.0,0.0,0.0,0.0,0,265157,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0415,0.20750000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,LYMPHOCYTE SUBSET PANEL 1,ABSOLUTE CD8 CELLS,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,NASH FIBROSURE,HAPTOGLOBIN,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,CBC INCLUDES DIFF PLT,ABSOLUTE NEUTROPHILS,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,HEPATITIS BS AB QUANT,HEPATITIS BS AB QUANT,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,RENAL FUNCTION PANEL,CHLORIDE,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.06,0.045,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,GLUCOSE,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0625,0.0,0.0,0.0625,0.0,0.0,0.027776438468458897,0.0,0.0,0.022679367039845966,0.0,0,339143,IMMUNOFIXATION SERUM,IGG SERUM NR,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD4 CELLS,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,CARDIO IQ R VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,Specimen source identified,Specimen source XXX,Specimen source
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,HIV 1 RNA QN RT PCR,HIV 1 RNA QN RT PCR,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.25,0.205,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.16666666666666666,0.0,0.0,0.16666666666666666,0.0,0.0,0.15322199094318423,0.0,0.0,0.0,0.0,0,19687,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,CD4 CD8 RATIO PROFILE,HEMATOLOGY COMMENTS,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,FIBROACT COMPLETE,HEIGHT INCHES,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,HIV AB AG RFLX CONF,HIV AG AB,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.022,0.044,0.0,0.05,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,BUN CREATININE,BUN,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,CD4 CD8 RATIO PROFILE,HEMATOLOGY COMMENTS,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,LYMPHOCYTE SUBSET PANEL 3,ANALYZED DATE TIME,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06691275831255872,0.06348916544989514,0.09169555407390673,1,59055,CBC INC DIFF PLT,MONOCYTES,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.1569574215481997,0.0,0.0,1,264648,CBC WITH MANUAL DIFFERENTIAL,WBC,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.03666666666666667,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,CBCI COMPLETE BLOOD COUNT W DIFF,ABS MONOCYTES,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,CBC INCLUDES DIFF PLT WITH PATHOLOGIST REVIEW,ABSOLUTE LYMPHOCYTES,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CBC WITH ABSOLUTE WBCS MPV,MCHC,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,GGTP,GGTP,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,HEPATITIS C AB,HEPATITIS C AB,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,CMP13 LP TP TSH 2AC CBC D P,NEUTROPHILS ABSOLUTE,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,LYMPHOCYTE SUBSET PANEL 5,CD4 % POS,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,SPECIAL NEW ANNUAL COMM INSURANCE #6925,ABSOLUTE EOS,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,CBC WITH PLT DIFF,NO CELLS DIFF,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,URINALYSIS CULTURE IF INDICATED,GLUCOSE,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,HCV FIBROSURE,COMMENT,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,CBC WITH AUTO DIFF,LYMPHOCYTES #,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,EIA 10 ALCOHOL W GCMS,URINE CREATININE MG DL,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0125,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,CMP14 CBC D PLT TSH,EGFR IF AFRICN AM,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,VITAMIN D 25 OH,25 OH VITAMIN D,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,COMPREHENSIVE METABOLIC PANEL E GFR,AST,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,DRUG ABUSE SCREEN I NO GCMS,METHADONE,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.24333333333333332,0.0,1.0,0.0,0.0,0.0,0.0,0.34003516797720323,1.0,0,28852,URINALYSIS COMPLETE WITH REFLEX CULTURE,PROTEIN,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.07870803013413097,0.08411277379800186,0.09704900074164846,1,264788,CBC W AUTO DIFF,% LYMPHOCYTES,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.2,0.42857142857142855,0.6,0.0,0.0,0.0,0.027472891895522933,0.11914151160658715,0.12021277498881155,0.0,0.0,0.0,0,51953,HEPATITIS B SURFACE ANTIGEN W REFL CONFIRM,CONFIRMATION,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,BUN CREATININE,BUN,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.16666666666666666,0.3333333333333333,0.6,0.16666666666666666,0.1111111111111111,0.2,0.033947326516491017,0.11089370552514821,0.15519402517768222,0.033947326516491017,0.055446852762574106,0.07759701258884111,1,51961,HEPATITIS B SURFACE ANTIGEN,HBS AG SCREEN,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,LIPID PANEL WITH DIRECT LDL,TRIGLYCERIDES,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.39999999999999997,0.2285714285714286,0.5333333333333333,0.0,0.0,0.0,0.0,0.9748006147710161,1.0,1,433961,LIPID PROFILE,CHOLESTEROL NON HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,CBC INCLUDES DIFF PLT,RDW,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,URINALYSIS W REFLEX MICRO,BACTERIA,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,ESR WES CRP,C REACTIVE PROTEIN QUANT,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,ANA CRP ASO PE,P E INTERPRETATION S,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,BASIC METABOLIC PANEL,AFRICAN AMERICAN,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,PROTEIN ELECTROPHORESIS,BETA GLOBULINS,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,CBC WITH PLT DIFF,MONOCYTES ABSOLUTE,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,CMP14 HP5 LP 6AC CBC D PLT,INR,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,LIVER FIBROSIS FIBROMETER,FIBROMETER PATIENT SCORE,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,MICROALBUMIN CONC,ALB CREAT RATIO,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,HEPATITIS B CORE AB TOTAL REFL,HEPATITIS B CORE AB TOTAL REFL,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.011111111111111112,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHADONE,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,ACCUTYPE R IL28B NY,IL28B GENOTYPE,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,HCV FIBROSURE LABCORP,RESULT,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.375,0.14285714285714285,0.0,0.275,0.14285714285714285,0.0,0.034234837021806186,0.0,0.0,0.0,0.09338639438323382,0.0,1,21329,VIT B 12 FOLATE PANEL,VITAMIN B 12,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.055,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,RPR REFLEX PER CDC,RPR,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.016117066729945173,0.0,0.0,0.0,0.0,0,7732,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06635350960296393,0.05287307875068503,0.08777198612321668,1,7096,CBC WITH PLT DIFF,BLASTS,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,823781,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.07849999999999999,0.25,0.0,0.0,0.0,0.0,0.019934693104725842,0.14539805437566944,0.0,0.0,0.0,0,347047,HEPATITIS BE AG,HB E AG,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,LMG CBC DIFF PLT,LYMPHOCYTES #,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.20750000000000002,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,204081,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,CULTURE ROUTINE,CULTURE ROUTINE,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.15333333333333335,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD LOG IU ML,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.31,0.09857142857142856,0.45999999999999996,0.0,0.0,0.0,0.02488757391749208,0.0843257732197713,0.6324555320336758,0.0,0.0,0.0,1,295410,HIV 1 RNA QN RT PCR,LOGCOPIES ML,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,PTH INTACT,PTH INTACT,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.3333333333333333,0.3333333333333333,0.5,0.3333333333333333,0.3333333333333333,0.5,0.05339016372965322,0.5576035828430085,0.8164965809277261,0.05339016372965322,0.5576035828430085,0.8164965809277261,1,44859,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,CBC WITH AUTO DIFF,NRBC,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.3333333333333333,0.2,0.5,0.3333333333333333,0.2,0.5,0.043852780155159476,0.0499428412414229,0.0,0.09805779742929044,0.11167558800530164,0.0,1,205070,RPR REFLEX PER CDC,RPR,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,URINALYSIS CULTURE IF INDICATED,BILIRUBIN,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,30346,COMP METAB PANEL,CALCIUM PLASMA,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,MAGNESIUM,ICTERUS,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.5566666666666666,0.2,0.3333333333333333,0.0,0.0,0.0,0.05352091133427317,0.05336825693147673,0.05352091133427317,1,111567,CBC WITH PLT DIFF,WBC MORPHOLOGY,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,CBC W AUTO DIFF WITH PLATELETS,MCHC,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,VITAMIN D 25 OH,25 OH VITAMIN D,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,PTH INTACT,PTH INTACT,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.16,0.0,0.1675,0.192,0.96,0.0,0.05524858071613015,0.0,0.0,0.0,0.0,1,193433,DRUG ABUSE SCREEN I NO GCMS,AMPHETAMINES,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,CEA,CEA CENTAUR,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,HEPASCORE R,AGE,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,PSA FREE TOTAL,PSA FREE,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,CBCI COMPLETE BLOOD COUNT W DIFF,ABS BASOPHILS,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,PROFILE 104 LIVER,BILIRUBIN TOTAL,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,CMP14 LP CBC D PLT,NEUTROPHILS,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.2333333333333333,0.1325,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,HEPATITIS B VIRUS PNL 6 TESTS,HB CORE AB TOTAL,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.2,0.21875,0.4375,0.2,0.21875,0.4375,0.011046777232682325,0.014851550505174838,0.0201163555976559,0.011046777232682325,0.014851550505174838,0.0201163555976559,0,139550,HEP B SURFACE AB,HEP B SURFACE AB,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.06,0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,COMP METABOLIC PANEL W GFR,GLOBULIN,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,CMP14 LP CBC D PLT,HEMATOCRIT,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,RPR REFLEX TP PA,RPR TITER,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,HCV RNA QN PCR W RFL GENO,HCV RNA QN REAL TIME PCR,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,CMP14 1AC,ALT SGPT,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,STOOL CULTURE,RESULT 1,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,URINALYSIS W REFLEX MICRO,PROTEIN,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.45,0.0,0.0,0.2,0.348,0.87,0.029191354220793775,0.0,0.0,0.0,0.5995868643465051,0.9567642781036875,1,422543,ANA IFA SCREEN WITH REFLEX TITER,ANTI NUCLEAR AB IFA,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,URINALYSIS REFLEX,GLUCOSE QL,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,CREATINE KINASE CPK TOTAL,CREATINE KINASE CPK TOTAL,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,CBC WITH ABSOLUTE WBCS MPV,MCHC,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,CMP14 LP CBC D PLT TSH,PLATELETS,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.07507973713479688,0.0,0,28712,CMP14 TP TSH 2AC CBC D PLT,AMYLASE SERUM,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.1,0.16666666666666666,0.0,0.1,0.16666666666666666,0.0,0.014773989683119937,0.020585999559104562,0.0,0.014773989683119937,0.020585999559104562,0,241133,HIV AB AG COMBO RFLX CONF,HIV AB AG COMBO RFLX CONF,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.17,0.0,0.0,0.17,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,HB S AB QL,HB S AB QL,Specimen source identified,Specimen source XXX,Specimen source
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,CBC WITH DIFFERENTIAL PLATELETS,MCH,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,CMP,ALT SGPT,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,VITAMIN D 25 OH TOTAL IA,VITAMIN D 25 OH TOTAL IA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.16666666666666666,0.0,0.0,0.16666666666666666,0.0,0.0,0.1858678609476695,0.0,0.0,0.1858678609476695,0.0,0,15586,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CMP14 CBC D PLT TSH,ALBUMIN,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,T LYMPHOCYTE HELPER SUPPRESSOR,LYMPHS,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.05562292353768172,0.042260315089851286,0.5773502691896257,0,7328,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,DRUG ABUSE SCREEN III,METHAQUALONE,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.0,0.0,0.2075,0.16599999999999998,0.27666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,CBC DIFF PLT,PLATELET COUNT,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,NASH FIBROSURE,ALT SGPT P5P,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.592,0.49333333333333335,0.9866666666666667,0.592,0.49333333333333335,0.9866666666666667,0.40795382993965124,0.5255474069833806,0.530075858529406,0.40795382993965124,0.5255474069833806,0.530075858529406,1,497818,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06605502583691747,0.05720402135206337,0.7071067811865476,0,7047,CBC WITH PLT DIFF,BASOPHILS ABSOLUTE,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,BILIRUBIN FRACTIONATED,BILIRUBIN INDIRECT,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,CBC INCLUDES DIFF PLT,LYMPHOCYTES ABSOLUTE,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,C4 C3,COMPLEMENT C3 SERUM,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,CYSTIC FIBROSIS SCREEN,ETHNICITY,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,PT PTT,PARTIAL THROMBOPLASTIN,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.25,0.2,0.0,0.0,0.0,0.0,0.038616531850708125,0.0,0.0,0,422543,CMP14 HP4 1AC PT AFP,EGFR IF NONAFRICN AM,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,CMP12 LP TP TSH 6AC CBC D PLT,URIC ACID,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.25,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.06368655985836624,0.0,0.0,0.0,0.0,0,205088,IFE PE SERUM,BETA GLOBULIN,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,HEPATITIS BC AB IGM,HEPATITIS B CORE AB IGM,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0825,0.10600000000000001,0.0,0.5,0.2,1.0,0.0,0.0,0.0,0.1079337582384392,0.06903090216751562,0.7071067811865476,1,254284,URINALYSIS COMPLETE,GLUCOSE QL,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,COMP METABOLIC PANEL 14,EGFR IF NONAFRICN AM,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,PROTEIN TOTAL URINE,URINE TOTAL PROTEIN,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,LIVER FIBROSIS,NECROINFLAM ACT GRADE,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.2857142857142857,0.4,0.0,0.2857142857142857,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,HCV RNA NAA QUALITATIVE,HCV RNA NAA QUALITATIVE,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH TOTAL,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,CBC W AUTO DIFF WITH PLATELETS,MCHC,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,LIVER FIBROSIS FIBROMETER,FIBROMETER PATIENT SCORE,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,FIBROACT COMPLETE,WEIGHT LBS,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Body weight Measured,Weight Measured,Body weight
0.27,0.0,0.0,0.0,0.0,0.0,0.006570998517002713,0.0,0.0,0.0,0.0,0.0,0,487959,HCV FIBROSURE,LIMITATIONS,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,HEPATITIS B CORE TOTAL AB,HEPATITIS B CORE TOTAL AB,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,CMP14 4AC,EGFR IF AFRICN AM,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.4175,0.18142857142857144,0.0,0.6675,0.3242857142857143,0.0,0.017678793819410732,0.0,0.0,0.061241138223508074,0.059062741744354885,0.0,1,19901,CARDIO IQ R VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,CBC W AUTO DIFF WITH PLATELETS,RDW,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,NASH FIBROSURE,WEIGHT,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.1425,0.2,0.0,0.0,0.0,0.0,0.0,0.0488122190340754,0.0,0,254284,EIA 10 ALCOHOL W GCMS,URINE CREATININE MG DL,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.059019084403312494,0.24044117311858715,0.7071067811865476,1,29512,CMP WITH ESTIMATED GFR CALCULATED,CHEMISTRY SODIUM,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,OBSTETRIC PANEL,NEUTROPHILS,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CALCIUM,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.2783333333333333,0.3655555555555556,0.5483333333333333,0.04833333333333333,0.19444444444444445,0.2916666666666667,0.025199782485376465,0.025425559932405584,0.04202185668774028,0.0,0.02842664018742691,0.04698186404727078,1,481598,HEPATITIS C ANTIBODY W REFL HCV RIBA,SIGNAL CUT OFF,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,HEPATIC FUNCT PANEL W O TP,BILIRUBIN DIRECT,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,CBC WITH AUTO DIFF,BASOPHILS #,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,FSRC NEW PATIENT PANEL,D BILIRUBIN,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.22400000000000003,0.376,0.47,0.0,0.0,0.0,0.0,0.42501189506304327,0.054596653825419894,1,265058,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.1,0.0,0.2,0.125,0.5,0.0,0.028972496951288118,0.0,0.05623518965539054,0.07096783410499707,0.7071067811865476,1,196444,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,OXYCODONE,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,CMP,EGFR NON AFRICAN AMERICAN,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.16666666666666666,0.019,0.095,0.0,0.0,0.0,0.020983850759697886,0.015441346881271856,0.11262484863358568,0.0,0.024414913142778216,0.0,0,347047,HIV 1 RNA QN RT PCR,LOGCOPIES ML,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,LYMPHOCYTE SUBSET PANEL 1,ABSOLUTE CD8 CELLS,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,BUN CREATININE RATIO,EGFR NON AFR AMERICAN,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HCV RNA QUAL TMA,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.06,0.0,0.124,0.15833333333333333,0.31666666666666665,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,UA MICROSCOPIC REFLEX CULTURE,LEUKOCYTE ESTERASE,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.2,0.3333333333333333,0.4466666666666667,0.4,0.6666666666666666,0.0,0.0,0.0,0.0,0.5319935785070767,0.5335152913507774,1,111252,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.11399999999999999,0.08142857142857142,0.11399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,DRUG ABUSE PANEL 10 WITH OXYCODONE,AMPHETAMINES,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,CMP14 LP CBC D PLT TSH,PLATELETS,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,CBC WITH ABSOLUTE WBCS MPV,MCHC,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,HEP A AB IGM,HEPATITIS A AB IGM,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,CBC W O DIFF WITH PLATELETS,MCV,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,CBCI COMPLETE BLOOD COUNT W DIFF,ABS BASOPHILS,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,CBCI COMPLETE BLOOD COUNT W DIFF,BASOPHILS,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.4333333333333333,0.192,0.27,0.4333333333333333,0.364,0.41,0.0,0.030812935781862727,0.015750799349785072,0.0,0.16979300806363473,0.08679392382276507,1,28902,PROTEIN TOTAL URINE,PROTEIN CR RATIO,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,BMP,CHLORIDE,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.125,0.13333333333333333,0.0,0.0,0.0,0.0,0.024372659705731436,0.0741413717618874,0.0,0,426171,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.16666666666666666,0.14285714285714285,0.0,0.0,0.0,0.0,0.03140805245861067,0.0,0.0,0.0,0.0,0.0,0,716951,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,CK TOTAL,CREATINE KINASE TOTAL,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,CBC INCLUDES DIFF PLT,BLASTS,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,UROGRAM,APPEARANCE,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,IFE PE SERUM,GAMMA GLOBULIN,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.055,0.033,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,RPR REFLEX TP PA,RPR TITER,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,HEPATIC FUNCTION PANEL 6,AST SGOT,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,CREATINE KINASE CK,CREATINE KINASE CK,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,HCV GENOTYPE REFLEX NSA,HEPATITIS C GENOTYPE,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,HCV FIBROSURE,LIMITATIONS,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,CBC WITH PLT DIFF,NO CELLS DIFF,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,TESTOSTERONE TOTAL LC MS MS,TESTOSTERONE TOTAL LC MS MS,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0775,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.01,0.02,0.16999999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,486423,COMP METABOLIC PANEL 13,EGFR IF NONAFRICN AM,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.3733333333333333,0.5,0.3333333333333333,0.26166666666666666,0.5,0.3333333333333333,0.0065058524063457135,0.09932291697899664,0.9802699163255667,0.026741090613181417,0.40824829046386313,0.08109682212111924,1,487959,LIVER FIBROSIS FIBROMETER,FIBROMETER PATIENT SCORE,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,GLUCOSE,GLUCOSE,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,PTH INTACT,PTH INTACT,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,VITAMIN D 25 OH TOTAL IA,VITAMIN D 25 OH TOTAL IA,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.2,0.125,0.5,0.0,0.0,0.0,0.022957920040724278,0.028972496951288118,0.288675134594813,0.0,0.0,0.0,0,196444,DRUG ABUSE PANEL 10 WITH OXYCODONE,OPIATES,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.14285714285714285,0.2,0.346,0.5714285714285714,0.8,0.0,0.050346477724547034,0.050799169127257904,0.035467350927838925,0.1538110300980966,0.15519402517768222,1,51953,SUNRISE LABS ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.25,0.16699999999999998,0.5,0.0,0.0,0.0,0.050366252651508736,0.0,0.0,1,17434,ASH FIBROSURE,ALT SGPT P5P,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,CMP14,EGFR IF AFRICN AM,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,CBC WITH PLT DIFF,NUCLEATED RBCS,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,NASH FIBROSURE,HEIGHT,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.25,0.0,0.0,0.0,0.0,0.0,0.041776866509185884,0.0,0.0,0.0,0.0,0.0,0,7898,CBC W AUTO DIFF WITH PLATELETS,BASOPHILS,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.0,0.16666666666666666,0.5,0.0,0.16666666666666666,0.5,0.0,0.06368655985836624,0.0652954005184736,0.0,0.06368655985836624,0.0652954005184736,0,205088,HB S AB QL,HB S AB QL,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.18555555555555556,0.33399999999999996,0.0,0.18555555555555556,0.33399999999999996,0.0,0.055446852762574106,0.07759701258884111,0.0,0.055446852762574106,0.07759701258884111,0,51961,HEPATITIS BE ANTIGEN,HEPATITIS BE ANTIGEN,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,SPECIAL CUM 50 PLUS PROFILE # 10190,SEDIMENTATION RATE,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,CMP14 LP CBC D PLT,HEMATOCRIT,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0825,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,URINALYSIS W REFLEX MICRO,BACTERIA,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.010714285714285714,0.0375,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,LYMPHOCYTE SUBSET PANEL 1,CD4 ABSOLUTE,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06803603656800117,0.06673966886790239,0.10240603634159506,1,7708,HELPER T LYMPH CD4,NEUTROPHILS,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,CMP14 CBC D PLT TSH,EGFR IF AFRICN AM,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.26666666666666666,0.16666666666666666,0.5,0.26666666666666666,0.16666666666666666,0.5,0.0,0.13142842488073536,0.288675134594813,0.0,0.13142842488073536,0.288675134594813,1,44859,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.2,0.05555555555555555,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,DRUG ABUSE SCREEN 9 NO THC W CONF,BARBITURATES,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.06818181818181818,0.1875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,HEPATIC LIVER PANEL,DIRECT BILIRUBIN,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.11499999999999999,0.33,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,RPR REFLEX TP PA,RPR TITER,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.1425,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,LIVER PANEL II,LD,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,URINALYSIS W REFLEX MICRO,SPECIFIC GRAVITY,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,HEPATIC FUNCT PANEL W O TP,BILIRUBIN DIRECT,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.25,0.2,1.0,0.0,0.0,0.0,0.01102935257589821,0.02327427767615642,0.16732250730743758,0,108340,PE INTERP RFX IFE S,BETA GLOBULIN,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,CBC WITH DIFFERENTIAL PLATELETS,POLYS,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,COMPREHENSIVE METABOLIC PANEL AMA,SODIUM,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,CBC H H RBC INDICES WBC PLT,MPV,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,CBCI COMPLETE BLOOD COUNT W DIFF,ABS BASOPHILS,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,FOLATE,FOLATE,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,MICROALBUMIN CREATININE RANDOM RATIO,MICROALBUMIN RANDOM,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,CMP14,EGFR IF AFRICN AM,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,HEPATITIS C ANTIBODY W REFL HCV RIBA,SIGNAL CUT OFF,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,LIVER PANEL II,LD,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,CMP14 LP 6AC CBC D PLT ESR,CREATININE,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODY IGG,CCP ANTIBODY IGG,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.021150650734580778,0.0,0.0,0.0,0.0,0,237610,CBCI COMPLETE BLOOD COUNT W DIFF,ABS BASOPHILS,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,ASH FIBROSURE,WEIGHT,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,URINALYSIS RX ALB CREA,KETONES,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,RPR REFLEX TP PA,RPR,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,DRUG ABUSE PANEL NO CONFIRM,CREATININE,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.05357142857142857,0.0,0.0,0.05357142857142857,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,IMMUNOGLOBULIN M IGM,IMMUNOGLOBULIN M,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,URINALYSIS REFLEX,GLUCOSE QL,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,CBC D PLT,HEMOGLOBIN,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,HEPATITIS BE ANTIGEN,HEPATITIS BE ANTIGEN,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,CMP14 6AC,PHOSPHORUS,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,HIV AB AG RFLX CONF,HIV AG AB,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.42857142857142855,1.0,0.0,0.42857142857142855,0.4066666666666667,0.0,0.9131129509166843,0.9888882125258499,0.0,0.9233732785472102,1.0,1,19885,C REACTIVE PROTEIN INFLAMMATORY,C REACTIVE PROTEIN,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.05,0.1875,0.0,0.0,0.0,0.0,0.03964139192383853,0.0,0.0,0.0,0.0,0,381806,CBC D WITH PLT CITRATED BLD,LYMPHS,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,CMP WITH EGFR,ANION GAP,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,T LYMPHOCYTE HELPER SUPPRESSOR,LYMPHS,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,CBC,NEUTROPHIL,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,HEPATITIS C AB,HEPATITIS C AB,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,CMP,C02 BICARBONATE,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0834655896020069,0.34003516797720323,1.0,1,20750,RENAL FUNCTION PANEL,CHLORIDE,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.06666666666666667,0.25,0.0,0.06666666666666667,0.25,0.0,0.04432042353220711,0.12591840875016092,0.0,0.013744565837046196,0.03904957852907265,0,381806,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE AG,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.5,0.5714285714285714,0.6,0.0,0.0,0.0,0.4543382861631333,0.013656950654702071,0.034646396615759856,0.0,0.0,0.0,1,487967,HCV FIBROSURE,LIMITATIONS,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,CBC WITH MANUAL DIFFERENTIAL,PLATELET COUNT,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,IRON BINDING CAPACITY % SATURATION,CALCULATED % IRON SAT,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,TRICHOMONAS MALE,SOURCE,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,URINALYSIS W REFLEX MICRO,SPECIFIC GRAVITY,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,PHOSPHORUS,PHOSPHORUS,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,HEPATITIS B CORE AB,HEPATITIS B CORE AB,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.25,0.2857142857142857,0.3333333333333333,0.0,0.0,0.0,0.023431114657866403,0.0,0.0,0.0,0.0,0.0,0,7765,CBC D WITH PLT CITRATED BLD,LYMPHS,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,HAV AB TOTAL,HAV AB TOTAL,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,HEPATITIS BS AB QUANT,HEPATITIS BS AB INTERP,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,CMP14 1AC,ALT SGPT,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.3333333333333333,0.14285714285714285,0.3333333333333333,0.3333333333333333,0.0,0.0,0.014475995637726058,0.040691512448715605,0.061372572100865885,0.09629383728860574,0.0,0.0,1,25007,IRON TIBC,TIBC,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,X HEPATITIS COMPLEX PROFILE,ANTI HCV,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.2857142857142857,0.2757142857142857,0.965,0.2857142857142857,0.2757142857142857,1.0,0.2458696638252934,0.011170953400621464,0.04372412516808821,0.2458696638252934,0.011170953400621464,0.04372412516808821,1,296095,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,TRICHOMONAS MALE,SOURCE,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,428102,CBC WITH DIFFERENTIAL PLATELETS,MCH,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,HELPER T LYMPH CD4,NEUTROPHILS,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,MICROALBUMIN RANDOM SPEC,MICROALBUMIN,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,TSH SML,TSH,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,COMP METABOLIC PANEL CLARIFICATION,EGFR NON AFR AMERICAN,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,COMPREHENSIVE METABOLIC PANEL,ALBUMIN,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,URINALYSIS RX ALB CREA,KETONES,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,PROTHROMBIN PTT,CONTROL,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,COMP METABOLIC PANEL W GFR,ANION GAP,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,CBC WITH PLT DIFF,MONOCYTES ABSOLUTE,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,HEPATITIS C VIRUS RNA QUALITATIVE PCR,HEPATITIS C VIRUS RNA QUALITATIVE PCR,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,FERRITIN,FERRITIN SERUM,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,PATHOLOGIST SMEAR REVIEW,MONOCYTES,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.09090909090909091,0.14285714285714285,0.0,0.0,0.0,0.0,0.032032103921319166,0.04565527673226788,0.0,0.0,0.0,0,831008,ANA REFLEX AUTOIMMUNE AB PROFILE,ANTI NUCLEAR ANTIBODIES,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,GLUCOSE,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.2866666666666667,0.3333333333333333,1.0,0.0,0.0,0.0,0.0,0.042056338045787456,0.046108379515458875,1,20859,CMP14 HP5 LP 6AC CBC D PLT,HDL CHOLESTEROL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,PSA TOTAL % FREE,PSA FREE,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,CREATININE,EGFR IF AFRICN AM,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.1,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,PROTHROMBIN TIME,PT POP MEAN,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.0769832768017027,0.08055537486383768,0.09169555407390673,1,264853,MA CBC DIFF PLT,MONOCYTES %,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,HAPTOGLOBIN,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.0,0.0,0.0,0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.026788804540796574,0.0,0,32896,CBC DIFF PLT,PLATELET COUNT,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.1425,0.57,0.0,0.1425,0.57,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,AFP SERUM TUMOR MARKER,AFP SERUM TUMOR MARKER,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.25,0.0,0.0,0.25,0.16666666666666666,1.0,0.0672790962344263,0.051758104169687846,0.0,0.0672790962344263,0.051758104169687846,0.7071067811865476,1,7534,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,HIV 1 RNA QN RT PCR,HIV 1 RNA QN RT PCR,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,82511,HCV FIBROSURE,LIMITATIONS,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,LYMPHOCYTE SUBSET PANEL 4,HELPER SUPPRESSOR RATIO,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,PHOSPHATE AS PHOSPHORUS,LIPEMIA,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,CBC WITH PLT DIFF,PROMYELOCYTES,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.045454545454545456,0.125,0.0,0.0,0.0,0.0,0.03540360693747757,0.0,0.0,0.0,0.0,0,322867,CBC WITH AUTO DIFF,LYMPHOCYTES #,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,AUTOMATED BLD CNT,HEMOGLOBIN,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,PROTHROMBIN TIME,PT POP MEAN,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,URINALYSIS CULTURE IF INDICATED,BILIRUBIN,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,DRUG ABUSE SCREEN W ETOH NO GCMS,BENZODIAZEPINES,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CMP WITH EGFR,CARBON DIOXIDE,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,IMMUNOFIXATION SERUM,IGG SERUM NR,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.2857142857142857,0.3333333333333333,0.0,0.2857142857142857,0.3333333333333333,0.0,0.1229667561500386,0.17375497797569384,0.0,0.1229667561500386,0.17375497797569384,1,18259,ALPHA 1 ANTITRYPSIN SERUM,ALPHA 1 ANTITRYPSIN SERUM,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,LYMPHOCYTE SUBSET PANEL 1,CD4 ABSOLUTE,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,CBC W DIFF PLT,MONOCYTES %,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,URINALYSIS CULTURE IF INDICATED,BILIRUBIN,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,MITOCHONDRIAL ANTIBODY W RFX,MITOCHONDRIAL AB,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.14666666666666667,0.088,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,HBSAB AG,HEP B SURFACE AB QUAL,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,TESTOSTERONE FR DIALYSIS TOTAL LC MS MS,FREE TESTOSTERONE,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.24666666666666667,0.148,0.37,0.5333333333333333,0.2,0.0,0.0,0.0,0.0,0.015199507661834533,0.019538279191327113,0.0,1,93187,MICROALBUMIN CONC,ALB CREAT RATIO,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,MANUAL DIFFERENTIAL,BLASTS %,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,PE INTERP RFX IFE S,ALBUMIN,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,RENAL FUNCTION PANEL,CREATININE,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,PHOSPHORUS,PHOSPHORUS,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.01,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,CMP12 2AC,BILIRUBIN TOTAL,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,CBC PLATELET HEM REVIEW,NEUTROPHILS,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.5,0.3333333333333333,0.5,0.0,0.0,0.0,0.14187034543632637,0.140463816246154,0.7071067811865476,1,31419,ASH FIBROSURE,WEIGHT,Body weight Measured,Weight Measured,Body weight
0.0,0.007000000000000001,0.035,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,COMPREHENSIVE METABOLIC PANEL W EGF,EGFR NON AFR AMERICAN,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.047619047619047616,0.0,0.0,0.0,0.0,0.0,0.004447289633887519,0.0,0,882944,CBC INCLUDES DIFF PLT W SMEAR RVW,WHITE BLOOD CELL COUNT,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,HEPATIC FUNCTION PNL,GLOBULIN,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.066,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06846967404361237,0.3219325786555107,1.0,1,15586,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,CBC WITH PLT DIFF,BLASTS,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,CBC WITH PLT MAN DIFF,BANDS,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,GLUCOSE,GLUCOSE,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.07870803013413097,0.08752895424186691,0.10240603634159506,1,265116,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,HCV RNA QN PCR W REFL GENOTYPE LIPA R,HCV RNA QUANTITATIVE REAL TIME PCR,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,CBC WITH DIFFERENTIAL PLATELETS,MCH,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.01,0.015,0.0,0.028333333333333335,0.0425,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,CMP14 LP CBC D PLT TSH UA M,HDL CHOLESTEROL,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,495499,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A RESIST ASSAY INTERP,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,CMP CBC TSH,ABSOLUTE BLASTS,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.0,0.0,0.0,0.16636363636363638,0.4575,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,CMP14 CBC D PLT RPR UA TSH,HCV AB,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.16666666666666666,0.25,0.25,0.555,0.8325,0.0,0.07184578234577044,0.07240860968350848,0.052680508392901615,0.14369156469154098,0.14481721936701708,1,161281,HEPATITIS PANEL ACUTE,HEPATITIS C AB CIA,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,URINALYSIS COMPLETE,BILIRUBIN,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,CMP14 LP 5AC CBC D PLT RPR,CHOLESTEROL TOTAL,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,TSH 3RD GENERATION,TSH 3RD GENERATION,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,URINALYSIS CULTURE IF INDICATED,BACTERIA,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,FE TIBC FER,IRON BIND CAP TIBC,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.4,0.25,0.6666666666666666,0.0,0.0,0.0,0.43159805011496677,0.036870751523516376,0.02890669461985995,1,141358,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.054435397064445,0.056961251827243986,0.0648385480903172,0,301804,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.16625,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,HCV FIBROSURE,NECROINFLAMMAT ACTIVITY SCORE,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,1,460980,HEPASCORE R,SEX,Sex,Sex,Sex
0.0,0.03142857142857143,0.044,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,URINALYSIS COMPLETE,GLUCOSE,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.06888888888888889,0.124,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,CLR CBC W DIFF PLT,ABSOLUTE BLASTS,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,CBC WITH AUTO DIFF,MONOCYTES #,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,DRUG ABUSE PANEL NO CONFIRM,CREATININE,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,GLYCOHEMOGLOBIN A1C,GLYCOHEMOGLOBIN A1C,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.018125,0.03625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,MANUAL DIFFERENTIAL,BLASTS %,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,RENAL FUNCTION PANEL,BUN,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,CREATININE,EGFR IF AFRICN AM,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,URINALYSIS COMPLETE,BILIRUBIN,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,LYMPHOCYTE SUBSET PANEL 3,ANALYZED DATE TIME,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,HDL AS % CHOLESTEROL,HDL AS % CHOLESTEROL,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,CBC W AUTO DIFF,% EOSINOPHILS,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,CBC,MO%,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,ASH FIBROSURE,COMMENT,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.3333333333333333,0.4166666666666667,0.75,0.3333333333333333,0.4166666666666667,0.75,0.059107272304839475,0.09603676610456913,0.13440196831943452,0.059107272304839475,0.09603676610456913,0.13440196831943452,0,139527,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.154,0.06625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,URINALYSIS W MICRO W REFLEX CULTURE,WBC,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,IRON BINDING CAPACITY,UIBC NR,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,MA CBC DIFF PLT,MONOCYTES %,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,RPR,TREPONEMA PALLIDUM ANTIBODIES,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,URINALYSIS CULTURE IF INDICATED,COLOR,Specimen source identified,Specimen source XXX,Specimen source
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,GLUCOSE,Color of Urine,Color Ur,Color
0.0,0.08333333333333333,0.125,0.1,0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,CBC WITH PLT DIFF,MONOCYTES ABSOLUTE,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,LIVER FIBROSIS PANEL,ALT,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.084,0.0,0.0,0.084,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD LOG IU ML,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.07761546026945332,0.0,0.0,0.0,0.0,0,30841,IFE PE SERUM,ALPHA 1 GLOBULIN,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.05714285714285715,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,COMP METAB PANEL,EGFR NON AFR AMERICAN,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,CEA,CEA,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,TESTOSTERONE,TESTOSTERONE,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,CBC INC DIFF PLT,BASOPHILS,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,COMP METABOLIC PANEL,GLUCOSE NON FASTING,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,COMP METABOLIC PANEL,GLUCOSE NON FASTING,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.16666666666666666,0.0,0.0,0.16666666666666666,0.0,0.0,0.022155855810859326,0.0,0.0,0.03837506794957857,0.0,0,7146,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,CBC DIFF PLT,PLATELET COUNT,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,GLUCOSE,GLUCOSE FASTING,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,PHOSPHATE AS PHOSPHORUS,LIPEMIA,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,CBC WITH DIFFERENTIAL PLATELETS,EOS,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,ACCUTYPE R IL28B NY,IL28B GENOTYPE,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,CMP14 LP CBC D PLT TSH HB A,ALT SGPT,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,CHOLESTEROL TOTAL,ICTERUS,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.0,0.0,0.0,0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.05117681691383591,0.0,0,381806,HEMOGRAM W O DIFFERENTIAL,MEAN PLATELET VOLUME,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,RPR,RPR RESULT,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,URINALYSIS COMPLETE,GLUCOSE QL,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,HEPATIC FUNCTION PANEL,,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,HEPATIC FUNCTION PANEL,ALK PHOS,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,CHEM SCREEN PANEL,BILIRUBIN DIRECT,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,CBC W DIFF PLT,BASOPHILS ABSOLUTE,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,ACCUTYPE R IL28B NY,IL28B GENOTYPE,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,DRUG ABUSE SCREEN III,METHADONE,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,APTT,PARTIAL THROMBOPLASTIN,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,CMP13 LP TP TSH 2AC CBC D P,LDL CHOLESTEROL CALC,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,DIRECT LDL,LDL CHOLESTEROL DIRECT,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.1,0.09090909090909091,0.14285714285714285,0.1,0.09090909090909091,0.14285714285714285,0.006866470170078465,0.007908587791602084,0.008518356482276168,0.006866470170078465,0.007908587791602084,0.008518356482276168,0,568881,HEPATITIS B CORE AB,HEPATITIS B CORE AB,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.07571428571428572,0.0,0.0,0.07571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,CERULOPLASMIN,CERULOPLASMIN,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,COMP METABOLIC PANEL,ANION GAP,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.07142857142857142,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,CBC WITH MANUAL DIFFERENTIAL,RDW,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06797427042040116,0.05720402135206337,0.7071067811865476,1,7310,CBC INCLUDES DIFF PLT WITH PATHOLOGIST REVIEW,ABSOLUTE LYMPHOCYTES,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,HEMOGLOBIN A1C,AVERAGE WHOLE BLOOD GLUCOSE,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.028894352326416572,0.0,0,24729,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.088,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,UA MICROSCOPIC REFLEX CULTURE,PH,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,CBC WITH MANUAL DIFFERENTIAL,MCHC,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.3333333333333333,0.235,0.94,0.0,0.0,0.0,0.11098565713428754,0.0,0.0,1,265157,CBC DIFF PLT,PLATELET COUNT,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.2857142857142857,0.26666666666666666,1.0,0.5714285714285714,0.4,1.0,0.2855798754616614,0.01538990021601927,0.04372412516808821,0.342193711333066,0.032041686606521624,0.022758346319911804,1,381806,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD LOG IU ML,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,CMP14 6AC,PHOSPHORUS,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.24333333333333332,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.094701559498232,0.34003516797720323,1.0,1,178616,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CALCIUM,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.155,0.2,0.5,0.0,0.0,0.0,0.0,0.07982873259716383,0.5,1,304519,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,COMPLETE BLOOD COUNT,MCV,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,LYMPHOCYTE SUBSET PANEL 5,CD4 % POS,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,LIVER FIBROSIS FIBROTEST ACTITEST P,APOLIPOPROTEIN A1,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,LIPID PANEL WITH REFLEX DIRECT L,HDL CHOLESTEROL,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,HEPATITIS C VIRUS RNA QN REAL TIME PCR,HCV RNA PCR QN,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,TESTOSTERONE,TESTOSTERONE,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,CBC ESR,ABSOLUTE NEUTROPHILS,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,GENERAL HEALTH PANEL,HEMATOCRIT,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,IFE PE SERUM,M SPIKE,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,CBC WITH DIFFERENTIAL,MCHC,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.3333333333333333,0.16666666666666666,0.5,0.3333333333333333,0.16666666666666666,0.5,0.09247447620418048,0.0,0.0,0.06538932921065,0.0,0.0,1,20396,CEA,CEA CENTAUR,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.02125,0.0425,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,LIPID PROFILE WRFL LDL DIRECT,NON HDL CHOLESTEROL,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.1825,0.0,0.0,0.1325,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,PROTIME PTT,PROTHROMBIN TIME PT,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,ARTHRITIS PROFILE,RHEUMATOID FACTOR QUANT,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,PSA FREE TOTAL,FREE PSA,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,CBC WITH AUTO DIFF,NRBC,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,CMP,ALT SGPT,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,CBC W AUTO DIFF,% LYMPHOCYTES,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.08333333333333333,0.125,0.1875,0.22666666666666666,0.09,0.0,0.0,0.0,0.0,0.07184578234577044,0.0,0,161281,C4 C3,COMPLEMENT C3 SERUM,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,COMP METAB PANEL,GLUCOSE FASTING,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,CBC WITH DIFF PLATELET,EOS ABSOLUTE,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,PROTEIN ELEC INTERP SERUM,ALPHA 2 GLOBULIN,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,CREATINE KINASE CK,CREATINE KINASE CK,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,HEPASCORE R,SEX,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,ACCUTYPE R IL28B,IL28B GENOTYPE,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,CMP12 LP TP TSH 6AC CBC D PLT,URIC ACID,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CBCI COMPLETE BLOOD COUNT W DIFF,MCH,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,CBC PLT DIFF,ABSOLUTE EOS,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,CBC INC DIFF PLT,RBC,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,CHOL HDL RATIO,CHOL HDL RATIO,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.022727272727272728,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,AUTOMATED BLD CNT,MCH,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,CBC W AUTO DIFF,MCV,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,RPR REFLEX TITRE TPPA,RPR,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,SPECIAL A 2 PANEL #9633,POLYS,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,CBC WITH DIFFERENTIAL PLATELETS,MCH,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,SEGMENTED NEUTROPHILS,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,CBC PLATELET NO DIFFERENTIAL,HEMATOCRIT,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,OXYCODONE,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,HIV 1 RNA QN RT PCR,HIV 1 RNA QN RT PCR,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,PROTEIN TOTAL URINE,PROTEIN CR RATIO,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,CBC WITH DIFFERENTIAL PLATELETS,MCH,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.25,0.2,1.0,0.0,0.0,0.0,0.07962607175736813,0.12353958214165095,1.0,1,195503,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHADONE,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,CBC WITH DIFFERENTIAL,NEUTROPHILS,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,BUN CREATININE RATIO,EGFR NON AFR AMERICAN,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,CBC WITH PLT DIFF,NRBC,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,CBC WITH PLT DIFF,RBC MORPHOLOGY,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0825,0.08833333333333333,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.07163871665340582,0.09716253076254433,1.0,1,57976,URINALYSIS RX ALB CREA,KETONES,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,VITAMIN D 25 OH TOTAL IA,VITAMIN D 25 OH TOTAL IA,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,SPECIAL A 2 PANEL #9633,POLYS,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,LIPID PANEL,VLDL CHOL CALC,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,VITAMIN D 25 OH,VITAMIN D 25 OH,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,CREATINE KINASE CK,CREATINE KINASE CK,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,LD,LD,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.165,0.265,0.0,0.5,0.5,1.0,0.0,0.0,0.0,0.1503314858492919,0.7071067811865476,1.0,1,57786,URINALYSIS W REFLEX MICRO,COLOR,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,URINALYSIS CULTURE IF INDICATED,APPEARANCE,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.46499999999999997,0.25142857142857145,0.5,0.0,0.0,0.0,0.008912499759331616,0.025541167468744463,0.04409367683763299,1,134577,LIPID CASCADE,LDL CHOLESTEROL CALC,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.0691807192705608,0.0556189409485538,0.10240603634159506,1,237610,CBC PLATELET HEM REVIEW,NEUTROPHILS,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,RENAL FUNCTION PANEL,BUN,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,APOLIPOPROTEIN A1,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,LIPID PANEL WITH DIRECT LDL,TRIGLYCERIDES,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.06538932921065,0.4808823462371743,0.7071067811865476,0.0,0.0,0.0,1,24588,IGA SERUM,IMMUNOGLOBULIN A,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,MICROALBUMIN CREATININE RANDOM RATIO,MICROALBUMIN RANDOM,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,NASH FIBROSURE,WEIGHT,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,HEPATITIS A IGM,HEPATITIS A IGM,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,LIVER FIBROSIS PNL HEPASCORE TM,F2,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,URINALYSIS W REFLEX MICRO,BACTERIA,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.05896036458680387,0.0,0,327692,FERRITIN,FERRITIN SERUM,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,COMPREHENSIVE METABOLIC PANEL E GFR,ALT,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.047,0.15666666666666665,0.0,0.047,0.15666666666666665,0.0,0.35622065033847605,0.9888882125258499,0.0,0.35622065033847605,0.9888882125258499,1,305227,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN TOTAL RANDOM UR,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,CBC WITH PLT DIFF,MPV,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,COMPREHENSIVE METABOLIC PANEL W EGF,EGFR NON AFR AMERICAN,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.25,0.16666666666666666,0.0,0.2375,0.16666666666666666,1.0,0.013498539226855177,0.010384485502120788,0.0,0.0,0.051758104169687846,0.7071067811865476,1,7120,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.24,0.25,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,1,192526,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.22333333333333336,0.25,0.5,0.22333333333333336,0.25,0.5,0.0,0.05054166547762551,0.40824829046386313,0.0,0.05054166547762551,0.40824829046386313,1,148692,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,CMP14 LP TP TSH 4AC CBC D PLT,URIC ACID,Specimen source identified,Specimen source XXX,Specimen source
0.31,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.032615729323927534,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,823773,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.3333333333333333,0.0,0.0,0.3333333333333333,0.2,0.0,0.05034268654663743,0.0,0.0,0.08719609088829028,0.21223170681007852,0.0,1,7872,CBC W AUTO DIFF,MCV,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CMP14 LP CBC D PLT TSH T4F,NEUTROPHILS ABSOLUTE,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,CBC W AUTO DIFF,% EOSINOPHILS,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,SPECIAL PROFILE # 5144,TSH ULTRASENSITIVE,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.012857142857142857,0.045,0.0,0.012857142857142857,0.045,0.0,0.06317690320497038,0.0,0.0,0.06317690320497038,0.0,0,204164,C4 SERUM,C4 SERUM,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.004285714285714286,0.015,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,CMP13 LP TP TSH 2AC CBC D P,AST SGOT,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,143149,DRUG ABUSE PANEL 10 WITH OXYCODONE,COCAINE METABOLITE,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,HIV 1 RNA QN RT PCR,RACE NR,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.05,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,CBC WITH MANUAL DIFFERENTIAL,WBC,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,CBC WITH MANUAL DIFFERENTIAL,PLATELET COUNT,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,LIVER FIBROSIS FIBROTEST,ALPHA 2 MACROGLOBULIN,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,BUN CREATININE,BUN,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,FE TIBC FER,IRON BIND CAP TIBC,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.2,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,COMPREHENSIVE METABOLIC PANEL WITH GFR,T BILIRUBIN,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,HIV AG AB 4TH GEN RFL,RACE NR,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,WESTERGREN SED RATE,WESTERGREN SED RATE,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,PROTEIN ELECTRO S,GAMMA GLOBULIN,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,HEPATIC LIVER PANEL,DIRECT BILIRUBIN,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,PTT,PTT,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,ASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,CBC W O DIFF WITH PLATELETS,MCV,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,PROTEIN TOTAL URINE,URINE TOTAL PROTEIN,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.13799999999999998,0.0,0.0,0.13799999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.0,0.0,0.0,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,CBC W DIFF PLT,ABSOLUTE NEUTROPHILS,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,CBC WITH PLT DIFF,MYELOCYTES,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,IMMUNOGLOBULIN M IGM,IMMUNOGLOBULIN M,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,HIGH SENSITIVITY CRP,HIGH SENSITIVITY CRP,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.5,0.3333333333333333,0.0,0.0,0.0,0.0,0.1503314858492919,0.7071067811865476,0.0,1,304287,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.146,0.3333333333333333,0.5,0.0,0.0,0.0,0.0,0.10468302532759188,0.5,0.0,0.0,0.0,0,128512,PROTEIN ELECTROPHORESIS,BETA GLOBULINS,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.14666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,DRUG ABUSE SCREEN W ETOH NO GCMS,COCAINE METABOLITE,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp,Daclatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,COMMENTS,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,SED RATE WESTERGREN,SED RATE WESTERGREN,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.356,0.39,0.25,0.0,0.0,0.0,0.0488962690001733,0.0,0.051702018527091775,0.07731178956241591,0.0,1,50484,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,NASH FIBROSURE,ALT SGPT P5P,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,COMP METABOLIC PANEL W EGFR,UREA NITROGEN,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.2,0.36363636363636365,1.0,0.0,0.2727272727272727,0.75,0.028666628507924785,0.03540360693747757,0.051861339431772846,0.0,0.10013652217581392,0.14668601917449553,1,322867,HCV GENOTYPE REFLEX NSA,HEPATITIS C GENOTYPE,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,TESTOSTERONE FR DIALYSIS TOTAL LC MS MS,FREE TESTOSTERONE,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,CHEM SCREEN PANEL HDL,URIC ACID,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,IMMUNOGLOBULIN M,IMMUNOGLOBULIN M,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.2,0.25,0.0,0.0,0.0,0.0,0.027385328599057512,0.07274033002715963,0.0,0.0,0.0,0,345355,HEPATIC FUNCT PANEL W O TP,BILIRUBIN DIRECT,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,CBC COMPLETE BLOOD COUNT W O DIFF,RED BLOOD CELL COUNT,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,CBCI COMPLETE BLOOD COUNT W DIFF,MCH,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,CBC WITH DIFFERENTIAL,IMMATURE GRANS,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,VIT B 12 FOLATE PANEL,FOLIC ACID,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.07142857142857142,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,CBC WITH DIFFERENTIAL,MYELOCYTES,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,COMPREHENSIVE METABOLIC PANEL E GFR,ALT,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,HCV FIBROSURE,LIMITATIONS,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,TESTOSTERONE FR DIALYSIS TOTAL LC MS MS,FREE TESTOSTERONE,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,OBSTETRIC PANEL,RPR RESULT,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,VITAMIN B12 FOLATE,VITAMIN B12,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,CBC WITH MANUAL DIFFERENTIAL,MCH,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,NASH FIBROSURE,AST SGOT P5P,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.15,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.20714285714285716,0.7250000000000001,0.0,0.0,0.0,0.0,0.0,0.0,1,67686,HEPATIC FUNCTION PANEL,ALK PHOS,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.25,0.16666666666666666,0.0,0.0,0.0,0.0,0.013148975468412205,0.009990122975599758,0.0,0.0,0.0,0.0,0,7328,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,MCCARJUH MCCARTHY PROFILE 1,PROTHROMBIN TIME PT,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CMP,ALT SGPT,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,RBC,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,URINALYSIS CULTURE IF INDICATED,GLUCOSE,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.004285714285714286,0.015,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,CMP14 LP 2AC CBC D PLT MG T,WBC,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.22333333333333336,0.25,0.5,0.5566666666666666,0.45,0.9,0.0,0.05054166547762551,0.40824829046386313,0.0360154199639221,0.03573835439169104,0.28867513459481287,1,148692,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,CMP14 LP CBC D PLT TSH HB A,ALT SGPT,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,CBC W AUTO DIFF,MCV,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,CK TOTAL,CREATINE KINASE TOTAL,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.092,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,1,7138,ANEMIA PROFILE B,EOS,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,CBC COMPLETE BLOOD COUNT W O DIFF,RED BLOOD CELL COUNT,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,COMPREHENSIVE METABOLIC PANEL E GFR,AST,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.028999999999999998,0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,CMP CBC TSH,ABSOLUTE BLASTS,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,TSH 3RD GENERATION REFL,TSH 3RD GENERATION REFL,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,HCV RNA GENO W REFL NS5A,HCV RNA GENOTYPE LIPA R,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,LIPID PANEL,,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,FSRC NEW PATIENT PANEL,D BILIRUBIN,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,ANA REFLEX AUTOIMMUNE AB PROFILE,ANTI NUCLEAR ANTIBODIES,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,HCV FIBROSURE,INTERPRETATION,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.47250000000000003,0.47250000000000003,0.845,0.0,0.0,0.0,0.04253195834778967,0.048957493004297636,0.0,1,81240,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,ASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CBC INCLUDES DIFF PLT,ABSOLUTE NEUTROPHILS,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,COMPREHENSIVE METABOLIC PANEL WITH GFR,ALBUMIN,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.125,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.04518224294020212,0.0,0.0,0.0,0.0,0,427682,IFE PE SERUM,ALPHA 1 GLOBULIN,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,OXYCODONE,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,CMP,TCO2,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,TESTOSTERONE,TESTOSTERONE,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,ASH FIBROSURE,HEIGHT,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,UROGRAM,APPEARANCE,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,MITOCHONDRIAL AB SCREEN,MITOCHONDRIAL AB SCREEN,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.115,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,7112,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,IRON BINDING CAPACITY,TIBC,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,BUN CREATININE RATIO,HEMOLYSIS,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,DRUG ABUSE PANEL 10 WITH OXYCODONE,OPIATES,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,CMP14 HP5 LP 6AC CBC D PLT,BILIRUBIN INDIRECT,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,CMP14 CBC D PLT ESR WES ANA,POTASSIUM,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,HCV FIBROSURE,COMMENT,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,IGA SERUM,IMMUNOGLOBULIN A,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,CBC WITH DIFFERENTIAL,MCHC,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,RENAL FUNCTION PANEL,ANION GAP,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.06,0.045,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,CBC WITH MANUAL DIFFERENTIAL,WBC,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.2,0.0,0.0,0.2,0.0,0.0,0.025209020374968416,0.0,0.0,0.025209020374968416,0,63016,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,CREATINE KINASE CK,CREATINE KINASE CK,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,ASH FIBROSURE,WEIGHT,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,LD,LD,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,COMPREHENSIVE METABOLIC PANEL E GFR,BUN,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.08,0.08857142857142856,0.155,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,CBC WITH AUTO DIFF,RDW,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,GLUCOSE,GLUCOSE,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.01611111111111111,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.5,0.2857142857142857,1.0,0.5,0.2857142857142857,1.0,0.10268539797375953,0.18516494256834526,0.10031748330730439,0.10268539797375953,0.18516494256834526,0.10031748330730439,1,30247,FREE T4,FREE T4,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,CBC WITH AUTO DIFF,RDW,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,ARTHRITIS PROFILE,RHEUMATOID FACTOR QUANT,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,CMP14 CBC D PLT TSH,EGFR IF AFRICN AM,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.335,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,CMP12 LP TP TSH 6AC CBC D PLT,URIC ACID,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,HEPATITIS B SURFACE ANTIGEN W REFL CONFIRM,CONFIRMATION,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESISTANCE ASSAY PDF,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,HEP C VIRUS ANTIBODY,HEP C VIRUS ANTIBODY,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,DIRECT LDL,TRIGLYCERIDES,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,CBC PLATELET NO DIFFERENTIAL,HEMATOCRIT,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.316,0.125,0.3333333333333333,0.0,0.0,0.0,0.0,0.624939177332759,1.0,1,28688,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,CBC D WITH PLT CITRATED BLD,LYMPHS,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA PATTERN,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.11200000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,PSA WITH FREE RATIO,PSA ROCHE E170,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,SPECIAL CUM 50 PLUS PROFILE # 10190,SEDIMENTATION RATE,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,CBC WITH PLT DIFF,BANDS,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.08,0.05714285714285715,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,MITOCHONDRIAL M2 ANTIBODY,MITOCHONDRIAL M2 ANTIBODY,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual,Promyelocytes/100 leukocytes
0.24666666666666667,0.2,1.0,0.24666666666666667,0.2,1.0,0.0,0.04684727929085075,0.13777186509717598,0.0,0.04684727929085075,0.13777186509717598,1,29868,TESTOSTERONE TOTAL LC MS MS,TESTOSTERONE TOTAL LC MS MS,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.03140805245861067,0.0,0.0,0.0,0.0,0.0,0,716951,CBC W AUTO DIFF,% LYMPHOCYTES,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.0877518356997824,0.5773502691896257,1.0,1,23366,HEPATIC FUNCTION PANEL AMA,GLOBULIN,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,PROTEIN ELEC INTERP SERUM,M SPIKE,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,COMP METABOLIC PANEL CLARIFICATION,ALT,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.51,0.07714285714285715,0.18000000000000002,0.5733333333333334,0.14285714285714285,0.0,0.0,0.026851387692230055,0.02730695787333337,0.0,0.11392078992866939,0.07723574034323777,1,110544,LP WITHOUT VLDL CHOL HDL LD,LDL HDL RATIO,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,HELPER T LYMPH CD4,NEUTROPHILS,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,CBC,HEMOGLOBIN,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,ASH FIBROSURE,HEIGHT,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,HEPASCORE R,AGE,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,PE INTERP RFX IFE S,ALBUMIN,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,UREA NITROGEN BUN,ICTERUS,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.04421732307181936,0.0,0.0,0,143164,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.36,0.5242857142857142,0.9175,0.0,0.11857142857142856,0.2075,0.007003812612930815,0.6069574118776362,0.6844120915582587,0.0,0.04612090043126471,0.0520064526950299,1,632117,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,HEPATITIS C AB,HEPATITIS C AB,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,CMP14,EGFR IF AFRICN AM,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,24588,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,LYMPHOCYTE SUBSET PANEL 3,% CD3 CD4 HELPER T4,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.134,0.0,0.0,0.08,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CBC PLT DIFF,ABSOLUTE EOS,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.09499999999999999,0.18999999999999997,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,DRUG ABUSE PANEL 10 WITH OXYCODONE,OPIATES,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,COMP METABOLIC PANEL,GLUCOSE NON FASTING,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.03142857142857143,0.044,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,BMP8 ANION GAP,EGFR IF NONAFRICN AM,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,CBC WITH DIFF PLATELET,EOS ABSOLUTE,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0778627478619458,0.0,0,28746,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.372,0.125,0.0,0.372,0.125,0.5,0.036291544283745814,0.1429123037254596,0.11098565713428754,0.007209164079868158,0.042583400634602975,0.04409367683763299,1,182626,DIRECT LDL,LDL CHOLESTEROL DIRECT,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,URINALYSIS C,BILIRUBIN,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD LOG IU ML,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,COMP METABOLIC PANEL W EGFR,UREA NITROGEN,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.4333333333333333,0.48250000000000004,0.93,0.5766666666666667,0.48250000000000004,0.93,0.0,0.1319329443888393,0.11425728143681435,0.017380646215893303,0.10927182779409028,0.18926435757528148,1,28886,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN TOTAL RANDOM UR,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,PSA FREE TOTAL,% FREE PSA,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.16666666666666666,0.3509090909090909,0.965,0.16666666666666666,0.3509090909090909,0.965,0.013981027486543729,0.338287383181624,0.9420374874901866,0.013981027486543729,0.338287383181624,0.9420374874901866,1,112599,HEPATITIS C VIRUS RNA QUALITATIVE PCR,HEPATITIS C VIRUS RNA QUALITATIVE PCR,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.09,0.315,0.0,0.0,0.0,0.0,0.0,0.0,1,20289,CMP,C02 BICARBONATE,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.05142857142857143,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,CBC INCLUDES DIFF PLT,MCHC,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.02428571428571429,0.034,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,VIT B 12 FOLATE PANEL,FOLIC ACID,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,ASH FIBROSURE,ALT SGPT P5P,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.25,0.0,0.0,0.0,0.0,0.0,0.047471586974075164,0.0,0.0,0.0,0.0,0.0,0,7773,CBC WITH DIFF PLATELET,EOS ABSOLUTE,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,HEPATITIS BS AB QUANT,HEPATITIS BS AB QUANT,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,CMP13 LP TP TSH 2AC CBC D P,NEUTROPHILS ABSOLUTE,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,ASH FIBROSURE,ALT SGPT P5P,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,HEPATITIS C VIRUS RNA QUALITATIVE PCR,HEPATITIS C VIRUS RNA QUALITATIVE PCR,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,COMP METABOLIC PANEL 14,EGFR IF NONAFRICN AM,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.16,0.0,0.0,0.16,0.0,0.0,0.07132561100505608,0.0,0.0,0.07132561100505608,0.0,0,195503,MITOCHONDRIAL AB SCREEN,MITOCHONDRIAL AB SCREEN,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.26,0.2,1.0,0.0,0.0,0.0,0.0,0.34003516797720323,1.0,1,20933,CHEM 20,CHOLESTEROL,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,URINALYSIS CULTURE IF INDICATED,APPEARANCE,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.19,0.266,0.25,0.42857142857142855,0.9339999999999999,0.0,0.11861986140776393,0.06222027266620478,0.04482534670398419,0.41091125349005164,0.21553734703731142,1,223149,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,OBSTETRIC PANEL,RPR RESULT,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,HCV GENOTYPE REFLEX NSA,HEPATITIS C GENOTYPE,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,CMP14 HP4 1AC PT AFP,PROTHROMBIN TIME,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,DIRECT LDL,TRIGLYCERIDES,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,T4,T4,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN TOTAL RANDOM UR,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,PTH INTACT WITHOUT CALCIUM,PARATHYROID HORMONE INTACT,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0666653772073269,0.0,0,295410,COMP METABOLIC PANEL 13,ALBUMIN SERUM,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,CMP13 LP 2AC CBC D PLT,CHOLESTEROL TOTAL,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.05714285714285715,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,COMPREHENSIVE METABOLIC PNL W O CO2 ALT,POTASSIUM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,EIA 10 ALCOHOL W GCMS,URINE CREATININE MG DL,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,CMP,EGFR NON AFRICAN AMERICAN,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.02001250768888385,0.0,0.0,0.0,0.0,0.0,0,19208,ALB ALP ALT AST GGT LD PROT,LDH,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.055,0.033,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,HEPATIC FUNCTION PANEL,,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.03142857142857143,0.07333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,FIBROACT COMPLETE,HEIGHT INCHES,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,CEA,CEA,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,NMR LIPOPROFILE,LDL P,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,COMP METABOLIC PANEL 13,EGFR IF NONAFRICN AM,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,URINALYSIS CULTURE IF INDICATED,COLOR,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.10714285714285714,0.0,0.0,0.20717899254074368,0.0,0.0,0.0,0.0,0,17426,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,ASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,HEPATIC FUNCTION PNL,PROTEIN TOTAL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,RPR,RPR RESULT,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.11600000000000002,0.19333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,HCV FIBROSURE,NECROINFLAMMAT ACTIVITY SCORE,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.08833333333333333,0.0,0.22,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.08318397885080242,1.0,1,57703,UA W RFLX MICROSCOPIC,BILIRUBIN,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.010717468726271995,0.0,0.0,0,193433,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,CMP14 HP4 DBILI CBC D PLT R,WBC,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp,Daclatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,TSH 3RD GENERATION REFL,TSH 3RD GENERATION REFL,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.3875,0.2,0.0,0.0,0.0,0.0,0.0,0.06350553280338445,0.0,0.0,0.0,0.0,0,422543,IFE PE SERUM,BETA GLOBULIN,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,COMPLETE BLOOD COUNT,MCV,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.22333333333333336,0.156,0.78,0.22333333333333336,0.156,0.78,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,CMP14 LP CBC D PLT,HEMATOCRIT,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0775,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,UA W MICRO HOLD SPEC 24 HR,GLUCOSE,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.088,0.0,0.0,0.088,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,HEP B SURFACE AB,HEP B SURFACE AB,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,CBC WITH PLT DIFF,OTHERS,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,PROTEIN TOTAL URINE,PROTEIN CR RATIO,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,CBC INC DIFF PLT,RBC,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,ASH FIBROSURE,FIBROSIS STAGE,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,IRON BINDING CAPACITY,UIBC,Body weight Measured,Weight Measured,Body weight
0.15,0.1,0.0,0.0,0.0,0.0,0.0,0.01764119077999482,0.0,0.0,0.0,0.0,0,17434,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,COMP METABOLIC PANEL,CARBON DIOXIDE,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.0,0.0,0.0,0.165,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.3175,0.18142857142857144,0.0,0.6675,0.3242857142857143,0.0,0.0,0.058554296133023875,0.0,0.061241138223508074,0.058554296133023875,0.0,1,22368,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,CMP12 LP TP TSH 6AC CBC D PLT,URIC ACID,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,NASH FIBROSURE,APOLIPOPROTEIN A 1,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,RPR,TREPONEMA PALLIDUM ANTIBODIES,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.04125,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,RPR,TREPONEMA PALLIDUM ANTIBODIES,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.09090909090909091,0.0,0.178,0.08090909090909092,0.2225,0.0,0.014772156923696378,0.0,0.0,0.0,0.0,0,542183,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.266,0.0,0.0,0.27999999999999997,0.0,0.0,0.05340417440283707,0.0775423479082279,0.12872694659872408,0.0,0.0,0.0,1,333583,PROTEIN ELECTRO S,M SPIKE,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.125,0.0,0.0,0.0,0.0,0.0,0.016390301665365148,0.0,0.0,0.0,0.0,0.0,0,486423,CMP WITH ESTIMATED GFR CALCULATED,CHEMISTRY SODIUM,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.05,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,LIPID PROFILE WRFL LDL DIRECT,NON HDL CHOLESTEROL,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,CMP13 LP 2AC CBC D PLT,NEUTROPHILS ABSOLUTE,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.17001758398860156,0.0,0.0,0.0,0.0,0,20750,PROTEIN ELEC INTERP SERUM,ALPHA 2 GLOBULIN,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,FIBROACT COMPLETE,HEIGHT INCHES,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,COMP METABOLIC PANEL W GFR,GLOBULIN,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.03636363636363637,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,COMP METAB PANEL,GLUCOSE FASTING,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,HCV FIBROSURE,LIMITATIONS,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,PROTEIN TOTAL URINE,URINE TOTAL PROTEIN,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,DRGABU2,METHAQUALONE,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,CBC WITH MANUAL DIFFERENTIAL,PLATELET COUNT,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.14285714285714285,0.5,0.0,0.0,0.0,0.0,0.03995658192873952,0.11262484863358568,0.0,0.0,0.0,0,204164,HEPATITIS C GENO TYPE 1 NS5A RESIST,VELPATASVIR RESISTANCE,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,HEPATITIS C AB,HEPATITIS C AB,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,COCAINE METABOLITE,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,CMP,ALT SGPT,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.26666666666666666,0.2,0.0,0.24333333333333332,0.1111111111111111,0.0,0.0,0.03458598148635306,0.0,0.0,0.048911964085985304,0.0,1,59014,PROTHROMBIN PTT,CONTROL,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.26666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,CMP14 LP CBC D PLT,NEUTROPHILS,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.11000000000000001,0.0,0.0,0.58,0.9666666666666667,0.9666666666666667,0.0,0.0,0.0,0.3757978134029263,0.022046838418816495,0.022046838418816495,1,487934,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,FIBROACT COMPLETE,NECROINFL SCORE,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,CBC W DIFF PLT,HEMATOCRIT,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,LIVER FIBROSIS FIBROTEST,ALPHA 2 MACROGLOBULIN,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,HELPER T LYMPH CD4,NEUTROPHILS,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,CBC W DIFF PLT,BASOPHILS ABSOLUTE,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,COMP METABOLIC PANEL W GFR,ANION GAP,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.022,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,BUN CREAT RATIO,EGFR AFRICAN AMERICAN,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,1.0,1,205708,GENERAL HEALTH PANEL,HEMATOCRIT,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,HIV AB EIA WITH REFLEXES,HIV EIA AB SCREEN,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,HB S AG W REFLEX CONF,HFLAG,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,PSA FREE TOTAL,INTERNAL %,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,LMG CBC DIFF PLT,LYMPHOCYTES #,Color of Urine,Color Ur,Color
0.0,0.014285714285714287,0.05,0.1142857142857143,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,CMP14 1AC,EGFR IF NONAFRICN AM,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.09090909090909091,0.14285714285714285,0.0,0.03636363636363637,0.05714285714285715,0.0,0.011488648308043081,0.016374741386697145,0.0,0.0,0.0,0,831008,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.0,0.0,0.22333333333333336,0.25,1.0,0.0,0.0,0.0,0.0,0.15505905338492743,1.0,1,384834,COMP METABOLIC PANEL,CREATININE,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,IRON BINDING CAPACITY,UIBC NR,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.1569574215481997,0.0,0.0,1,303842,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.5566666666666666,0.3333333333333333,0.5,0.0,0.0,0.0,0.01112594487153995,0.9402300820764442,0.9900858126069512,1,17590,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,HIGH SENSITIVITY CRP,HIGH SENSITIVITY CRP,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.134,0.20875,0.0,0.0,0.0,0.0,0.0,0.022015146808507913,0.0,0.0,0.0,0.0,0,7633,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.033955663578360995,0.0,0.0,0,45377,IFE PE FLC SERUM,IMMUNOGLOBULIN G QN SERUM,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD4 CELLS,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,APOLIPOPROTEIN A1,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,DRUG ABUSE PANEL NO CONFIRM,CREATININE,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,APTT,PARTIAL THROMBOPLASTIN,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.11399999999999999,0.285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,DRUG ABUSE PANEL NO CONFIRM,CREATININE,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.05888888888888889,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.06290250689706056,0.0,0.0,1,58214,URINALYSIS W MICRO W REFLEX CULTURE,WBC,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,CBC INCLUDES DIFF PLT,LYMPHOCYTES ABSOLUTE,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,IRON TIBC,TIBC,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0825,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.4,0.5714285714285714,0.8,0.4,0.5714285714285714,0.8,0.4360065673004285,0.8512784030381061,0.8593267568211221,0.4360065673004285,0.8512784030381061,0.8593267568211221,1,223222,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.06666666666666667,0.25,0.0,0.09333333333333332,0.35,0.0,0.05117681691383591,0.14539805437566944,0.0,0.013582254489849288,0.038588437029685174,0,381806,HEPATITIS PANEL ACUTE,HEPATITIS B CORE AB IGM,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,HIV AG AB 4TH GEN RFL,RACE NR,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,LYMPHOCYTE SUBSET PANEL 4,COMMENT S,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.16666666666666666,0.3655555555555556,0.5483333333333333,0.16666666666666666,0.3655555555555556,0.5483333333333333,0.025199782485376465,0.0,0.0,0.023004148852440398,0.0,0.0,0,481598,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESIST ASSAY INTERP,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,CMP13 LP 2AC CBC D PLT,CHOLESTEROL TOTAL,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,REFLEXED LDL,LDL DIRECT,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.124,0.125,0.3333333333333333,0.0,0.0,0.0,0.0,0.03813135280842339,0.07899888361701268,0,7633,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,CBC W AUTO DIFF,MONOCYTES %,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,FOLLOW UP PNL ARAKAWA,SODIUM,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.01,0.022222222222222223,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,COMP METAB PANEL,GLUCOSE FASTING,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp,Daclatasvir
0.25,0.16666666666666666,0.0,0.25,0.16666666666666666,1.0,0.06812389033458222,0.051758104169687846,0.0,0.06812389033458222,0.051758104169687846,0.7071067811865476,1,7328,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.0,0.0,0.0,0.0,0.08287539106540942,0.7071067811865476,0.0,1,285403,CBC WITH ABSOLUTE WBCS MPV,MCHC,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,ACCUTYPE R IL28B NY,IL28B GENOTYPE,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,URINALYSIS CULTURE IF INDICATED,BILIRUBIN,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.17166666666666666,0.09888888888888889,0.14833333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,COMP METABOLIC PANEL CLARIFICATION,EGFR NON AFR AMERICAN,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,CMP WITH EGFR,ANION GAP,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,ACCUTYPE R IL28B NY,IL28B GENOTYPE,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.25,0.16666666666666666,0.5,0.0,0.16666666666666666,0.5,0.02919946346325475,0.16096628932775536,0.35355339059327373,0.0,0.2276407094521833,0.5,1,25023,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,DRUG ABUSE PANEL 10 WITH OXYCODONE,COCAINE METABOLITE,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,APTT,PARTIAL THROMBOPLASTIN,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.05043482321394899,0.0,0.0,0.12353958214165095,1.0,1,196592,DRUG ABUSE SCREEN 9 NO THC W CONF,PHENCYCLIDINE,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,COMMENTS,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.09499999999999999,0.07125,0.11399999999999999,0.04,0.015,0.024,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,CBC WITH PLT DIFF,NUCLEATED RBCS,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.5,0.0,0.0,0.0,0.05498668394218953,0.07826082456743577,0.10031748330730439,1,312082,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,Specimen source identified,Specimen source XXX,Specimen source
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,CBC W DIFF PLT,HEMATOCRIT,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.1111111111111111,0.0,0.0,0.1111111111111111,0.0,0.0,0.055446852762574106,0.0,0.0,0.055446852762574106,0.0,0,51961,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,CRP,C REACTIVE PROTEIN ULTRA,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,CBC INCLUDES DIFF PLT,HEMOGLOBIN,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.072,0.06,0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,CBC PLATELET NO DIFFERENTIAL,HEMATOCRIT,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,CMP14 CBC D PLT TSH,EGFR IF AFRICN AM,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,BUN CREATININE RATIO,EGFR NON AFR AMERICAN,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.08333333333333333,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,CMP14 4AC,EGFR IF AFRICN AM,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,FE TIBC FER,IRON BIND CAP TIBC,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,1.0,0.0,0.0,0.0,0.060037523066651444,0.45528141890436646,0.7071067811865476,1,17988,CMP14 TP TSH 2AC CBC D PLT,AMYLASE SERUM,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.1325,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.2,0.14285714285714285,0.0,0.0,0.0,0.0,0.009778668679543912,0.010356777779722548,0.0,0.0,0.0,0.0,0,7344,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,CBC WITH PLT DIFF,BLASTS,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.11166666666666668,0.0,0.0,0.22166666666666668,0.149,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,ANA CRP ASO PE,P E INTERPRETATION S,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.01,0.022222222222222223,0.1075,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.2857142857142857,0.6666666666666666,0.0,0.0,0.0,0.0,0.12793313413942875,0.15892726613090935,1,326231,HEMOGRAM W O DIFFERENTIAL,MEAN PLATELET VOLUME,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,PT PTT,PARTIAL THROMBOPLASTIN,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,URINALYSIS W MICRO,GLUCOSE,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,DIFFERENTIAL MANUAL,NEUTROPHILS,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.05555555555555555,0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,CBC WITH AUTO DIFF,BASOPHILS #,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,RPR REFLEX TITRE TPPA,RPR,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,CMP14 LP CBC D PLT TSH UA M,HDL CHOLESTEROL,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,CMP14 LP CBC D PLT TSH T4F,NEUTROPHILS ABSOLUTE,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,UROGRAM,KETONES,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CBC INC DIFF PLT,BASOPHILS,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.16666666666666666,0.0,0.0,0.16666666666666666,0.0,0.0,0.046068179126551256,0.0,0.0,0.046068179126551256,0.0,0,30940,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0825,0.10600000000000001,0.0,0.25,0.2,1.0,0.0,0.0,0.0,0.0763206923693498,0.09762443806815091,1.0,1,58024,URINALYSIS REFLEX,NITRITE,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.052529819653824195,0.0,0,203943,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.066,0.06625,0.0,0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,URINALYSIS W REFLEX MICRO,UROBILINOGEN,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.06642246921932382,0.0,0,28571,C4 C3,COMPLEMENT C3 SERUM,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,COMP METABOLIC PANEL W EGFR,PROTEIN TOTAL,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,C4 SERUM,C4 SERUM,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,T LYMPHOCYTE HELPER SUPPRESSOR,LYMPHS,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.03666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,HEPATITIS B VIRUS PNL 6 TESTS,HB CORE AB TOTAL,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,COMPREHENSIVE METABOLIC PANEL,ALBUMIN,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.11,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,204081,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,BUN CREATININE RATIO,BUN CREATININE RATIO,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,HEMOGLOBIN A1C,AVERAGE WHOLE BLOOD GLUCOSE,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.31,0.25,0.4,0.31,0.25,0.4,0.006751865324062245,0.46201313277809963,0.6330691643858172,0.007014211704169937,0.4799648345862786,0.6576673155134074,0,134999,HIV AB EIA WITH REFLEX,HIV AB,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.4375,0.25142857142857145,0.5,0.0,0.0,0.0,0.008847605454379015,0.012581831776840247,0.021116134204346215,0,134585,LIPID CASCADE,LDL CHOLESTEROL CALC,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.3333333333333333,0.16666666666666666,1.0,0.0,0.0,0.0,0.042798044679898894,0.06872782032043556,0.5773502691896257,1,747741,COMP METABOLIC PANEL,GLUCOSE NON FASTING,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.2866666666666667,0.375,1.0,0.2866666666666667,0.375,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,23242,GGTP,GGTP,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,LYMPHOCYTE SUBSET PANEL 4,%CD8 SUPPRESSOR T CELLS,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.10333333333333333,0.06888888888888889,0.124,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,HEPASCORE R,SEX,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,HEPATITIS C GENO TYPE 1 NS5A RESIST,VELPATASVIR RESISTANCE,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,CMP14 LP CBC D PLT TSH T4F,NEUTROPHILS ABSOLUTE,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.0,0.0,0.2866666666666667,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.16666666666666666,0.5,0.0,0.16666666666666666,0.5,0.0,0.01670732641598427,0.01712938447846235,0.0,0.01670732641598427,0.01712938447846235,0,205088,HEPATITIS B CORE AB TOTAL REFL,HEPATITIS B CORE AB TOTAL REFL,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.2,0.4,0.0,0.1,0.2,0.0,0.0,0.0,0.0,0.06813568816319682,0.09746345547029489,0,51938,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,NASH FIBROSURE,HAPTOGLOBIN,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.165,0.265,0.0,0.5,0.5,1.0,0.0,0.0,0.0,0.14187034543632637,0.7071067811865476,1.0,1,57679,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,LYMPHOCYTE SUBSET PANEL 5,CD4 % POS,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,HEPATITIS PANEL ACUTE,HEPATITIS B CORE AB IGM,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.038571428571428576,0.09090909090909091,0.14285714285714285,0.038571428571428576,0.09090909090909091,0.14285714285714285,0.0,0.041353268343751526,0.05894070881685487,0.0,0.041353268343751526,0.05894070881685487,0,831008,MITOCHONDRIAL AB SCREEN,MITOCHONDRIAL AB SCREEN,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,HEPASCORE R,AGE,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,CBC PLT DIFF,POLYS,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,NMR LIPOPROFILE,LDL P,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,HBSAB AG,HEP B SURFACE AB QUAL,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.029411764705882353,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,CBC WITH PLT MAN DIFF,BANDS,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,CBC W AUTO DIFF WITH PLATELETS,MCV,Sex,Sex,Sex
0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,CBC WITH PLT DIFF,NUCLEATED RBCS,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,MITOCHONDRIAL AB SCREEN,MITOCHONDRIAL AB SCREEN,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.2,0.25,0.0,0.0,0.0,0.0,0.031621853677024414,0.08399329824424573,0.0,0.0,0.0,0,345355,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS C ANTIBODY,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,PHOSPHATE AS PHOSPHORUS,LIPEMIA,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.215,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,CBC W AUTO DIFF WITH PLATELETS,MCHC,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,MICROALBUMIN CREATININE RANDOM RATIO,MICROALBUMIN RANDOM,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,HAV HBV IMMUNE STATUS PRO IV,HEP A AB IGM,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,LD,LIPEMIA,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.14285714285714285,0.2,0.346,0.5714285714285714,0.8,0.0,0.0769055150490483,0.07759701258884111,0.035467350927838925,0.1538110300980966,0.15519402517768222,1,51953,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,NASH FIBROSURE,AST SGOT P5P,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,DIFFERENTIAL MANUAL,EOSINOPHILS,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.20545454545454545,0.0,0.0,0.0,0.0,0.0,0.12705867340885235,0.0,1,542183,LYMPHOCYTE SUBSET PANEL 4,HELPER SUPPRESSOR RATIO,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,HB S AB QL,HB S AB QL,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.734,0.0,0.0,0.534,0.0,0.0,0.07351849991010495,0.0,0.0,0.08201332011404516,0.0,0.0,1,19893,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH TOTAL,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.018,0.025714285714285714,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.25,0.0,0.25,0.25,0.3333333333333333,0.0,0.015316711982292452,0.0,0.0769832768017027,0.08055537486383768,0.09169555407390673,1,301804,CBCI COMPLETE BLOOD COUNT W DIFF,BASOPHILS,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.2,0.0,0.0,0.2,0.0,0.0,0.01519841291954016,0.0,0.0,0.0,0.0,0,111567,COMPLETE BLOOD COUNT,RBC,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,HCV GENOTYPE REFLEX NSA,HCV GENOSURE R NSA INTERP,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,RPR W RFLX CONFIRM,RPR SYPHILIS SCREEN,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.057999999999999996,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,HEPASCORE R,AGE,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,LIPID PANEL,VLDL CHOL CALC,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,HEPATIC LIVER PANEL,DIRECT BILIRUBIN,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.6666666666666666,0.14285714285714285,0.25,0.16666666666666666,0.14285714285714285,0.25,0.06190747163367705,0.06999602978068009,0.14534604904475734,0.04894215363617116,0.1106734406379627,0.11490614097199336,1,427682,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.2,0.0,0.0,0.0,0.0,0.0,0.018953187239064584,0.0,0.0,0.0,0.0,0.0,0,130682,FE ANA TIBC FER PTT PT A1A,PROTHROMBIN TIME,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.3333333333333333,0.235,0.94,0.0,0.0,0.0,0.11098565713428754,0.0,0.0,1,265157,CBC WITH MANUAL DIFFERENTIAL,PLATELET COUNT,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,COMP METABOLIC PANEL,POTASSIUM,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,CMP14 6AC,PHOSPHORUS,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.022222222222222223,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,CBC WITH AUTO DIFF,NRBC,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,HIV AB EIA WITH REFLEX,HIV AB,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,CMP,TCO2,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,URINALYSIS COMPLETE,BILIRUBIN,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,SEGMENTED NEUTROPHILS,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,7765,CBC H H RBC INDICES WBC PLT,MPV,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.15,0.375,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,CBC WITH AUTO DIFF,NRBC,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,CCP IGG,CCP IGG,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,PT PROTIME,INR,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,COCAINE METABOLITE,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,PROTEIN TOTAL 24HR URINE W CREAT,UR CREAT RANDOM MG DL,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,APTT,PARTIAL THROMBOPLASTIN,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,HDL AS % CHOLESTEROL,HDL AS % CHOLESTEROL,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,HDL AS % CHOLESTEROL,HDL AS % CHOLESTEROL,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,FREE T3,FREE T3,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,GENERAL HEALTH PANEL,HEMATOCRIT,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,DRUG ABUSE SCREEN I NO GCMS,AMPHETAMINES,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,CHEM SCREEN PANEL HDL,URIC ACID,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Specimen source identified,Specimen source XXX,Specimen source
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,CBC WITH DIFFERENTIAL PLATELETS,POLYS,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.16666666666666666,0.29666666666666663,0.445,0.09499999999999999,0.0,0.0,0.038211926035394805,0.13917887610023483,0.290796108751339,0.0,0.0,0.0,1,139543,HEPATITIS BE AG,HBEAG INS NR,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.010792196169189583,0.013527273772293902,0,178566,HEPATIC FUNCTION PNL,PROTEIN TOTAL,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.05714285714285715,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,MA COMP METABOLIC PNL,ALKALINE PHOSPHATASE,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0778704158893051,0.14740142971618808,1.0,1,382507,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,HEPATITIS PANEL ACUTE,HEPATITIS B CORE AB IGM,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,LIPID PANEL,,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,HEPATITIS PANEL CHRONIC,HAV AB TOTAL,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.03571428571428571,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,ASH FIBROSURE,COMMENT,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.03571428571428571,0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,HCV FIBROSURE,COMMENT,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,HEPATIC FUNCTION PANEL,,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,CCP IGG,CCP IGG,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.2,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.009586772624209705,0.0135134095262055,0.026064938546347505,0,52217,CUSTOM HEPATITIS PANEL,HEP B SURFACE AB,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,TRANSFERRIN SATURATION,TRANSFERRIN,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,LYMPHOCYTE SUBSET PANEL 1,ABSOLUTE CD8 CELLS,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.06666666666666667,0.05,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,PT PROTIME,INR,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CMP13 LP 2AC CBC D PLT,NEUTROPHILS ABSOLUTE,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,MAGNESIUM,MAGNESIUM,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.47,0.3333333333333333,0.25,0.0,0.0,0.0,0.04524395250155222,0.43337723529131744,0.1063004130698838,1,19687,HEPATIC LIVER PANEL,DIRECT BILIRUBIN,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.30333333333333334,0.25,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,303768,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.6975,0.93,0.6666666666666666,0.0,0.0,0.0,0.4224956153898245,0.022046838418816495,0.022046838418816495,1,487926,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.3175,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,URINALYSIS COMPLETE W REFLEX CULTURE,PROTEIN,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,AFP TUMOR MARKER,AFP TUMOR MARKER,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.39999999999999997,0.42857142857142855,1.0,0.0,0.0,0.0,0.0,0.41219810878268626,0.4228537636689047,1,433961,LIPID PROFILE WRFL LDL DIRECT,NON HDL CHOLESTEROL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS C ANTIBODY,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,VIT B 12 FOLATE PANEL,VITAMIN B 12,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,COMP METAB PANEL,EGFR NON AFR AMERICAN,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,HCV FIBROSURE,LIMITATIONS,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.053000000000000005,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,MICROALBUMIN CREATININE RANDOM RATIO,MICROALBUMIN RANDOM,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,COMP METABOLIC PANEL,ANION GAP,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,UREA NITROGEN BUN,ICTERUS,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,CEA,CEA CENTAUR,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,CBC WITH DIFFERENTIAL,HEMATOCRIT,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.036,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,CBC WITH DIFFERENTIAL,MYELOCYTES,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,CBC INC DIFF PLT,BASOPHILS,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,COMPREHENSIVE METABOLIC PANEL E GFR,AST,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,HEMOGLOBIN A1C WITH MPG,HEMOGLOBIN A1C,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,HIV 1 RNA QN RT PCR,HIV 1 RNA QN RT PCR,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,CHEM SCREEN PANEL,BILIRUBIN DIRECT,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,CBC WITH PLT DIFF,NO CELLS DIFF,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,CD4 CD8 RATIO PROFILE,HEMATOLOGY COMMENTS,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,HEMOGLOBIN A1C WITH MPG,HEMOGLOBIN A1C,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,PROTEIN ELECTRO S,M SPIKE,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.43333333333333335,0.2857142857142857,1.0,0.43333333333333335,0.2857142857142857,1.0,0.0,0.43337723529131744,0.10031748330730439,0.0,0.43337723529131744,0.10031748330730439,1,30510,T3 FREE,T3 FREE,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,PTH INTACT,PTH INTACT,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.060000000000000005,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,CBC W DIFF PLT,HEMATOCRIT,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,203927,MAGNESIUM,ICTERUS,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,CMP CBC TSH,ABSOLUTE BLASTS,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,MAGNESIUM,HEMOLYSIS,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,LYMPHOCYTE SUBSET PANEL 3,% CD3 CD4 HELPER T4,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.045454545454545456,0.07142857142857142,0.0,0.045454545454545456,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,RPR REFLEX PER CDC,RPR,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,CMP14 TP TSH 2AC CBC D PLT,AMYLASE SERUM,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,VITAMIN D 25 OH,VITAMIN D 25 OH,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.10333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,CMP14 LP 7AC CBC D PLT T B,IRON SATURATION,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,CRP,C REACTIVE PROTEIN ULTRA,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.15625,0.3125,0.2,0.0,0.0,0.0,0.05345799931322692,0.07240860968350848,0.04869923401997367,0.0,0.0,1,139550,X HEPATITIS COMPLEX PROFILE,ANTI HCV,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.05,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.05,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,CBC,MCHC,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.042260315089851286,0.0,0,7534,HEMOGRAM W O DIFFERENTIAL,MEAN PLATELET VOLUME,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,PROTIME PTT,PTT,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.25,0.0,0.0,0.235,0.16666666666666666,1.0,0.047471586974075164,0.0,0.0,0.0,0.08089870281836808,1.0,1,7773,CBC PLATELET HEM REVIEW,PLATELETS,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.27,0.25,0.4,0.0,0.0,0.0,0.03937969291800214,0.06185427189076809,0.13271332481154674,1,7641,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.3333333333333333,0.2,0.5,0.0,0.0,0.0,0.07306851338365716,0.0772290548600788,0.10486728028628622,1,772020,ASH FIBROSURE,COMMENT,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,COMP METABOLIC PANEL W EGFR,PROTEIN TOTAL,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,DRUG ABUSE SCREEN II,METHAQUALONE,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.07333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,PROTEIN TOTAL 24HR URINE W CREAT,UR CREAT RANDOM MG DL,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,CHEM SCREEN PANEL HDL,TRIGLYCERIDES,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.0,0.0,0.1425,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,BUN CREATININE RATIO,HEMOLYSIS,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CMP WITH EGFR,ANION GAP,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.31,0.16666666666666666,0.0,0.0,0.0,0.0,0.05153731836902975,0.0,0.0,0,7732,CBC W AUTO DIFF WITH PLATELETS,RBC,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.06285714285714286,0.03636363636363637,0.05714285714285715,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.11857142857142858,0.049999999999999996,0.0,0.11857142857142858,0.049999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,HEPATITIS B CORE AB TOTAL REFL,HEPATITIS B CORE AB TOTAL REFL,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,HEMATOPATH CONSULTATION SMEAR,HEMATOLOGY COMMENTS,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,PROTHROMBIN TIME,PT POP MEAN,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,RPR SCREEN W TITER,RPR SCREEN,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.14285714285714285,0.0,0.27999999999999997,0.2857142857142857,1.0,0.0,0.06130234866751405,0.0,0.011862808335706188,0.6345756122357417,1.0,1,28712,IFE PE SERUM,BETA GLOBULIN,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.125,0.2,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,CHOLESTEROL TOTAL,ICTERUS,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,IFE PE SERUM,GAMMA GLOBULIN,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.2,0.4,0.6666666666666666,0.2,0.4,0.3333333333333333,0.007719821827095519,0.36957415218469236,0.4632357174935542,0.007806566737586396,0.37372692636381444,0.46844093359181893,1,178566,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,CBC WITH PLT DIFF,NUCLEATED RBCS,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,HIV AG AB 4TH GEN RFL,RACE NR,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,RPR,RPR RESULT,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,CBC,HEMOGLOBIN,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.028999999999999998,0.041428571428571426,0.0,0.028999999999999998,0.041428571428571426,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,TESTOSTERONE TOTAL LC MS MS,TESTOSTERONE TOTAL LC MS MS,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,495499,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESIST ASSAY INTERP,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.435,0.3333333333333333,1.0,0.435,0.3333333333333333,1.0,0.010606315746132022,0.8842696816801202,0.957651366164057,0.010451985424486443,0.03938663461739855,0.0426551596547905,1,29918,TESTOSTERONE FREE TOTAL LC MS MS,FREE TESTOSTERONE,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,UREA NITROGEN BUN,ICTERUS,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.025,0.125,0.0,0.0165,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.3333333333333333,0.16666666666666666,1.0,0.3333333333333333,0.16666666666666666,1.0,0.084905879372146,0.3219325786555107,1.0,0.084905879372146,0.3219325786555107,1.0,1,17988,AMYLASE,AMYLASE,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.08,0.06666666666666667,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,REFLEX ANA PATTERN,PATTERN 1,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,CMP WITH EGFR,ANION GAP,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,SPECIAL NEW ANNUAL COMM INSURANCE #6925,ABSOLUTE EOS,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,CBC PLT DIFF,ABSOLUTE EOS,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.3333333333333333,0.25,0.74,0.3333333333333333,0.25,0.74,0.05056050164439552,0.33333333333333337,0.0,0.08757335770426278,0.5773502691896257,0.0,1,149575,MICROALBUMIN RANDOM SPEC,MICROALBUMIN,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,ALPHA 1 ANTITRYPSIN SERUM,ALPHA 1 ANTITRYPSIN SERUM,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,CMP14 CBC D PLT TSH,ALBUMIN,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.09,0.10857142857142857,0.19,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,MA COMP METABOLIC PNL,ALKALINE PHOSPHATASE,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.03666666666666667,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,LIPID PROFILE,CHOLESTEROL NON HDL,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.3333333333333333,0.351,0.608,0.3333333333333333,0.351,0.608,0.31830503283138056,0.5707899377594806,0.8164760814988351,0.31830503283138056,0.5707899377594806,0.8164760814988351,1,51938,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,HELPER T LYMPH CD4,NEUTROPHILS,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,CBC WITH MANUAL DIFFERENTIAL,RDW,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.0,0.125,0.0,0.182,0.25,0.3333333333333333,0.0,0.12384407788226937,0.0,0.0,0.10725211755430386,0.17162008951344032,1,28654,PROTEIN ELECTROPHORESIS SERUM,ALPHA 1,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,HCV AB WITH RFL RNA QT,HCV SIGNAL CUTOFF,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,ANA IFA SCREEN WITH REFLEX TITER,ANTI NUCLEAR AB IFA,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,RENAL FUNCTION PANEL,ANION GAP,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,HEPATITIS BS AB QUANT,HEPATITIS BS AB INTERP,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.033032193196675164,0.0,0,326231,HEMOGLOBIN A1C,AVERAGE WHOLE BLOOD GLUCOSE,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,UROGRAM,NITRITE,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,BUN CREATININE RATIO,EGFR NON AFR AMERICAN,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,CREATINE KINASE TOTAL,HEMOLYSIS,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,HAV AB TOTAL,HAV AB TOTAL,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,HCV GENOTYPE REFLEX NSA,HEPATITIS C GENOTYPE,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,LIPID PROFILE,FASTING NON FASTING,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.041428571428571426,0.057999999999999996,0.0,0.041428571428571426,0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,TESTOSTERONE TOTAL LC MS MS,TESTOSTERONE TOTAL LC MS MS,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,HCV FIBROSURE LABCORP,RESULT,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.3333333333333333,0.25,0.74,0.3333333333333333,0.25,0.74,0.012877229495112386,0.08489650403181737,0.0,0.05056050164439552,0.33333333333333337,0.0,1,149575,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.11,0.0,0.0,0.25,0.2,1.0,0.0,0.0,0.0,0.0763206923693498,0.09762443806815091,1.0,1,58024,UROGRAM,NITRITE,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,IRON BINDING CAPACITY,TIBC,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,CBC WITH PLT DIFF,MONOCYTES ABSOLUTE,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,HEPATIC FUNCTION PANEL,ALK PHOS,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,CBC INCLUDES DIFFERENTIAL PLATELETS,MEAN PLATELET VOLUME,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,URINALYSIS COMPLETE,BILIRUBIN,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,FSRC NEW PATIENT PANEL,D BILIRUBIN,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.013715782873157667,0.0,0.0,0.0,0.0,0,295410,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.06666666666666667,0.1,0.0,0.0,0.0,0.0,0.0,0.02098136829662256,0.0,0.0,0.0,0.0,0,17434,HCV AB WITH RFL RNA QT,HCV SIGNAL CUTOFF,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,HEPASCORE R,SEX,Race,Race,Race
0.0,0.09857142857142856,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,HCV RNA QN REAL TIME PCR W RFLX QL,HCV RNA LOG IU ML,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,LIVER FIBROSIS FIBROTEST ACTITEST P,GGT,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,CERULOPLASMIN,CERULOPLASMIN,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,URINALYSIS CULTURE IF INDICATED,APPEARANCE,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,T LYMPHOCYTE HELPER SUPPRESSOR,LYMPHS,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,HIV AB AG RFLX CONF,HIV AG AB,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Body height Measured,Body height Measured,Body height
0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,BUN CREAT RATIO,EGFR AFRICAN AMERICAN,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,HEP A AB IGM,HEPATITIS A AB IGM,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,CBC WITH PLT DIFF,BANDS ABSOLUTE,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,CMP14 4AC,EGFR IF AFRICN AM,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,DIRECT LDL,TRIGLYCERIDES,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,HEP A AB TOTAL,HEP A AB TOTAL,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.5,0.45454545454545453,1.0,0.5,0.45454545454545453,1.0,0.32919781270269133,0.03140282649351023,0.04372412516808821,0.32919781270269133,0.03140282649351023,0.04372412516808821,1,112599,HCV RNA NAA QUALITATIVE,HCV RNA NAA QUALITATIVE,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.142,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,VITAMIN D 25 OH,VITAMIN D 25 OH,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.14666666666666667,0.1325,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,MICROALBUMIN RANDOM SPEC,MICROALBUMIN,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,DRUG ABUSE SCREEN I NO GCMS,METHADONE,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,RENAL FUNCTION PANEL,ANION GAP,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,LD,LIPEMIA,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,BASIC METABOLIC PANEL,AFRICAN AMERICAN,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,CULTURE ROUTINE,CULTURE ROUTINE,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,HEPATITIS C ANTIBODY W REFL HCV RIBA,SIGNAL CUT OFF,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,COMP METAB PANEL,EGFR NON AFR AMERICAN,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.6666666666666666,0.5,1.0,0.0,0.0,0.0,0.1625018229625479,0.15505905338492743,1.0,1,264747,CBC WITH AUTO DIFF,LYMPHOCYTES #,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,CBC WITH MANUAL DIFFERENTIAL,WBC,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,CBC INC DIFF PLT,MONOCYTES,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,BILIRUBIN FRACTIONATED,BILIRUBIN INDIRECT,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,APOLIPOPROTEIN A1,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,HEPATITIS A IGM,HEPATITIS A IGM,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,HEPATIC FUNCTION PANEL,ALK PHOS,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.33375,0.445,0.0,0.33375,0.445,0.0,0.13203801005478755,0.09797879251983521,0.0,0.13203801005478755,0.09797879251983521,0,519132,HEPATITIS B CORE TOTAL AB,HEPATITIS B CORE TOTAL AB,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,HEPATITIS C REFLEX PCR,HEPATITIS C ANTIBODY,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.06999999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,PE INTERP RFX IFE S,BETA GLOBULIN,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,UA MICROSCOPIC REFLEX CULTURE,LEUKOCYTE ESTERASE,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,COMP METAB PANEL,GLUCOSE FASTING,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,CBC WITH PLT DIFF,MPV,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.1925,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,204081,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,COMPREHENSIVE METABOLIC PNL W O CO2 ALT,POTASSIUM,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0825,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,URINALYSIS,BILIRUBIN,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,FE ANA TIBC FER PTT PT A1A,PROTHROMBIN TIME,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.17142857142857143,0.3,0.25,0.25,0.4375,0.0,0.07075841156459017,0.07240860968350848,0.01348660606631813,0.019657902213288447,0.0201163555976559,0,223271,CUSTOM HEPATITIS PANEL,HEP B SURFACE AB,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,PSA WITH FREE RATIO,PSA ROCHE E170,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.20750000000000002,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,HCV GENOTYPE REFLEX NS5A,PLEASE NOTE,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.14285714285714285,0.0,0.20750000000000002,0.14285714285714285,0.0,0.0,0.023344188693653956,0.0,0.0,0.0,0.0,0,128413,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,PHOSPHATE AS PHOSPHORUS,LIPEMIA,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,BUN CREATININE RATIO,HEMOLYSIS,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN TOTAL RANDOM UR,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.057999999999999996,0.12444444444444445,0.22400000000000003,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,RBC,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,CBC INCLUDES DIFF PLT,BLASTS,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,IMMUNOGLOBULIN M IGM,IMMUNOGLOBULIN M,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD4 CELLS,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,HEP C VIRUS ANTIBODY,HEP C VIRUS ANTIBODY,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.0666653772073269,0.0,0,295410,CMP14 5AC CBC D PLT TSH T4F,CALCIUM SERUM,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,CBC WITH DIFFERENTIAL,NEUTROPHILS,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,HCV GENOTYPE PCR PROBE,HCV GENOTYPE,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,UROGRAM,SPECIFIC GRAVITY,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,FREE T3,FREE T3,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.06,0.04,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,MAGNESIUM,HEMOLYSIS,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,CLR CBC W DIFF PLT,ABSOLUTE BLASTS,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.16666666666666666,0.034545454545454546,0.095,0.0,0.0,0.0,0.026355222038017434,0.04044378894834488,0.11262484863358568,0.0,0.0,0.0,0,112599,HIV 1 RNA QN RT PCR,LOGCOPIES ML,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.09090909090909091,0.0,0.0,0.0,0.0,0.0,0.008627647515398906,0.0,0.0,0.0,0.0,0,602797,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.13285714285714284,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,HCV RNA QN PCR W REFL GENOTYPE LIPA R,HCV RNA QUANTITATIVE REAL TIME PCR,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.2,0.3336363636363636,0.9175,0.2,0.2727272727272727,0.75,0.009667106742768716,0.0,0.0,0.009532550287061903,0.0,0.0,0,322867,HCV RNA QN PCR W RFL GENO,HCV RNA QN REAL TIME PCR,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,HEPATITIS C REFLEX PCR,HEPATITIS C ANTIBODY,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.04418912374513384,0.0,0.0,0.04418912374513384,0.0,0.0,1,30163,TSH 3RD GENERATION REFL,TSH 3RD GENERATION REFL,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.16666666666666666,0.073,0.146,0.0,0.0,0.0,0.008405430858161367,0.015072759967678873,0.02156055526152023,0,51938,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.016642660834240153,0.0,0.0,0.0,0.0,0,265116,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,BMP8 CBC D PLT UA,EOS ABSOLUTE,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,PTH INTACT WITHOUT CALCIUM,PARATHYROID HORMONE INTACT,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.047142857142857146,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,DRUG ABUSE SCREEN III,AMPHETAMINES,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,CBC PLATELET HEM REVIEW,NEUTROPHILS,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,BUN CREATININE RATIO,EGFR NON AFR AMERICAN,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.11,0.066,0.165,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.25,0.0,0.0,0.0,0.0,0.0,0.029740704692654774,0.0,0.0,0.0,0.0,0.0,0,7856,CBC W AUTO DIFF WITH PLATELETS,RDW,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,URINALYSIS CULTURE IF INDICATED,COLOR,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,URINALYSIS COMPLETE,GLUCOSE,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,PROTEIN TOTAL URINE,URINE TOTAL PROTEIN,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,MITOCHONDRIAL M2 ANTIBODY,MITOCHONDRIAL M2 ANTIBODY,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,CBC W DIFF PLT,PLATELET SUFFICIENCY,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,RPR REFLEX TP PA,RPR TITER,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,CMP14 HP5 LP 6AC CBC D PLT,HDL CHOLESTEROL,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,CMP WITH EGFR,ANION GAP,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,CULTURE ROUTINE,CULTURE ROUTINE,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,HEPATIC FUNCTION PANEL,ALT,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.2,0.42857142857142855,0.75,0.0,0.11857142857142856,0.2075,0.007080782168622735,0.6067712898584496,0.6842022182492856,0.0,0.04612090043126471,0.0520064526950299,1,632117,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,IMMUNOFIXATION SERUM,IGG SERUM NR,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,CBC,BA%,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.12285714285714286,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,622381,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,LIVER FIBROSIS FIBROTEST,ALPHA 2 MACROGLOBULIN,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.05504399149282735,0.0,0.0,0.0,0.0,0,339358,PROTEIN ELECTROPHORESIS SERUM,ALPHA 1,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,URINALYSIS SCREEN,BACTERIA,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.08,0.05714285714285715,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD4 CELLS,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,REFLEX ANA PATTERN,PATTERN 1,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,HCV GENOTYPE REFLEX NS5A,PLEASE NOTE,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.16666666666666666,0.193,0.965,0.16666666666666666,0.193,0.965,0.011131600174783984,0.12915735555679042,0.9420374874901866,0.011131600174783984,0.12915735555679042,0.9420374874901866,0,347047,HEPATITIS C VIRUS RNA QUALITATIVE PCR,HEPATITIS C VIRUS RNA QUALITATIVE PCR,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,CBC WITH PLT DIFF,MYELOCYTES,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,CBC INCLUDES DIFF PLT,EOSINOPHILS,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual,Promyelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,URINALYSIS COMPLETE WITH REFLEX CULTURE,PROTEIN,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.15,0.0,0.0,0.15,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,24729,IMMUNOGLOBULIN M,IMMUNOGLOBULIN M,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,LMG CBC DIFF PLT,LYMPHOCYTES #,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.125,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,IMMUNOGLOBULIN M,IMMUNOGLOBULIN M,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,RENAL FUNCTION PANEL,ANION GAP,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,DRUG ABUSE SCREEN W ETOH NO GCMS,COCAINE METABOLITE,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.172,0.0,0.0,0.372,0.125,0.0,0.0,0.0714561518627298,0.11098565713428754,0.036291544283745814,0.1429123037254596,0.11098565713428754,1,182626,REFLEXED LDL,LDL DIRECT,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.25,0.16666666666666666,0.0,0.2375,0.16666666666666666,1.0,0.0672790962344263,0.051758104169687846,0.0,0.0,0.051758104169687846,0.7071067811865476,1,7120,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,MA CBC DIFF PLT,MONOCYTES %,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.008571428571428572,0.03,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,CBC PLATELET HEM REVIEW,EOS,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,CBC WITH ABSOLUTE WBCS MPV,MCHC,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,TSH FREE T4 PROFILE,TSH THIRD GENERATION,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.0,0.02,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,URINALYSIS,BILIRUBIN,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0825,0.10600000000000001,0.0,0.0725,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,TSH 3RD GENERATION,TSH 3RD GENERATION,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,CMP14 HP4 1AC PT AFP,EGFR IF NONAFRICN AM,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,CBC W DIFF PLATELET,EOSINOPHILS,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,CBC W DIFF PLT,BASOPHILS ABSOLUTE,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.33399999999999996,0.835,0.0,0.0,0.0,0.0,0.06312481184311647,0.10133615137556884,0,50484,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.025,0.03571428571428571,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,CBC,MCH,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.007000000000000001,0.035,0.0,0.031,0.045,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,PE INTERP RFX IFE S,BETA GLOBULIN,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,IRON TOTAL BINDING CAPACITY,LIPEMIA,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,CCP IGG,CCP IGG,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,CMP14 HP4 DBILI CBC D PLT R,AMYLASE,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,CBC INC DIFF PLT,BASOPHILS,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,CMP14 HP5 LP 6AC CBC D PLT,BILIRUBIN INDIRECT,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.03571428571428571,0.125,0.0,0.03571428571428571,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,CD4 T HELPER PANEL,CD4 CD3 %HELPERS,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,COMPREHENSIVE METABOLIC PANEL,ALBUMIN,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.11,0.1325,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,URINALYSIS,BILIRUBIN,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,HCV RNA QT REALTIME PCR,HCV RNA QN PCR,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,HCV AB WITH RFL RNA QT,HCV SIGNAL CUTOFF,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,FIBROACT,FIBROSIS SCORE,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual,Promyelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,NASH FIBROSURE,AST SGOT P5P,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,CBC WITH PLT DIFF,MYELOCYTES,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,CBC WITH MANUAL DIFFERENTIAL,WBC,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,IRON BINDING CAPACITY,IRON TOTAL,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.041999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CREATININE,EGFR IF AFRICN AM,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,COMP METABOLIC PANEL W O EGFR,CREATININE,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,TESTOSTERONE FR DIALYSIS TOTAL LC MS MS,FREE TESTOSTERONE,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.0,0.0,0.0,0.0,0.08779161868611507,1.0,0.0,1,285395,CBC W O DIFF WITH PLATELETS,MCH,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.25,0.42857142857142855,0.75,0.25,0.42857142857142855,0.75,0.014383252316800266,0.0,0.0,0.014598428619085002,0.0,0.0,0,223271,HCV RNA GENO W REFL NS5A,HCV RNA GENOTYPE LIPA R,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,PROTIME PTT,PTT,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0825,0.08833333333333333,0.0,0.3225,0.16666666666666666,1.0,0.0,0.0,0.0,0.07097576385288318,0.09716253076254433,1.0,1,204057,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,CBC,MCHC,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,COMP METABOLIC PANEL,CREATININE,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,HEPATITIS PANEL CHRONIC,HAV AB TOTAL,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,HCV RNA QN REAL TIME PCR W RFLX QL,HCV RNA LOG IU ML,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,LIPID PANEL AMA,CHOL HDLC RATIO,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,RENAL FUNCTION PANEL,CREATININE,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,HB S AG W REFLEX CONF,HFLAG,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,COMP METABOLIC PANEL W EGFR,PROTEIN TOTAL,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,HEPATITIS C REFLEX PCR,HEPATITIS C ANTIBODY,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CBC INCLUDES DIFF PLT,ABSOLUTE NEUTROPHILS,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.03190476190476191,0.067,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,CARETC CMP LIPID URIC ACID DIR BILI PROFILE,RISK RATIO LDL HDL,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,DRUG ABUSE SCREEN W ETOH NO GCMS,BENZODIAZEPINES,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.1,0.5,0.0,0.0,0.0,0.0,0.015441346881271856,0.11262484863358568,0.0,0.0,0.0,0,347047,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.16666666666666666,0.3055555555555556,0.55,0.16666666666666666,0.3055555555555556,0.55,0.009480677768291423,0.01540408815772154,0.02155778305060363,0.009480677768291423,0.01540408815772154,0.02155778305060363,0,139527,HEP B SURFACE AB,HEP B SURFACE AB,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,URINALYSIS W MICRO W REFLEX CULTURE,WBC,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,AMYLASE,AMYLASE,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,UA MICROSCOPIC REFLEX CULTURE,LEUKOCYTE ESTERASE,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,GLUCOSE,GLUCOSE FASTING,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,CBC WITH PLT DIFF,BASOPHILS ABSOLUTE,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,CMP13 LP TP TSH 2AC CBC D P,AST SGOT,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,HEPATITIS C VIRUS RNA QUALITATIVE PCR,HEPATITIS C VIRUS RNA QUALITATIVE PCR,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.4,0.3814285714285714,0.6675,0.4,0.3814285714285714,0.6675,0.47662402489215927,0.01604041949885182,0.018644381728446624,0.47662402489215927,0.01604041949885182,0.018644381728446624,1,139519,HAV AB TOTAL,HAV AB TOTAL,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,URINALYSIS WITH MICROSCOPIC,COLOR,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.02250574538159411,0.0,0,7773,CBC INCLUDES DIFF PLT W SMEAR RVW,WHITE BLOOD CELL COUNT,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,COMP METABOLIC PANEL 13,EGFR IF NONAFRICN AM,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,CBC WITH PLT DIFF,NO CELLS DIFF,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,LIPID PROFILE,CHOLESTEROL NON HDL,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,PROFILE 104 LIVER,BILIRUBIN TOTAL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.06818181818181818,0.1875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,HEPATIC FUNCTION PANEL,,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,ASH FIBROSURE,HEIGHT,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,HEPATITIS B CORE AB,HEPATITIS B CORE AB,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,HEPASCORE R,AGE,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,LIPID CASCADE,LDL CHOLESTEROL CALC,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.1875,0.05714285714285715,0.0,0.0,0.0,0.0,0.0,0.1677538167696766,0.0,0.0,0.0,0.0,0,223149,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,IFE PE SERUM,ALBUMIN,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,HEPATITIS BS AB QUANT,HEPATITIS BS AB QUANT,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.1569574215481997,0.0,0.0,0,303842,CBC NO DIFF,RBC,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,OBSTETRIC PANEL,NEUTROPHILS,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,CBCI COMPLETE BLOOD COUNT W DIFF,ABS BASOPHILS,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.07142857142857142,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,VITAMIN B 12,VITAMIN B 12,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.125,0.0,0.0,0.125,0.0,0.0,0.0,0.08539469110668363,0.0,0.0,0.08539469110668363,0.0,0,241109,C4 SERUM,C4 SERUM,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,CMP13 LP TP TSH 2AC CBC D P,AST SGOT,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.0,0.2,0.0,0.155,0.2,0.5,0.0,0.02146570986203966,0.0,0.0,0.07982873259716383,0.5,1,304519,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.22,0.16666666666666666,0.5,0.22,0.16666666666666666,0.5,0.0,0.05660928660351461,0.5773502691896257,0.0,0.06933193344079114,0.7071067811865476,1,151522,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,LYMPHOCYTE SUBSET PANEL 3,ANALYZED DATE TIME,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,CBCI COMPLETE BLOOD COUNT W DIFF,ABS BASOPHILS,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.01611111111111111,0.03625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,CBC WITH MANUAL DIFFERENTIAL,WBC,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.045454545454545456,0.125,0.0,0.06636363636363636,0.1825,0.0,0.04088056399127271,0.0,0.0,0.0,0.0,0,322867,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,BUN CREATININE RATIO,EGFR NON AFR AMERICAN,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.25,0.16666666666666666,0.0,0.0,0.0,0.0,0.013400971592869015,0.010181580650666988,0.0,0.0,0.0,0.0,0,7328,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.24666666666666667,0.4,1.0,0.24666666666666667,0.4,1.0,0.0,0.10223598408605306,0.1503314858492919,0.0,0.10223598408605306,0.1503314858492919,1,29868,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,ANA IFA SCREEN WITH REFLEX TITER,ANTI NUCLEAR AB IFA,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,IGA SERUM,IMMUNOGLOBULIN A,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,CBC WITH PLT DIFF,MPV,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,CUSTOM HEPATITIS PANEL,HEP B SURFACE AB,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,COMPREHENSIVE METABOLIC PANEL E GFR,AST,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.02250574538159411,0.0,1,66902,CBC INCLUDES DIFF PLT W SMEAR RVW,WHITE BLOOD CELL COUNT,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,HCV RNA NAA QUALITATIVE,HCV RNA NAA QUALITATIVE,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,CARDIO IQ R VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,PATHOLOGIST SMEAR REVIEW,MONOCYTES,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,LIPID PANEL,VLDL CHOL CALC,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,RBC,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.46499999999999997,0.25142857142857145,0.5,0.0,0.0,0.0,0.008912499759331616,0.025541167468744463,0.04409367683763299,1,134577,CMP13 LP TP TSH 2AC CBC D P,LDL CHOLESTEROL CALC,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,CHOLESTEROL TOTAL,ICTERUS,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,IRON BINDING CAPACITY % SATURATION,CALCULATED % IRON SAT,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.022,0.07333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,BMP,CHLORIDE,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.25,0.35,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.45,0.3333333333333333,1.0,0.45,0.3333333333333333,1.0,0.008516468395054266,0.913744925535582,0.9900858126069512,0.008516468395054266,0.913744925535582,0.9900858126069512,1,115725,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,FREE T4,FREE T4,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,URINALYSIS W REFLEX MICRO,KETONES,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,MAGNESIUM,MAGNESIUM,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,LIPID PANEL,VLDL CHOL CALC,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.010526315789473684,0.022222222222222223,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,486431,BASIC METABOLIC PANEL,AFRICAN AMERICAN,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,HCV RNA GENO W REFL NS5A,HCV RNA GENOTYPE LIPA R,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.0356341430099808,0.0,0.0,0.0,0.0,0,295410,ANA IFA SCREEN WITH REFLEX TITER,ANTI NUCLEAR AB IFA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.0,0.08928571428571429,0.3125,0.0,0.09999999999999999,0.35,0.0,0.03217053905643563,0.12591840875016092,0.0,0.009858850925073437,0.038588437029685174,0,296095,HEPATITIS BC AB IGM,HEPATITIS B CORE AB IGM,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.05714285714285715,0.08,0.0,0.09571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODY IGG,CCP ANTIBODY IGG,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,CMP WITH EGFR,CARBON DIOXIDE,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.134,0.11166666666666668,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,CBC WITH PLT MAN DIFF,BANDS,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.3333333333333333,0.4,1.0,0.0,0.0,0.0,0.06809002533324715,0.4808823462371743,0.7071067811865476,1,17517,COMP METABOLIC PANEL 13,ALBUMIN SERUM,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.19999999999999998,0.038571428571428576,0.09000000000000001,0.19999999999999998,0.0,0.0,0.0,0.0329295894158842,0.033780845966761563,0.0,0.04656947195532102,0.04777333051463073,0,433961,LP WITHOUT VLDL CHOL HDL LD,LDL HDL RATIO,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,CK TOTAL,CREATINE KINASE TOTAL,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.03625,0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,CBC WITH PLT DIFF,BLASTS,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,DRUG ABUSE SCREEN III,METHAQUALONE,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.04,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,CMP14 LP CBC D PLT TSH HB A,ALT SGPT,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,COMP METAB PANEL,EGFR NON AFR AMERICAN,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,HCV FIBROSURE,LIMITATIONS,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,LIPID PANEL STANDARD,LDL CHOL CALCULATED,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,ALB ALP ALT AST GGT LD PROT,LDH,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,COMP METABOLIC PANEL,POTASSIUM,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,IRON BINDING CAPACITY % SATURATION,CALCULATED % IRON SAT,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,PROTIME PTT,INR,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,UROGRAM,KETONES,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CBC WITH DIFFERENTIAL,MYELOCYTES,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,CERULOPLASMIN,CERULOPLASMIN,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,PROTEIN ELECTROPHORESIS SERUM,ALPHA 2,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.08645951418136177,0.0,0,17830,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,LMG CBC DIFF PLT,LYMPHOCYTES #,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.041428571428571426,0.0725,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,LIPID PANEL WITH REFLEX DIRECT L,HDL CHOLESTEROL,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,URINALYSIS W REFLEX MICRO,SPECIFIC GRAVITY,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,ASH FIBROSURE,ALT SGPT P5P,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,HEPATITIS C VIRUS RNA QUALITATIVE PCR,HEPATITIS C VIRUS RNA QUALITATIVE PCR,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,NASH FIBROSURE,HEIGHT,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,CBC,NEUTROPHIL,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.03238095238095238,0.0,0.0,0.03238095238095238,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,HCV RNA QN PCR W REFL GENOTYPE LIPA R,HCV RNA QUANTITATIVE REAL TIME PCR,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.086,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,RENAL FUNCTION PANEL,BUN,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,CMP14 HP4 1AC PT AFP,EGFR IF NONAFRICN AM,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,HEPATIC FUNCTION PANEL,,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,VITAMIN B12 FOLATE,VITAMIN B12,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,FIBROACT COMPLETE,WEIGHT LBS,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,HIGH SENSITIVITY CRP,HIGH SENSITIVITY CRP,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,HCV RNA NAA QUALITATIVE,HCV RNA NAA QUALITATIVE,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS C ANTIBODY,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,HELPER T LYMPH CD4,NEUTROPHILS,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,DRUG ABUSE PANEL 10 WITH OXYCODONE,AMPHETAMINES,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,CMP WITH EGFR,ANION GAP,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,APOLIPOPROTEIN A1,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,CMP12 2AC,BILIRUBIN TOTAL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,C REACTIVE PROTEIN INFLAMMATORY,C REACTIVE PROTEIN,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.12999999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.022000000000000002,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,HEPATITIS C AB,HEPATITIS C AB,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,COMP METABOLIC PANEL CLARIFICATION,EGFR NON AFR AMERICAN,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,LYMPHOCYTE SUBSET PANEL 5,CD4 % POS,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.08,0.05714285714285715,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCH,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.26666666666666666,0.3,0.9,0.26666666666666666,0.3,0.9,0.0,0.16096628932775536,0.35355339059327373,0.0,0.16096628932775536,0.35355339059327373,1,44982,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,HEPATITIS BE ANTIGEN,HEPATITIS BE ANTIGEN,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.25,0.0,0.25,0.25,0.3333333333333333,0.0,0.015316711982292452,0.0,0.054435397064445,0.056961251827243986,0.0648385480903172,0,264853,CBCI COMPLETE BLOOD COUNT W DIFF,ABS MONOCYTES,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,CBC,BA%,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CMP13 LP 2AC CBC D PLT,CHOLESTEROL TOTAL,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,MORPHOLOGICAL REVIEW,PLATELET ESTIMATE,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,PT PTT,PARTIAL THROMBOPLASTIN,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,HCV GENOTYPE REFLEX NS5A,PLEASE NOTE,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,HCV FIBROSURE LABCORP,RESULT,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc,Bilirubin.glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,FREE T4,FREE T4,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.1416666666666667,0.42500000000000004,0.0,0.1416666666666667,0.42500000000000004,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.2,0.1142857142857143,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.11,0.0,0.0,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,CBC PLT DIFF,ABSOLUTE EOS,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,HDL AS % CHOLESTEROL,HDL AS % CHOLESTEROL,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,PSA FREE TOTAL,FREE PSA,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,HEPATIC FUNCTION PANEL,ALK PHOS,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,CHEM 20,CHOLESTEROL,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,PROTEIN ELECTRO S,GAMMA GLOBULIN,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,GLYCOHEMOGLOBIN A1C,GLYCOHEMOGLOBIN A1C,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,CBC,MCHC,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,COMPLETE BLOOD COUNT,RBC,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.31,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.0840117798597445,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,823781,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,IRON BINDING CAPACITY IBC % SATURATION,UNSATURATED IBC,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,CMP,TCO2,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.1675,0.2783333333333333,0.0,0.0,0.0,0.0,0.0,0.029882555375113973,0.0,0.0,0.0,0.0,0,7534,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,HEPATITIS A IGM,HEPATITIS A IGM,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,UROGRAM,APPEARANCE,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.04833333333333333,0.0,0.0,0.0,0.031,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.25,0.0,0.25,0.25,0.3333333333333333,0.0,0.016221639518710917,0.0,0.0769832768017027,0.08055537486383768,0.09169555407390673,0,301804,COMPLETE BLOOD COUNT,BASOPHILS %,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,CMP14 CBC D PLT TSH,EGFR IF AFRICN AM,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,CHEM SCREEN PANEL HDL,TRIGLYCERIDES,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.25,0.3233333333333333,0.94,0.0,0.0,0.0,0.06713496212611103,0.05720402135206337,0.0,1,7773,CBC INCLUDES DIFF PLT W SMEAR RVW,PLATELET COUNT,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,MA COMP METABOLIC PNL,ALKALINE PHOSPHATASE,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.2,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,LD,LD,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0504013971841859,0.0,0,183145,HEMOGLOBIN A1C,AVERAGE WHOLE BLOOD GLUCOSE,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,CMP13 LP TP TSH 2AC CBC D P,AST SGOT,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.14285714285714285,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,SED RATE WESTERGREN,SED RATE WESTERGREN,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,CBC WITH PLT DIFF,BASOPHILS ABSOLUTE,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.14285714285714285,0.25,0.0,0.2857142857142857,0.5,0.0,0.07075841156459017,0.07240860968350848,0.0,0.08666100167154711,0.08868207335447242,1,223271,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,FIBROACT,FIBROSIS SCORE,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,CBC,MCHC,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.3333333333333333,0.0,0.25,0.16666666666666666,0.0,0.0,0.03026068163391893,0.0,0.09341591340147393,0.0,0.0,1,7898,COMPLETE BLOOD COUNT,RBC,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.3333333333333333,0.16666666666666666,1.0,0.3333333333333333,0.16666666666666666,1.0,0.09247447620418048,0.3219325786555107,0.0,0.09247447620418048,0.3219325786555107,0.0,1,30262,T4,T4,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,CBC WITH MANUAL DIFFERENTIAL,MCHC,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,CBC PLATELET HEM REVIEW,NEUTROPHILS,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.396,0.1142857142857143,0.26666666666666666,0.0,0.0,0.0,0.0,0.34003516797720323,1.0,1,18697,NASH FIBROSURE,APOLIPOPROTEIN A 1,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,CBC WITH PLT DIFF,PROMYELOCYTES,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,NASH FIBROSURE,APOLIPOPROTEIN A 1,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,LIVER FIBROSIS PNL HEPASCORE TM,F2,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.2,0.2,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,AAA MALE PANEL,HIV 1 HIV 2 AB SCREEN,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,URINALYSIS COMPLETE WITH REFLEX CULTURE,PROTEIN,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.6125,0.6666666666666666,0.6666666666666666,0.0,0.0,0.0,0.03495267088951648,0.18123881916432538,0.18123881916432538,1,487926,HCV FIBROSURE,NECROINFLAMMAT ACTIVITY SCORE,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,AMYLASE,AMYLASE,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODY IGG,CCP ANTIBODY IGG,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,TRANSFERRIN SATURATION,TRANSFERRIN,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,IRON BINDING CAPACITY,IRON TOTAL,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,FIBROACT COMPLETE,WEIGHT LBS,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,SED RATE WESTERGREN,SED RATE WESTERGREN,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.22,0.16666666666666666,0.25,0.0,0.0,0.0,0.0,0.30644398188636846,0.1503314858492919,0,19687,URINALYSIS,BILIRUBIN,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.31,0.16666666666666666,0.0,0.0,0.0,0.0,0.03644238730291094,0.0,0.0,0,7732,CBC WITH PLT DIFF,RBC MORPHOLOGY,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,CMP14 LP CBC D PLT TSH,PLATELETS,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,PROFILE 104 LIVER,BILIRUBIN TOTAL,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,UA W RFLX MICROSCOPIC,BILIRUBIN,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,URINALYSIS CULTURE IF INDICATED,GLUCOSE,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.25,0.0,0.25,0.25,0.3333333333333333,0.0,0.015993111973885865,0.0,0.07870803013413097,0.08411277379800186,0.09704900074164846,1,264788,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,TESTOSTERONE TOTAL LC MS MS,TESTOSTERONE TOTAL LC MS MS,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,DRUG ABUSE SCREEN III,AMPHETAMINES,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.25,0.0,0.0,0.0,0.0,0.0,0.009433194695584124,0.0,0.0,0.0,0.0,0.0,0,539627,LIVER FIBROSIS PNL HEPASCORE TM,F2,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,FERRITIN,FERRITIN,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,STOOL CULTURE,RESULT 1,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.08333333333333333,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,CMP14 LP 7AC CBC D PLT T B,IRON SATURATION,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0.0,0.0,0.0,0,21600,IFE PE SERUM,ALBUMIN,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,CBC ESR,ABSOLUTE NEUTROPHILS,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,CBC W AUTO DIFF WITH PLATELETS,RDW,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,CBC,MO%,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.08833333333333333,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06860647178857471,0.0793317966039091,1.0,1,251454,URINALYSIS SCREEN,BACTERIA,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,HIV ANTIGEN ANTIBODY FOURTH GEN,HIV AG AB 4TH GEN,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,PHOSPHORUS,PHOSPHORUS,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,DIFFERENTIAL MANUAL,NEUTROPHILS,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.06,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.046706887849276346,0.0,0,7047,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.39666666666666667,0.1,0.2,0.09499999999999999,0.056999999999999995,0.11399999999999999,0.025474992674050623,0.03132695058051882,0.06720098415971731,0.0,0.0,0.0,1,79053,HB S AG W REFLEX CONF,HFLAG,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,CMP,C02 BICARBONATE,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,772020,HCV GENOTYPE REFLEX NS5A,PLEASE NOTE,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,TESTOSTERONE,TESTOSTERONE,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,HCV FIBROSURE,FIBROSURE STAGE,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.386,0.26,0.40857142857142853,0.386,0.26,0.40857142857142853,0.26600715605116654,0.3063788081381891,0.3300012562429049,0.26600715605116654,0.3063788081381891,0.3300012562429049,1,568881,HIV AB AG COMBO RFLX CONF,HIV AB AG COMBO RFLX CONF,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,COMP METABOLIC PANEL,ANION GAP,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,CBC WITH PLT DIFF,WBC MORPHOLOGY,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,HBSAB AG,HEP B SURFACE AB QUAL,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.375,0.20000000000000004,0.0,0.0,0.0,0.0,0.03960996495528413,0.0,0.0,0.0,0.0,0.0,1,204552,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,MICROALBUMIN RANDOM SPEC,MICROALBUMIN,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.2375,0.1357142857142857,0.95,0.25,0.14285714285714285,1.0,0.0,0.0,0.0,0.052570301148225806,0.05162000400267441,0.7071067811865476,1,303644,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0165,0.03666666666666667,0.1075,0.075,0.05555555555555555,0.0,0.0,0.0,0.0,0.0193228926416793,0.0,0,882936,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.11249999999999999,0.15,0.0,0.04125,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,DRUG ABUSE SCREEN W ETOH NO GCMS,COCAINE METABOLITE,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,FSRC NEW PATIENT PANEL,D BILIRUBIN,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,URINALYSIS W MICRO W REFLEX CULTURE,WBC,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,LIVER FIBROSIS PANEL,ALT,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,MA CBC DIFF PLT,MONOCYTES %,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.13428571428571429,0.3133333333333333,0.0,0.42857142857142855,1.0,0.0,0.0,0.0,0.0,0.10683799300987995,0.15892726613090935,1,7765,CBC INCLUDES DIFFERENTIAL PLATELETS,MEAN PLATELET VOLUME,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,CUSTOM HEPATITIS PANEL,HEP B SURFACE AB,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,URINALYSIS SCREEN,PH,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,COMPREHENSIVE METABOLIC PANEL E GFR,ALT,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,HCV GENOTYPE PCR PROBE,HCV GENOTYPE,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,LIPID PROFILE,FASTING NON FASTING,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,CBC W O DIFF WITH PLATELETS,MCV,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,CBCI COMPLETE BLOOD COUNT W DIFF,ABS MONOCYTES,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.16625,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,HCV FIBROSURE,LIMITATIONS,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.1111111111111111,0.0,0.0,0.1111111111111111,0.2,0.0,0.049770499071561725,0.0,0.0,0.017083235011580045,0.01776986060024932,0,539627,PROTEIN ELEC INTERP SERUM,ALPHA 2 GLOBULIN,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,PSA TOTAL % FREE,% FREE PSA,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,HIV ANTIGEN ANTIBODY FOURTH GEN,HIV AG AB 4TH GEN,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,NASH FIBROSURE,HAPTOGLOBIN,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,HEPATIC FUNCTION PANEL AMA,GLOBULIN,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CMP14 1AC,ALT SGPT,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,VITAMIN D 25 OH,VITAMIN D 25 OH,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.1925,0.08833333333333333,0.0,0.22,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.08318397885080242,1.0,1,57703,URINALYSIS CULTURE IF INDICATED,BILIRUBIN,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,PTH INTACT MOLECULE,PTH,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,COMP METABOLIC PANEL CLARIFICATION,ALT,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,ALPHA 2 MACROGLOBULIN,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,NASH FIBROSURE,ALT SGPT P5P,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.02064286656232517,0.0,0.0,0.0,0.0,0,81224,CBCI COMPLETE BLOOD COUNT W DIFF,BASOPHILS,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,PATHOLOGIST SMEAR REVIEW,MONOCYTES,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06635350960296393,0.05287307875068503,0.08777198612321668,1,7492,CBC WITH PLT DIFF,MYELOCYTES,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,LP WITHOUT VLDL CHOL HDL LD,LDL HDL RATIO,Specimen source identified,Specimen source XXX,Specimen source
0.24666666666666667,0.2,1.0,0.24666666666666667,0.2,1.0,0.0,0.34003516797720323,1.0,0.0,0.34003516797720323,1.0,1,29868,TESTOSTERONE,TESTOSTERONE,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,ASH FIBROSURE,FIBROSIS STAGE,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,URINALYSIS,BILIRUBIN,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,ASH FIBROSURE,AST SGOT P5P,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CBC COMPLETE BLOOD COUNT W O DIFF,HEMATOCRIT,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,RPR REFLEX TITRE TPPA,RPR,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.16,0.0,0.1675,0.192,0.96,0.0,0.061769791070825475,0.0,0.0,0.0,0.0,1,193433,DRUG ABUSE SCREEN III,AMPHETAMINES,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,CBC,NEUTROPHIL,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.2,0.08333333333333333,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,CBC W AUTO DIFF ABS WBC MPV PLT,BASOPHILS,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,IRON BINDING CAPACITY,UIBC,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,NMR LIPOPROFILE,LDL P,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,CBC H H RBC INDICES WBC PLT,MPV,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.08333333333333333,0.1,0.0,0.08333333333333333,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,CHOL HDL RATIO,CHOL HDL RATIO,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.05714285714285715,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,HCV RNA GENO W REFL NS5A,HCV RNA GENOTYPE LIPA R,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,URINALYSIS,BILIRUBIN,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,PROTHROMBIN TIME PT,PT CONTROL,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,CMP WITH EGFR,CARBON DIOXIDE,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,LYMPHOCYTE SUBSET PANEL 4,HELPER SUPPRESSOR RATIO,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Beta globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,BMP8 ANION GAP,EGFR IF NONAFRICN AM,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,CBC WITH PLT DIFF,MPV,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.16,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,LD,LIPEMIA,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,CBC WITH DIFFERENTIAL PLATELETS,POLYS,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,CBC W AUTO DIFF WITH PLATELETS,MCV,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.11,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.07163871665340582,0.09716253076254433,1.0,1,57976,UROGRAM,KETONES,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,CREATININE,EGFR IF AFRICN AM,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.05714285714285715,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,CBC PLT DIFF,POLYS,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,HEPATIC FUNCT PANEL W O TP,BILIRUBIN DIRECT,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,PHOSPHATE AS PHOSPHORUS,LIPEMIA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0834655896020069,0.34003516797720323,1.0,1,29512,FOLLOW UP PNL ARAKAWA,SODIUM,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHADONE,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,LIPID PANEL W REFL DLDL,NON HDL CHOLESTEROL,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,CBC INCLUDES DIFF PLT W SMEAR RVW,PLATELET COUNT,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.1503314858492919,0.0,0.0,0,304287,COMPLETE BLOOD COUNT,RBC,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.17857142857142858,0.3125,0.0,0.0,0.0,0.0,0.048254027760822216,0.05608746788525232,0.0,0.0,0.0,0,139519,HEPATITIS B SURFACE ANTIGEN W REFL CONFIRM,CONFIRMATION,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.1425,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,LIVER FIBROSIS FIBROTEST ACTITEST P,NECROINFLAMMATION ACT GRADE,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.3333333333333333,0.25,0.0,0.0,0.0,0.0,0.1503314858492919,0.0,0.0,1,264531,CBC NO DIFF,RBC,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,LIPID CASCADE,LDL CHOLESTEROL CALC,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,MICROALBUMIN RANDOM SPEC,MICROALBUMIN,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,CMP14 LP CBC D PLT,NEUTROPHILS,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CREATINE KINASE TOTAL,HEMOLYSIS,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,URINALYSIS ROUTINE,WBC,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.08399999999999999,0.0,0.1175,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,IMMUNOFIXATION SERUM,IGG SERUM NR,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,ANA CRP ASO PE,P E INTERPRETATION S,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.0,0.0,0.12285714285714286,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,622381,CMP14 4AC,EGFR IF AFRICN AM,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,HIV AB AG COMBO RFLX CONF,HIV AB AG COMBO RFLX CONF,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,CMP14 LP CBC D PLT TSH,NEUTROPHILS,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,URINALYSIS W REFLEX MICRO,SPECIFIC GRAVITY,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.014499999999999999,0.03222222222222222,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,IRON TIBC,TIBC,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,HEMOGRAM W O DIFFERENTIAL,MEAN PLATELET VOLUME,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,CARETC CMP LIPID URIC ACID DIR BILI PROFILE,RISK RATIO LDL HDL,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual,Promyelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,COMPREHENSIVE METABOLIC PANEL WITH GFR,ALBUMIN,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,HCV RNA NAA QUALITATIVE,HCV RNA NAA QUALITATIVE,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,CMP14 LP 6AC CBC D PLT ESR,CREATININE,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.25,0.3333333333333333,0.6,0.25,0.3333333333333333,0.6,0.034234837021806186,0.14931149721468506,0.15531276656446735,0.034234837021806186,0.14931149721468506,0.15531276656446735,1,539627,AFP TUMOR MARKER,AFP TUMOR MARKER,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,HEPATITIS A IGM,HEPATITIS A IGM,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,RENAL FUNCTION PANEL,CHLORIDE,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.2857142857142857,0.6666666666666666,0.3333333333333333,0.0,0.0,0.0,0.6630243943799374,1.0,0.09629383728860574,0.0,0.0,1,25007,IRON BINDING CAPACITY,TIBC,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,ALPHA 1 ANTITRYPSIN SERUM,ALPHA 1 ANTITRYPSIN SERUM,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.0,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,URINALYSIS REFLEX,NITRITE,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,HEPATITIS BC AB IGM,HEPATITIS B CORE AB IGM,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,CEA,CEA,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,AUTOMATED BLD CNT,HEMOGLOBIN,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.0,0.0,0.0,0.0,0.06999999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,HEPATIC LIVER PANEL,DIRECT BILIRUBIN,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0625,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,RENAL FUNCTION PANEL,BUN,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.2375,0.25,0.3333333333333333,0.0,0.0,0.0,0.0,0.08253790759907542,0.0946521642027649,1,264507,CBC W DIFF PLATELET,EOSINOPHILS,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.02,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,CBC W AUTO DIFF WITH PLATELETS,BASOPHILS,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.047142857142857146,0.0275,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,PROTIME PTT,PROTHROMBIN TIME PT,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.25,0.34285714285714286,0.6,0.25,0.34285714285714286,0.6,0.042041113341922176,0.1225571638927394,0.1254153908772606,0.042041113341922176,0.1225571638927394,0.1254153908772606,0,223271,HEPATITIS B CORE TOTAL AB,HEPATITIS B CORE TOTAL AB,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,CBC PLATELET HEM REVIEW,EOS,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,CBC,MO%,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.134,0.0,0.0,0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,LD,LD,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.03571428571428571,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,CBC INCLUDES DIFF PLT,MCHC,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.02414352270933806,0.0,0.0,0.0,0.0,0,59055,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.3333333333333333,0.2,0.5,0.3333333333333333,0.4,0.5,0.04272417415933216,0.05549282856714377,0.0,0.06042110653731758,0.1569574215481997,0.0,1,311472,RPR REFLEX TP PA,RPR TITER,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.05833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.13636363636363635,0.125,0.0,0.0,0.0,0.0,0.04521753067807699,0.0,0.0,0.0,0.0,0,112599,CBC W O DIFF WITH PLATELETS,MCH,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,CBC NO DIFF,RBC,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,URINALYSIS COMPLETE,GLUCOSE QL,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,UROGRAM,NITRITE,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.24333333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,PTH INTACT WITHOUT CALCIUM,PARATHYROID HORMONE INTACT,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.09499999999999999,0.07125,0.11399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0125,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,CBC W DIFF PLT,MONOCYTES %,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,HEPATITIS BS AB QUANT,HEPATITIS BS AB INTERP,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CBC W DIFF PLT,PLATELET SUFFICIENCY,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.042727272727272725,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.020363161301333976,0.0,0,7120,CBC INCLUDES DIFF PLT W SMEAR RVW,WHITE BLOOD CELL COUNT,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,CMP14 HP4 DBILI CBC D PLT R,AMYLASE,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,CHEM SCREEN PANEL,BILIRUBIN DIRECT,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.1111111111111111,0.0,0.3333333333333333,0.2222222222222222,0.6666666666666666,0.0,0.007718143826505375,0.0,0.03726472851187701,0.045920637739157,0.125634656602176,1,273532,HEMOGLOBIN A1C,AVERAGE WHOLE BLOOD GLUCOSE,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.012857142857142857,0.0225,0.1875,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.08666100167154711,0.0,0,223271,CMP13 LP 2AC CBC D PLT,ALBUMIN SERUM,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,URINALYSIS RX ALB CREA,KETONES,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,URINALYSIS W REFLEX MICRO,KETONES,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,PROTHROMBIN TIME PT,PT CONTROL,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.20666666666666667,0.188,0.3133333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE EOS,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.0,0.015263157894736841,0.03222222222222222,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,LP WITHOUT VLDL CHOL HDL LD,LDL HDL RATIO,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODY IGG,CCP ANTIBODY IGG,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,PROFILE 104 LIVER,BILIRUBIN TOTAL,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,CMP14 HP4 1AC PT AFP,PROTHROMBIN TIME,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,CMP WITH ESTIMATED GFR CALCULATED,CHEMISTRY SODIUM,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS C ANTIBODY,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,CBC WITH PLT DIFF,NRBC,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,HB S AB QL,HB S AB QL,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,PROTEIN ELECTROPHORESIS,BETA GLOBULINS,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,LIPID PANEL WITH DIRECT LDL,TRIGLYCERIDES,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.09247447620418048,0.34003516797720323,1.0,1,23457,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,GLUCOSE,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,CBC INCLUDES DIFF PLT W SMEAR RVW,PLATELET COUNT,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.385,0.265,0.0,0.5,0.5,1.0,0.0,0.0,0.0,0.1503314858492919,0.7071067811865476,1.0,1,57786,URINALYSIS CULTURE IF INDICATED,COLOR,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,FOLLOW UP PNL ARAKAWA,SODIUM,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,Specimen source identified,Specimen source XXX,Specimen source
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,PTH INTACT WITHOUT CALCIUM,PARATHYROID HORMONE INTACT,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,HEMATOPATH CONSULTATION SMEAR,WBC,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.25,0.0,0.65,0.5,1.0,0.0,0.02948276095739455,0.0,0.0,0.15505905338492743,1.0,0,264499,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,STOOL CULTURE,RESULT 1,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,HEPATITIS BE AG,HBEAG INS NR,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,COMP METABOLIC PANEL,GLOBULIN,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.09666666666666668,0.038,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,CBCI COMPLETE BLOOD COUNT W DIFF,ABS MONOCYTES,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,HELPER T LYMPH CD4,NEUTROPHILS,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.2,0.23857142857142857,0.4175,0.0,0.0,0.0,0.007533800503776389,0.011218996386622493,0.013040260652611102,0.0,0.0,0.0,0,139519,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.023571428571428573,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,LYMPHOCYTE SUBSET PANEL 4,%CD8 SUPPRESSOR T CELLS,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,CBC W AUTO DIFF ABS WBC MPV PLT,BASOPHILS,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,ASH FIBROSURE,AST SGOT P5P,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.4175,0.08571428571428572,0.0,0.6675,0.3242857142857143,0.0,0.027952627376922723,0.0,0.0,0.061241138223508074,0.059062741744354885,0.0,1,19901,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,COMPREHENSIVE METABOLIC PANEL,ALBUMIN,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.31,0.31,0.0,0.0,0.0,0.0,0.14187034543632637,0.14187034543632637,0,82644,LYMPHOCYTE SUBSET PANEL 4,COMMENT S,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,URINALYSIS ROUTINE,WBC,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,AFP TUMOR MARKER,AFP TUMOR MARKER,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A RESIST ASSAY INTERP,Race,Race,Race
0.0,0.084,0.0,0.0,0.084,0.0,0.0,0.02478016669940941,0.0,0.0,0.02676563914036567,0.0,0,121855,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,LYMPHOCYTE SUBSET PANEL 4,%CD8 SUPPRESSOR T CELLS,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,COMP METAB PANEL,EGFR NON AFR AMERICAN,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,URINALYSIS W REFLEX MICRO,COLOR,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,PROTHROMBIN PTT,CONTROL,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.055,0.1,0.0,0.0,0.0,0.0,0.0,0.03617324670110522,0.0,0,79053,C4 C3,COMPLEMENT C3 SERUM,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,LIVER FIBROSIS FIBROTEST ACTITEST P,GGT,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,LIPID PANEL WITH DIRECT LDL,TRIGLYCERIDES,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,HCV RNA GENO W REFL NS5A,HCV RNA GENOTYPE LIPA R,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.24333333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0.04357905440832277,0.0,0.0,0.0,0.0,1,64634,STOOL CULTURE,RESULT 2,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,IRON BINDING CAPACITY,TIBC,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,URINALYSIS C,BILIRUBIN,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,COMPREHENSIVE METABOLIC PANEL WITH GFR,ALBUMIN,Race,Race,Race
0.0,0.04857142857142858,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,HCV FIBROSURE LABCORP,RESULT,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,URINALYSIS W REFLEX MICRO,BACTERIA,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,URINALYSIS CULTURE IF INDICATED,BILIRUBIN,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.14285714285714285,0.2,0.0,0.14285714285714285,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,PSA TOTAL % FREE,% FREE PSA,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,CMP13 LP TP TSH 2AC CBC D P,LDL CHOLESTEROL CALC,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,CBC WITH PLT DIFF,BASOPHILS ABSOLUTE,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.5,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,NASH FIBROSURE,HAPTOGLOBIN,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,UROGRAM,APPEARANCE,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.05263157894736842,0.0,0.0,0.0,0.0,0.0,0.023692166672912185,0.0,0,486431,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.124,0.1985714285714286,0.0,0.292,0.2571428571428572,0.9,0.0,0.0,0.0,0.008931533211845588,0.45222488980749964,1.0,1,204537,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,HAV HBV IMMUNE STATUS PRO IV,HEP A AB IGM,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.08952338621207645,0.0,0,264846,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,URINALYSIS W MICRO W REFLEX CULTURE,WBC,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,MAGNESIUM,ICTERUS,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,LIVER PANEL II,LD,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.05222222222222222,0.094,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,CMP14 LP 2AC CBC D PLT TSH,EGFR IF AFRICN AM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.4,0.18181818181818182,0.25,0.0,0.0,0.0,0.04802835732051414,0.11003603894321656,0.12851200387967032,1,542183,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.11166666666666668,0.0,0.0,0.19999999999999998,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.03622836077219149,0.18114949547659975,0.22056758755212558,1,241109,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,PROTIME PTT,PROTHROMBIN TIME PT,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,BUN CREATININE,BUN,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.1,0.125,0.0,0.0,0.0,0.0,0.05117681691383591,0.0,0.0,0.0,0.0,0,381806,CBC WITH DIFFERENTIAL,IMMATURE GRANS,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,CBC,MCHC,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,URINALYSIS CULTURE IF INDICATED,PH,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,CMP13 LP TP TSH 2AC CBC D P,AST SGOT,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,CMP14 HP4 DBILI CBC D PLT R,WBC,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,MITOCHONDRIAL M2 ANTIBODY,MITOCHONDRIAL M2 ANTIBODY,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,CBC W AUTO DIFF WITH PLATELETS,MCV,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.22,0.0,0.0,0.5,0.5,1.0,0.0,0.0,0.0,0.14187034543632637,0.7071067811865476,1.0,1,57679,UROGRAM,APPEARANCE,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.09341591340147393,0.08089870281836808,1.0,0,7427,MA CBC DIFF PLT,MONOCYTES %,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,LYMPHOCYTE SUBSET PANEL 1,% CD8,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.20750000000000002,0.20750000000000002,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,HEPATITIS PANEL ACUTE,HEPATITIS C AB CIA,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,Cells.CD3/100 cells
0.066,0.125,0.25,0.0,0.25,0.5,0.0,0.05345799931322692,0.07240860968350848,0.0,0.06547241049372987,0.08868207335447242,1,139550,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS C ANTIBODY,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.030763983977592058,0.0,0.0,0.0,0.0,0,7112,CBC COMPLETE BLOOD COUNT W O DIFF,HEMATOCRIT,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,PROFILE 104 LIVER,BILIRUBIN TOTAL,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.25666666666666665,0.1325,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,URINALYSIS CULTURE IF INDICATED,BACTERIA,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,IRON BINDING CAPACITY IBC % SATURATION,UNSATURATED IBC,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,TSH SML,TSH,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,PSA TOTAL,PSA TOTAL,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,LIVER FIBROSIS FIBROTEST ACTITEST P,NECROINFLAMMATION ACT GRADE,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.008095238095238096,0.017,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,URINALYSIS WITH MICROSCOPIC,APPEARANCE,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.276,0.18666666666666668,0.0,0.0,0.0,0.0,0.0,0.07402207708426334,0.0,1,128512,ANA CRP ASO PE,P E INTERPRETATION S,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,HELPER T LYMPH CD4,NEUTROPHILS,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,DRUG ABUSE SCREEN I NO GCMS,BARBITURATES,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,IRON BINDING CAPACITY,IRON TOTAL,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,ALPHA FETOPROTEIN TUMOR MARKER,AFP TUMOR MARKER,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,HEPASCORE R,SEX,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,URINALYSIS CULTURE IF INDICATED,COLOR,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,CBC WITH AUTO DIFF,MONOCYTES #,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,URINALYSIS W REFLEX MICRO,PROTEIN,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.534,0.534,0.5,0.36,0.0,0.0,0.016107508969110285,0.3644215793074378,0.9679688834828893,0.027385328599057512,0.0,0.0,1,345355,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,IRON BINDING CAPACITY,UIBC NR,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,CYSTIC FIBROSIS SCREEN,ETHNICITY,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.055,0.033,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,COMP METABOLIC PANEL,CREATININE,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CMP WITH EGFR,ANION GAP,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.178,0.2225,0.0,0.178,0.2225,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,LIPID PANEL W REFL DLDL,NON HDL CHOLESTEROL,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,NASH FIBROSURE,APOLIPOPROTEIN A 1,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,DIFFERENTIAL MANUAL,NEUTROPHILS,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.172,0.0,0.0,0.392,0.09571428571428572,0.1675,0.0,0.0,0.0,0.03321870600293453,0.043355289534301455,0.043726732586310324,1,142513,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,CUSTOM HEPATITIS PANEL,HEP B SURFACE AB,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,IRON TOTAL BINDING CAPACITY,IRON TOTAL,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.03666666666666667,0.066,0.0,0.03666666666666667,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,RPR,TREPONEMA PALLIDUM ANTIBODIES,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,COMPLETE BLOOD COUNT,MCV,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,PROTIME PTT,INR,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,CMP12 LP TP TSH 6AC CBC D PLT,URIC ACID,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,NASH FIBROSURE,WEIGHT,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,URINALYSIS RX ALB CREA,KETONES,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.392,0.392,0.98,0.392,0.392,0.98,0.03737810203089009,0.05195195509007766,0.06743073700930258,0.03737810203089009,0.05195195509007766,0.06743073700930258,1,172841,MITOCHONDRIAL AB SCREEN,MITOCHONDRIAL AB SCREEN,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,BASIC METABOLIC PANEL W EGFR,BUN CREATININE RATIO,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,PE INTERP RFX IFE S,ALBUMIN,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,URINALYSIS COMPLETE,GLUCOSE QL,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.22333333333333336,0.2,1.0,0.0,0.0,0.0,0.0,0.17001758398860156,0.5,0,21600,EIA 10 ALCOHOL W GCMS,URINE CREATININE MG DL,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.1,0.034444444444444444,0.0775,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.030714285714285715,0.1075,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,COMPREHENSIVE METABOLIC PNL W O CO2 ALT,POTASSIUM,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD4 CELLS,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.6666666666666666,0.5,1.0,0.0,0.0,0.0,0.1625018229625479,0.15505905338492743,1.0,1,264747,LMG CBC DIFF PLT,LYMPHOCYTES #,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,FREE T4 THYROXINE,FREE T4,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,CMP14 LP 6AC CBC D PLT ESR,CREATININE,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,LIPID PANEL,VLDL CHOL CALC,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.25,0.2,0.25,0.0,0.0,0.0,0.0746172002260781,0.0,0.0,1,349993,CBC PLT DIFF,POLYS,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,30841,CHEM SCREEN PANEL HDL,URIC ACID,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,URINALYSIS W MICRO,GLUCOSE,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,HIV 1 RNA QN RT PCR,LOGCOPIES ML,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06803603656800117,0.06673966886790239,0.10240603634159506,1,7708,CMP14 LP CBC D PLT,NEUTROPHILS,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,CBC,NEUTROPHIL,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual,Promyelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,HEPATITIS BS AB QUANT,HEPATITIS BS AB INTERP,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,HEPATITIS PANEL ACUTE,HEPATITIS B CORE AB IGM,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0.0,0.0,0.0,0,22848,IFE PE SERUM,ALBUMIN,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,LYMPHOCYTE SUBSET PANEL 1,% CD8,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,LIVER FIBROSIS PNL HEPASCORE TM,F2,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,CMP14 5AC CBC D PLT TSH T4F,CALCIUM SERUM,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,RPR REFLEX TITRE TPPA,RPR,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CBC WITH AUTO DIFF,BASOPHILS #,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,CHEM SCREEN PANEL HDL,TRIGLYCERIDES,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,OBSTETRIC PANEL,NEUTROPHILS,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,HEMOGLOBIN A1C W EAG INT CHART,ESTIMATED AVERAGE GLUCOSE,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.25,0.16699999999999998,0.5,0.0,0.0,0.0,0.050366252651508736,0.0,0.0,1,17434,NASH FIBROSURE,ALT SGPT P5P,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,CBC W AUTO DIFF,MONOCYTES %,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,PSA TOTAL % FREE,% FREE PSA,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,STOOL CULTURE,RESULT 2,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,COMP METABOLIC PANEL,CARBON DIOXIDE,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.155,0.2316666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,327767,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,CBC WITH AUTO DIFF,LYMPHOCYTES #,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,URINALYSIS,BILIRUBIN,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,CBC WITH MANUAL DIFFERENTIAL,RDW,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.02948276095739455,0.0,0.0,0.0,0.0,0,264648,CBC COMPLETE BLOOD COUNT W O DIFF,HEMATOCRIT,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.05339016372965322,0.1963193957655779,0.5773502691896257,0,30916,CMP WITH ESTIMATED GFR CALCULATED,UREA NITROGEN,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,CBC INCLUDES DIFF PLT W SMEAR RVW,PLATELET COUNT,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CMP14 HP4 1AC PT AFP,PROTHROMBIN TIME,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,STOOL CULTURE,RESULT 1,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,CMP14 HP4 1AC PT AFP,PROTHROMBIN TIME,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,ARTHRITIS PROFILE,RHEUMATOID FACTOR QUANT,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,LIVER FIBROSIS FIBROTEST,ALPHA 2 MACROGLOBULIN,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,CMP14 1AC,EGFR IF NONAFRICN AM,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,24588,COMP METABOLIC PANEL 13,ALBUMIN SERUM,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,BASIC METABOLIC PANEL,OSMOLALITY,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.3,0.2,1.0,0.0,0.0,0.0,0.0,0.34003516797720323,1.0,1,45427,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,HAPTOGLOBIN,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,CMP14 LP 5AC,VLDL CHOLESTEROL CAL,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,HIV AB EIA WITH REFLEX,HIV AB,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.11857142857142858,0.049999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,HEPATITIS BC AB IGM,HEPATITIS B CORE AB IGM,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,ASH FIBROSURE,FIBROSIS STAGE,Race,Race,Race
0.0,0.09090909090909091,0.0,0.0,0.09090909090909091,0.0,0.0,0.007667464283621639,0.0,0.0,0.007667464283621639,0.0,0,568881,TESTOSTERONE SERUM,TESTOSTERONE SERUM,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,HEPATITIS A IGM,HEPATITIS A IGM,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD4 CELLS,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.372,0.21875,0.375,0.372,0.21875,0.375,0.02963192182426555,0.11668740736434247,0.09061940958216264,0.02963192182426555,0.11668740736434247,0.09061940958216264,1,182626,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.205,0.14285714285714285,1.0,0.0,0.0,0.0,0.0,0.9309084648501563,1.0,1,18358,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,ALPHA 2 MACROGLOBULIN,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD LOG IU ML,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,RPR REFLEX TP PA,RPR TITER,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,CMP14 HP5 LP 6AC CBC D PLT,INR,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,MICROALBUMIN RANDOM SPEC,MICROALBUMIN,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,CMP,ALT SGPT,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.06835323508016788,0.0,0.0,0.06835323508016788,0.0,0,20289,C4 SERUM,C4 SERUM,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,COMP METABOLIC PANEL,CREATININE,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.09142857142857143,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,CBC WITH PLT DIFF,BANDS,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.022,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,MICROALBUMIN CREATININE RANDOM RATIO,MICROALBUMIN RANDOM,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,HEMATOPATH CONSULTATION SMEAR,HEMATOLOGY COMMENTS,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,COMP METABOLIC PANEL CLARIFICATION,ALT,Color of Urine,Color Ur,Color
0.2,0.0,0.0,0.0,0.0,0.0,0.026965410719833605,0.0,0.0,0.0,0.0,0.0,0,505511,CBC W AUTO DIFF WITH PLATELETS,RDW,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,DIRECT LDL,TRIGLYCERIDES,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,UROGRAM,APPEARANCE,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HCV RNA QUAL TMA,Specimen source identified,Specimen source XXX,Specimen source
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,UREA NITROGEN BUN,ICTERUS,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.25,0.0,0.3333333333333333,0.0,0.0,0.0,0.0633025934653415,0.0,0.1569574215481997,0.0,0.0,1,264648,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,TESTOSTERONE FREE TOTAL LC MS MS,FREE TESTOSTERONE,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,ASH FIBROSURE,ALT SGPT P5P,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,VITAMIN B12 FOLATE,VITAMIN B12,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.3333333333333333,0.25,0.74,0.3333333333333333,0.25,0.74,0.012877229495112386,0.08489650403181737,0.0,0.06192371508395944,0.40824829046386313,0.0,1,149575,MICROALBUMIN CREATININE RANDOM RATIO,MICROALBUMIN RANDOM,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,CBC WITH PLT DIFF,WBC MORPHOLOGY,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.06714285714285714,0.094,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,CARDIO IQ R VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,HCV RNA GENO W REFL NS5A,HCV RNA GENOTYPE LIPA R,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESISTANCE ASSAY PDF,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.175,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,HEPATITIS B VIRUS PNL 6 TESTS,HB CORE AB TOTAL,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.2,0.2857142857142857,0.3333333333333333,0.0,0.0,0.0,0.036756887805291405,0.1399625538799285,0.04933362690358978,0,81018,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,UROGRAM,APPEARANCE,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,ANA AUTOIMMUNE PROFILE,RHEUMATOID FACTOR QUANT,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.25,0.0,0.0,0.1775,0.16666666666666666,1.0,0.05393370274893572,0.0,0.0,0.0,0.0,0.0,1,7427,CBC W AUTO DIFF,MONOS ABSOLUTE,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CBC WITH DIFFERENTIAL,NEUTROPHILS,Color of Urine,Color Ur,Color
0.22333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,HEMOGLOBIN A1C W EAG INT CHART,ESTIMATED AVERAGE GLUCOSE,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.044,0.14285714285714285,0.0,0.22999999999999998,0.1142857142857143,0.26666666666666666,0.0,0.0,0.0,0.0,0.24044117311858715,0.7071067811865476,1,18697,LIVER FIBROSIS FIBROTEST ACTITEST P,APOLIPOPROTEIN A1,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.124,0.0,0.0,0.0,0.0,0.0,0.0,0.03095396539820583,0.0,0.0,0.0,0.0,0,505511,AUTOMATED BLD CNT,MCH,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.23399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,CMP14 HP5 LP 6AC CBC D PLT,INR,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin
0.405,0.16666666666666666,0.0,0.0,0.0,0.0,0.038760388455545525,0.03302675712634284,0.0,0.0,0.0,0.0,0,66902,AUTOMATED BLD CNT,HEMOGLOBIN,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,COMP METABOLIC PANEL,CARBON DIOXIDE,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,RPR SCREEN W TITER,RPR SCREEN,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,CBC WITH PLT DIFF,OTHERS,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CMP14 CBC D PLT RPR UA TSH,HCV AB,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0825,0.266,0.0,0.0,0.0,0.0,0.0,0.0696348771716293,0.0,0.0,0.0,0.0,0,143149,URINALYSIS SCREEN,PH,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.0,0.0,0.0,0.0,0.08287539106540942,0.7071067811865476,0.0,1,285403,CBC W AUTO DIFF WITH PLATELETS,MCHC,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Iron saturation
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,27771,CMP14 6AC,PHOSPHORUS,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,HEPATITIS C VIRUS RNA QN REAL TIME PCR,HCV RNA PCR QN,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HCV RNA QUAL TMA,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,RBC,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,HEPATITIS C REFLEX PCR,HEPATITIS C ANTIBODY,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.14285714285714285,0.36363636363636365,0.5714285714285714,0.14285714285714285,0.36363636363636365,0.5714285714285714,0.007859893039378507,0.033318761517623696,0.6583833712146145,0.007859893039378507,0.033318761517623696,0.6583833712146145,1,831008,HEPATITIS B CORE AB,HEPATITIS B CORE AB,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,PROTHROMBIN PTT,APTT,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.375,0.13799999999999998,0.0,0.0,0.0,0.0,0.011057036615965687,0.0,0.0,0.0,0.0,0.0,0,7856,HCV RNA QN PCR W REFL GENOTYPE LIPA R,HCV RNA QUANTITATIVE REAL TIME PCR,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,GGTP,GGTP,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,PSA WITH FREE RATIO,PSA ROCHE E170,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.15,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.09418963513805056,0.0,0,51953,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,HIV 1 RNA QN RT PCR,HIV 1 RNA QN RT PCR,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,PSA FREE TOTAL,PSA FREE,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,PSA TOTAL % FREE,PSA FREE,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.2866666666666667,0.3333333333333333,1.0,0.0,0.0,0.0,0.0,0.042056338045787456,0.046108379515458875,1,20859,CMP14 LP CBC D PLT TSH UA M,HDL CHOLESTEROL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,CMP14 LP CBC D PLT TSH UA M,HDL CHOLESTEROL,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.31,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.0840117798597445,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,825208,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,ANA REFLEX AUTOIMMUNE AB PROFILE,ANTI NUCLEAR ANTIBODIES,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.132,0.09090909090909091,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,ANA CRP ASO PE,P E INTERPRETATION S,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,CBC INCLUDES DIFF PLT,BLASTS,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,CBC WITH MANUAL DIFFERENTIAL,MCHC,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,LYMPHOCYTE SUBSET PANEL 5,CD4 % POS,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.2,0.14285714285714285,0.3333333333333333,0.4,0.14285714285714285,0.3333333333333333,0.03696139574387214,0.09912686727665487,0.06205807818513498,0.07392279148774428,0.09912686727665487,0.12411615637026996,1,81232,CD4 T HELPER PANEL,CD4 CD3 %HELPERS,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,LIPID PANEL WITH REFLEX DIRECT L,HDL CHOLESTEROL,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,FOLLOW UP PNL ARAKAWA,SODIUM,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,SEGMENTED NEUTROPHILS,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,RPR REFLEX TITRE TPPA,RPR,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,GENERAL HEALTH PANEL,HEMATOCRIT,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.055,0.033,0.0,0.16666666666666666,0.1,0.5,0.0,0.0,0.0,0.0872369085792638,0.0,0.0,1,17434,LIVER FIBROSIS PANEL,ALT,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.08181818181818182,0.225,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,CBC PLATELET NO DIFFERENTIAL,HEMATOCRIT,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,RENAL FUNCTION PANEL,ANION GAP,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,WESTERGREN SED RATE,WESTERGREN SED RATE,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,VITAMIN D 25 OH,25 OH VITAMIN D,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,CBC WITH PLT DIFF,MONOCYTES ABSOLUTE,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,C4 SERUM,C4 SERUM,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,CBC WITH DIFFERENTIAL PLATELETS,POLYS,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,DRUG ABUSE PANEL 10 WITH OXYCODONE,OPIATES,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,FIBROACT COMPLETE,NECROINFL SCORE,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,RENAL FUNCTION PANEL,BUN,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,T4,T4,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,CBC W AUTO DIFF WITH PLATELETS,BASOPHILS,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,REFLEX ANA PATTERN,PATTERN 1,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,CMP14 CBC D PLT ESR WES ANA,POTASSIUM,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.0,0.022,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,LP WITHOUT VLDL CHOL HDL LD,LDL HDL RATIO,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,CBC,HEMOGLOBIN,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.0769832768017027,0.08055537486383768,0.09169555407390673,1,301804,CBC W AUTO DIFF ABS WBC MPV PLT,BASOPHILS,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL AB,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,CMP13 LP 2AC CBC D PLT,CHOLESTEROL TOTAL,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESIST ASSAY INTERP,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,UROGRAM,KETONES,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc,Alpha-2-Macroglobulin
0.0,0.088,0.14666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.0672790962344263,0.051758104169687846,0.7071067811865476,1,7534,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,URINALYSIS COMPLETE,BILIRUBIN,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,CBC PLT DIFF,POLYS,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,PE INTERP RFX IFE S,BETA GLOBULIN,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.0,0.0,0.0,0.0,0.15714285714285717,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,PROTEIN TOTAL URINE,PROTEIN CR RATIO,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.0,0.0,0.0,0.24333333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.083,0.27666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD4 CELLS,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.24666666666666667,0.148,0.37,0.4366666666666667,0.348,0.37,0.0,0.0,0.0,0.0,0.08030844563447248,0.0,1,93187,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.15666666666666665,0.94,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,CHEM SCREEN PANEL HDL,TRIGLYCERIDES,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,PROTHROMBIN PTT,APTT,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,ASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,CBC INCLUDES DIFF PLT W SMEAR RVW,PLATELET COUNT,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,LYMPHOCYTE SUBSET PANEL 1,% CD8,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.05555555555555555,0.0,0.0,0.05555555555555555,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,CBC WITH DIFFERENTIAL,MYELOCYTES,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.07065997001469593,0.09716253076254433,1.0,0,57927,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,GLUCOSE,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,COMMENTS,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,LIVER FIBRO HEPSCORE R,AGE,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.2,0.2,0.0,0.0,0.0,0.0,0.032370385903997545,0.0,0.0,0,172841,CMP14 4AC,EGFR IF AFRICN AM,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,PROTIME PTT,PTT,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,CMP14 LP CBC D PLT TSH UA M,HDL CHOLESTEROL,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,HAV HBV IMMUNE STATUS PRO IV,HEP A AB IGM,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,URINALYSIS W REFLEX MICRO,COLOR,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,UROGRAM,APPEARANCE,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,FERRITIN,FERRITIN SERUM,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,URINALYSIS CULTURE IF INDICATED,BILIRUBIN,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.4,0.18181818181818182,0.25,0.0,0.0,0.0,0.04802835732051414,0.11003603894321656,0.12851200387967032,1,542183,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.275,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,183145,CD4 CD8 RATIO PROFILE,HEMATOLOGY COMMENTS,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,326249,CYSTIC FIBROSIS SCREEN,ETHNICITY,Race,Race,Race
0.0,0.0625,0.125,0.08,0.05,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,CBC W DIFF PLT,ABSOLUTE NEUTROPHILS,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,DRUG ABUSE PANEL 10 WITH OXYCODONE,COCAINE METABOLITE,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,DRUG ABUSE SCREEN W ETOH NO GCMS,COCAINE METABOLITE,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,HEPASCORE R,SEX,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,HEPATIC FUNCTION PANEL,,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,HB S AG W RFX CONF,HEPATITIS B SURFACE ANTIGEN,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,CBC W AUTO DIFF WITH PLATELETS,MCV,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.018125,0.03625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,BILIRUBIN FRACTIONATED,BILIRUBIN INDIRECT,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,CBC INCLUDES DIFF PLT,RDW,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.06666666666666667,0.1,0.0,0.0,0.0,0.0,0.0,0.05741909150255753,0.0,0.0,0.0,0.0,0,302398,CBC WITH DIFFERENTIAL,NEUTROPHILS,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,PROTEIN ELEC INTERP SERUM,ALPHA 2 GLOBULIN,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,PSA FREE TOTAL,% FREE PSA,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,CMP WITH ESTIMATED GFR CALCULATED,CHEMISTRY SODIUM,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,ANA TITER PATTERN,ANA TITER,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB,HIV 1 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,PROTHROMBIN PTT,APTT,Body weight Measured,Weight Measured,Body weight
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,CBC W AUTO DIFF,MONOS ABSOLUTE,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,URINALYSIS CULTURE IF INDICATED,BACTERIA,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,HCV FIBROSURE,LIMITATIONS,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,PSA TOTAL % FREE,PSA FREE,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.1,0.25,0.0,0.1,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,PSA TOTAL % FREE,% FREE PSA,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.08,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CMP CBC TSH,ABSOLUTE BLASTS,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,LYMPHOCYTE SUBSET PANEL 4,HELPER SUPPRESSOR RATIO,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,CBC W AUTO DIFF WITH PLATELETS,MCV,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,URINALYSIS COMPLETE WITH REFLEX CULTURE,PROTEIN,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.134,0.09571428571428572,0.22333333333333336,0.134,0.09571428571428572,0.22333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,HIV AB EIA WITH REFLEX,HIV AB,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,COMP METABOLIC PANEL 13,EGFR IF NONAFRICN AM,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.0,0.0,0.5,0.16666666666666666,0.2,0.0,0.0,0.0,0.11136168435129556,0.05936451274361987,0.17946985244079683,1,63016,CMP14 HP5 LP 6AC CBC D PLT,INR,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,COMP METABOLIC PANEL,CREATININE,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.04,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,ANA AUTOIMMUNE PROFILE,RHEUMATOID FACTOR QUANT,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,HCV RNA QN PCR W REFL GENOTYPE LIPA R,HCV RNA QUANTITATIVE REAL TIME PCR,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,Race,Race,Race
0.12,0.2966666666666667,0.5933333333333334,0.32,0.16666666666666666,0.3333333333333333,0.0,0.030370472012839267,0.04117677821098442,0.03790637447812928,0.04801993258748538,0.06510620292715197,1,130682,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA PATTERN,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CBC W DIFF PLATELET,EOSINOPHILS,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,CBC WITH DIFFERENTIAL,MCHC,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,CBC W DIFF PLT,PLATELET SUFFICIENCY,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,PE FLC SERUM,ALBUMIN,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,IRON BINDING CAPACITY,UIBC NR,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,LYMPHOCYTE SUBSET PANEL 1,% CD8,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,URINALYSIS WITH MICROSCOPIC,COLOR,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,MICROALBUMIN CONC,ALB CREAT RATIO,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.03666666666666667,0.0,0.0,0.03333333333333333,0.02,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,CBC PLATELET HEM REVIEW,PLATELETS,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,IRON BINDING CAPACITY % SATURATION,CALCULATED % IRON SAT,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,IRON BINDING CAPACITY % SATURATION,CALCULATED % IRON SAT,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.2,0.14285714285714285,0.0,0.0,0.0,0.0,0.03367976760134472,0.0,0.0,0,632117,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,Mitochondria Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.02948276095739455,0.0,0.1063004130698838,0.10964330813284906,0.7071067811865476,1,264440,CBCI COMPLETE BLOOD COUNT W DIFF,ABS BASOPHILS,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,HEPATITIS B SURFACE ANTIGEN W REFL CONFIRM,CONFIRMATION,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,COMPLETE BLOOD COUNT,BASOPHILS %,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,URINALYSIS,BILIRUBIN,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Carbon dioxide
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,LYMPHOCYTE SUBSET PANEL 3,ANALYZED DATE TIME,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.03636363636363637,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,COMP METABOLIC PANEL,ANION GAP,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,TRICHOMONAS MALE,SOURCE,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Sex,Sex,Sex
0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,CBC INCLUDES DIFF PLT,LYMPHOCYTES ABSOLUTE,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.025,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,CBC WITH PLT DIFF,BLASTS,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,LYMPHOCYTE SUBSET PANEL 4,%CD8 SUPPRESSOR T CELLS,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,FERRITIN,FERRITIN,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,HEPATITIS C GENO TYPE 1 NS5A RESIST,VELPATASVIR RESISTANCE,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,MICROALBUMIN CONC,ALB CREAT RATIO,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,HIV AB AG COMBO RFLX CONF,HIV AB AG COMBO RFLX CONF,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,CBC INCLUDES DIFF PLT,ABSOLUTE NEUTROPHILS,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,CMP12 2AC,BILIRUBIN TOTAL,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,LIVER FIBROSIS FIBROMETER,FIBROMETER PATIENT SCORE,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,URINALYSIS CULTURE IF INDICATED,APPEARANCE,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,COMP METABOLIC PANEL,GLOBULIN,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.5,0.3333333333333333,0.5,0.0,0.0,0.0,0.14187034543632637,0.140463816246154,0.7071067811865476,1,31419,NASH FIBROSURE,WEIGHT,Body weight Measured,Weight Measured,Body weight
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,CBC WITH PLT DIFF,PROMYELOCYTES,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.14285714285714285,0.2573333333333333,0.965,0.2857142857142857,0.2573333333333333,0.965,0.011578260050036038,0.30669297671980944,0.8713430180861237,0.2855798754616614,0.01538990021601927,0.04372412516808821,0,381806,HEPATITIS C VIRUS RNA QN REAL TIME PCR,HCV RNA PCR QN,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,IGA SERUM,IMMUNOGLOBULIN A,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.1425,0.285,0.285,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.004285714285714286,0.015,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,RPR W RFLX CONFIRM,RPR SYPHILIS SCREEN,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,CBC W AUTO DIFF,% MONOCYTES,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,HCV FIBROSURE,LIMITATIONS,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.03125,0.041666666666666664,0.0,0.03125,0.041666666666666664,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,CMP14 LP 5AC,VLDL CHOLESTEROL CAL,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,SEGMENTED NEUTROPHILS,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.1111111111111111,0.2,0.0,0.0,0.0,0.0,0.04885356914637384,0.050802639896347035,0.0,0.0,0.0,0,139501,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.06696411491014109,0.4808823462371743,0.7071067811865476,1,178616,COMP METAB PANEL,CALCIUM PLASMA,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.066,0.0,0.0,0.346,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.04841537082187086,0.45528141890436646,0.7071067811865476,1,15586,COMP METAB PANEL,GLUCOSE FASTING,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,CBC,MCH,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CK TOTAL,CREATINE KINASE TOTAL,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,HEPATIC FUNCTION PANEL,BILIRUBIN INDIRECT,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,FREE T3,FREE T3,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.14285714285714285,0.3409090909090909,0.5357142857142857,0.14285714285714285,0.3409090909090909,0.5357142857142857,0.025344837556394273,0.07162596183040726,0.10208830230491539,0.025344837556394273,0.07162596183040726,0.10208830230491539,1,831008,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,FE TIBC FER,IRON BIND CAP TIBC,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,Bacteria identified
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,HAPTOGLOBIN,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.05142857142857143,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,COMP METABOLIC PANEL,CREATININE,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,Hepatitis A virus Ab.IgM
0.0,0.14285714285714285,0.0,0.0,0.14285714285714285,0.0,0.0,0.125105231728049,0.0,0.0,0.125105231728049,0.0,0,30510,AFP SERUM TUMOR MARKER,AFP SERUM TUMOR MARKER,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.075,0.125,0.0,0.02,0.03333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.19,0.44333333333333336,0.0,0.19,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,HCV RNA QUANT BDNA,HCV RNA QN BDNA,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,Cells.CD3+CD8+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,DIFFERENTIAL MANUAL,EOSINOPHILS,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.09090909090909091,0.0,0.0,0.0,0.0,0.0,0.042352891136284154,0.0,0,542183,PROTEIN TOTAL URINE,PROTEIN CR RATIO,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.2,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,LD,LD,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.596,0.548,0.435,0.348,0.148,0.185,0.005387097078791703,0.27303974821821997,0.04292727961786891,0.024494182533464692,0.0,0.0,1,345355,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,PROTIME PTT,PROTHROMBIN TIME PT,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,MICROALBUMIN CONC,ALB CREAT RATIO,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.10714285714285714,0.125,0.0,0.023571428571428573,0.0825,0.0,0.012378518002517436,0.0,0.0,0.0,0.0,0,110114,CBC WITH MANUAL DIFFERENTIAL,PLATELET COUNT,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,CBC W AUTO DIFF ABS WBC MPV PLT,BASOPHILS,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,LIVER FIBRO HEPSCORE R,AGE,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,TRANSFERRIN,TRANSFERRIN,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.27999999999999997,0.09090909090909091,0.2,0.2,0.09090909090909091,0.2,0.02475914086502795,0.018524468044861964,0.02925507076854461,0.04288408992998327,0.032085319836887005,0.0506712689501424,1,602797,ACCUTYPE R IL28B NY,IL28B GENOTYPE,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,TRANSFERRIN,TRANSFERRIN,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.20875,0.33399999999999996,0.0,0.0,0.0,0.0,0.0666872623744319,0.0795785781568974,0.0,0.0,0.0,0,109009,HEPATITIS BE AG,HBEAG INS NR,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,URINALYSIS COMPLETE WITH REFLEX CULTURE,PROTEIN,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,URINALYSIS REFLEX,GLUCOSE QL,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,PTH INTACT,PTH INTACT,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,URINALYSIS CULTURE IF INDICATED,COLOR,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,FE ANA TIBC FER PTT PT A1A,PROTHROMBIN TIME,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,DIFFERENTIAL MANUAL,NEUTROPHILS,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.055,0.033,0.0,0.0,0.054000000000000006,0.16,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,COMPLETE BLOOD COUNT,RBC,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,COMP METABOLIC PANEL,POTASSIUM,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,PE INTERP RFX IFE S,BETA GLOBULIN,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,HEPATITIS C AB,HEPATITIS C AB,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,PT PTT,PARTIAL THROMBOPLASTIN,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,BASIC METABOLIC PANEL,OSMOLALITY,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A RESIST ASSAY INTERP,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,COMP METABOLIC PANEL 13,EGFR IF NONAFRICN AM,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,HIV 1 RNA QN RT PCR,RACE NR,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.31,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.032615729323927534,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,823799,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp,Daclatasvir
0.0,0.0125,0.025,0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,339143,COMPREHENSIVE METABOLIC PANEL W EGF,EGFR NON AFR AMERICAN,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,URINALYSIS COMPLETE,GLUCOSE QL,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,COMPREHENSIVE METABOLIC PANEL W EGF,EGFR NON AFR AMERICAN,Reference lab test method,Ref lab test method,Reference lab test method
0.2,0.39285714285714285,0.55,0.4,0.42857142857142855,0.6,0.010998893664768583,0.020922233730318207,0.02112004156661662,0.021997787329537277,0.041844467460636414,0.04224008313323324,0,223222,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,GLYCOHEMOGLOBIN A1C,GLYCOHEMOGLOBIN A1C,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,CMP14 6AC,PHOSPHORUS,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,PROTEIN ELECTRO S,M SPIKE,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,CERULOPLASMIN,CERULOPLASMIN,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,RPR,TREPONEMA PALLIDUM ANTIBODIES,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,CBC WITH PLT DIFF,BANDS,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.2,0.2,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,HBSAB AG,HEP B SURFACE AB QUAL,Reference lab test method,Ref lab test method,Reference lab test method
0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,HIV ANTIGEN ANTIBODY FOURTH GEN,HIV AG AB 4TH GEN,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.046295985440745646,0.0,0.0,0.0,0.0,0,139550,PROTEIN ELEC INTERP SERUM,ALPHA 2 GLOBULIN,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,CCP IGG,CCP IGG,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.16666666666666666,0.13285714285714284,0.2866666666666667,0.16666666666666666,0.06142857142857143,0.2866666666666667,0.02488757391749208,0.0843257732197713,0.3162277660168379,0.009662054247360441,0.01636881517662514,0.12276848839929855,0,295410,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,CMP14 LP 5AC CBC D PLT RPR,CHOLESTEROL TOTAL,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.03818181818181818,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,COMP METABOLIC PANEL CLARIFICATION,EGFR NON AFR AMERICAN,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.26,0.2,1.0,0.0,0.0,0.0,0.0,0.05111799204302647,0.1503314858492919,1,20933,CMP14 LP 5AC CBC D PLT RPR,CHOLESTEROL TOTAL,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,CBC WITH DIFF PLATELET,EOS ABSOLUTE,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL AB,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,CMP14 1AC,ALT SGPT,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.15,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.04612090043126471,0.0,0,632117,CMP14 3AC CBC D PLT RPR MG,MAGNESIUM SERUM,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.2857142857142857,0.5,0.0,0.0,0.0,0.0,0.5074828171487041,1.0,1,67686,MA COMP METABOLIC PNL,ALKALINE PHOSPHATASE,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.0,0.026363636363636363,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,NASH FIBROSURE,APOLIPOPROTEIN A 1,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.009,0.012857142857142857,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,CMP13 LP 2AC CBC D PLT,NEUTROPHILS ABSOLUTE,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp,Hepatitis C virus NS5 gene mutations detected
0.25,0.0,0.0,0.0,0.0,0.0,0.027306011537541974,0.0,0.0,0.0,0.0,0.0,0,422543,FE ANA TIBC FER PTT PT A1A,PROTHROMBIN TIME,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,203935,MAGNESIUM,HEMOLYSIS,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,HIV AB EIA WITH REFLEX,HIV AB,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.25,0.16666666666666666,0.0,0.25,0.16666666666666666,0.0,0.0,0.06368655985836624,0.0,0.0,0.06368655985836624,0.0,0,205088,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.031224633643310185,0.0,0.0,0.0,0.0,0,264648,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,HEPATIC FUNCTION PANEL,ALT,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,UROGRAM,NITRITE,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.215,0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,REFLEXED LDL,LDL DIRECT,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.26666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,ALB ALP ALT AST GGT LD PROT,LDH,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.47,0.3333333333333333,0.25,0.0,0.0,0.0,0.03694153252517385,0.530776546300907,0.08679392382276507,1,19687,CHEM SCREEN PANEL,BILIRUBIN DIRECT,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,IFE PE SERUM,ALPHA 1 GLOBULIN,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,DRUG ABUSE SCREEN II,METHAQUALONE,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,CBC WITH PLT DIFF,BLASTS,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,CBC W AUTO DIFF,% EOSINOPHILS,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Cholesterol.non HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,CBC WITH PLT DIFF,BANDS,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP,Prothrombin.activity actual/Normal
0.3333333333333333,0.4,0.6666666666666666,0.3333333333333333,0.375,0.625,0.3590775716115062,0.609238940219434,0.06123184324815101,0.3590775716115062,0.5945908194933505,0.04082122883210071,1,241133,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,LIPID PROFILE,FASTING NON FASTING,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,CBC WITH MANUAL DIFFERENTIAL,MCH,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.09090909090909091,0.14285714285714285,0.0,0.18181818181818182,0.2857142857142857,0.0,0.035812980915203685,0.05104415115245775,0.0,0.011106253839207936,0.01582971551707446,0,831008,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE AG,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,LIPID PANEL W REFL DLDL,NON HDL CHOLESTEROL,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,MAGNESIUM,HEMOLYSIS,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,CBC WITH AUTO DIFF,RDW,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.041638589269199056,0.0,0,349993,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,CBC W O DIFF WITH PLATELETS,MCH,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,FREE T4 THYROXINE,FREE T4 THYROXINE,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,HEPATITIS A IGM,HEPATITIS A IGM,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.021568451983879244,0.0,0,384834,CBC INCLUDES DIFF PLT W SMEAR RVW,WHITE BLOOD CELL COUNT,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,HEPATITIS C VIRUS RNA QN REAL TIME PCR,HCV RNA PCR QN,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,CBC W AUTO DIFF,% MONOCYTES,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,IFE PE FLC SERUM,IMMUNOGLOBULIN G QN SERUM,Body weight Measured,Weight Measured,Body weight
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,CMP14 LP 5AC CBC D PLT RPR,EGFR IF AFRICN AM,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Protein pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.03666666666666667,0.055,0.07333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,HEMOGLOBIN A1C W EAG INT CHART,ESTIMATED AVERAGE GLUCOSE,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,CMP,C02 BICARBONATE,Body weight Measured,Weight Measured,Body weight
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,PHOSPHATE AS PHOSPHORUS,LIPEMIA,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,CBC PLATELET HEM REVIEW,PLATELETS,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CMP12 2AC,BILIRUBIN TOTAL,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.07142857142857142,0.0,0.0,0.07142857142857142,0.0,0.0,0.06317690320497038,0.0,0.0,0.051583725460460195,0.0,0,204164,IMMUNOGLOBULINS A E G M SERUM,IMMUNOGLOBULIN G QN SERUM,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,CMP14 HP5 LP 6AC CBC D PLT,INR,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,URINALYSIS SCREEN,PH,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,COMPREHENSIVE METABOLIC PANEL E GFR,BUN,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.2375,0.1357142857142857,0.95,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,LYMPHOCYTE SUBSET PANEL 4,COMMENT S,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,CBC WITH ABSOLUTE WBCS MPV,MCHC,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,HEPATITIS B SURFACE ANTIGEN W REFL CONFIRM,CONFIRMATION,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,LIVER FIBROSIS,NECROINFLAM ACT GRADE,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,Glucose
0.3333333333333333,0.3333333333333333,0.5,0.3333333333333333,0.3333333333333333,0.5,0.05339016372965322,0.5576035828430085,0.8164965809277261,0.05339016372965322,0.5576035828430085,0.8164965809277261,1,44982,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.1858678609476695,0.0,0,19711,HEMOGRAM W O DIFFERENTIAL,MEAN PLATELET VOLUME,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.06,0.07666666666666666,0.13799999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,BASIC METABOLIC PANEL,OSMOLALITY,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.16,0.0,0.25,0.2,1.0,0.0,0.061769791070825475,0.0,0.07962607175736813,0.12353958214165095,1.0,1,195586,DRUG ABUSE SCREEN II,METHAQUALONE,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,CBC NO DIFF,RBC,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,BUN CREATININE RATIO,EGFR NON AFR AMERICAN,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.088,0.2933333333333333,0.0,0.088,0.2933333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CMP12 LP TP TSH 6AC CBC D PLT,URIC ACID,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,HCV FIBROSURE,FIBROSURE STAGE,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,TSH SML,TSH,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,PSA TOTAL % FREE,% FREE PSA,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.235,0.15666666666666665,1.0,0.0,0.0,0.0,0.0,0.0,0.447213595499958,0.0,0.0,0.0,0,93179,CBC W AUTO DIFF WITH PLATELETS,MCV,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CEA,CEA,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,PSA FREE TOTAL,FREE PSA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.25,0.2,0.25,0.0,0.0,0.0,0.0746172002260781,0.0,0.0,1,349993,SPECIAL A 2 PANEL #9633,POLYS,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,RPR REFLEX PER CDC,RPR,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,HEPATIC FUNCTION PANEL,,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,HEMOGLOBIN A1C WITH MPG,HEMOGLOBIN A1C,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.006,0.02,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.038291893659327836,0.0,0,305227,CMP14 TP TSH 2AC CBC D PLT,AMYLASE SERUM,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,COMPLETE BLOOD COUNT,WBC,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.084,0.0,0.0,0.084,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,HCV RNA QN REAL TIME PCR W RFLX QL,HCV RNA LOG IU ML,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,COMP METABOLIC PANEL W EGFR,PROTEIN TOTAL,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CMP14 LP CBC D PLT TSH UA M,HDL CHOLESTEROL,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,ANA TITER PATTERN,ANA TITER,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,CYSTIC FIBROSIS SCREEN,ETHNICITY,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,CBC WITH PLT DIFF,BANDS ABSOLUTE,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,PROTHROMBIN PTT,APTT,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,CMP12 2AC,BILIRUBIN TOTAL,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,CBCI COMPLETE BLOOD COUNT W DIFF,MCH,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CARDIO IQ R VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.16666666666666666,0.175,0.27999999999999997,0.16666666666666666,0.175,0.27999999999999997,0.006692952775925076,0.012093855767859263,0.016571492500925267,0.006692952775925076,0.012093855767859263,0.016571492500925267,0,134999,HEPATITIS B CORE AB,HEPATITIS B CORE AB,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,LIVER FIBROSIS PNL HEPASCORE TM,GGT,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,LIPID PANEL W REFL DLDL,NON HDL CHOLESTEROL,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,FSRC NEW PATIENT PANEL,D BILIRUBIN,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.2857142857142857,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,CBC WITH PLT DIFF,NUCLEATED RBCS,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,MITOCHONDRIAL M2 ANTIBODY,MITOCHONDRIAL M2 ANTIBODY,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,GGTP,GGTP,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,Epithelial cells
0.5466666666666667,0.3,0.5333333333333333,0.5299999999999999,0.20857142857142857,0.15333333333333335,0.0,0.019349643319108933,0.019672694668938395,0.0,0.06525802301826944,0.03317376812494377,1,98301,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,FASTING,FASTING STATUS,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,HEPATITIS A IGM,HEPATITIS A IGM,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.1111111111111111,0.0,0.4166666666666667,0.2222222222222222,1.0,0.0,0.0075494158994710014,0.0,0.290759678007509,0.014423058883279771,1.0,1,273532,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.06200000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,UROGRAM,SPECIFIC GRAVITY,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CD4 CD8 RATIO PROFILE,HEMATOLOGY COMMENTS,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,COMPREHENSIVE METABOLIC PANEL AMA,SODIUM,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.11,0.18333333333333335,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,UA MICROSCOPIC REFLEX CULTURE,LEUKOCYTE ESTERASE,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,CBC WITH MANUAL DIFFERENTIAL,PLATELET COUNT,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,CBC WITH DIFFERENTIAL,IMMATURE GRANS,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,CMP14 LP 5AC,VLDL CHOLESTEROL CAL,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,VITAMIN B12 FOLATE,VITAMIN B12,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,HEPATITIS C GENO TYPE 1 NS5A RESIST,VELPATASVIR RESISTANCE,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,MANUAL DIFFERENTIAL,BLASTS %,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,URINALYSIS,BILIRUBIN,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,UROGRAM,SPECIFIC GRAVITY,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,CHOLESTEROL TOTAL,ICTERUS,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,NASH FIBROSURE,AST SGOT P5P,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,ARTHRITIS PROFILE,RHEUMATOID FACTOR QUANT,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.25,0.25,0.0,0.3333333333333333,0.0,1.0,0.0,0.33333333333333337,0.0,0.015059977897765364,0.0990849048789324,0.17162008951344032,0,23366,IFE PE SERUM,ALPHA 1 GLOBULIN,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.24333333333333332,0.335,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,825208,HEPATITIS C GENO TYPE 1 NS5A RESIST,VELPATASVIR RESISTANCE,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,URINALYSIS,LEUKOCYTE ESTERASE,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,COMPREHENSIVE METABOLIC PANEL AMA,SODIUM,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CREATINE KINASE CPK TOTAL,CREATINE KINASE CPK TOTAL,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,T4,T4,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CHEM 20,CHOLESTEROL,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06713496212611103,0.05720402135206337,0.7071067811865476,0,7518,CBC INCLUDES DIFF PLT,ABSOLUTE NEUTROPHILS,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE EOS,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,PE RFX IFE S,GAMMA GLOBULIN,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,BUN CREATININE,BUN,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.05555555555555555,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,COMP METABOLIC PANEL CLARIFICATION,ALBUMIN GLOBULIN RATIO,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.0,0.0,0.066,0.047142857142857146,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CMP14 LP 2AC CBC D PLT MG T,WBC,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Iron binding capacity.unsaturated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,HIV 1 RNA QN RT PCR,RACE NR,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Creatinine
0.2,0.3333333333333333,0.5,0.4,0.3333333333333333,1.0,0.05093349536754144,0.1013425379002848,0.14187034543632637,0.3590143888836951,0.7143320726301394,1.0,1,495416,FASTING,FASTING STATUS,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,T4 THYROXINE,T4 THYROXINE,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.04833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,CBC WITH MANUAL DIFFERENTIAL,MCHC,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,IFE PE SERUM,ALPHA 1 GLOBULIN,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,LIVER FIBROSIS PNL HEPASCORE TM,F2,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,MA CBC DIFF PLT,MONOCYTES %,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,HCV FIBROSURE,LIMITATIONS,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,TESTOSTERONE FR DIALYSIS TOTAL LC MS MS,FREE TESTOSTERONE,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,CMP14 HP5 LP 6AC CBC D PLT,HDL CHOLESTEROL,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.09,0.0,0.0,0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,HDL AS % CHOLESTEROL,HDL AS % CHOLESTEROL,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,COMPREHENSIVE METABOLIC PANEL E GFR,BUN,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,CREATINE KINASE TOTAL,HEMOLYSIS,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,FIBROACT COMPLETE,WEIGHT LBS,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,HEPATITIS BS AB QUANT,HEPATITIS BS AB QUANT,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,IRON BINDING CAPACITY IBC % SATURATION,UNSATURATED IBC,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.14285714285714285,0.0,0.0,0.14285714285714285,0.0,0.0,0.01124751316961603,0.0,0.0,0.01124751316961603,0.0,0,544346,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc,Lipoprotein.beta.subparticle
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,MAGNESIUM,MAGNESIUM,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,HEPATIC FUNCTION PNL,PROTEIN TOTAL,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.5425,0.7233333333333333,0.0,0.5425,0.7233333333333333,0.0,0.1524643612967882,0.11313616447240271,0.0,0.1524643612967882,0.11313616447240271,1,519132,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL AB,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql,Hepatitis A virus Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,LIVER FIBROSIS PANEL HEPASCORE,FIBROSIS SCORE,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,STOOL CULTURE,RESULT 2,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl,Cholesterol.in LDL/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,CBC,HEMOGLOBIN,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.0,0.0,0.0,0.0,0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.005456075568330165,0.0,0,426171,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,PROTEIN ELECTROPHORESIS SERUM,ALPHA 1,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,19638,CMP,TCO2,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc,Bicarbonate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,BUN CREATININE RATIO,BUN CREATININE RATIO,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA PATTERN,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Prostate specific Ag.free/Prostate specific Ag.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,CMP,EGFR NON AFRICAN AMERICAN,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,URINALYSIS REFLEX,GLUCOSE QL,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,MICROALBUMIN RANDOM SPEC,MICROALBUMIN,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,CBC,HEMOGLOBIN,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.03142857142857143,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,PROTIME PTT,INR,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.2,1.0,0.0,0.0,0.0,0.0,0.13909830811578938,1.0,1,303503,CBC,HEMOGLOBIN,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,FIBROACT COMPLETE,NECROINFL SCORE,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.04135584299524686,0.1520683500675173,0.447213595499958,0.06538932921065,0.24044117311858715,0.7071067811865476,1,24984,IRON TOTAL BINDING CAPACITY,IRON TOTAL,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,LIPID CASCADE,LDL CHOLESTEROL CALC,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,COMP METABOLIC PANEL,ANION GAP,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,RENAL FUNCTION PANEL,ANION GAP,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,82644,HCV FIBROSURE LABCORP,RESULT,Service comment 03,Service Cmnt 03 XXX-Imp,Service comment 03
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,PSA TOTAL % FREE,PSA FREE,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,CMP14 LP CBC D PLT TSH,NEUTROPHILS,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,HCV RNA GENO W REFL NS5A,HCV RNA GENOTYPE LIPA R,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,IMMUNOGLOBULIN M,IMMUNOGLOBULIN M,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.057999999999999996,0.0,0.0,0.08,0.08857142857142856,0.155,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,LD,LD,Fibrosis stage,Fibrosis stage SerPl Ql,Fibrosis stage
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.2,0.16666666666666666,0.0,0.2,0.16666666666666666,0.3333333333333333,0.048918155723576384,0.039328530307136456,0.0,0.0691807192705608,0.0556189409485538,0.10240603634159506,1,237610,DIFFERENTIAL MANUAL,NEUTROPHILS,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.2,0.4,0.6666666666666666,0.2,0.4,0.3333333333333333,0.007635905779136087,0.36555680528551404,0.4582002501529394,0.007806566737586396,0.37372692636381444,0.46844093359181893,1,178566,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,SPECIAL A 2 PANEL #9633,POLYS,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.08333333333333333,0.1111111111111111,0.3333333333333333,0.0,0.0,0.0,0.0,0.0229603188695785,0.062817328301088,0.0,0.0,0.0,0,273532,CMP WITH ESTIMATED GFR CALCULATED,CHEMISTRY SODIUM,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,RENAL FUNCTION PANEL,ANION GAP,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,LIVER FIBROSIS FIBROMETER,FIBROMETER PATIENT SCORE,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,LIPID PROFILE,FASTING NON FASTING,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,LIVER FIBROSIS FIBROTEST ACTITEST P,APOLIPOPROTEIN A1,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,UROGRAM,NITRITE,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,CMP14 1AC,ALT SGPT,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,CUSTOM HEPATITIS PANEL,HEP B SURFACE AB,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,LIVER FIBROSIS,NECROINFLAM ACT GRADE,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CYSTIC FIBROSIS SCREEN,ETHNICITY,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.2,0.4077777777777778,0.734,0.2,0.4077777777777778,0.734,0.04649709143472869,0.1692337277851974,0.17598550691819748,0.04649709143472869,0.1692337277851974,0.17598550691819748,1,139501,HEPATITIS A IGM,HEPATITIS A IGM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.061769791070825475,0.0,0.0,0.0,0.0,0,195586,DRUG ABUSE SCREEN II,OPIATES,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,LIVER FIBROSIS PANEL HEPASCORE,FIBROSIS SCORE,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,HBSAB AG,HEP B SURFACE AB QUAL,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Testosterone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,HEPATIC FUNCT PANEL W O TP,BILIRUBIN DIRECT,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,LYMPHOCYTE SUBSET PANEL 4,HELPER SUPPRESSOR RATIO,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,IFE PE SERUM,ALPHA 1 GLOBULIN,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.2866666666666667,0.172,0.0,0.2866666666666667,0.172,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,121855,PTT,PTT,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.06,0.05142857142857143,0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,COMPREHENSIVE METABOLIC PANEL E GFR,AST,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.0,0.0,0.0,0.23666666666666666,0.25,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,264846,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,ASH FIBROSURE,FIBROSIS STAGE,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.22333333333333336,0.2,1.0,0.0,0.0,0.0,0.0,0.34003516797720323,1.0,1,21600,COMP METABOLIC PANEL W O EGFR,CREATININE,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.2,0.14285714285714285,0.0,0.0,0.0,0.0,0.009407312728814343,0.009963467485149535,0.0,0.0,0.0,0.0,0,7344,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,CBC WITH DIFFERENTIAL,NEUTROPHILS,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.25,0.26666666666666666,1.0,0.25,0.26666666666666666,0.965,0.22848423004998408,0.011147902332567239,0.04372412516808821,0.22848423004998408,0.011147902332567239,0.04372412516808821,1,426171,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,1,305250,HEPASCORE R,AGE,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,183145,HEMATOPATH CONSULTATION SMEAR,HEMATOLOGY COMMENTS,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp,Morphology
0.19,0.0,0.0,0.142,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,1,7369,T LYMPHOCYTE HELPER SUPPRESSOR,LYMPHS,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,CMP14 LP TP TSH 4AC CBC D PLT,URIC ACID,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,COMPREHENSIVE METABOLIC PANEL,ALBUMIN,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,HCV AB WITH RFL RNA QT,HCV SIGNAL CUTOFF,Body height Measured,Body height Measured,Body height
0.2,0.16666666666666666,0.0,0.0,0.0,0.0,0.009441968543049462,0.007406987836270251,0.0,0.0,0.0,0.0,0,7146,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,COMMENTS,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc,Urea
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,COMPREHENSIVE METABOLIC PANEL W EGF,EGFR NON AFR AMERICAN,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.4333333333333333,0.24,0.54,0.4333333333333333,0.5,1.0,0.0,0.12098235034630989,0.10477378880945343,0.0,0.6666666666666667,0.5773502691896257,1,28886,PROTEIN TOTAL URINE,URINE TOTAL PROTEIN,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,CBC WITH MANUAL DIFFERENTIAL,WBC,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,LIPID PANEL AMA,CHOL HDLC RATIO,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,LIVER FIBROSIS,NECROINFLAM ACT GRADE,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,PROTEIN ELECTRO S,M SPIKE,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,LIPID PANEL WITH REFLEX DIRECT L,HDL CHOLESTEROL,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.04833333333333333,0.051666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,CBC PLATELET NO DIFFERENTIAL,HEMATOCRIT,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,HEPATITIS PANEL ACUTE,HEPATITIS C AB CIA,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.16666666666666666,0.0,0.0,0.16666666666666666,0.0,0.0,0.2276407094521833,0.0,0.0,0.1858678609476695,0.0,0,17988,IMMUNOGLOBULINS A E G M SERUM,IMMUNOGLOBULIN G QN SERUM,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,CMP14 LP TP TSH 4AC CBC D PLT,URIC ACID,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.2,0.16666666666666666,0.0,0.0,0.16666666666666666,0.0,0.009622921004768359,0.007736500585135864,0.0,0.0,0.039328530307136456,0.0,0,237610,CBC WITH MANUAL DIFFERENTIAL,PLATELET COUNT,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,CBC WITH MANUAL DIFFERENTIAL,PLATELET COUNT,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,COMPREHENSIVE METABOLIC PANEL AMA,SODIUM,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,Leukocytes other/100 leukocytes
0.14285714285714285,0.08333333333333333,1.0,0.14285714285714285,0.08333333333333333,1.0,0.02319962292068234,0.0,0.0,0.026788617076707433,0.0,0.0,1,115790,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,DRUG ABUSE SCREEN I NO GCMS,AMPHETAMINES,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,CBC WITH PLT DIFF,NRBC,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,HCV FIBROSURE,INTERPRETATION,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,COMPREHENSIVE METABOLIC PANEL,ALBUMIN,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,ANA IFA SCREEN WITH REFLEX TITER,ANTI NUCLEAR AB IFA,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,CD4 T HELPER PANEL,CD4 CD3 %HELPERS,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,495499,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Reference lab test method,Ref lab test method,Reference lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,CMP14 LP 7AC CBC D PLT T B,IRON SATURATION,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,HEPATITIS B SURFACE ANTIGEN,HBS AG SCREEN,MCHC [Mass/volume],MCHC RBC-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.3333333333333333,0.0,0.0,0.3333333333333333,0.3333333333333333,0.5,0.05339016372965322,0.1858678609476695,0.40824829046386313,0.05339016372965322,0.5576035828430085,0.8164965809277261,1,44859,C4 C3,COMPLEMENT C3 SERUM,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,Complement C3
0.047142857142857146,0.09090909090909091,0.14285714285714285,0.14285714285714285,0.3409090909090909,0.5357142857142857,0.0,0.041353268343751526,0.05894070881685487,0.025344837556394273,0.07162596183040726,0.10208830230491539,1,831008,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.11857142857142858,0.041666666666666664,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,LIPID PANEL WITH DIRECT LDL,TRIGLYCERIDES,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,CMP14 LP 3AC,ALKALINE PHOSPHATASE S,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.17500000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,LIVER FIBROSIS FIBROTEST ACTITEST P,NECROINFLAMMATION ACT GRADE,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Body weight Measured,Weight Measured,Body weight
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,SED RATE WESTERGREN,SED RATE WESTERGREN,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.21428571428571427,0.02,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,CBC W DIFF PLT,ABSOLUTE NEUTROPHILS,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,PSA TOTAL,PSA TOTAL,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,APOLIPOPROTEIN A1,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,URINALYSIS SCREEN,BACTERIA,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,CBC INCLUDES DIFF PLT,MCHC,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,HEPATITIS A IGM,HEPATITIS A IGM,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.057549248626998395,0.1125015497193188,1,303925,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.10333333333333333,0.11875,0.19,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,URINALYSIS,LEUKOCYTE ESTERASE,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,CMP14 LP 6AC CBC D PLT ESR,CREATININE,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,TSH 3RD GENERATION REFL,TSH 3RD GENERATION REFL,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,URINALYSIS CULTURE IF INDICATED,PH,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,PROTHROMBIN PTT,APTT,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,SEGMENTED NEUTROPHILS,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,FIBROACT COMPLETE,WEIGHT LBS,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,HEPATITIS BS AB QUANT,HEPATITIS BS AB QUANT,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,CBC H H RBC INDICES WBC PLT,MPV,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,HEPASCORE R,SEX,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,NASH FIBROSURE,ALT SGPT P5P,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,UA MICROSCOPIC REFLEX CULTURE,LEUKOCYTE ESTERASE,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.072,0.06,0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,GLUCOSE,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HIV AB AG RFLX CONF,HIV AG AB,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,CBC W AUTO DIFF ABS WBC MPV PLT,BASOPHILS,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.3333333333333333,0.0,0.25,0.16666666666666666,1.0,0.0,0.030763983977592058,0.0,0.06605502583691747,0.05720402135206337,0.7071067811865476,1,7427,CBCI COMPLETE BLOOD COUNT W DIFF,ABS MONOCYTES,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,PROTEIN ELEC INTERP SERUM,M SPIKE,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,HEPASCORE R,SEX,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,ASH FIBROSURE,AST SGOT P5P,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,ALPHA 1 ANTITRYPSIN SERUM,ALPHA 1 ANTITRYPSIN SERUM,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,ASH FIBROSURE,ALT SGPT P5P,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,Neutrophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,TSH 3RD GENERATION REFL,TSH 3RD GENERATION REFL,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,CLR CBC W DIFF PLT,ABSOLUTE BLASTS,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,DRUG ABUSE SCREEN I NO GCMS,AMPHETAMINES,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql,IL28B gene associated variant rs12979860
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,VITAMIN D 25 OH,25 OH VITAMIN D,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,CBC INCLUDES DIFF PLT W SMEAR RVW,PLATELET COUNT,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,CBC ESR,ABSOLUTE NEUTROPHILS,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,SED RATE WESTERGREN,SED RATE WESTERGREN,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0.0,0.0,0.0,0,45427,IFE PE SERUM,M SPIKE,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,Haptoglobin
0.0,0.07142857142857142,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,LMG CBC DIFF PLT,LYMPHOCYTES #,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl,Hepatitis C virus FibroSURE panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,CBC WITH PLT MAN DIFF,BANDS,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Estimated average glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,MCV [Entitic volume],MCV RBC,Erythrocyte mean corpuscular volume
0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,HCV GENOTYPE REFLEX NSA,HCV GENOSURE R NSA INTERP,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.12833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HCV RNA QUAL TMA,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE EOS,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,URINALYSIS CULTURE IF INDICATED,BILIRUBIN,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,IRON TOTAL BINDING CAPACITY,IRON TOTAL,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,PTH INTACT WITHOUT CALCIUM,PARATHYROID HORMONE INTACT,Body weight Measured,Weight Measured,Body weight
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,CMP14 HP4 1AC PT AFP,PROTHROMBIN TIME,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.054000000000000006,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.004285714285714286,0.015,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,CMP13 LP TP TSH 2AC CBC D P,NEUTROPHILS ABSOLUTE,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,CBC WITH DIFFERENTIAL,NEUTROPHILS,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,CBC,HEMOGLOBIN,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,HEPATITIS BE AG,HB E AG,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0825,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,LIPID PANEL STANDARD,LDL CHOL CALCULATED,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.14333333333333334,0.07142857142857142,0.3333333333333333,0.2866666666666667,0.21428571428571427,0.3333333333333333,0.0,0.054432052556039556,0.40824829046386313,0.032129719769984244,0.16329615766811867,0.40824829046386313,1,295410,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,CBC INCLUDES DIFF PLT WITH PATHOLOGIST REVIEW,ABSOLUTE LYMPHOCYTES,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,PE INTERP RFX IFE S,ALBUMIN,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.3333333333333333,0.2,1.0,0.3333333333333333,0.3285,1.0,0.2539585678404015,0.005994763961878147,0.04372412516808821,0.16069190982168602,0.19983987779463963,0.02766637581197129,1,347047,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,HEPATIC FUNCTION PANEL,,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,PSA FREE TOTAL,PSA FREE,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,LIVER FIBROSIS FIBROTEST,ALPHA 2 MACROGLOBULIN,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,DIRECT LDL,TRIGLYCERIDES,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,HCV FIBROSURE,LIMITATIONS,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,CBC INC DIFF PLT,MONOCYTES,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Protein.monoclonal
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,MITOCHONDRIAL AB SCREEN,MITOCHONDRIAL AB SCREEN,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate
0.0,0.12571428571428572,0.29333333333333333,0.0,0.12571428571428572,0.29333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.18999999999999997,0.1425,0.57,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,LIVER FIBROSIS FIBROTEST,ALPHA 2 MACROGLOBULIN,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,CBC WITH PLT DIFF,WBC MORPHOLOGY,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CBC D PLT,HEMOGLOBIN,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.055,0.07649999999999998,0.15299999999999997,0.03875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,MCCARJUH MCCARTHY PROFILE 1,PROTHROMBIN TIME PT,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,ACCUTYPE R IL28B NY,IL28B GENOTYPE,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Aspartate aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,CBC INC DIFF PLT,RBC,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl,Urea nitrogen/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,URINALYSIS COMPLETE,BILIRUBIN,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,HIV 1 RNA QN RT PCR,LOGCOPIES ML,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,IFE PE SERUM,GAMMA GLOBULIN,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,DRUG ABUSE SCREEN I NO GCMS,METHADONE,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.182,0.16285714285714287,0.22800000000000004,0.0,0.0,0.0,0.0,0.023005461933579552,0.031045756027934357,0.0,0.0,0.0,0,728626,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp,Hepatitis C virus resistance panel
0.0,0.008571428571428572,0.02,0.0,0.03142857142857143,0.07333333333333333,0.0,0.0,0.0,0.0,0.9131129509166843,0.9888882125258499,1,19885,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.43,0.2285714285714286,0.5333333333333333,0.0,0.0,0.0,0.0,0.01619948895196177,0.016469947000524954,0,20958,LIPID PROFILE,CHOLESTEROL NON HDL,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl,Cholesterol.in HDL/Cholesterol.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,PROTEIN ELECTROPHORESIS SERUM,ALPHA 2,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,URINALYSIS CULTURE IF INDICATED,PH,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,HCV RNA GENO W REFL NS5A,HCV RNA GENOTYPE LIPA R,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,MCH [Entitic mass],MCH RBC Qn,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,PT PTT,PARTIAL THROMBOPLASTIN,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,COMP METABOLIC PANEL CLARIFICATION,ALBUMIN GLOBULIN RATIO,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.07257572557143144,0.13610564768002043,1.0,0,28621,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,CREATINE KINASE CK,CREATINE KINASE CK,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,CBC WITH DIFFERENTIAL,MYELOCYTES,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,HCV RNA QN PCR W RFL GENO,HCV RNA QN REAL TIME PCR,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,BMP,CHLORIDE,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld,Polymorphonuclear cells/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,CBC W DIFF PLT,HEMATOCRIT,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.012142857142857144,0.0425,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,CHEM SCREEN PANEL HDL,URIC ACID,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,COMPREHENSIVE METABOLIC PANEL WITH GFR,T BILIRUBIN,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc,Rheumatoid factor
0.0,0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.013865547924266641,0.0,0.0,0.0,0.0,0,381806,HIV AB EIA WITH REFLEX,HIV AB,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.017111820417164192,0.017329306516888465,0,205070,HEPATITIS PANEL ACUTE,HEPATITIS B CORE AB IGM,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,BMP,CHLORIDE,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.155,0.2316666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,UA W RFLX MICROSCOPIC,BILIRUBIN,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,CBC WITH PLT DIFF,MYELOCYTES,Service comment,Service Cmnt XXX-Imp,Service comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,PROTHROMBIN PTT,CONTROL,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,CBC W AUTO DIFF,% EOSINOPHILS,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,Leukocytes
0.0,0.0,0.0,0.2,0.125,0.3333333333333333,0.0,0.0,0.0,0.012582767318463417,0.018740924323912944,0.018181249052485082,0,244673,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,CMP13 LP TP TSH 2AC CBC D P,NEUTROPHILS ABSOLUTE,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,ASH FIBROSURE,HEIGHT,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.2,0.0,0.0,0.2,0.0,0.0,0.24044117311858715,0.0,0.0,0.1963193957655779,0.0,1,24653,IMMUNOGLOBULINS A E G M SERUM,IMMUNOGLOBULIN G QN SERUM,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc,IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,FREE T4,FREE T4,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,MITOCHONDRIAL M2 ANTIBODY,MITOCHONDRIAL M2 ANTIBODY,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,CMP14 4AC,EGFR IF AFRICN AM,Erythrocytes [#/volume] in Blood,RBC # Bld,Erythrocytes
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0633025934653415,0.0,0.0,0.0,0.0,0,264499,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.16666666666666666,0.0,0.0,0.125,0.0,0.0,0.2276407094521833,0.0,0.0,0.0,0.0,0,30262,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,CBC INCLUDES DIFF PLT,LYMPHOCYTES ABSOLUTE,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.05043482321394899,0.0,0.0,0.12353958214165095,1.0,1,196592,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,CBC W AUTO DIFF,MONOCYTES %,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Parathyrin.intact
0.0,0.005,0.0175,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,CMP14 LP CBC D PLT TSH T4F,NEUTROPHILS ABSOLUTE,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.057999999999999996,0.0625,0.125,0.16,0.05,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,COMP METAB PANEL,GLUCOSE FASTING,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.39666666666666667,0.5,0.6666666666666666,0.2783333333333333,1.0,0.3333333333333333,0.0064426062651455895,0.0983573569202505,0.9707402981187775,0.03275101358391164,1.0,0.1986458339579933,1,487959,LIVER FIBROSIS PANEL HEPASCORE,FIBROSIS SCORE,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.045454545454545456,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,CMP,TCO2,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.32499999999999996,0.312,0.56,0.25,0.2,0.0,0.0,0.03630906140943979,0.18596297263238892,0.033865144617218124,0.0,0.0,0,204545,PROTEIN TOTAL 24HR URINE W CREAT,UR CREAT RANDOM MG DL,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,SPECIAL PROFILE # 5144,TSH ULTRASENSITIVE,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.13428571428571429,0.3133333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,CBC W O DIFF WITH PLATELETS,MCH,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,Platelet mean volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,CBC WITH DIFFERENTIAL,NEUTROPHILS,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,C reactive protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,OBSTETRIC PANEL,RPR RESULT,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,VITAMIN D 25 OH,VITAMIN D 25 OH,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker,Platelet mean volume
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.013880466255054902,0.0,0.0,0.0,0.0,0,303644,CBCI COMPLETE BLOOD COUNT W DIFF,ABS BASOPHILS,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,COMP METABOLIC PANEL CLARIFICATION,ALT,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt,Hepatitis B virus surface Ag
0.0,0.047142857142857146,0.066,0.08,0.08571428571428573,0.12000000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.14285714285714285,0.25,0.0,0.14285714285714285,0.25,0.0,0.008633582730140588,0.011006540827219524,0.0,0.0,0.0,0,327692,ALPHA FETOPROTEIN TUMOR MARKER,AFP TUMOR MARKER,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,PT PROTIME,INR,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.0,0.0,0.0,0.25,0.14285714285714285,1.0,0.0,0.0,0.0,0.052570301148225806,0.05162000400267441,0.7071067811865476,1,303644,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,COMP METABOLIC PANEL CLARIFICATION,ALT,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual,Promyelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1059787103279074,0.0,0.0,0.0,0.0,0,30163,IGA SERUM,IMMUNOGLOBULIN A,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,VITAMIN D 25 OH,VITAMIN D 25 OH,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,HEPASCORE R,AGE,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Urea nitrogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,HIV ANTIGEN ANTIBODY FOURTH GEN,HIV AG AB 4TH GEN,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,CBC WITH DIFFERENTIAL PLATELETS,POLYS,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,CMP WITH ESTIMATED GFR CALCULATED,UREA NITROGEN,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,HEPATIC FUNCTION PANEL,ALT,Sex,Sex,Sex
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.02948276095739455,0.0,0.0,0.0,0.0,0,264846,CBC COMPLETE BLOOD COUNT W O DIFF,HEMATOCRIT,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,LMG CBC DIFF PLT,LYMPHOCYTES #,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,UROGRAM,SPECIFIC GRAVITY,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.0,0.0,0.08,0.07272727272727274,0.1142857142857143,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,LIVER FIBRO HEPSCORE R,AGE,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur,Protein/Creatinine
0.125,0.1,0.5,0.125,0.1,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,WESTERGREN SED RATE,WESTERGREN SED RATE,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.066,0.06625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,URINALYSIS W REFLEX MICRO,NITRITE,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,CEA,CEA CENTAUR,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,PROFILE 1236 LIPID PANEL WITH DIRECT LDL,CHOL HDL,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,PSA FREE TOTAL,FREE PSA,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,URINALYSIS COMPLETE WITH REFLEX CULTURE,PROTEIN,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp,Telaprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,HCV GENOTYPE REFLEX NS5A,PLEASE NOTE,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,SPECIAL A 2 PANEL #9633,POLYS,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,Hematocrit
0.235,0.39999999999999997,0.7,0.235,0.39999999999999997,0.7,0.0,0.08338254724112037,0.1063004130698838,0.0,0.08338254724112037,0.1063004130698838,1,327692,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,GLUCOSE,GLUCOSE,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe,Hepatitis C virus genotype
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,RPR REFLEX TP PA,RPR TITER,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Creatinine
0.0,0.16666666666666666,0.0,0.0,0.16666666666666666,0.0,0.0,0.007452423659995988,0.0,0.0,0.007452423659995988,0.0,0,203927,ALPHA 1 ANTITRYPSIN SERUM,ALPHA 1 ANTITRYPSIN SERUM,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,CBC WITH PLT DIFF,PROMYELOCYTES,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,NASH FIBROSURE,WEIGHT,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,PROTIME PTT,PROTHROMBIN TIME PT,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,LIVER FIBROSIS FIBROTEST ACTITEST P,APOLIPOPROTEIN A1,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,HB S AB QL,HB S AB QL,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.034444444444444444,0.062,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,CMP14 HP5 LP 6AC CBC D PLT,HDL CHOLESTEROL,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,RENAL FUNCTION PANEL,CHLORIDE,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,CULTURE ROUTINE,CULTURE ROUTINE,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.1875,0.2,0.0,0.1875,0.2,0.0,0.0,0.09553982688249574,0.0,0.0,0.07800794199198469,0.0,0,473835,IMMUNOFIXATION SERUM,IGG SERUM NR,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,CBC WITH DIFFERENTIAL PLATELETS,EOS,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,CLR CBC W DIFF PLT,ABSOLUTE BLASTS,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.0,0.0,0.24333333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0.06679361170328513,0.1964314811924487,1,28852,COMP METABOLIC PANEL W EGFR,PROTEIN TOTAL,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,MAGNESIUM,ICTERUS,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.3333333333333333,0.4,0.8,0.3333333333333333,0.4,0.8,0.3222721996715985,0.5931645460412418,0.8484814328311875,0.326391495961589,0.6007463992583407,0.8593267568211221,1,51938,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,CBC WITH DIFFERENTIAL,NEUTROPHILS,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CMP CBC TSH,ABSOLUTE BLASTS,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Folate
0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,HCV GENOTYPE REFLEX NSA,HCV GENOSURE R NSA INTERP,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.09338639438323382,0.0,0,21329,COMP METAB PANEL,CALCIUM PLASMA,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc,Cobalamins
0.0,0.0,0.0,0.10333333333333333,0.0775,0.31,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,CBC INCLUDES DIFF PLT,LYMPHOCYTES ABSOLUTE,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,UA W MICRO HOLD SPEC 24 HR,GLUCOSE,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,URINALYSIS W REFLEX MICRO,NITRITE,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.1675,0.192,0.96,0.0,0.0,0.0,0.0,0.0,0.0,1,193433,DRUG ABUSE PANEL 10 WITH OXYCODONE,AMPHETAMINES,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,CMP14 LP CBC D PLT TSH,PLATELETS,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,CMP14 6AC,PHOSPHORUS,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,134585,LIPID PANEL,,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Cholesterol.in VLDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,COMP METAB PANEL,GLUCOSE FASTING,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0625,0.0,0.0,0.0,0.0,0.0,0.027776438468458897,0.0,0,339143,CMP14 5AC CBC D PLT TSH T4F,CALCIUM SERUM,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.072,0.05142857142857143,0.072,0.0,0.028571428571428574,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,COMPREHENSIVE METABOLIC PANEL WITH GFR,T BILIRUBIN,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,NASH FIBROSURE,HEIGHT,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.25,0.16666666666666666,0.94,0.0,0.0,0.0,0.05026217761451124,0.056942591518096664,0.0,1,93179,MORPHOLOGICAL REVIEW,PLATELET ESTIMATE,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Blasts [#/volume] in Blood,Blasts # Bld,Blasts
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,CBC INCLUDES DIFF PLT,ABSOLUTE NEUTROPHILS,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,COMPREHENSIVE METABOLIC PNL W O CO2 ALT,POTASSIUM,Laboratory comment [Text] in Report Narrative,Laboratory comment Report,Laboratory comment
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA PATTERN,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc,IgA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,CBC ESR,ABSOLUTE NEUTROPHILS,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CMP13 LP TP TSH 2AC CBC D P,AST SGOT,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,CBC ESR,ABSOLUTE NEUTROPHILS,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,CMP14 LP 5AC,VLDL CHOLESTEROL CAL,Necroinflammatory activity score,Necroinflammatory act score SerPl,Necroinflammatory activity score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,LIPID PANEL W REFL DLDL,NON HDL CHOLESTEROL,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,LYMPHOCYTE SUBSET PANEL 1,CD4 ABSOLUTE,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,CBC W DIFF PLATELET,EOSINOPHILS,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,CMP,EGFR NON AFRICAN AMERICAN,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.16666666666666666,0.29666666666666663,0.445,0.4666666666666666,0.2222222222222222,0.3333333333333333,0.038211926035394805,0.13917887610023483,0.290796108751339,0.046799860437844454,0.08522930735490397,0.17807552140691663,1,139543,HEPATITIS BE AG,HB E AG,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,PROTEIN ELECTROPHORESIS SERUM,ALPHA 2,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,PROTHROMBIN TIME PT,PT CONTROL,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.3333333333333333,0.2857142857142857,1.0,0.3333333333333333,0.2857142857142857,1.0,0.040881275582819065,0.439493011634871,0.8660254037844386,0.040881275582819065,0.439493011634871,0.8660254037844386,1,21576,CREATINE KINASE CK,CREATINE KINASE CK,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,URINALYSIS REFLEX,NITRITE,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.09499999999999999,0.285,0.0,0.055,0.165,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,DRUG ABUSE PANEL 10 WITH OXYCODONE,COCAINE METABOLITE,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.06666666666666667,0.10777777777777778,0.16166666666666665,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,URINALYSIS COMPLETE W REFLEX CULTURE,PROTEIN,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.017069280070973192,0.0,0.0,0.0,0.0,0,7732,COMPLETE BLOOD COUNT,BASOPHILS %,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,Erythrocytes.nucleated/100 erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,COMP METABOLIC PANEL W GFR,ANION GAP,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,CBC W AUTO DIFF,MONOCYTES %,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,CBC W AUTO DIFF,% LYMPHOCYTES,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,HEPATITIS BE ANTIGEN,HEPATITIS BE ANTIGEN,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,CMP12 2AC,BILIRUBIN TOTAL,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.17857142857142858,0.01,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,PROTEIN TOTAL 24HR URINE W CREAT,UR CREAT RANDOM MG DL,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.16666666666666666,0.15,0.75,0.16666666666666666,0.15,0.75,0.020983850759697886,0.0,0.0,0.0191555473406807,0.0,0.0,0,347047,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A RESIST ASSAY INTERP,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,CBC WITH PLT DIFF,WBC MORPHOLOGY,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,GLYCOHEMOGLOBIN A1C,GLYCOHEMOGLOBIN A1C,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc,Ferritin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Erythrocyte distribution width [Entitic volume],RDW RBC,Erythrocyte distribution width
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.155,0.10333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,Prothrombin time (PT),Prothrombin time,Coagulation tissue factor induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Appearance of Urine,Appearance Ur,Appearance
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,URINALYSIS REFLEX,GLUCOSE QL,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,URINALYSIS W REFLEX MICRO,NITRITE,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,RENAL FUNCTION PANEL,BUN,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.4333333333333333,0.48250000000000004,0.93,0.5766666666666667,0.48250000000000004,0.93,0.0,0.21473154461722554,0.18596297263238892,0.017380646215893303,0.10927182779409028,0.18926435757528148,1,28886,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Protein [Mass/volume] in Urine,Prot Ur-mCnc,Protein
0.0,0.072,0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,COMP METABOLIC PANEL,GLOBULIN,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,COMP METAB PANEL,GLUCOSE FASTING,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,CARETC CMP LIPID URIC ACID DIR BILI PROFILE,RISK RATIO LDL HDL,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,CMP14 LP 5AC CBC D PLT RPR,CHOLESTEROL TOTAL,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,GLUCOSE,GLUCOSE,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted
0.25,0.16666666666666666,0.0,0.25,0.16666666666666666,1.0,0.05393370274893572,0.0,0.0,0.06605502583691747,0.05720402135206337,0.7071067811865476,1,7047,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,Basophils
0.11499999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,SPECIAL PROFILE # 5144,TSH ULTRASENSITIVE,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.16,0.0,0.1875,0.2,1.0,0.0,0.05043482321394899,0.0,0.0,0.12353958214165095,1.0,1,143164,DRUG ABUSE SCREEN W ETOH NO GCMS,BENZODIAZEPINES,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,Neutrophils.band form
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,PROTEIN ELEC INTERP SERUM,M SPIKE,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.34,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,URINALYSIS CULTURE IF INDICATED,BACTERIA,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,FASTING,FASTING STATUS,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.3333333333333333,0.42857142857142855,1.0,0.3333333333333333,0.42857142857142855,1.0,0.050078247894864814,0.0,0.0,0.050078247894864814,0.0,0.0,1,28571,PSA WITH FREE RATIO,PSA ROCHE E170,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Prostate specific Ag
0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,CBC INCLUDES DIFF PLT W SMEAR RVW,PLATELET COUNT,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.11166666666666668,0.0,0.0,0.2783333333333333,0.5,0.3333333333333333,0.0,0.0,0.0,0.03275101358391164,1.0,0.1986458339579933,1,487959,FIBROACT,FIBROSIS SCORE,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.25,0.0,0.0,0.25,0.0,0.0,0.045533636989106174,0.0,0.0,0.045533636989106174,0.0,0,181826,AFP SERUM TUMOR MARKER,AFP SERUM TUMOR MARKER,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Osmolality
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.03571428571428571,0.125,0.0,0.0,0.0,0.0,0.044495573563027246,0.0,0.0,0.0,0.0,0,110114,CBC WITH PLT DIFF,PROMYELOCYTES,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,GGTP,GGTP,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,CBCI COMPLETE BLOOD COUNT W DIFF,ABS MONOCYTES,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,BASIC METABOLIC PANEL,AFRICAN AMERICAN,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,RBC,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Amylase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,CBC WITH PLT DIFF,BASOPHILS ABSOLUTE,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.025,0.125,0.0,0.0365,0.1825,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,CBC INCLUDES DIFF PLT W SMEAR RVW,WHITE BLOOD CELL COUNT,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,CBC WITH DIFFERENTIAL PLATELETS,EOS,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Alkaline phosphatase
0.0,0.13599999999999998,0.285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,DRUG ABUSE SCREEN I NO GCMS,METHADONE,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF,Actin.smooth muscle Ab
0.0,0.2,0.0,0.24333333333333332,0.2,0.0,0.0,0.17001758398860156,0.0,0.0,0.0,0.0,0,20750,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,CBCI COMPLETE BLOOD COUNT W DIFF,BASOPHILS,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Testosterone.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.007000000000000001,0.035,0.0,0.011,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,CBC W DIFF PLT,MONOCYTES %,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,GGTP,GGTP,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,URINALYSIS COMPLETE,GLUCOSE,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,BASIC METABOLIC PANEL,AFRICAN AMERICAN,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp,Alpha 1 antitrypsin phenotyping
0.0,0.1475,0.0,0.0,0.1475,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,TESTOSTERONE,TESTOSTERONE,Pathologist review of Blood tests,Path Rev Bld -Imp,Pathologist review
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,HCV FIBROSURE,LIMITATIONS,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur,Albumin/Creatinine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,MA CBC DIFF PLT,MONOCYTES %,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,CRP,C REACTIVE PROTEIN ULTRA,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,Barbiturates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql,Sample hemolyzed
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,TRANSFERRIN SATURATION,TRANSFERRIN,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.01,0.0375,0.0,0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.0626785440493669,0.0,0,381806,CMP12 7AC MG,PHOSPHORUS SERUM,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,CBC INCLUDES DIFF PLT,RDW,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual,Eosinophils
0.0,0.07142857142857142,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,IRON BINDING CAPACITY % SATURATION,CALCULATED % IRON SAT,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,Hepatitis A virus Ab
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0834655896020069,0.34003516797720323,1.0,1,29512,COMPREHENSIVE METABOLIC PANEL AMA,SODIUM,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Sodium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Iron
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,OXYCODONE,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,AFP TUMOR MARKER,AFP TUMOR MARKER,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,CMP14 HP5 LP 6AC CBC D PLT,HDL CHOLESTEROL,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,ASH FIBROSURE,COMMENT,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,CMP WITH ESTIMATED GFR CALCULATED,CHEMISTRY SODIUM,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,VITAMIN B12 FOLATE,VITAMIN B12,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,FERRITIN,FERRITIN SERUM,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,URINALYSIS W REFLEX MICRO,NITRITE,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,Hemoglobin
0.0,0.0,0.0,0.1875,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.08799275345909874,0.0,0,161281,FERRITIN,FERRITIN SERUM,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,GLUCOSE,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Gamma globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,IFE PE SERUM,BETA GLOBULIN,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Cholesterol
0.0,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,COMP METABOLIC PANEL W EGFR,PROTEIN TOTAL,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Gamma glutamyl transferase
0.045000000000000005,0.0,0.0,0.045000000000000005,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,MITOCHONDRIAL M2 ANTIBODY,MITOCHONDRIAL M2 ANTIBODY,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA,Hepatitis B virus little e Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,CHEM SCREEN PANEL HDL,URIC ACID,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,HCV QUANT GT1A NS5A PROFILE,HCV NS5A DRUG RESISTANCE ASSAY,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Anion gap 3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESIST ASSAY INTERP,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.10964330813284906,0.0,0,7187,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,Cells.CD3+CD4+/Cells.CD3+CD8+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn,Methaqualone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,URINALYSIS SCREEN,BACTERIA,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,HEPATIC FUNCTION PNL,GLOBULIN,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld,Erythrocytes.nucleated
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,DIRECT LDL,TRIGLYCERIDES,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Globulin
0.0,0.020714285714285713,0.0725,0.0,0.024999999999999998,0.0875,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,LIPID CASCADE,LDL CHOLESTEROL CALC,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,FREE T4 THYROXINE,FREE T4 THYROXINE,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,CBC COMPLETE BLOOD COUNT W O DIFF,HEMATOCRIT,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.16,0.0,0.25,0.2,1.0,0.0,0.061769791070825475,0.0,0.07962607175736813,0.12353958214165095,1.0,1,195503,DRUG ABUSE SCREEN III,METHADONE,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,HCV RNA NAA QUALITATIVE,HCV RNA NAA QUALITATIVE,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.08952338621207645,0.0,0,265157,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,HB S AG W REFLEX CONF,HFLAG,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,HCV AB WITH RFL RNA QT,HCV SIGNAL CUTOFF,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Iron binding capacity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,HEPATITIS B SURFACE ANTIGEN W REFL CONFIRM,CONFIRMATION,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,URINALYSIS REFLEX,GLUCOSE QL,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp,Ledipasvir
0.0,0.025,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,CBC WITH MANUAL DIFFERENTIAL,WBC,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,SED RATE WESTERGREN,SED RATE WESTERGREN,Body weight Measured,Weight Measured,Body weight
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,HEMOGLOBIN A1C,HEMOGLOBIN A1C,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld,Coagulation surface induced
0.0,0.015714285714285715,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,IRON BINDING CAPACITY,IRON TOTAL,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.14285714285714285,0.25,0.0,0.0,0.0,0.0,0.03754678212513474,0.0378684612442336,0,142513,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 Ab.IgG
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,Leukocyte morphology finding
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,HEPATIC FUNCTION PANEL,ALT,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc,Cyclic citrullinated peptide Ab.IgG
0.06,0.045,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,COMPREHENSIVE METABOLIC PANEL E GFR,AST,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.2866666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,CBC WITH PLT DIFF,NRBC,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,DRUG ABUSE SCREEN III,METHAQUALONE,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chloride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,HEP A AB IGM,HEPATITIS A AB IGM,Cells Counted Total [#] in Blood,Total Cells Counted Bld,Cells counted.total
0.0,0.0,0.0,0.3333333333333333,0.14285714285714285,0.5,0.0,0.0,0.0,0.0872369085792638,0.0,0.0,1,17426,COMP METABOLIC PANEL CLARIFICATION,ALT,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Alanine aminotransferase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,CBC H H RBC INDICES WBC PLT,MPV,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,Nitrite
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,LIVER FIBROSIS FIBROTEST ACTITEST P,NECROINFLAMMATION ACT GRADE,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,Myelocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,HB S AB QL,HB S AB QL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,CBC W O DIFF WITH PLATELETS,MCV,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp,Daclatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,AFP TUMOR MARKER,AFP TUMOR MARKER,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,Urobilinogen
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,DRUG ABUSE SCREEN W ETOH NO GCMS,COCAINE METABOLITE,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Alpha 1 antitrypsin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,COMP METABOLIC PANEL W GFR,ANION GAP,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql,Sample lipemic
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,LIVER FIBROSIS FIBROTEST ACTITEST P,NECROINFLAMMATION ACT GRADE,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,CK TOTAL,CREATINE KINASE TOTAL,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,CBC WITH PLT DIFF,BLASTS,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,Opiates
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Transferrin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,MAGNESIUM,ICTERUS,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,TESTOSTERONE FR DIALYSIS TOTAL LC MS MS,FREE TESTOSTERONE,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,203927,UREA NITROGEN BUN,ICTERUS,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql,Sample icteric
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,CMP14 LP CBC D PLT,NEUTROPHILS,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc,oxyCODONE cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,CMP14 HP4 DBILI CBC D PLT R,AMYLASE,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.0,0.0,0.0,0.0,0.0,0.1325,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur,Microalbumin/Creatinine ratio panel
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,IRON TIBC,TIBC,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Thyroxine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,ALPHA FETOPROTEIN TUMOR MARKER,AFP TUMOR MARKER,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,COMP METABOLIC PANEL,ANION GAP,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,Phencyclidine
0.16666666666666666,0.075,0.0,0.0,0.075,0.0,0.04082244634602894,0.06759723732583833,0.09418963513805056,0.0,0.0,0.0,0,241133,IMMUNOGLOBULIN M IGM,IMMUNOGLOBULIN M,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,IGA SERUM,IMMUNOGLOBULIN A,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,BASIC METABOLIC PANEL,BUN,Fibrosis score,Liver fibr score SerPl Calc.FibroSure,Liver fibrosis score
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,CBC ESR,ABSOLUTE NEUTROPHILS,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.09571428571428572,0.0,0.0,0.09571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,VITAMIN D 25 OH,VITAMIN D 25 OH,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc,Alanine aminotransferase
0.0,0.1416666666666667,0.42500000000000004,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.08333333333333333,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,CBC,MCH,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,Hepatitis C virus Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESIST ASSAY INTERP,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Protein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,LIVER FIBROSIS PNL HEPASCORE TM,GGT,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.02,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,IRON TOTAL BINDING CAPACITY,IRON TOTAL,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Platelets [#/volume] in Blood,Platelet # Bld,Platelets
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,CMP14 HP4 DBILI CBC D PLT R,WBC,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,CMP14 LP CBC D PLT TSH HB A,ALT SGPT,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,RPR SCREEN W TITER,RPR SCREEN,pH of Urine by Test strip,pH Ur Strip,pH
0.0,0.0,0.0,0.2,0.17333333333333334,0.26,0.0,0.0,0.0,0.0360154199639221,0.07165999577194615,0.10031748330730439,1,495416,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,HB S AG W REFLEX CONF,HFLAG,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc,IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,CBC PLT DIFF,ABSOLUTE EOS,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.007000000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,LIVER FIBROSIS FIBROTEST,ALPHA 2 MACROGLOBULIN,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.1875,0.2,0.0,0.0,0.0,0.0,0.0,0.07800794199198469,0.0,0.0,0.0,0.0,0,473835,IFE PE SERUM,ALPHA 1 GLOBULIN,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual,Lymphocytes.variant
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,BASIC METABOLIC PANEL,OSMOLALITY,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,LYMPHOCYTE SUBSET PANEL 3,% CD3 CD4 HELPER T4,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.0,0.0,0.5766666666666667,0.14285714285714285,0.0,0.0,0.0,0.0,0.04313018718088768,0.037676737156380646,0.0,1,98301,LIPID PANEL AMA,CHOL HDLC RATIO,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,LYMPHOCYTE SUBSET PANEL 3,% CD3 CD4 HELPER T4,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Urate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.03571428571428571,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,IRON TOTAL BINDING CAPACITY,LIPEMIA,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,CBC WITH PLT DIFF,MPV,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Cholesterol.in LDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,COMP METABOLIC PANEL,ANION GAP,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,Platelet morphology finding
0.1675,0.10600000000000001,0.0,0.21000000000000002,0.2,0.5,0.0,0.0,0.0,0.0,0.38075107277079945,1.0,1,58115,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,Specific gravity
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,NASH FIBROSURE,WEIGHT,Fasting status - Reported,Fasting status Patient Ql Reported,Fasting status
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,18697,FERRITIN,FERRITIN SERUM,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Ceruloplasmin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Color of Urine,Color Ur,Color
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,COMP METABOLIC PANEL,ANION GAP,MCV [Entitic volume] by Automated count,MCV RBC Auto,Erythrocyte mean corpuscular volume
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,CMP14 5AC CBC D PLT TSH T4F,CALCIUM SERUM,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,Amphetamine
0.0,0.15666666666666665,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,CBC W O DIFF WITH PLATELETS,MCV,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP,Coagulation surface induced
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Calcidiol
0.0,0.0,0.0,0.0,0.02,0.03333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,URINALYSIS,BILIRUBIN,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA,Hepatitis B virus core Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CBC WITH PLT DIFF,NO CELLS DIFF,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql,Necroinflammatory activity grade
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,CBC WITH DIFFERENTIAL,NEUTROPHILS,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,Eosinophils
0.15,0.14285714285714285,0.0,0.15,0.14285714285714285,0.0,0.0,0.02002479424415282,0.0,0.0,0.02002479424415282,0.0,0,51953,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.04609462130653097,0.0,0,7369,CBC DIFF PLT,PLATELET COUNT,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,HIV 1 RNA QN RT PCR,RACE NR,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.115,0.25,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,1,264507,CBC WITH DIFFERENTIAL PLATELETS,EOS,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,HEMATOPATH CONSULTATION SMEAR,WBC,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql,Hepatitis B virus core Ab
0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,CBC W DIFF PLT,MONOCYTES %,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP,Coagulation tissue factor induced
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.02146570986203966,0.0,0.0,0.0,0.0,0,304519,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.39666666666666667,0.1111111111111111,0.2,0.16666666666666666,0.3333333333333333,0.6,0.029399247153846342,0.04801838305228456,0.06720098415971731,0.033947326516491017,0.11089370552514821,0.15519402517768222,1,51961,HB S AG W RFX CONF,HEPATITIS B SURFACE ANTIGEN,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA,Hepatitis B virus surface Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,ANA CRP ASO PE,P E INTERPRETATION S,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,FASTING,FASTING STATUS,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Creatine kinase
0.25,0.5,0.6666666666666666,0.25,0.5,0.3333333333333333,0.009742953581810432,0.3950952737044747,0.4582002501529394,0.009960706634886463,0.40392557361123926,0.46844093359181893,1,45484,HEMOGLOBIN A1C WITH MPG,HEMOGLOBIN A1C,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA,HIV 1+2 Ab
0.041428571428571426,0.03636363636363637,0.05714285714285715,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,CBC WITH PLT DIFF,MYELOCYTES,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,Bacteria
0.0,0.06625,0.0,0.0,0.06625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,CERULOPLASMIN,CERULOPLASMIN,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Prostate specific Ag.free
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,LIVER FIBROSIS FIBROTEST ACTITEST P,APOLIPOPROTEIN A1,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Bilirubin.non-glucuronidated
0.0,0.0,0.0,0.0,0.0365,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV,Glomerular filtration rate/1.73 sq M.predicted.non black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,CMP14 LP 2AC CBC D PLT MG T,WBC,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Thyroxine
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,CMP14,EGFR IF AFRICN AM,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,HIV 1+2 Ab+HIV1 p24 Ag
0.0,0.0,0.0,0.1,0.03142857142857143,0.07333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,CBCI COMPLETE BLOOD COUNT W DIFF,ABS MONOCYTES,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,COMP METABOLIC PANEL 13,EGFR IF NONAFRICN AM,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,Bilirubin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,VITAMIN B12 FOLATE,FOLATE SERUM,Specimen source identified,Specimen source XXX,Specimen source
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,SPECIAL CUM 50 PLUS PROFILE # 10190,SEDIMENTATION RATE,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,Ketones
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,Cells.CD3+CD4+
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,LYMPHOCYTE SUBSET PANEL 4,HELPER SUPPRESSOR RATIO,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld,Megakaryocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,CEA,CEA CENTAUR,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,BUN CREATININE,BUN,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,Eosinophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Bilirubin
0.0,0.0,0.0,0.044,0.03142857142857143,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Apolipoprotein A-I
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.03302675712634284,0.0,0.0,0.0,0.0,0,7518,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,LIVER FIBROSIS PANEL,ALT,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,Cells.CD3
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl,Cholesterol.total/Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,URINALYSIS REFLEX,GLUCOSE QL,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,PROTEIN TOTAL URINE,URINE TOTAL PROTEIN,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,Neutrophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,PSA WITH FREE RATIO,PSA ROCHE E170,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,Hemoglobin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,TRICHOMONAS MALE,SOURCE,Leukocytes [#/volume] in Blood,WBC # Bld,Leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,MITOCHONDRIAL M2 ANTIBODY,MITOCHONDRIAL M2 ANTIBODY,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,Benzodiazepines
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,CBC W DIFF PLT,MONOCYTES %,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Calciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,TESTOSTERONE,TESTOSTERONE,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,Glucose^post CFst
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA,Hepatitis B virus core Ab.IgG+IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld,Neutrophils.segmented/100 leukocytes
0.0,0.0,0.0,0.15,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,FIBROACT,FIBROSIS SCORE,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,Hepatitis C virus Ab Signal/Cutoff
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,CMP14 HP5 LP 6AC CBC D PLT,HDL CHOLESTEROL,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Anion gap
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,CMP,ALT SGPT,Basophils [#/volume] in Blood,Basophils # Bld,Basophils
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,SED RATE WESTERGREN,SED RATE WESTERGREN,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,Neutrophils.band form/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,CBC W O DIFF WITH PLATELETS,MCH,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODY IGG,CCP ANTIBODY IGG,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Albumin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,CBC WITH PLT DIFF,RBC MORPHOLOGY,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Bilirubin.glucuronidated+Bilirubin.albumin bound
0.0,0.06666666666666667,0.0,0.0,0.06666666666666667,0.0,0.0,0.03210415570861036,0.0,0.0,0.037070685880943643,0.0,0,426171,IFE PE FLC SERUM,IMMUNOGLOBULIN G QN SERUM,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU,Hepatitis C virus RNA
0.0825,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,URINALYSIS,BILIRUBIN,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,Glucose
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,URINALYSIS,BILIRUBIN,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted.black
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,FERRITIN,FERRITIN,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Alpha-1-Fetoprotein
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,PHOSPHATE AS PHOSPHORUS,LIPEMIA,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,CBC W DIFF PLT,ABSOLUTE NEUTROPHILS,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,Lymphocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,CMP WITH EGFR,CARBON DIOXIDE,INR in Platelet poor plasma by Coagulation assay,INR PPP,Coagulation tissue factor induced.INR
0.0,0.3333333333333333,0.0,0.0,0.3333333333333333,0.0,0.0,0.028572583211454283,0.0,0.0,0.020902601012917743,0.0,1,7898,CBC COMPLETE BLOOD COUNT W O DIFF,RED BLOOD CELL COUNT,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,Erythrocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,SPECIAL NEW ANNUAL COMM INSURANCE #6925,ABSOLUTE EOS,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.19,0.44333333333333336,0.0,0.19,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,HCV GENOTYPE REFLEX NSA,HCV GENOSURE R NSA INTERP,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,Cells.CD3+CD4+/100 cells
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD4 CELLS,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp,Velpatasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,STOOL CULTURE,RESULT 2,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA,Treponema pallidum Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,CMP14 LP CBC D PLT,NEUTROPHILS,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,Complement C4
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,CBC WITH DIFF PLATELET,EOS ABSOLUTE,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp,Ombitasvir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,HEPATITIS BE AG,HB E AG,Neutrophils [#/volume] in Blood,Neutrophils # Bld,Neutrophils
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,728592,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,Lymphocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,PSA FREE TOTAL,FREE PSA,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA,Hepatitis B virus core Ab
0.0,0.0,0.0,0.0,0.05833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc,Reagin Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,CBC NO DIFF,RBC,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Magnesium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,CBC,HEMOGLOBIN,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,Erythrocyte morphology finding
0.0,0.10600000000000001,0.0,0.0,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,CERULOPLASMIN,CERULOPLASMIN,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Potassium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,UA W MICRO HOLD SPEC 24 HR,GLUCOSE,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Cholecalciferol
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,Monocytes/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,VITAMIN B12 FOLATE,FOLATE SERUM,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,Blasts/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,CBC PLATELET HEM REVIEW,PLATELETS,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,Leukocyte esterase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,PTH INTACT MOLECULE,PTH,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,Methadone
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Monocytes [#/volume] in Blood,Monocytes # Bld,Monocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,ANA REFLEX AUTOIMMUNE AB PROFILE,ANTI NUCLEAR ANTIBODIES,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Thyrotropin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,DRUG ABUSE SCREEN W ETOH NO GCMS,COCAINE METABOLITE,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Triglyceride
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,MA COMP METABOLIC PNL,ALKALINE PHOSPHATASE,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl,Albumin/Globulin
0.3333333333333333,0.2857142857142857,1.0,0.3333333333333333,0.2757142857142857,0.965,0.3120512265900537,0.015450719614443886,0.04372412516808821,0.3120512265900537,0.015450719614443886,0.04372412516808821,0,110114,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,CBC WITH AUTO DIFF,BASOPHILS #,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Globulin
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Specimen source identified,Specimen source XXX,Specimen source
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,HEPATITIS PANEL ACUTE,HEPATITIS B SURF AG,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Phosphate
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,VITAMIN D 25 OH,25 OH VITAMIN D,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld,Neutrophils.segmented
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,CMP13 LP 2AC CBC D PLT,NEUTROPHILS ABSOLUTE,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Alpha-1-Fetoprotein.tumor marker
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0550626991291443,0.10422855050890889,0.7071067811865476,0,382507,CMP14 5AC CBC D PLT TSH T4F,CALCIUM SERUM,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc,Calcium
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,CBC W AUTO DIFF,MCV,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp,Boceprevir
0.3,0.0,0.0,0.32,0.16666666666666666,0.3333333333333333,0.023974096238033038,0.0,0.0,0.03790637447812928,0.04801993258748538,0.06510620292715197,1,130682,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,Nuclear Ab pattern
0.0,0.18555555555555556,0.33399999999999996,0.0,0.0,0.0,0.0,0.06908938005713361,0.07184578234577044,0.0,0.0,0.0,0,139501,HEPATITIS BE AG,HBEAG INS NR,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA,Hepatitis A virus Ab.IgM
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,CHOL HDL RATIO,CHOL HDL RATIO,Date of analysis of unspecified specimen,Date Of Analysis XXX,Date of analysis
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,FIBROACT COMPLETE,WEIGHT LBS,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Cholesterol.in HDL
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,NASH FIBROSURE,HAPTOGLOBIN,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Carcinoembryonic Ag
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,Nuclear Ab
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,Benzoylecgonine
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.21668861764565872,0.0,0,30510,VITAMIN B12 FOLATE,FOLATE SERUM,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Triiodothyronine.free
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,CMP14 LP CBC D PLT,NEUTROPHILS,Eosinophils [#/volume] in Blood,Eosinophil # Bld,Eosinophils
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.5,0.0,0.0,0.0,0.08432989233649546,0.08432989233649546,0.1503314858492919,1,31377,NASH FIBROSURE,HEIGHT,Body height Measured,Body height Measured,Body height
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,LYMPHOCYTE SUBSET PANEL 1,CD4 ABSOLUTE,Sex,Sex,Sex
0.2,0.16666666666666666,0.0,0.2,0.16666666666666666,0.3333333333333333,0.03863209902397613,0.0,0.0,0.06691275831255872,0.06348916544989514,0.09169555407390673,1,59055,CBC W AUTO DIFF,MONOCYTES %,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,Monocytes/100 leukocytes
0.0,0.0,0.0,0.26666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,25320,LIVER PANEL II,LD,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Lactate dehydrogenase
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU,Hepatitis C virus RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#,HIV 1 RNA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA PATTERN,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc,Mitochondria M2 Ab
0.2,0.16666666666666666,0.0,0.0,0.0,0.0,0.0334563791562793,0.0,0.0,0.0,0.0,0.0,0,7062,CBC WITH AUTO DIFF,RDW,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,Basophils/100 leukocytes
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,COMP METABOLIC PANEL,GLOBULIN,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto,Granulocytes.immature/100 leukocytes
